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ABSTRACT
Estimates of total prevalent human immunodeficiency virus (HIV) infections make an
important contribution to public health planning. HIV test data has become increasingly
important to the monitoring of the HIV epidemic, however a large proportion of HIV
infections remain undiagnosed in the early stages of infection. This thesis aims to
develop a method to estimate total HIV infections in men who have sex with men
(MSM) in the United Kingdom (UK) using surveillance data on HIV testing.
A conceptual framework for the relationship between HIV testing and risk of HIV
infection was developed. A review of literature showed that HIV testing was associated
with socio-demographic factors like increasing age and area of residence. HIV testing
was also associated with higher-risk behaviours such as unprotected anal intercourse
and increased numbers of sexual partners. This thesis identified and quantified factors
associated with both HIV testing and risk of HIV infection in MSM in the UK through two
studies. The first was an analysis of a national representative study and the second a
cross-sectional unlinked anonymous HIV seroprevalence study of MSM attending a
genitourinary medicine clinic (GUM) in inner London. An investigation of the National
Survey of Sexual Attitudes and Lifestyles found that 36.6% of MSM had HIV tested in
the past 5 years. HIV testing was associated with area of residence and increased
numbers of sexual partners. The unlinked anonymous study found that MSM who had
HIV tested were at higher risk of HIV infection compared to MSM who had not and that
history of sexually transmitted infections was associated with HIV infection. A
comparative analysis with a community-recruited study of MSM provided upper and
lower behavioural bounds.
Finally, a model based on the conceptual framework which extrapolated all diagnosed
HIV infections in MSM to give reliable estimates of total HIV infections in the general
MSM population, including undiagnosed HIV infections, was developed. This thesis has
provided a unique methodology to estimate total HIV infections in MSM in the UK.
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Summary
This chapter provides some background information, which leads on to the aim and
objectives of the thesis. A statement of authorship is given in this chapter.
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INTRODUCTION AND BACKGROUND
1.1 Introduction
With many infections, the period between infection and disease is short and so disease
incidence can be related directly to infection incidence if the ratio of disease to infection
is known. When considering infections with a long incubation period (e.g. human
immunodeficiency virus (HIV), hepatitis C virus), the situation is more complex and the
difficulty in estimating prevalent infections is increased. If all the population at risk were
tested frequently throughout their period of risk, and positive results were reported
completely, then the annual number of new positives would equal annual incidence. If
no one was tested, infection incidence could only be estimated indirectly through
combining surveillance data on the outcome of infection (however that outcome is
measured) with knowledge of the natural history of the infection.
In order to evaluate current transmission of HIV, a measure of current HIV incidence is
needed. Previously this had been accomplished using a back-calculation method that
used acquired immune deficiency syndrome (AIDS) incidence data, which represents
HIV infections that occurred on average 10 years before, along with other data, by
calculating back to previous transmission. These patterns were then projected, to
estimate future numbers of HIV infected persons 1. AIDS case reporting is very
complete and is a good marker for past HIV incidence up to 1996. However, with the
advent of highly active anti-retroviral therapies (ART), there have been substantial
decreases in AIDS incidence and AIDS-related mortality in the United Kingdom (UK)2,
and in the rest of the developed world3.4. Consequently monitoring the HIV epidemic
through AIDS incidence is no longer feasible and, thus, a novel approach to the
monitoring of current HIV transmission is needed. HIV test data have thus become
increasingly important to the monitoring of the HIV epidemic. Unlinked anonymous
(UA) seroprevalence studies have shown that a large proportion of HIV infections
remain undiagnosed in the early stages of infections. Estimates of the total number of
prevalent HIV infections attributable to the major routes of infection make an important
contribution to public health policy. Numbers of persons with severe HIV infection and
the proportion of total prevalent infections which are undiagnosed can be used for the
planning of health-care services. They can also be used to calculate recent HIV
incidence. In addition estimates of the future numbers with severe HIV infection can be
used for planning health promotion programmes".
Estimates of current transmission of HIV might be improved by exploring the existing
surveillance data on HIV testing, utilising survey information on HIV testing pattems
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(such as ever tested and frequency, or never) and monitoring this within each major
exposure category. Combining all the available data on HIV testing and HIV diagnosis
with behavioural data from other sources about high-risk persons would answer the
following questions: who tests for HIV infection, who doesn't test for HIV, are the
characteristics of people undergoing HIV tests (or not) changing over time, are the risks
of HIV in those who are not tested different from those who are, and, from all this, what
can be deduced about undiagnosed infections?
HIV surveillance is comprehensive in the UK. Data are captured at different stages of
HIV infection; laboratory and clinical reports of HIV diagnosis, clinical reports of AIDS
and death reports from the Office of National Statistics (ONS) and clinicians. Additional
surveys collect data throughout the natural history of the infection through an annual
survey of individuals receiving HIV care and CD4 laboratory surveillance. This thesis is
focussed on men who have sex with men (MSM). The thesis will attempt to make use
of the usual surveillance data, as well as other sources of surveillance data that focus
on MSM as outlined in Figure 1.1. Such additional sources of data include UA
surveillance programmes at genitourinary medicine (GUM) clinics, behavioural surveys
of MSM recruited through community venues, and surveillance of HIV tests, both
positive and negative7. HIV surveillance systems capture information on HIV testing,
and from HIV infection onwards. Behavioural studies can capture information on MSM
at different points both before and after infection. Most data are available at the time
point at which risk behaviour may lead to subsequently undergoing an HIV test.
Alternatively, knowing a HIV result may influence subsequent risk behaviour. The UA
GUM study can capture MSM at the point of HIV test, which is often subsequent to risk
behaviour, and at HIV diagnosis. These issues are illustrated below in Figure 1.2. Most
surveillance data are cross-sectional and thus do not allow disentangling the direction
of association between risk behaviour and HIV testing.
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Figure 1.1 Available surveillance systems in the UK and the stages, both pre and
post-HIV infection in MSMat which they collect information
Risk Behaviour
,,
,,,
, '
This thesis will develop a method to estimate total HIV infections in MSM in the UK
using surveillance data and the other available data sources that are outlined above. In
order to understand the thesis scope, a brief background will be given below on current
estimation methods of HIV prevalence in MSM, followed by a description of the thesis
scope, aims and objectives. This will be followed by an outline of the structure of the
thesis with detailed chapter descriptions.
1.2 Background: Estimating total prevalent HIV infections, previous
methods
It is difficult to assess the extent of undiagnosed HIV infection in the population
because the motivation behind testing is complex. Individuals may be influenced by a
range of behavioural and policy factors". The UA methodology approach, based on
specimens routinely gathered for other reasons, is particularly useful in contributing to
the surveillance of HIV infection in subgroups of the population regardless of their HIV
testing behaviour. UA testing allows the measurement of HIV prevalence in populations
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with both clinically diagnosed and undiagnosed HIV infection9.10. While some
mathematical models have been developed in the UK and in Europe and the US11-H,
some simpler methods using surveillance data have been used to estimate
undiagnosed HIV infection. The latter require less technical inputs and are relatively
cheap and effective methods of producing estimates. These are illustrated below.
1.2.1 UNAIDS methodology
The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health
Organization (WHO) developed a set of methods, part of which includes the estimation
and projections workbook, with support from the UNAIDS Reference Group on
Estimates. This was to enable individual countries to produce their own estimates of
HIV incidence and mortality18.19.UNAIDS recommends its use in countries with low-
level and concentrated epidemics. The HIV prevalence rate in a subgroup is multiplied
by the proportion of the national population in that subgroup. This method is illustrated
simply in Figure 1.2. Rather than complete a general population survey in countries
where HIV is concentrated in some high-risk groups, the population is stratified into risk
groups and then the HIV prevalence rate for each risk group is estimated (e.g. injecting
drug users (IDUs» using specialised surveys. Various approaches, including capture-
recapture methods, have been proposed to measure the size of a high-risk sub-
population.
Figure 1.2 UNAIDS Workbook method to estimate HIV infections in low-level and
concentrated epidemics
HIV prevalence measured in a study
of sub-group of population at risk
(e.g. MSM, IOU), tt
Estimated national size of
the population in that sub-
group, N
These methods were produced through an expert advisory group and tested by a user
group of surveillance experts in Europe. The Estimations and Projections Package
(EPP) provides projection curves based on assumptions and inputs that are country-
specific. These assumptions are: (1) female-to-male prevalence ratio; (2) effects of HIV
on fertility; (3) transmission of HIV from mother to child; (4) survival time from infection
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to death for adults and children; (5) age patterns of prevalence; and (6) effects and
coverage levels for anti-retroviral therapy (ART)20.
1.2.2 Indirect estimates
A range of 'indirect' methods have been used to estimate total HIV infections as well.
For example, the ratio of early to late diagnosed AIDS cases in each risk group has
been used to total up the number of non-AIDS diagnosed infections to provide an
estimate of all prevalent HIV21.The ratio of diagnosed to undiagnosed HIV cases has
been used in a similar wal1. Finally, an estimate of total HIV infections has been
represented through indirect estimation by Hughes et al21 as a combination of total
diagnosed HIV infections and the proportion of HIV tests that have been taken within
the sub-population. If total diagnosed HIV infections equals the total prevalent HIV
infections multiplied by the proportion HIV tested, then the total prevalent HIV infections
equals the total MSM with diagnosed HIV infection divided by the proportion of MSM
who have HIV tested (see Figure 1.3). Archibald et al used a similar method but to
estimate the populations, rather than the infections22.
Figure 1.3 The indirect method of estimating total HIV infections
Proportion of population in each
sub-group that have HIV tested p
Total numbers of HIV
infections diagnosed by
sub-groups (e.g. MSM, IOU,
heterosexuals) Y Estimated total HIV
infections by sub-
group,Z
This simplified method requires very little inputs, other than the numbers of HIV
infections diagnosed and the numbers HIV tested stratified by age and area-specific
categories. This method assumes that the proportion that has not HIV tested have the
same probability of being HIV infected as the proportion that have tested. With
universal annual testing this would hold true and in fact the results of HIV testing would
equal annual HIV incidence. In reality it does not hold (at least in the UK) because
people who choose to not test may be different and have a different risk of HIV
infection when compared to those who test.
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1.2.3 Direct estimates
Estimates of prevalent HIV infections have been previously calculated using a "direct
method" in the UK. Population estimates derived from the Natsal were combined with
prevalence data from the UA HIV Prevalence Monitoring Programme (UAPMP) to
produce estimates of the numbers of adults infected and alive in the population,
through a series of assumptions based on available data. The method was first
developed in 199423, and further developed in 199724, to use a combination of data
from different sources and estimate prevalent undiagnosed infections. Further
developments in 2006 by McGarrigle et al25 focussed on the potential source of error
around the necessary assumptions. The direct method estimates the total number of
adults aged 16 years or more infected with HIV in the population. The method is based
on the principle of combining the total of the diagnosed HIV infections in the UK with
estimates of the total undiagnosed prevalent infections. The method is illustrated
simply below in Figure 1.4. The numbers of prevalent diagnosed HIV infections for
each major behavioural category in the UK were taken to be the number of reported
infections from the national Survey of Prevalent HIV Infections Diagnosed (SOPHID),
adjusted for under-reporting and for failure to access services in a given year. The total
number of undiagnosed infections is estimated by the age- and region-specific
undiagnosed infections in different behavioural categories. Each major component of
the populations at risk was accounted for separately and adjustments made for
overlapping risk groups and differential fertility among HIV infected and uninfected
women.
The principle of the method relies on combining data from several sources. The
undiagnosed prevalence estimate was derived from the UAPMP surveys which
represent four groups: MSM and heterosexuals attending GUM clinics, IDUs attending
specialist centres, and the general heterosexual population measured through the
survey of pregnant women. This prevalence was adjusted firstly for geographic
coverage, and secondly to produce specific prevalence estimates derived for the
different behavioural categories that represent varying levels of HIV risk. Each adjusted
undiagnosed prevalence estimate was multiplied by the estimated population sizes of
that behavioural category. The resulting estimates of the number of undiagnosed HIV
infections were finally added to the number of diagnosed HIV infections from SOPHID,
producing an estimate of total prevalent HIV infections within each behavioural
category. As the undiagnosed estimates were only for adults aged 16 to 44 in Britain,
they were then scaled up to include all adults in the UK.
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Figure 1.4 The direct method to estimate total HIV infections in the UK
Estimated size of population in 10 mutually exclusive hierarchical
behavioural categories,
Total population N (Office of National Statistics)
Proportion of population in each category p
(National survey of sexual attitudes and lifestyles)
Prevalence of undiagnosed
HIV infections in each sub-
group 1C
(Unlinked anonymous
surveys of GUM clinics,
IDUs and pregnant women) L tt.p.N
1Total number of patients
with HIV infections
diagnosed, seen for
treatment or care, Y
(Survey of prevalent HIV
infections diagnosed)
Estimated
undiagnosed HIV
--+ infections by sub-
group, X
Estimated total HIV
infections by sub-
group,Z
1.3 Study rationale and thesis scope
This thesis will present the background work for a further development of the indirect
estimation method which focussed on the potential source of error around the
necessary assumptions. This study will develop an adjustment method which will allow
the use of routine surveillance data to calculate an estimate of total HIV infections in
the UK. This will utilise available surveillance data, investigate the relationship between
HIV testing and risk of HIV infection and provide recommendations for future
surveillance which would allow the monitoring of changes within that relationship as
service provision and HIV test uptake change over time.
1.4 Aims
The aim of this thesis is to estimate total HIV infections in MSM in the UK using
surveillance and other available data on HIV testing.
1.6 Objectives
This aim will be accomplished through the following objectives:
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1. Review current factors associated with HIV testing and sexual behaviour and
develop a conceptual framework of the relationship.
2. Describe the trends of HIV, STI, and HIV testing in MSM in the UK.
3. Estimate the size and characteristics of the population of MSM HIV testing and
their associated sexual behaviours.
4. Estimate how the association between sexual behaviour and HIV testing may
have changed over time.
5. Model the association between HIV testing and HIV prevalence, HIV testing and
sexual behaviour in the general population of MSM.
6. Estimate how much the risk of HIV infection is affected by HIV testing history
and develop a new method to estimate total HIV infections for MSM.
1.6 Outline of thesis
The thesis is presented in eight parts: an introduction to the thesis including project
rationale, a systematic literature review and development of a conceptual framework, a
description of HIV and sexually transmitted infections (STI) trends in the UK, four
chapters that address an aspect of the aim and objectives, a general discussion and
appendices.
The adjustment method that will be presented in this thesis is based on (at the time of
start of this thesis) newly available data such as Natsal 2000 and community surveys of
MSM. The plan was to take into account the differences in HIV prevalence between
subgroups (testers, not testers) within the major behavioural categories25.
The factors associated with both HIV testing and risk of HIV infection will be explored
using the survey data available at the time. Hence, background data in Chapters two
and three will be presented up to the end of 2002 which corresponds with the year prior
to which the survey in Chapter five was carried out and for which total HIV infections
estimates are produced in Chapter seven. Overall HIV diagnoses trends are presented
for the UK; however, specific rates of STls and HIV are presented just for England and
Wales.
Chapter two provides a review of factors associated with HIV testing and risk of HIV
infection, and a conceptual framework for the relationship between HIV testing and risk
of HIV infection is developed. This review provides a general context and rationale for
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the thesis as a whole while the literature review presented in each of the subsequent
chapters provides a more specific context and rationale for each of the studies.
Chapter three describes trends in current HIV infections and STls in MSM in the UK
and presents a review of current levels of HIV testing within MSM in the UK.
In order to better understand the assumptions of the estimation method, data from
surveys in different settings were analysed as part of this thesis. Chapter four
characterises the population of MSM presenting for HIV testing. In this chapter, an
analysis of the National Survey of Sexual Attitudes and Lifestyles (Natsal) is carried
out, assessing the prevalence of and characteristics associated with HIV testing in a
representative sample of MSM in the population. The second part of the chapter
assesses whether there has been a change in prevalence of HIV testing, or of the
characteristics associated with it, through an analysis comparing the Natsal 2000
survey with the Natsal 1990 survey. The relevance of this is to provide estimates of
population testing, and to estimate whether MSM who have had an HIV test are more
at risk of HIV than men who have not tested. This analysis had never been carried out
on a representative sample before, and thus these are the first national estimates
made available. It is relevant to describe changes in the relationship between HIV
testing and behaviour as these will affect the interpretation of the study carried out and
described in Chapter five and the estimation method developed in Chapter seven.
The survey described in Chapter five measures the association of HIV test history with
undiagnosed HIV infection. This is followed in Chapter six with a comparative analysis
with another community-recruited survey of MSM to provide upper and lower estimates
of behavioural risk associated with HIV infection in these two different populations.
Chapter seven describes the development of an estimation model that uses the
analyses from Chapters four to six to estimate total prevalent HIV infections and
finishes with sensitivity analyses and comparisons with estimates provided from other
methods. In collaboration with a statistician, a Bayesian multi-parameter evidence
synthesis (MPES) of surveillance data method for developing plausibility bounds
around the estimates was developed through the triangulation of surveillance data 12.
This was based on the direct method principle above (Figure 1.5) and used all the
same data inputs. The MPES method developed a Bayesian framework for synthesis
of surveillance and other information incorporating a hierarchical structure to spread
information more evenly over the parameter space, thus each source of evidence
contributes to each parameter. The MPES method is discussed further in Chapter
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seven, section 7.7.
Finally, in Chapter eight, recommendations for further research and development of
surveillance methods are made based on the findings of this thesis.
1.7 Peer review and ethical approval
The studies carried out in Chapters four, five and six received ethical approval. The
study proposal for Chapter four was presented to the Natsal Survey Research Board
for review and approval. Natsal was approved by the University College Hospital and
North Thames Multi-Centre Research Ethics Committee and all the Local Ethics
Committees in Britain. The UA survey of GUM clinic attendees received ethical
approval from the Local University College London Ethics Committee. Additional ethics
approval was obtained for this short survey acquiring additional history on HIV testing,
and previous acute STI diagnoses from the University College London Ethics
Committee. The survey data used in Chapter six from the Gay Men's Sexual Health
Survey (GMSHS) obtained ethical approval from the local University College London
Ethics Committee.
1.8 Confidentiality of patient identifiable information
All data capture, storage, handling and retrieval procedures were audited by the
Communicable Disease Surveillance Centre (COSC) Caldicott Committee and
complied with established Health Protection Agency (HPA) policy for handling patient-
identifiable information.
1.9 Statement of authorship
The studies that form this thesis are the product of a combined effort of several
individuals and institutions, in which I, the author, played an integral part.
Members of Dr John Parry's laboratory at the Centre for Infections HPA laboratory
wrote the protocols for the laboratory testing for HIV carried out in the study in Chapter
five. The studies in Chapters four and five were instigated, planned, conducted,
analysed and interpreted by Christine McGarrigle. Or Oanielle Mercey was in overall
charge of the day-ta-day management of the study at the Mortimer Market Centre
described in Chapter five. She met with the health-care staff and ensured on-going
recruiting, standard study procedures, and other management issues. Christine
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McGarrigle was responsible for supervising the UA data collection and data
management at the CDSC in collaboration with Ms Alison Brown, ensuring that the
methodology and analysis were conducted consistently and correctly. Dr John Parry
was responsible for the day-ta-day supervision of the laboratory aspects of the HIV
testing programme. Christine McGarrigle was responsible for setting up the database,
and conducted the analyses and statistical interpretation. Alison Brown monitored the
timeliness and accuracy of data collection and inputting. The study was conducted
according to existent UA survey practice, as part of the national Unlinked Anonymous
Seroprevalence Monitoring Programme. The investigations in Chapters five and six
were supported by grants from the Department of Health (England).
Other authors collected two datasets used in the thesis. The National Surveys of
Sexual Attitudes and Lifestyles 2000 and 1990 used in Chapter four were collected by
a collaboration of institutions, the Royal Free and University College Medical School,
the London School of Hygiene and Tropical Medicine, and the National Centre for
Social Research". The analysis of the data presented here was undertaken by
Christine McGarrigle and was an original interpretation of the dataset - data relating to
HIV testing from this dataset - and had not been published before. The analysis of the
full dataset, including MSM was published by the author and is included in Published
papers in this thesis. Ms Julie Dodds provided the data used for the comparison in
Chapter six, and the comparison was carried out in collaboration with this survey
group; however, Christine McGarrigle developed the aims and objectives, generated
the hypotheses and analytical technique used here and carried out the analysis. The
estimation method developed in Chapter seven is based on previous methods used in
the UK and developed in Canada; however, this is a unique method and interpretation
developed by the author.
The author has written all the components of this thesis herself. She was supervised
throughout the work programme of this thesis by Professor Laura Rodrigues (primary
supervisor), in addition to supervision from Dr Kevin Fenton and Professor Noel Gill.
The writing-up phase was supervised by Dr Dorothea Nitsch (primary supervisor).
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Summary
A systematic review of evidence on factors associated with HIV testing and risk of HIV
infection was carried out. Due to heterogeneity of studies and study designs it was not
possible to do a formal meta-analysis. However, the data were used to develop a
conceptual framework for the associations that will be explored more formally in later
parts of this thesis. The results suggest that demographic variables, information on
sexually transmitted infections, and previous HIV testing patterns may proxy risk
behaviour for HIV infection, in particular unprotected anal intercourse.
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2.1 Introduction
The aim of this thesis is to estimate total HIV infections in MSM in the UK using
surveillance data on HIV testing. Data on diagnosed HIV infections in MSM in the UK
are available through national surveillance systems", However, HIV diagnoses are not
a true measure of HIV burden in the MSM population in the UK, because not every
MSM chooses to undergo HIV testing. Studies have shown that the proportion of MSM
who have ever had an HIV test ranges from 53-64% in the UK27-30 to 83% in Australia",
63% in Canada" and 84% in the US33• In order to understand potential biases in
current estimates of total HIV infections, a review of the literature on the relationships
between HIV testing and risk of HIV infection was carried out and is presented below.
This review will then inform the conceptual framework about key factors that can be
collected through surveillance systems. In order to understand how HIV testing is
associated with risk of HIV infection, this review will focus on the relationship between
HIV testing and factors related to risk of HIV infection in MSM. As unprotected anal
intercourse (UAI) is the most important determinant of risk of HIV infection (see Table
2.1), the review will concentrate on this aspect. Following the establishment of this
association, the review will then investigate other factors that are related to HIV testing
and whether they are also associated with UAI or risk of HIV infection. A conceptual
framework for the relationship between HIV testing, UAI and risk of HIV infection and
each of the individual factors is presented within each section below as Figures 2.2,
2.4, 2.6, 2.8, 2.10 and 2.12.
2.2 Methods
A series of MEDLINE searches were carried out using PUBMED, AIDSLINE and
HealthSTAR via the National Library of Medicine (NLM) gateway on the terms:
'homosexual', 'gay', 'men who have sex with men', 'HIV testing'; these were combined
with each of the individual areas of interest: 'unprotected anal intercourse', 'age',
'sexually transmitted infection', 'number of sexual partners', 'residence', 'socio-
economic status' or 'education'. This was followed up with a 'snowball' search including
papers by authors already retrieved and references within retrieved papers. The
inclusion criteria were as follows:
(1) Does the study relate to HIV testing?
(2) Does the study include MSM?
(3) Is there a disaggregated outcome measure of association with HIV
testing for MSM?
(4) Does the study focus on demographic and behavioural factors
before HIV testing or UAI?
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(5) Was the study carried out before 2003?
Only studies carried out up to 2003 were included as both HIV testing policies and
factors associated with HIV changed in the mid-2000s, and the purpose of this review
was to determine a conceptual framework for the study in Chapter four which was
carried out in 2003. A summary of the studies reviewed are presented in Tables 2.1 -
2.7 below, and the numbers of papers extracted and screened are presented in Figures
2.1 -2.6.
2.3 Association between unprotected anal intercourse and HIV
seroconversion and HIV testing
To investigate the associations between UAI and HIV seroconversion, and HIV testing,
MEDLINE searches were carried out using PUBMED, AIDSLINE and HealthSTAR via
the National Library of Medicine (NLM) gateway on the terms: 'homosexual', 'gay',
'men who have sex with men', 'unprotected anal intercourse' and (a) 'HIV testing' and
(b) HIV seroconversion/HIV serostatus. This was followed up with a 'snowball' search
including papers by authors already retrieved and references within retrieved papers.
Figure 2.1 Systematic review data flow for investigation of the association
between unprotected anal intercourse HIV testing, and HIV seroconversion
Records identified
through database Records excluded on
searching and _., abstract...
screened n=61
n=133
Additional records
from other sources
n=2 Full-text articles excluded,r n=32
Full-text articles for the following reasons
assessed for .. 4 studies not about HIV testing
eligibility - 26 studies reported no outcomen=70 measure for HIV testing or UAI
2 studies were not focused on
behaviour before testing
V
Studies included in review factors
associated with HIV testing and UAI
n=23
HIV serostatus or seroconversion and
UAI
n=15
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In total 135 studies and surveys were extracted, of which 61 were excluded on abstract
due to non-relevance or date of survey post 2003 (Figure 2.1). A further 32 full-text
articles were excluded due to the study not being about HIV testing (4 studies), no
measures of association available on HIV testing or UAI or no disaggregate data
available for MSM (26 studies), and studies not focussed on behaviours before HIV
testing (2 studies). The excluded studies are listed in Table A.1, Appendix A.
UAI is a major risk factor for HIV infection in MSM. This has been determined through
HIV seroconversion studies within four cohort studies":" and six case control studies
in North America38-40, Europe41.42 and Austrana" and through five cross-sectional
studies in the US44.45, South America" and the UK47,48 that met the inclusion criteria.
Table 2.1 provides a descriptive summary of each study.
Three of the US studies collected data from multiple US cities, and the most often
surveyed cities were San Francisco, Los Angeles, New York City, Seattle and Chicago.
The Canadian studies were based in Vancouver and Montreal. UK studies were in
three cities, London, Manchester and Brighton. Participants were mainly recruited from
medical settings (primarily HIV clinics) and multiple gay venues and events. Twelve
studies used convenience samples, one study used probability sampling based on
telephone index, and one used recruitment methods that were more systematic (e.g.
every third person who came into the venue) than convenience sampling. Ten studies
recruited from HIV test clinics or sexually transmitted disease (STD) clinics, while nine
also recruited from the community through gay bars and clubs, advertising in gay
media and 'snowballing' techniques. Nine studies used self-administered
questionnaires, and seven studies used interviewers to administer the questionnaires.
Two studies focussed on young MSM. Sample size varied between the studies,
although most of the cross-sectional studies sampled at least 2,000 MSM. The studies
took place over a period of time ranging from 1983 to 2003. The association between
UAI and HIV seroconversion remained over time.
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Results of the systematic review of HIV testing and UAI are presented below in Table
2.2. Twenty-three studies that met the inclusion criteria found an association between
HIV testing and UAI. The UK studies were based in five cities in England, London,
Manchester, Brighton, Oxford and Northampton, and two in Scotland, Edinburgh and
Glasgow. Most of the US studies collected data from multiple US cities, and the most
often surveyed cities were San Francisco, Los Angeles, New York City, Seattle and
Chicago. The Canadian studies were based in Vancouver and Montreal. Participants
were mainly recruited from community settings, from multiple gay venues and events
and medical settings (primarily HIV test clinics). All the studies were cross-sectional
samples. One study used probability sampling based on a telephone index, one based
on the proportion of the population who were adult males, while five used recruitment
methods that were more systematic (e.g. every third person who came into the venue)
than convenience sampling, and the rest were convenience samples Fourteen studies
used self-administered questionnaires, and ten studies used interviewers to administer
the questionnaires. Seven studies were focussed on young MSM, and three on ethnic
minority MSM, particularly Asian and South Pacific ethnicity. Sample sizes varied
between the studies, although most of the cross-sectional studies sampled at least
2,000 MSM. The studies took place over a period of time ranging from 1987 to 2003. A
descriptive summary of these studies is given in Table 2.2 below.
The association between previous HIV testing and UAI remained over time. Seventeen
studies that met the inclusion criteria showed that having had a previous HIV test was
associated with risk behaviour such as unprotected anal intercourse30-32,50-63, and five
studies showed that MSM who have repeat HIV tests have increased risk behaviours
such as UAI with partners of unknown status27.64-67. Repeat HIV testers were more
likely to have a HIV positive primary partner". Regular HIV testing has been
associated with increased health awareness", and decreased HIV risk behaviour
compared with irregular testing67 or no difference in HIV risk behaviour compared with
non-regular HIV testers" and decreased UAI with partners of unknown HIV status6S,S8.
However, two of these studies had small sample sizes and three did not control for
confounding, while the one larger study by MacKellar et al66 excluded all MSM who
tested HIV positive, thus possibly sampling a population of different MSM who may be
lower-risk in their behaviour. While regular testing was not associated with UAI in these
four studies, regular HIV testing was associated with an increased numbers of
protected sexual partners" and increased number of casual partners" in the two
studies that collected these data. A further US study, while finding that men who had
been tested reported higher rates of protected and safer-sex practices, found that they
showed no difference in high-risk practices such as UA169. While they may have had
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more protected sex proportionately, they correspondingly had more sexual acts, and
therefore more unsafe sex69. Additional studies found that regular HIV testing was
associated with UAI with concordant partners" and because the knowledge of HIV
status can be lncorrect", regular testing was associated with higher risk behaviour.
Both HIV testing and UAI were associated with HIV serostatus. HIV incidence at a
London GUM clinic was higher in MSM who had three or more previous HIV tests than
MSM with one or two previous tests". Ever having an HIV test was associated with
HIV infection in both GUM cnmc-recrulted" and community-recruited MSM49.UAI was
associated with MSM being HIV positive35.44-47,49.UAI was associated with other factors
that have been associated with risk of HIV infection. These included sites where sexual
partners were met; visiting sex venues and bathhouses":", gay bars72and cruisinq",
with increased numbers of sexual partners61,73,74,andthe use of amyl nitrate (poppers),
in both the US, (odds ratios (OR) 1.92, 95% confidence intervals (Cl) 1.30 - 1.60)73,
and two studies in Canada (OR 1,70,95% C11.59 _1.81)32, (OR 2.20, 95% Cl 1.52-
3.81f5.
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REVIEW OF FACTORS ASSOCIATED WITH HIV TESTING AND RISK OF HIV INFECTION
There was a positive association between HIV testing and UAI. MSM who had
previously tested showed an increased likelihood of UAI. This was seen in the UK, US,
Canada and Australia in studies carried out between 1990 and 2002. Repeat testing
was found to be associated with increased likelihood of UAI in the UK. This positive
association was found in a large US study too, but a study of young MSM aged less
than 22 found repeat HIV testing to be protective of UAI (OR 0.6, 95% Cl 0.6 - 0.8). A
further small study (253 individuals) found no evidence of an association between
repeat HIV testing and UAI. Both these US studies recruited only MSM who had either
never tested or tested HIV negative, excluding all positive MSM.
There are a number of possible reasons for the relationship between HIV testing and
UAI. Prior testing may be a marker of sexual risk behaviour. Men may choose to
undergo an HIV test because they are, or perceive themselves to be, at risk of HIV
infection. The data suggest that men who choose to test for HIV have more risk
behaviour (UAI) then those who don't. An alternative explanation is reverse causality,
namely that men HIV test to determine their serostatus to then make decisions about
UAI based on the test results. There is some evidence for this when comparing men
who have previously tested HIV negative with those who have either tested HIV
positive or are untested. Men who have tested HIV positive may be motivated to
reduce their risk, and some studies have found that testing HIV positive reduces the
likelihood of having UAI52.76. There was no evidence of a reduction in high-risk
behaviour in MSM who had tested HIV negative. They were either more likely to have
had UAI compared with men who were untested", or showed no difference in the
proportion of UAI76.77. A case control study among repeat testers in the UK found that
previous HIV negative tests and the adoption of risk reduction strategies diminished the
perceived threat of HIV infection78. This led to loss of control over risk reduction
strategies resulting in subsequent UAI.
Clearly an individual's HIV serostatus is an important determinant of future sexual
behaviour. It has been shown that some MSM are using HIV testing to determine their
HIV status in order to make decisions about their sexual behaviour within relationships
based on their test results54.68,79, MSM are moving away from the 100% condom use
message, and starting to use risk reduction methods instead. This has been termed
'negotiated safety,80. However, studies have shown that seroconcordance is often
based on perceived status rather than on actual status. Two studies within Britain
found that 25% of men who reported that they had UAI with a partner of the same
serostatus as themselves had never had a HIV tese8. Other studies have shown that of
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men who stated that they were practising negotiated safety, many of the partners with
whom they were engaging in UAI were casual partners of unknown HIV sercstatus":".
There is certainly evidence that serosorting (that is choosing a partner of the same HIV
serostatus as oneself) has been taking place among HIV positive men to have
concordant UAI81-83. While some would disclose their status and then have UAI with
concordant partners and some did not disclose and still had UA181. The internet in
particular has facilitated this disclosure and serosorting between HIV positive men but
this has been followed by large rises in STls in HIV positive MSM82.84•
Thus, while HIV testing may denote many different types of behaviour and there are
many reasons for having an HIV test, most of the evidence suggests that those who
have tested have higher behavioural risk than those who haven't tested. Repeat HIV
testers were even more likely to have had UAI than men who had not tested repeatedly
(Table 2.2). When comparing UAI by HIV serostatus (Table 2.1b), most of the evidence
found that men who had tested negative were more likely to have had UAI then men
who were untested and less likely than men who had tested HIV positive. While men
within relationships may account for some of this increased UAI and so it could be
argued that they are not at increased risk of HIV infection if their partners serostatus is
the same as their own62.85. Clearly HIV status is not known completely enough to
remove the risk of HIV infection.
The studies reviewed sampled MSM from a variety of venues including bars, clubs
gay-identified events, sexual health services, the community through advertisement or
probability-sample phone surveys and so, overall, are probably representative of MSM.
However, cross-sectional studies comparing those who have HIV tested and those who
haven't cannot address the pre-existing differences in HIV risk behaviour or motivation
to reduce risk behaviour that may have influenced the participant's initial decision to
undergo HIV testing. It is not possible to determine the temporal relationship between
HIV testing and UAI. Sexual behaviour was obtained through both self-completion
questionnaire and face-ta-face interview in these studies. Sexual behaviour is open to
recall bias and social-desirability bias which may be more likely in the interviewed
samples. Thus, as in all behavioural surveys, bias cannot be ruled out, which may
affect the measurement of the true association between HIV testing and UAI. Due to
the different sampling methods, different outcome and exposure categories between
the studies, it is not possible to generate an overall measure of association between
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HIV testing and UAI through a meta-analysis.
In summary, MSM who had HIV tested had higher behavioural risk, indicated through
UAI, than untested MSM. Although there was some evidence that repeat testing may
be associated with health-seeking behaviour, most of the evidence suggests that
repeat testers were more likely to have more UAI partners. HIV seroconversion was
associated with UAI and HIV positive MSM were more likely to have had UAI than HIV
negative MSM. A summary of the likely association between HIV testing, UAI and HIV
infection is represented in the conceptual framework in Figure 2.2 below.
Figure 2.2 Conceptual framework of the relationship between HIV testing and
unprotected anal intercourse
HIVtesting
Key
Unprotected anal
intercourse
HIV infection risk
D factors associated with HIV testing and HIV infectionrisk that can be asked for I measured
Direction of innuence
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2.4 Association between HIV testing, HIV seroconversion or HIV
serostatus, unprotected anal intercourse and age
To investigate the associations between HIV testing, HIV seroconversion or HIV
serostatus, UAI and age, a series of MEDLINE searches were carried out using
PUBMED, AIDSLINE and HealthSTAR via the National Library of Medicine (NLM)
gateway on the terms: 'homosexual', 'gay', 'men who have sex with men', 'age' and (a)
'HIV testing', (b) HIV seroconversion/serostatus and (c) 'unprotected anal intercourse'.
This was followed up with a 'snowball' search including papers by authors already
retrieved and references within retrieved papers. In total 490 studies and surveys were
extracted, of which 461 were excluded on abstract due to non-relevance or date of
survey post 2003 (Figure 2.3). A further ten full-text articles were excluded as the study
was carried out after 2003 (5 studies), no measures of association available on HIV
testing or UAI (2 studies) or no disaggregate data available for MSM (3 studies). The
studies excluded are listed in Table A.2, Appendix A.
Figure 2.3 Systematic review data flow for Investigation of the association
between HIV testing, unprotected anal intercourse, HIV seroconversion or HIV
serostatus and age
Records identified
through database Records exduded
searches and t-------j.~ on abstrad due to
screened • non-relevance
n=480 n=461
Additional records
from other
sources
n=10
FUll-text artides
assessed for
eligibility
n=29
Full-text artides exduded
n=10
for the following reasons
5 studies were carried out after
2003
... 2 no outcome measure for HIV
testing or UAI
3 studies reported no
dlsaggregate outcome measure
for HIV testing for MSM
"
Studies induded in reviewfadors assodated
with HIV lesling and age
n=14
HIV serostatus or seroconversion and age
n=4
UAI and age
n=5
Fourteen studies that met the inclusion criteria presented an association between HIV
testing and age, four reported on HIV serostatus and age, and four reported on UAI
and age. The UK studies were based in one city in England, London, and two in
Scotland, Edinburgh and Glasgow. Most of the US studies collected data from multiple
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US cities, and the most often surveyed cities were San Francisco, Los Angeles, New
York City, Seattle and Chicago. A national Canadian study sampled from 35 cities and
an Australian study sampled from five large cities. Participants were mainly recruited
from community settings, from multiple gay venues and events and medical settings
(primarily HIV test clinics). Three of the studies were cohorts, while the rest were cross-
sectional convenience samples. Two studies used probability sampling based on a
telephone index, one based on the proportion of the population who were unmarried
adult males, while seven used recruitment methods that were more systematic in their
sampling methodology (e.g. every third person who came into the venue) than
convenience sampling Sixteen studies used self-administered questionnaires, and
eight studies used interviewers to administer the questionnaires. Four studies were
focussed on young MSM, and two on ethnic minority MSM, Asian and South Pacific
ethnicity and Latino MSM. Sample sizes varied between the studies, although most of
the cross-sectional studies sampled at least 2,000 MSM and the Australian study
sampled over 22,000 MSM. The studies took place over a period of time ranging from
1989 to 2003. A descriptive summary of these studies is given in Tables 2.3a-2.3c
below.
Previous HIV testing was associated with older age in MSM in Europe30,50,53, Australia54
and the US51,55,86 (see Table 2.3a below), although this association was not linear. In
MSM in general up to the age group, 26 to 30 years, there was an increased
association of previous HIV testing with age, whereas over 30 years this assoclatlon
became more level, In the UK, previous HIV testing, was positively associated with
being aged 26 to 30 compared with less than 25, and then no difference in ever HIV
tested between MSM aged over 30 compared with MSM aged less than 2530,5°. In the
Netherlands, previous HIV testing was associated with being aged more than 3053•
These studies were all carried out during the 1990's. In the US study carried out in
2002, previous HIV testing was associated with increasing age86• Studies investigating
HIV testing in adolescent and young adult MSM in the US found that previous HIV
testing increased by year of age in 13-21 year olds, and 15-25 year 0Ids51,55. In Canada
HIV testing was associated with younger age32 in a study carried out in the early
1990's.
Recent HIV testing was associated with younger age in the US. MSM aged 23 to 25
years were more likely to have tested than MSM aged 26 to 2987. Again a similar non-
linear trend was found in Australia, where recent HIV testing in MSM was associated
with increasing age up to 30 years; 25 to 29 compared with MSM aged less than 25.
There was no difference in recent testing in MSM aged 30 to 39 compared with MSM
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aged less than 25, while MSM aged more than 40 had a reduced likelihood of recent
HIV testing compared with MSM aged less than 2554.
Repeat HIV testing - defined as 3 or more tests - was associated with increasing age
in the US66•88 and MSM who had tested once or twice were more likely to be older
compared with first-time testers66. One US study in the 1992 found an overall
deceasing association of repeat HIV testing with age64, but this was not linear. Repeat
HIV testing was more common in MSM aged up to 40 years, and then the proportion
repeat tested decreased in MSM aged over 40 years; from 43% in 30 to 40 year aids to
27% (Table 2.3a). Regular testing (every 6 months) was associated with younger age
in the US64,67,88 (Table 2.3a).
Some studies in the US found no association with age69,89. However, one excluded all
who were positive (more than 15% of the sample), and the second recruited from
smaller cities, and in general had a lower testing rate (60%) than has been measured
overall in other US studies".
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As mentioned before, the study populations differ by recruited ages. Due to the
different outcome measures and study populations, it was not possible to generate an
overall measure of association between HIV testing and age through a meta-analysis.
With young MSM, other psychosocial factors, besides sexual behaviour, need to be
considered when comparing with older MSM. Thus HIV testing, and its relationship with
age, may indirectly be measuring the different sexual identities of MSM in different
locations. Myers et al59 hypothesise that the different testing patterns of older and
younger MSM may be due to cultural and societal differences over time within Canada;
the fact that the sexual identities of the older MSM had been developed with
discrimination and HIV testing is related to sexual identity and openness, hence older
MSM were less likely to have HIV tested. Since sexual identity and gay acculturation
will increase through teenage and twenties as years of sexual activity increase. This
would concur with the increase in HIV testing in MSM with age seen in the UK,
Australia and the US. Being of older age increases the likelihood of having an HIV test,
compared with younger age, but age is a marker for number of years of sexual activity,
which is directly related to probability of having an HIV test50. HIV testing was
associated with years since first sexual intercourse" and number of lifetime sexual
partners31.54,60,62.Reporting a previous HIV test was associated with gay socialisation in
Canada32 and younger age of self-identification as homosexual or bisexual (OR 0.91,
95% Cl 0.85 - 0.99). Gay acculturation were predictors of test seeking in the US51.HIV
testing was associated with being integrated into the gay scene and going more often
to gay bars". A predictor of recent HIV testing was found to be having more gay
friends51,54, and having a higher social support, defined as someone to talk to about
AIDS, sex and unsafe sex (OR 1.23, 95% Cl 1.12 - 1.35)55.A low social support
network was associated with UAI in young MSM in Canada (OR 1.65, 95% Cl 1.04 -
2.59)75. HIV testing had been found to be related to number of friends who have
AIDS27,33which is strongly age related. Repeat testing was associated with personal
knowledge of others who have been infected with HIV which may be age-related (OR
1.14, 95% Cl 1.05 - 1.23)27.In the UK previous HIV test was independently associated
with older age30.50and large proportions of undiagnosed infections are in young MSM90.
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REVIEW OF FACTORS ASSOCIATED WITH HIV TESTING AND RISK OF HIV INFECTION
Younger age was associated with increased likelihood of HIV seroconversion in three
cohort studies37.39.46(Table 2.3b).
Differences in HIV infection exist by age, and while HIV incidence was associated with
age less than 35 in the US37.39and age less than 25 in Brazil" (Table 2.3b), HIV
positive serostatus was associated with older age in the UK49and the US91. Again this
association of HIV positivity with increasing age was not linear. While MSM aged less
than 25 were less likely to be HIV positive, MSM aged 35 to 39 years were more likely
to be HIV positive than MSM aged 40 or over. In the US study, it was only comparing
MSM aged 20 to 22 with 15 to 21 year olds (Table 2.3b).
When considering the age at which an individual has HIV infection, in this context one
has to consider the age of the individual found to be HIV positive and the age of the
person they got their infection from. The survey results of HIV incidence and HIV
testing do not include any data on sexual partnerships. Therefore age is a proxy for a
multitude of other factors that are associated with choosing to HIV test and the risk of
being HIV positive. Conversely the sexual mixing patterns of younger men may put
themselves at higher risk of HIV infection. The tendency of young MSM to have sex
with older men will increase their risk of HIV infection since HIV prevalence increases
with increasing age, younger MSM may be more likely to meet a sexual partner who is
HIV positive49.62.There may be some kind of age-cohort sampling bias in the US if
more of the older MSM have died, since then a more select low-risk pool is left to be
surveyed and take part in cohorts".
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The review of the reported associations between UAI and age is presented in Table
2.3c. UAI was associated with younger age in a cohort study in San Francisco'" in
1984 (OR 0.51, 95% Cl 0.29 - 0.86) aged more than 36 years, but there was no
difference in UAI by age in the 1988 follow-up (OR 1.06, 95% Cl 0.36 - 3.12). Age was
associated with UAI in all studies, but the direction of the association differs by type of
study and between countries. These disparities in results can be explained by the
variety of different study populations.
Differences in risk of HIV infection, measured by UAI, have been seen by age;
however, this difference varied by continent. In their review of age and risk of HIV
infection in 1998, Mansergh and Marks concluded that younger age was fairly
consistently found to be associated with UAI in North American studies, while only
limited evidence was found for the association in European and Australian studies'".
Some of these regional differences in sexual behaviours may be because, in the US,
young gay men are more likely to go to bars than older gay men, and this leads to
increased UAI as this is a meeting place for new partners. A study in the UK, which
found no age difference in UAI in a same-day HIV test clinic, reported a higher rate of
UAI (50%) than reported in other UK studies at this time, and may be representing a
self-selected group92. UAI was associated with visiting a gay bar in the past 12
months".
More recent studies in the UK and in the Netherlands have found that younger gay
men were more likely to have been engaged in UAI in the previous year28.94.95. Hence
as the relationship between UAI and age is changing over time, HIV testing may
change with this relationship. UAI has continued to be associated with younger age in
the US74•
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A summary of the likely association between HIV testing, UAI and HIV infection and
age is represented in the conceptual framework in Figure 2.4.
Figure 2.4 Conceptual framework of the relationship between HIV testing,
unprotected anal intercourse and age
Age
Unknown confounders
HIV testing
Key
Factors associated with HIV testing and HIV infection
risk that can be asked for I measured
-___,.... Direction of influence
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2.5 Association between HIV testing, unprotected anal intercourse and
area of residence
To investigate the associations between HIV testing, UAI and area of residence
MEDLINE searches were carried out using PUBMED, AIDSLINE and HealthSTAR via
the National Library of Medicine (NLM) gateway on the terms: 'homosexual', 'gay',
'men who have sex with men', 'residence', and (a) 'HIV testing' and (b) 'unprotected
anal intercourse'. This was followed up with a 'snowball' search including papers by
authors already retrieved and references within retrieved papers. In total 44 studies
and surveys were extracted, of which 32 were excluded on abstract due to non-
relevance or date of survey post 2003 (Figure 2.5). A further 6 full-text articles were
excluded due to the study not being about HIV testing (one study), the study carried out
after 2003 (one study), no measures of association available on HIV testing or UAI and
area of residence (three studies) or no disaggregate data available for MSM (one
study). These are listed in Table A.3, Appendix A.
Figure 2.5 Systematic review data flow for investigation of the association
between HIV testing and unprotected anal intercourse and area of residence
Recorc1s identified Records exduded
through database on abstract for
searching
_.
non-relevance and-and saeened post2003
n=40 n= 32
Additional records
from other
sources
FUll-text artides exctudedn=4
" n= 6for the following reasons
FUll-text artides
assessed for 1 study not about HIV testing
eligibility - 1 study were carried out after 2003
n= 12 3 studies no outcome measure for HIV
testing or UAI and area of residence
1 study reported no disaggregate outcome
measure for HIV tesllng for MSM,
Studies induded in review
factors assodated with HIV
testing and area
n=4
HIV testing and UAI
n=4
(total n=6)
Four studies that met the inclusion criteria presented an association between HIV
testing and area of residence and four reported on UAI and area of residence. The UK
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studies were based in one city in England, London, and one in Scotland, Edinburgh.
The US studies collected data from multiple US cities, and the most often surveyed
cities were San Francisco, Los Angeles, New York City, Seattle and Chicago. A
national Canadian study sampled from 35 cities and an Australian study sampled from
five large cities. Participants were mainly recruited from community settings, from
multiple gay venues and events and medical settings (primarily HIV test clinics). All of
the studies were cross-sectional convenience samples. One study used probability
sampling based on a sampling frame of gay bars in the city, one based on the
proportion of the population who were unmarried adult males. Four studies used self-
administered questionnaires, and two studies used interviewers to administer the
questionnaires. Two studies were focussed on young MSM. Sample sizes varied
between the studies, although most of the cross-sectional studies sampled at least
2,000 MSM and the Australian study sampled over 22,000 MSM. The studies took
place over a period of time ranging from 1991 to 2001. A descriptive summary of these
studies is given in Tables 2.4a-2.4b.
Of the six studies that met the inclusion criteria, HIV testing has been found to be
associated with area of residence in four, that is associated with being from a
metropolitan area2B.32.54.59(see Table 2.4a). This could relate to a number of other
factors, such as availability of HIV testing, different policies of offering HIV testing, and
different levels of risk behaviour that then prompts HIV testing. Nardone et al surmise
that as 'negotiated safety' was a strategy promoted in London but not in Scotland, this
could account for some of the different levels of HIV testing between two cities2B.There
are differences in HIV testing levels between urban and rural areas within countries;
being resident in a metropolitan area in Canada was found to be independently
associated with having a previous HIV test with testing ranging from 55% compared
with 37%59 as was being from a larger city32. City of residence was important in
Australia with gay men surveyed 30 to 40% less likely to have had HIV tested if they
were from Perth of Melbourne compared with Sydney31.54.Levels of previous HIV
testing ranged from 60% to 85% in the US and 53% to 64% in the UK, but no clear
pattern could be seen and much of this disparity could be due to different HIV testing
policies.
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Being resident in a metropolitan area is related to sexual risk behaviour and four
studies found that UAI was associated with area of residence28,32,62,87, In metropolitan
areas this could be that more socialisation in bars and clubs is possible, giving an
increased availability of new sexual partners29,96 (Table 2,4b). All of these factors will
lead to an increase in sexual risk behaviour, which the HIV higher testing rates could
be reflecting. However, a larger Canadian study found that UAI was higher in small
towns in one particular region in British Columbia than in the more metropolitan areas
(OR 1.52, 95% Cl 1.39 - 1.65). They concluded that, while geographic differences are
important for explaining differences in HIV testing, they seem to be less important in
explaining UAI. Thus, policy programmes and social environment appear to be
important influences on behaviour such as test-seeking, possibly due to factors such as
access to and organisation of services and the degree of anonymity that larger cities
provide". HIV testing was lower in smaller cities within the same study (OR 0.79,95%
Cl 0.82 - 0.90). The context of behaviours in addition to health policy, cultural and
community structures would be needed to fully interpret regional differences in sexual
behaviour and health-seeking behaviours.
Areas of residence are related to HIV prevalence5,97, and so risk of HIV infection could
vary by area, as the probability of having UAI with a HIV positive partner will increase in
areas with higher background HIV prevalence.
A summary of the likely association between HIV testing, UAI, area of residence and
HIV infection (for simplicity subsuming age under 'other and unknown confounders') is
represented in the conceptual framework in Figure 2.6 below.
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Figure 2.6 Conceptual framework of the relationship between HIV testing, HIV
infection risk, unprotected anal intercourse and area of residence
Area of residence HIV testing
Unprotected anal
intercourse HIV infection risk
Key
Factors associated with HIV testing and HIV infection
risk that can be asked for I measured
Direction of influence
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2.6 Association between HIV testing, unprotected anal intercourse, HIV
serostatus and socio-economic status
To investigate the associations between HIV testing, UAI, HIV serostatus and socio-
economic status, a series of MEDLINE searches were carried out using PUBMED,
AIDSLINE and HealthSTAR via the National Library of Medicine (NLM) gateway on the
terms: 'homosexual', 'gay', 'men who have sex with men', 'socio-economic status' or
'education' and (a) 'HIV testing', (b) 'unprotected anal intercourse' and (c) HIV
serostatus. This was followed up with a 'snowball' search including papers by authors
already retrieved and references within retrieved papers.
Figure 2.7 Systematic review data flow for review of association between HIV
testing, unprotected anal intercourse, HIV serostatus and socio-economlc status
Additional records
from other sources
n=11 ~--------~
Records identified
through database
searching and
screened
n= 362
,
Full-text articles
assessed for
eligibility
n=23
"
Records excluded
on abstract for non
I--------.t:. relevance or study
after2003
n= 350
2 studies were carried out aller
2003
5 no outcome measure for HIV
testing or UAI
1study reported no disaggregate
outcome measure for HIV testing for
MSM
Full-text articles exduded
n=8
for the fOllowing reasons
..
Studies Induded in relliew factors associated
with HIV testing and SESieducationl
occupation
n=8
HIV serostatus and SES
n=3
UAI andSES
n=4
(total n=15)
In total 373 studies and surveys were extracted, of which 350 were excluded on
abstract due to non-relevance or date of survey post 2003 (Figure 2.7). A further eight
full-text articles were excluded due to the study not being about HIV testing (one
study), the studies carried out after 2003 (two studies), no measures of association
available on HIV testing or UAI and socio-economic status (six studies) or no
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disaggregate data available for MSM (one study). These are listed in Table A.4,
Appendix A.
Eight studies that met the inclusion criteria presented an association between HIV
testing and socia-economic status, three on HIV serostatus and socio-economic status
and four reported on UAI and socia-economic status. The UK studies were based in
one city in England, London, and one in Scotland, Edinburgh. The US studies collected
data from multiple US cities, and the most often surveyed cities were San Francisco,
Los Angeles, New York City, Seattle and Chicago. A national Canadian study sampled
from 35 cities and an Australian study sampled from five large cities. Participants were
mainly recruited from community settings, from multiple gay venues and events and
medical settings (primarily HIV test clinics). All of the studies were cross-sectional
convenience samples. One study used probability sampling based on a sampling frame
of gay bars in the city, one based on the proportion of the population who were
unmarried adult males. Four studies used self-administered questionnaires, and two
studies used interviewers to administer the questionnaires. Two studies were focussed
on young MSM. Sample sizes varied between the studies, although most of the cross-
sectional studies sampled at least 2,000 MSM and the Australian study sampled over
22,000 MSM. The studies took place over a period of time ranging from 1991 to 2001.
A descriptive summary of these studies is given in Tables 2.5a-2.5c.
Socia-economic status was reviewed, and was defined through various methods in the
studies, through an individual's occupation, income or education level, rather than
area-based measures (see Table 2.5). HIV testing rates have been associated with
socia-economic status, although the direction of the relationship varies by country.
Previous HIV test was found to be associated with unemployment in London". HIV
testing was associated with higher education levels55 and higher mcoms" in the US
while testing was associated with high socia-economic status in Australia31.
Unemployment does not measure educational attainment, however, and HIV positive
MSM could be unemployed due to ill health. A study of MSM receiving treatment for
STls between 1990 and 1995 in Switzerland found that MSM with higher education
refused HIV testing (OR 2.6, 95% Cl 1.1 - 6.1)98.This association was still found when
the data were stratified by year98. However, this study was carried out in the early
1990s when HIV testing was still an irregular occurrence in standard health settings.
The MSM were offered voluntary confidential HIV testing when attending for treatment
of STI. These men may perceive themselves not to be at risk of HIV, or they may
choose to have an HIV test carried out at an alternative testing clinic. Both regular HIV
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testing and repeat HIV testing were associated with more education in the US64,66,88
and while a further study in the US found no difference in educational level in those
tested previously from MSM who were untested, repeat testing was associated with
lower educatlonat level". In Canada, HIV testing was not found to be related to income
or educational level59. This Canadian study population had overall a very high
educational level and so there may have been little variation in the exposure, making it
difficult to detect differences if they did exist.
Socio-economic status is collected and defined in many different ways, and so it is
difficult to compare these different data sources. Availability of HIV tests may influence
the relationship between testing and socio-economic status. A study in the US found a
positive association between being uninsured and seeking HIV testing at public
cnrucs". The availability of free health-care services in the UK, through genitourinary
medicine clinics, takes away the issues of affordability of tests. This implies that in the
UK socio-economic differences in HIV testing patterns may reflect social differences in
risk behaviour. In both the UK and the US, there may be differences in openness to
admitting being gay by socio-economic status. This may influence the place of seeking
sex, which may be associated with a higher risk for HIV infection for lower socio-
economic grouped MSM. People from a more disadvantaged background may be less
likely to attend GUM clinics for HIV testing. However, the Natsal found no association
between reported GUM clinic attendance and social class".
UAI was associated with lower social class in the UK68, lower education levels in both
Canada32.75and Scotland52 and in being an infrequent visitor to the gay scene
(adjusted OR 1.48, 95% Cl 1.00 - 2.18)52. Being HIV positive was associated with
lower education in young MSM in canada" and with both less education" and
unemployment in the UK47.
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REVIEW OF FACTORS ASSOCIATED WITH HIV TESTING AND RISK OF HIV INFECTION
A summary of the likely association between HIV testing, UAI, socio-economic status
or education and HIV infection is represented in the conceptual framework in Figure 2.8
below. Other confounders as for example age and area of residence are grouped with
the 'unknown or other confounders' for simplicity.
Figure 2.8 Conceptual framework of the relationship between HIV testing, HIV
infection risk, unprotected anal intercourse and socio-economic status
HlVtesting
HIV infection risk
Key
Factors associated with HIV testing and HIV infection
risk that can be asked for I measured
Direction of influence
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2.7 Association between HIV testing, unprotected anal intercourse, HIV
serostatus and number of sexual partners
To investigate the associations between HIV testing, UAI, HIV serostatus and number
of sexual partners a series of MEDLINE searches were carried out using PUBMED,
AIDSLINE and HealthSTAR via the National Library of Medicine (NLM) gateway on the
terms: 'homosexual', 'gay', 'men who have sex with men', 'number of sexual partners'
and (a) 'HIV testing' (b) 'unprotected anal intercourse' and (c) 'HIV serostatus'. This
was followed up with a 'snowball' search including papers by authors already retrieved
and references within retrieved papers. In total 167 studies and surveys were
extracted, of which 136 were excluded on abstract due to non-relevance or date of
survey post 2003 (Figure 2.8). A further 13 full-text articles were excluded due to: the
study already included (four studies), the studies carried out after 2003 (one study), no
measures of association available on HIV testing or UAI and numbers of sexual
partners (seven studies) or no disaggregate data available for MSM (one study). These
are listed in Table AS, Appendix A
Figure 2.9 Systematic review data flow for Investigation of the association
between HIV testing and number of sexual partners
Records identified Records exduded on
through database .. abstrad due to non-relevance
searching a-----I_~ or carried out after 2003
and saeened n= 136
n= 140
Additional records
from other
sources
n=27
Full-text artides
assessed for
eligibility
n= 31
..
Full-text artides exduded
n= 13
for the following reasons,
- 4 studies were already induded1 carried out after 20037 studies reported no outcome
measure for HIV testing or UAI and
number of sexual partners
1 did not report dlsaggregate outcome
forMSM
"
Studies induded in review fadors assodated
with HIV testing and number of sexual
partners
n=8
UAI and number of sexual partners
n=6
HIV serostatus and number of sexual partners
n=6
(total n=18)
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Eight studies that met the inclusion criteria presented an association between HIV
testing and number of sexual partners, six on HIV serostatus and number of sexual
partners and six reported on UAI and socio-economic status. Most of the studies were
from the US and they collected data from multiple US cities, and the most often
surveyed cities were San Francisco, Los Angeles, New York City, Seattle and Chicago.
The only UK study was based in London. An Australian study sampled from five large
cities and one Swiss study reported on number of sexual partners. Participants were
mainly recruited from community settings, from multiple gay venues and events and
medical settings (primarily HIV test clinics). All, but one of the studies were cross-
sectional convenience samples. One study used probability sampling based on a
telephone index, one based on the proportion of the population who were unmarried
adult males, while two used recruitment methods that were more systematic (e.g. every
third person who came into the venue) than convenience sampling Eight studies used
self-administered questionnaires, and five studies used interviewers to administer the
questionnaires. Three studies were focussed on young MSM, and one on ethnic
minority MSM, in particular Asian and South-Pacific MSM. Sample sizes varied
between the studies, although most of the cross-sectional studies sampled at least
2,000 MSM and the Australian study sampled over 22,000 MSM. Two US studies were
small, sampling just over 250 MSM each. The studies took place over a period of time
ranging from 1991 to 2001. A descriptive summary of these studies is given in Tables
2.7a-2.7c below.
Previous HIV testing was associated with an increased number of sexual
partners31,54,60,69 and a higher number of sexual partners was associated with recent
HIV testing87 and repeat HIV testing66,67,88 (see Table 2.6a below). This clearly suggests
that as HIV risk behaviour increases, with number of sexual partners, HIV testing
increases. Although the timing of the HIV testing to the partner acquisition is not
known, increased numbers of partners was associated with increased risk of HIV
infection. Though, a study in Switzerland of MSM presenting for treatment of an STI
found that MSM with ten or more sexual partners were more likely to refuse the offer of
HIV testing98. This study was in the early 1990s before the normalisation of HIV testing,
and so the associated stigma of an HIV test may have encouraged refusal. Refusal to
undergo an HIV test was associated with higher education in this Swiss study98.
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REVIEW OF FACTORS ASSOCIATED WITH HIV TESTING AND RISK OF HIV INFECTION
UAI was found to be associated with increased number of sexual partners - six or
more partners in the past 12 months'":" - and greater frequency of sex with men in the
past 30 days" and acquiring a new partner" (Table 2.6b). Risk of HIV infection was
associated with more than 25 partners in young MSM62,91,10\ and 10 or more partners
in repeat anonymous testers in San Francisco" (Table 2.6c). Most of the studies were
from the US. The age at which MSM choose to undergo HIV testing was different in the
US, compared with the rest of Europe and Australia. The numbers of sexual partners is
likely to be age-related in all geographic settings. Hence, the association of numbers of
sexual partners with choosing to undergo HIV testing could be different in the US when
compared to the UK. Nonetheless the two (very large) Australian studies showed
similar associations as seen for the US31,54. The single UK study investigated the
association of UAI with starting a new relationship, rather than numbers of partners.
This UK study found a positive association of UAI with being in a retanonsmp". More
published evidence is required from studies collecting data on sexual behaviour and
numbers of sexual partners in order to confirm the association between increasing
numbers of sexual partners and UAI in the UK.
In summary, in most of the studies, MSM who undergo HIV testing reported increased
numbers of sexual partners when compared to those MSM who do not undergo an HIV
test. In MSM, having a higher numbers of sexual partners was associated with UAI and
a higher risk of HIV infection. A summary of the likely association between HIV testing,
UAI, number of sexual partners and HIV infection is represented in the conceptual
framework in Figure 2.10 below. Other confounders previously reviewed (age, area of
residence and socia-economic status) are grouped with the 'unknown or other
confounders' for simplicity.
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Figure 2.10 Conceptual framework of the relationship between HIV testing, HIV
infection risk, unprotected anal intercourse, and number of sexual partners
HIV testing
HIV infection risk
Key
Factors associated witn HIV testing and HIV infection
risk that can be asked for I measured
Direction of innuence
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2.8 Association between HIV testing, unprotected anal intercourse, HIV
seroconversion or HIV serostatus and sexually transmitted infections
To investigate the association between HIV testing, UAI, HIV seroconversion or
serostatus and STls, a series of MEDLINE searches were carried out using PUBMED,
AIDSLINE and HealthSTAR via the National Library of Medicine (NLM) gateway on the
terms: 'homosexual', 'gay', 'men who have sex with men', 'sexually transmitted
infections' and (a) 'HIV testing'; (b) 'unprotected anal intercourse', and (c) 'HIV
serostatus' or 'HIV seroconversion'. This was followed up with a 'snowball' search
including papers by authors already retrieved and references within retrieved papers. In
total 436 surveys were extracted, of which 391 were excluded on abstract due to non-
relevance or date of survey post 2003 (Figure 2.11). A further 28 full-text articles were
excluded due to the study not being about HIV testing (one study) and no measures of
association available on HIV testing or UAI and area of residence (27 studies). The
excluded studies are listed in Table A.6, Appendix A.
Figure 2.11 Systematic review data flow for investigation of the association
between HIV testing, unprotected anal Intercourse, HIV seroconversion or HIV
serostatus and sexually transmitted infections
Records identified Records excluded on
through database abstract due to non-
searching .. relevance or carried out-and screened post 2003
n=428 n= 391
Additional records
from other sources
n= 8
" Full-text articles excludedFull-text articles n= 28
assessed for .. due to the following reasons
eligibility - 1 study not about HIV testing
n=45 27 no outcome measure for
HIV testing. or UAI and S11s
,r
Studies included in review factors
associated with HIV testing and
sexually transmitted infections
n=7
UAI and S11
n=1
HIV seroconversionl serostatus and
511
n=9
(total n=17)
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Seven studies that met the inclusion criteria presented an association between HIV
testing and previous STI, one on UAI and STI, five found an association between HIV
seroconversion and previous STI, and four on being HIV positive and previous STI.
Most of the studies were from the UK and they collected data from four cities in
England (London, Brighton, Manchester and Oxford) and two in Scotland (Glasgow
and Edinburgh). The US studies collected from multiple US cities, and the most often
surveyed cities were San Francisco, Los Angeles, New York City, Seattle and Chicago.
Participants were mainly recruited from community settings, from multiple gay venues
and events and medical settings (primarily HIV test clinics). The studies were a mixture
of cross-sectional, cohort and case control studies. The majority were convenience
samples. Five studies used recruitment methods that were more systematic (e.g. every
third person who came into the venue) than convenience sampling. Seven studies
used self-administered questionnaires, and ten studies used interviewers to administer
the questionnaires. Two studies were focussed on young MSM. One study was a tri-
continental collaboration of cohort studies. Sample sizes varied between the studies,
although most of the cross-sectional studies sampled at least 2,000 MSM. One US
study surveyed almost 50,000 MSM attending STD clinics The studies took place over
a period of time ranging from 1987 to 2006. A descriptive summary of these studies is
given in Tables 2.7a-2.7c below.
HIV testing was associated with previous STI diagnosis in MSM in studies in the US88
and Europe30.53.56(see Table 2.7a). Repeat testers were more likely to have a previous
STI in the US and the UK27.65.SSwhile regular testers in the US were less likely toss. In
the five studies that met the inclusion criteria, HIV seroconversion was associated with
previous STl36.41.42.46.102(Table 2.7c). Previous STI was associated with being HIV
positive both in the UK49and the US62.86.91.These are illustrated below in Tables 2.7a-
2.7c.
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REVIEW OF FACTORS ASSOCIATED WITH HIV TESTING AND RISK OF HIV INFECTION
The positive association between HIV testing and STls could be due to a number of
factors which include symptoms and associated health-seeking behaviours, and/or
clinic HIV test policy while symptomatic. MSM may be offered an HIV test at the
diagnosis of the STI in the sexual health clinic (depending on the policy). In one UK
study, HIV testing was associated with being recruited from a GUM clinic (AOR 1.29,
95% Cl 1.25 - 1.32)50compared with MSM recruited from bars and clubs. HIV testing
was associated with GUM service use in the past year (AOR 2.66, 95% Cl 2.66 -
4.24)30.The association between HIV testing and having a STI may be due to previous
high-risk sexual behaviour that puts the individual at risk of an STI and of HIV infection.
MSM reporting UAI were more likely to report an STI in the past year52 (Table 2.7b). A
study of MSM in New York City found syphilis to be associated with UAI and an
increased risk of HIV infection103.
The biological association between STls and increased risk of HIV infection has been
well established104-106.Having an STI, in particular ulcerative STls, makes an individual
more susceptible to HIV co-infection due to the damaged mucosal barrier. Additional
HIV seroconversion studies have found an association between STI and HIV
seroconversion36.41.42.46.86.102.HIV seroconversion in a case control study of MSM in the
UK was associated with being diagnosed with both gonorrhoea and syphilis42 (Table
2.7c). The risk of being HIV positive was associated with history of an
STI47.49.62.62.86.91.103,although some of these associations are linked to STI outbreaks in
MSM who were already diagnosed HIV positive in particular syphilis 103.
In summary, HIV testing was associated with previous STI in most of the studies. Both
UAI and risk of HIV infection were associated with previous STI, and gonorrhoea and
syphilis were important, where the STI was reported. A summary of the likely
association between HIV testing, STI and HIV infection is represented in the
conceptual framework in Figure 2.12 below. For simplicity, the other factors found to be
associated in this review (age, socio-economic status and numbers of sexual partners
and area) are all included as 'unknown and other confounders'.
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Figure 2.12 Conceptual framework of the relationship between HIV testing,
unprotected anal intercourse and sexually transmitted infections
Sexually
transmitted
infections
HIVtesting
Key
Factors associated with HIV testing and HIV
infection risk that can be asked for I measured
Direction of innuence
2.9 Evidence of changing sexual behaviours over time; how will this affect
the relationship between HIV testing and unprotected anal intercourse
HIV testing was associated with UAI throughout the 1990's and the early 2000's
(section 2.3 Table 2.2). The strength of this association decreased over time, as HIV
testing 'normalised'. The association between previous HIV testing and UAI was OR
1.90 (95% Cl 1.30 - 2.79) in 1987 to 1989 in the UK, and AOR 1.29 (95% Cl 1.26 -
1.32) in 1996 to 1997 (Table 2.2). The corresponding increase in HIV testing in MSM
reporting UAI over the decade was from 58% in the study in 1987 to 75% in 1997.
Within Scotland the association between testing and UAI was AOR 1.57 (1.13-2.18) in
1999, and HIV testing was less common in Scotland (58% tested with UAI). Research
on the HIV testing behaviour of MSM in Scotland found this low rate of HIV testing was
due to both fear of a positive result, and HIV-related stigma and discrimination within
the MSM community107.108(Table 2.2). In the US a similar apparent decrease in the
strength of the association between testing and UAI was seen; AOR 1.78 (95% Cl 1.12
- 2.82) in a study in Minnesota in 1989, to AOR 1.32 (95% Cl 1.02 (95% Cl 1.02 -
1.79) in seven cities in 1999. HIV testing in MSM reporting UAI increased from 64% to
79% in these studies. This varied by subgroup, and the strength of the association
92
REVIEW OF FACTORS ASSOCIATED WITH HIV TESTING AND RISK OF HIV INFECTION
between testing and UAI in young Asian and Pacific-island MSM remained; AOR 2.21
(95% Cl 1.04 - 4.70) to AOR 2.6 (95% Cl 1.3 - 5.3) between 1999 and 2002 (Table
2.2).
The strength of the association between HIV seroconversion and UAI remained
throughout the 1990's in cohort studies in the US; AHR 2.0 (95% Cl 1.3 - 3.0) in 1995
in MSM with reported UAI in past year and AHR 2.85 (2.12 - 3.84) in 1999 to 2001 in
MSM with reported UAI with serostatus unknown partners (section 2.3 Table 2.1a).
Case control studies in the US, UK, and Australia, all maintained similar associations
between HIV seroconversions and UAI throughout the 1990's and up to 2002 (Table
2.3a).
There is evidence that UAI in MSM was increasing over time48,49,71,72,94,l09-115. This
phenomenon was seen throughout Europe48,49,72.94,110, the US71,73,109-111,l16 and
Australia 114.115. There has been a corresponding increasing trend in 8Tls in M8M82 and
in HIV diagnoses117,118. The re-emergence of syphilis at the end of the 1990s has been
seen in Europe, the US and Australia 119-122. It was suggested that the availability of
treatment might have diminished the perceived seriousness of HIV123. A meta-analysis
review of 25 studies in the U8 and Europe by Crepaz and colleagues 124 found that
there was no evidence to suggest that HIV positive M8M receiving ART or with
undetectable viral levels had more UAI than others. Regardless of their HIV serostatus,
the likelihood of UAI was higher in people who agreed that receiving ART or having
undetectable viral load protects against transmitting HIV, or that availability of ART
reduces their concerns about having unsafe sex 124. More recently evidence suggests
that there may be selective serosorting between HIV positive MSM resulting in an
increase in 8Tls in M8M with clinically diagnosed HIV infection80•83,84,125-129.
Changing sexual behaviour could affect the strength of the relationship between HIV
testing and UAI, which would affect the estimates of total HIV infections calculated in
Chapter seven. If HIV testing behaviour and its association with high-risk sexual
behaviour changes over time, and the groups that HIV test are different now than
people who tested 10 years earlier, the relationship between HIV testing and UAI could
change. This increase in high-risk sexual behaviour might affect the relationship
between HIV testing and risk of HIV infection in three ways:
(1) HIV testing could increase proportionately with UAI so there would be no
change in the risk of HIV infection between HIV testers and non-testers.
(2) Alternatively, if HIV testing remains the same, but those who HIV test have
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higher risk of HIV infection as they are now having a higher number of UAI
events Then the estimated adjustment would underestimate the true difference
between HIV testers and non-testers and thus overestimate numbers of
undiagnosed HIV infections.
(3) Finally, if the increase in UAI is in non-testers, then the adjustment factor
estimated for HIV testers would be too large and this would lead to an
underestimate of undiagnosed HIV infections.
Is there any corresponding HIV incidence or diagnosis surveillance data available to
monitor these changes? If there was no change in HIV testing then those who test are
more likely to become HIV positive and the adjustment factor for non-testers compared
with HIV testers would be an underestimate over time. Surveillance data must be able
to monitor this prospectively. This could be done through behavioural surveillance
surveys. Previous test history collected in all newly diagnosed HIV infections would
allow for the monitoring and for alteration of the adjustment factor derived in Chapter
seven if the relationship between HIV testing and UAI changed. A notification system
that indicated when the change in the relationship between HIV testing and UAI was
large enough to affect the estimates would need to be put in place. By how much this
relationship would need to change before recalibration of the adjustment factor would
be necessary would be determined through sensitivity analyses.
2.10 Conclusion
MSM who choose to undergo an HIV seem to have different levels of risk behaviour
when compared to men who do not test for HIV. It may be possible to use the pattern
of HIV testing as a proxy for different levels of risk behaviour. In cohort studies, risk
behaviour is associated with HIV infection. The associations between risk of HIV
infection and HIV testing from the literature are summarised below in Table 2.8.
A summary of the associations between HIV testing and UAI, with each of the factors
found through this review, by study is included in Table A.7, Appendix A.
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Table 2.8 Summary of known factors (based on this review) with the current
understanding of how they are associated with HIV testing and infection
Factor Association with HIV Association with risk of HIV
testing in MSM infection in MSM
Unprotected anal Increased HIV testing Increased HIV risk
intercourse
Age HIV tested increases Risk increases with increasing age
with increasing age (number of years since first sex)
Socio-economic HIV testing associated HIV risk increases with lower SES
status (SES) I with higher education and less education
education and unemployment
Number of sexual Increased HIV testing Increased HIV risk with increased
partners with numbers of partners number of partners
Area of residence
Sexually transmitted
infection
Behavioural
interventions
Sexual partnership
networks
Anti-retroviral
therapies (ART)
HIV testing higher in
urban areas
Increased HIV testing
May lead to an increase
in HIV testing, for MSM
to determine serostatus
Not associated with HIV
testing
Not associated with HIV
testing
HIV prevalence varies by area, and
so too does risk of infection
Increased HIV risk as facilitates
HIV transmission
Should reduce risk behaviour
HIV risk can be dependent on
sexual networks. Area of residence
may act as a proxy measure, for
locations of higher HIV risk,
although the network may be
independent of the urban
conurbation
Lower viral levels should lead to a
decrease in HIV transmission; this
will lessen the effect of UAI. It may
be dependent on the availability of
therapy and so will be provision
dependent. This may lessen the
association with area, if ART is
available for all diagnosed HIV
positives in high prevalence areas
The motivation behind HIV testing is complex and an individual's decision to do so can
be affected by distal factors unrelated to risk of HIV infection These can include HIV
testing policy which is often related to individual GUM clinic HIV testing policy rather
than an individual's risk behaviour. The availability of HIV testing can vary according to
whether GUM clinic or HIV testing clinic are accessible and close to an individual's
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area of residence, and these area-level or ecological covariates are not related to
individual-level covariates of risk behaviour. Additionally HIV testing may be affected by
media pro-testing campaigns, and health education messages promoting HIV testing.
These campaigns should also be related to risk, although they will be subject to self-
perception and have been the result of large numbers of "worried-well" coming forward
to test in the past130.131.
These findings are explored further below in a conceptual framework.
2.11 Final conceptual framework for the association of HIV testing with risk
of HIV infection
Based on the review of the available data presented in this chapter, a conceptual
framework (directed acyclic graph) is shown in Figure 2.13. This directed acyclic graph
identifies a set of factors that are associated with HIV testing and HIV infection via
sexual transmission between MSM. Single-headed arrows represent direct links from
exposures to outcomes; in Figure 2.13 the single arrow from UAI to HIV infection
represents a direct association of UAI on HIV infection (that is, an association not
mediated by another variable in the framework) 132. The absence of an arrow or a
variable implies that the relationship is independent. A dashed line with no arrow-heads
represents a relationship that is not specified in the framework. These are for example,
other distal factors that will affect risk of HIV infection but will not be associated with
HIV testing (such as behavioural interventions, effectiveness and availability of
medication and sexual partnership networks, as described in Table 2.8). The ways in
which different factors may influence the choice of having an HIV test and/or the risk of
HIV infection, either directly or indirectly, are shown. Factors that are important but are
proxied by HIV testing and / or HIV infection risk and thus are not considered further in
this study are in white surround boxes. For example if the number of people who have
an HIV test in a given year is known, how and whether media pro-testing campaigns
lead to testing has thus indirectly been quantified, therefore it is unnecessary to
measure this factor within the model.
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Figure 2.13 Conceptual framework of the relationship between HIV testing and
risk of HIV infection mediated through risk behaviour
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This graph can be viewed as a simplified representation of selected aspects of the
associations and provides an easily understood depiction of the assumptions about the
relationships between HIV testing, UAI and HIV infection 133. The framework is useful for
identifying variables that must be measured and controlled to obtain un-confounded
measures of association given the assumptions outlined in the graph. For example,
based on figure 2.13, area of residence is a confounder of the association between
STls and HIV infection risk, whereas HIV testing is on the causal pathway between STI
and HIV infection risk. In the conceptual framework, perception of risk acts as an
intermediate between UAI, age, STI and HIV testing. Within this conceptual framework,
the relationships between the factors are assumed rather than proven. Later analyses
will be based on this conceptual framework. If the assumptions of underlying relations
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are wrong, the analyses may be biased. This conceptual framework visualises the
relations between variables in the analyses. Its explicit framework enables us to test
the assumptions by targeted sensitivity analyses.
While most of the relationships shown in Figure 2.13 appear to be consistent in many
western countries, the framework is specifically intended to describe the UK. This
complex graph of the known relationships between HIV testing and HIV risk contrasts
the more simplified relationships implied in Chapter one, section 1.2, Figures 1.2-1.4,
which are the basis for previous estimates of total HIV infections in MSM through both
direct and indirect methods. This thesis will use these relationships through
surveillance methods and develop a quantifiable method to estimate different risks of
HIV infection between HIV testers and non-testers. Based on Figure 2.13, some factors
will have a direct association with both HIV testing and risk of HIV infection, while other
factors will act through them having a more indirect association. For example if HIV
testing and HIV infection risk differences between MSM of higher and lower
socioeconomic status are accounted for by differential numbers of STls and numbers
of sexual partners, then socioeconomic status has an indirect association with HIV
testing and HIV infection risk. This is a summary of 'proxy variables' that capture
indirectly the sum of rather complex behaviours, even though the complex behaviour
hasn't been measured. This obviously relies on the assumptions made in the
conceptual framework in Figure 2.8, specifically that things that are not connected via
arrows are truly independent. Although there was some suggestion that socio-
economic status or education was directly related to HIV testing, this appeared to be
mediated through both numbers of sexual partners and UAI. In the UK, area of
residence and socio-economic status are closely related at population level, and since
the purpose of this thesis is to arrive at estimates of total HIV infections in a population
by area, SES was dropped from the analyses. Similarly, number of sexual partners
while associated with HIV testing is probably reflecting UAI. In the UK STls in MSM are
strongly associated with age and STls are more common in younger men. This is likely
to be related to both UAI and sexual networks so age will remain in the framework.
STls in MSM in the UK are also associated with area of residence, sexual networks
and changing sexual behaviour over time. Hence, by including the factors age, area of
residence, STls and HIV testing, the framework is measuring for the association of
UAI with risk of HIV infection.
These assumptions will be tested further in subsequent analyses in Chapters four, five
and six. Other factors that are connected to HIV testing and I or HIV infection risk by
arrows within the graph (Le. open backdoor paths) must be considered. If all HIV
infections have been diagnosed, how and whether sexual partnerships affect risk of
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HIV infection has thus been indirectly quantified and the issue of sexual partnership
networks is irrelevant. However if all HIV infections are not known then not knowing
sexual partnerships may bias the result unless the model adjusted for area of
residence. Another unmeasured factor in the framework is availability of HIV testing.
Again if all HIV tests are known, availability of testing is not important, however if not all
HIV tests are known, and then availability of testing would bias our results unless the
model adjusted for area of residence. Finally changing sexual behaviour over time is
related to both HIV testing, STls and UAI in the framework. Similarly if how many
people HIV test is known, changing sexual behaviour over time will not be relevant.
However if all tests are not known, then not knowing how sexual behaviour is changing
over time will bias the results unless the model adjusts for STls. The associations
between changing sexual behaviour with HIV infection risk and their likely directions
are explored in sensitivity analyses in Chapter seven.
The potential effect of the other distal factors on these relationships, such as: HIV
testing policy and practice, availability of effective ART, availability of testing, and the
effect of media campaigns, will be examined through sensitivity analyses. The
importance of time as a factor will be dealt with through sensitivity analyses. The
framework will address factors related to HIV testing and risk of HIV infection, levels of
risk behaviour, frequency of HIV testing and the importance of population size within
risk strata. Sexual partnership networks are more complex and to allow for them would
require complex modelling methods and thus are outside the scope of this project.
Recommendations for key behavioural data to be collected in the future as part of HIV
and STI surveillance datasets will be made following sensitivity analyses in Chapter
seven to determine their importance in the estimations of the model.
2.12 Plan of analysis
This chapter explored factors that have been previously described to be associated
with HIV testing and risk of HIV infection. These associations were then summarised in
a conceptual framework. Subsequent chapters in the thesis will explore aspects of this
conceptual framework further in a series of independent data-sets. The analyses will
quantify associations, which will enable the development of a parametric adjustment
model to estimate total HIV infections in MSM in the UK. Seven analyses were carried
out as illustrated below in Figure 2.14
1. Description of the diagnosed HIV infections in MSM in the UK, and a summary
of available surveillance data on HIV testing (Chapter three).
2. Characterisation of the size of the MSM population, the general level of risk
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behaviour, and an investigation of the socia-demographic and behavioural
characteristics associated with HIV testing in MSM using the Natsal (a UK
based more representative survey study), in addition to providing estimates of
prevalence of HIV testing by age group (Chapter four).
3. Investigation of the socia-demographic and HIV testing characteristics in MSM
attending a GUM clinic in inner London. An UA study was carried out to
determine the prevalence of HIV infection in MSM who have HIV tested
compared with those have chosen to not have an HIV test (Chapter five).
4. Estimation of the prevalence of HIV infection by risk-behaviour levels, in a
higher-risk group of MSM and in MSM who have not attended a GUM clinic
compared with MSM who have attended a GUM clinic. This was achieved
through a comparison of a UA GUM survey with a community-recruited survey
of MSM (GMSHS) following standardisation with Natsal (Chapter six).
5. Calculation of an adjustment factor for MSM to estimate total risk of HIV
infection. Natsal was used to estimate the proportions of the population within
each subgroup, and the results from Chapters four, five and six were combined
to estimate the overall adjustment factor within each age group of MSM
(Chapter seven).
6. Estimation of total prevalent HIV infections in MSM in UK, using diagnosed HIV
infections from SOPHID, the proportions of MSM who have HIV tested from
Natsal, and the calculated adjustment factor (Chapter seven).
7. The model was compared with estimates derived from other methods, and
sensitivity analyses were carried out (Chapter seven).
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Figure 2.14 Plan of analysis
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Summary
This chapter includes a description of GUM clinics and their accessibility and an
investigation of where HIV tests are being carried out in the UK. This is followed by a
review of HIV test policy, and finally trends in HIV testing and a description of HIV and
STI trends using available surveillance data. All data are presented up to 2002, the
year prior to when the survey in Chapter four was carried out.
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3.1 History of Genitourinary Medicine clinics in England and Wales - What
population do GUM attendees represent?
The origins of surveillance data on STls in the UK can be traced to the Royal Commission
on Venereal Diseases chaired by Lord Sydenham of Combe which started to take
evidence in 1913 and reported in 1916. The commission recommended the establishment
of a free open-access medical service organised by local authorities and funded 75% by
central government and 25% by local government. The clinics were required to make
workload returns to the Department of Health (DH) each quarter and these mark the
beginning of all further STI surveillance in the UK. The clinics were slow to develop and
had little to offer in effective treatment, especially of gonorrhoea, and there was a large
backlog of untreated disease to contend with, which was increased by returning soldiers.
The first reported results from these clinics, in 1918, showed 27,000 cases of syphilis and
17,000 cases of gonorrhoea. In 1919 the case numbers had increased to 42,000 syphilis
and 38,000 gonorrhoea cases. Within a decade, the number of syphilis cases had
decreased but gonorrhoea continued to increase over time.
Data on the occurrence of new cases of gonorrhoea was collected on form SBH60 and
have been recorded on form KC60 since April 1988. The KC60 form records the number
of new diagnoses at GUM clinics each quarter by diagnosis, sex, and age group. In
addition, many clinics record data on the proportion of specific infections among new male
clinic attenders attributed to sex between men. The catchment population served by each
individual clinic is not known accurately, so KC60 data should only be used to generate
large-scale (national or regional) STD incidence rates. Electronic delivery of the KC60 is
under development and is available in some pilot clinics. This would enable more
accurate analyses of STls.
Data from GUM clinics will underestimate the true rate of diagnosis in the population as
not all STls will be diagnosed and treated in GUM clinics and some will be seen and
treated at General Practices (GPs). This effect is likely to be small for MSM. A national
survey of MSM carried out in 2003 found that although 79% reported visiting a GP or
local doctor in the past year, only 5% reported having a sexual health check-up and
4% an HIV test, as a reason for their last visit to a GP surgery or local doctor?". Open
access for GUM means that patients may travel outside their area of residence to
access services. This will tend to overestimate the rates for London (The survey of
prevalent HIV infections diagnosed (SOPHID) recorded that 6% of HIV positive MSM
seen for care in London in 2002 were resident outside London), but this effect is likely
to be minimal for England and Wales as a whole. Although these limitations may result
in a degree of error in the measurement of the rates described in section 3.5.2, this is
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likely to be consistent over time.
3.2 Review of historical HIV testing policy in England and Wales
HIV testing policy has changed over the past two decades in England and Wales. The
Chief Medical Officer's public health strategy in 1991135 stated that public education
about HIV infection and AIDS remained a major part of the government's strategy to
prevent HIV transmission and to contain the epidemic. Campaigns were directed at
both the general public and particular sectors of the population. Since 1992, all aspects
of HIV prevention, whether local, national, general or targeted at particular groups were
considered within the general field of sexual health. In 1994 the main aims of the
Governments strategy on HIV and AIDS moved towards bringing initiatives to combat
HIV infection and AIDS into the mainstream of health care and health promotion. In
1995, the Government strategy called for a more focussed health promotion strategy,
placing greater emphasis on appropriate targeting of high-risk groups, Le. homosexual
and bisexual men, people with links to high prevalence countries, IDUs and female
partners of men in these groups.
An examination of the policy and practice of testing in GUM clinics in the UK, which
was undertaken by the British Co-operative Clinical group in 1999136, found that a
substantial group of people with HIV infection fail to have their infection diagnosed and
concluded that the main barriers to HIV testing were non-offering of HIV test to those at
high-risk and lack of resources to increase the level of testing. At the time of this study,
a new sexual health strategy was under consultation 137, which amongst other things
aimed to identify key areas for health promotion and appropriate groups to target for
HIV prevention. It had set as a target to reduce by 25% the number of newly acquired
HIV infections by the end of 2007, and to reduce undiagnosed HIV by 50% by the end
of 2007. At the time it was thought was that this would be achieved through offering a"
attendees at GUM clinics an HIV test at first STI screening, and the aim was to
increase the uptake of testing to 40% by 2004 and to 60% by 2007. This was the
situation at the time of when this PhD study set out, and the estimations of total HIV
infections presented in Chapter seven are for 2003 to further inform this planned policy.
In general, HIV-related education campaigns have targeted sexual health and
practising safer sex, rather than encouraging people to get tested, although this has
been changing over time. Local campaigns promoting HIV testing for MSM began in
London in 1995, and nationwide campaigns started in 1998. Since 1998 several
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campaigns have targeted MSM, encouraging individuals to be HIV tested, citing
improved treatment and knowledge of partner's serostatus for determining whether to
have UAI as reasons for testing. Throughout the 2000s, HIV testing has been promoted
positively for MSM.
A review of the impact of national anti-HIV sexual health campaigns on the
transmission of HIV in England130 found that awareness of AIDS and campaigns in
1983-4 among MSM coincided with substantial declines in transmission of HIV,
although the improving trends in gay sexual health indices in the mid-1980s were not
sustained, and high levels of risk-taking behaviour were recorded in MSM in the early
1990s. These increases have continued and there was little evidence of any positive
impact of the government's more focussed health promotion strategy130 on HIV
transmission in the 1990s. There was some evidence of changed behaviour following
HIV negative testing76; however, previous increases in HIV testing following health
education campaigns, while showing a large overall increase in the number of tests,
had not led to an increase in the diagnosis of HIV infections in high-risk individuals 138.
In an effort to reduce the number of undiagnosed HIV infections in the population and
to reduce HIV transmission, testing promotion has been prioritised by the Department
of Health's National Strategy for Sexual Health and HIV for England137. Key strategies
include the provision of clear information to the public about HIV with the aim of
encouraging the demand for voluntary HIV testing while improving access to GUM
services and increasing the offer of HIV testing. At the same time, there is a growing
acknowledgement of the need to remove the exceptionalism and stigma associated
with HIV testing by providing these services outside traditional GUM and antenatal
settings 139. Guidelines in 2002 promoted HIV testing of all new attenders at a GUM
clinic including those who had recent sexual exposure.
3.3 Surveillance data sources used to describe HIV and STI trends
The capture of data through the existing surveillance systems in the UK, at the different
stages of HIV infection in MSM is illustrated below in Figure 3.1. The next sections
describe these different data-sources in more detail and how these data were analysed
to produce the graphs on trends as shown later in this chapter.
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Figure 3.1 The different stages of HIV infection and how they are monitored
through current surveillance system in the UK
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3.3.1 HIV infection reporting
Newly diagnosed HIV infections in England and Wales were reported to the HPA
CDSC. These reports had two sources, from microbiologists reporting specimens sent
for testing in their laboratories, and from clinicians reporting newly diagnosed patients.
Clinicians extended their reporting, which before had only covered AIDS cases, to
include all newly diagnosed infections from the beginning of 2000. Cases were
reported using a standard form. Voluntary confidential reporting methods were used to
collect a range of epidemiological information including Soundex code 140 (a non-unique
alphanumerical code that summarises patient's surname) and date of birth and gender,
which permitted the identification of duplicate reports for the same individual from other
laboratories and within that laboratory. These were checked by Soundex code, date of
birth, sex, and exposure category, using a predefined algorithm of likelihood. If data on
fields, such as Soundex, date of birth, gender or exposure category were missing,
active follow-up to reporting clinician by telephone was undertaken. Data presented in
this thesis include all males reported with a first HIV diagnosis in England and Wales
where the probable route of infection was sex between men. Data analysed included all
reports received by the end of 2003. In order to minimise the effects of delays in
reporting and ascertainment of route of infection these data were censored at the end
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of 2002.
3.3.2 Reports of deaths in HIV infected people
Deaths in HIV infected people were obtained from both the Office of National Statistics
(ONS) and clinicians. Deaths were adjusted for delayed ascertainment and non-
ascertainment. This adjustment factor was derived following a matching exercise that
linked reported AIDS cases with ONS death certificates. The proportion of HIV deaths
found in the death certificates that were not reported as AIDS cases, was assumed to
be the non-reported proportion for later years. This matching exercise was carried out
periodically to update the adjustment factor!".
3.3.3 National Survey of Prevalent HIVInfections Diagnosed (SOPHID)
People living with diagnosed HIV infection and receiving care in England and Wales
were reported annually to the SOPHID. Men where the probable route of infection was
sex between men and who were reported as living in England and Wales for each year
between 1997 and 2002 were included. An annual survey of prevalent HIV infections
that have been diagnosed has been undertaken since 1994142. Limited data including
Soundex code, exposure category, sex, and date of birth were captured from care
providers on HIV infected persons receiving care within a calendar year. The data were
adjusted for both under-ascertainment and non-attendance for care. Under-
ascertainment was measured by comparing data with laboratory HIV infection reports,
CD4 count reports and AIDS case reports of persons not known to have died. The
small number of individuals who did not access services within a particular calendar
year was estimated by comparing the survey across a three-year period'". The non-
attendance adjustment for 2002 for example, was based on the numbers of individuals
seen for care in both 2000 and 2002, but not 2001, as a proportion of the 2001
SOPHID total. The proportion not seen for care in 2001 was then applied to the 2002
survey data as the best available estimate of non-attendance for that survey year'".
3.3.4 Surveillance of sexually transmitted infections
Surveillance of other STls in England and Wales was based on statutory quarterly
aggregate statistical returns (KC60) from GUM clinics reported to CDSC and CDSC
Wales. Male homosexual acquisition of STls was reported for five acute conditions:
uncomplicated gonorrhoea, infectious syphilis (primary, secondary and early latent),
genital chlamydia infection, genital warts (first attack) and genital herpes (first attack).
Data on acute (male) homosexually acquired conditions were reviewed for the period
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1997 to 2002. Information was available by region of diagnosis within England and for
Wales for all five conditions. Age group at year of diagnosis was only reported for
uncomplicated gonorrhoea in MSM.
3.3.5 Estimating the populations of MSM for calculating rates
Natsal 2000 estimated the proportion of men, aged 16 to 44 years, reporting sex with
another man in the past 5 years to be 2.6% (95% Cl 2.2 - 3.1) in Britain, 5.5% (4.2 -
7.2) in Greater London and 2.1% (1.7 - 2.7) in the rest of Britain26. These point
prevalences were applied to the 2000 mid-year census 144 estimate of males aged 16 to
44 years to obtain estimates of the numbers of MSM living in England and Wales as a
whole and separately for London and the rest of England and Wales and for specific
age groups, based on the KC60 age group categories. These were; 16-24 years, 25-34
years, 35-44 years old and 45 and over. It was assumed that the proportion of males
aged 35-44 who were MSM was similar to the proportion of men aged 45- 59 who were
MSM, and the population of MSM aged 45 to 59 was extrapolated from these data.
Estimates were only made for MSM up to 59 years old. It was assumed that there was
no difference between the prevalence of MSM in the rest of Britain and the rest of
Britain excluding Scotland (otherwise defined as the rest of England and Wales) and
this proportion was applied to the census population aged 16 to 44 for this area only,
excluding men from Scotland. The population of MSM aged 45 to 59 was again
extrapolated. Chi-squared test and Chi-squared test for trend were used to examine
changes in the rates per 100,000 populations of diagnoses of HIV and other STls
between 1997 and 2002 using Epi-Info 6 (v.6.04d); 95% confidence intervals around
the rates were calculated using STATA 7.0 (StataCorp, 2001).
3.3.6 Sentinel survey of first HIV tests
The Sentinel Survey of first HIV tests was set up in 1986 by the Public Health
Laboratory Service to monitor trends and determinants of voluntary HIV testing in
England through the sentinel surveillance of 18 laboratories and has been published
before 145.146. Seven sentinel laboratories in England (three in London and four outside
London) were selected to continue after 1998. They were not a randomly selected
sample of laboratories and cannot be assumed to reflect all HIV testing in England.
Although these sentinel laboratories accounted for 16% of all HIV tests reported from
English GUM clinics in 2000 and areas outside London were well represented.
First tests of individuals were identified on each laboratory database in the laboratory
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by matching on either GUM number or name and date of birth. All patient identifiers
were then removed before extracts of all first tests were sent to the CDSC for addition
to a central database. Variables collected on each patient included: date and final
result of test, source of specimen, age, gender, reported risk factors, nature of contact
involved in the HIV transmission risk, reasons for testing and symptoms at the time of
test. Specimens referred to participating laboratories from other laboratories for
confirmatory testing were excluded. Only those tests requested by GUM clinics and
GPs were included from all first HIV tests performed from January 1990 to December
2000 in the seven sentinel sites. A total of 206,782 first HIV specimens were tested at
the seven sentinel sites over the 10-year period. Ninety-eight per cent were eligible for
inclusion in this study. Two laboratories, both in London and with more than 50,000
tests each, accounted for over 50% of the tests. Ninety per cent (182,746/202,892) of
the eligible tests were requested from GUM clinics. MSM accounted for 11.2%
(22,6851202,892) of individuals tested for HIV, with the proportion ranging from 3.8%
(522/13,817) to 19.5% (11,111/56,916) across sites. Overall, in GUM clinics 12% of
HIV tests were for MSM. In contrast, 3% of tests requested by GPs were for MSM and
13% for IDUs 147. Differences in proportions were tested by Pearson's Chi-squared
method and Fisher's exact test where appropriate. Point estimates and exact
confidence intervals for odds ratios were calculated for comparison of the odds of
testing positive by source. Trends were analysed using linear regression using ordinary
least squares.
3.4 Trendsin HIVtesting InMSMIn the UK
Two decades of intensive HIV health promotion have seen gradual and sustained
increases in HIV testing among GUM attendees in the UK up to 2003. Statutory returns
made by GUM clinics in England (form KC60) show that the number of episodes of HIV
counselling and testing increased by 35% in the last year, 56% in the last 3 years and
by 90% in the last 6 years to 201,347 in 2001148. Nevertheless, substantial numbers of
HIV infected individuals in the UK still do not know their HIV status" and therefore
cannot receive appropriate care, notify their partners or be guided in safer sexual
behaviour in knowledge of their status". At the time of starting this thesis, there is little
information on HIV testing trends in General Practice in England149 or in other settings
where individuals at increased risk may be seen (e.g. termination of pregnancy clinics).
3.4.1 Trendsin HIVtesting from sentinelsurveillanceof first HIVtests
Between 1990 and 2000 the number of overall voluntary HIV tests undertaken at these
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seven sentinel sites more than tripled. GUM clinics accounted for most of this increase
with a near quadrupling of tests, while little overall change was seen in the number of
HIV tests undertaken at GPs. The increased HIV testing at GUM clinics was observed
among all exposure groups except heterosexuals with high-risk partners and happened
over a period when new attendances at these sites doubled!". Much of the increase
was due to testing among low-risk heterosexuals, not MSM. This may have been a
direct response to sexual health promotion messages throughout the 1990s although
other factors such as changing clinic policies regarding the offer of routine HIV testing
may also have contributed!".
3.4.2 HIV testing by source of specimen in MSM
More first HIV tests for MSM from GUM clinics than from GPs were reported both
within and outside London (Table 3.1). Only 141 tests were done by a GP in London
which was 1% of all the tests done in MSM in London. Outside London, there was a
higher percentage (6%) of MSM who had an HIV test with their GP. MSM tested
outside London were younger than those tested in London with a modal age of 20 to 24
compared with 25 to 29 in London. Overall, HIV positivity was high in MSM (6.8%,
1,550 of 22,685). Within London, HIV positivity was higher among MSM tested at GPs
than in those tested at GUM clinics (Table 3.1) (OR 1.98, 95% Cl 1.20 - 3.16). There
was no difference in HIV positivity in MSM tested in GPs and GUM clinics outside
London (OR 0.89, 95% Cl 0.53-1.44).
Table 3.1 Number of first HIV tests for MSM by source and HIV prevalence
London Outside London Total
GP total GUM total GP total GUM
total
Total number tested 141 13,734 520 8,290 22,685
HIV prevalence 15.6% 8.5% 3.7% 4.1 % 6.8%
Source:Chadbomet al. HIV testing in Sentinel surveillanceof HIV tests
3.4.3 Trends in first HIV testing and HIV prevalence In MSM
The annual number of first tests in MSM increased from 1,437 in 1990 to 2,427 in 2000
(Figure 3.2). Linear regression analysis in MSM showed decreases in HIV prevalence
over time overall (test for trend: p<0.01) (Figure 3.2) and both within (test for trend:
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p<0.01) and outside London (test for trend: p=0.02).
The HIV positivity among MSM (6.8%) in this study was similar to that found among
testers attending a same-day testing service at a large inner-London hospital in
2000/2001152. The data provide evidence of a continual decline in HIV prevalence
among MSM first testers at GUM clinics between 1990 and 2000. This could not be
accounted for by changes in the age distribution and trends in HIV prevalence were
similar in all age groups. Decreasing trends in HIV prevalence in the UK have been
reported among MSM GUM clinic attendees tested for syphilis between 1993 and 2000
that were not previously diagnosed with HIV in the Unlinked Anonymous
Seroprevalence Surveys". Similar trends among GUM clinic attendees have been
found in Amsterdam (first testers) 153 and America (all testers) 154 where declines in HIV
prevalence among MSM contrast with stable prevalence among heterosexuals and
those with no identified risk.
Figure 3.2 Trends in HIV testing and HIV prevalence among MSM first testers at
GUM clinics. Sentinel Survey of first HIV tests .
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3.4.4 How much HIV testing is indicated in MSM from other studies
A review of other available surveillance data in England and Wales was carried out to
estimate the concurrent level of HIV testing among MSM from multiple sources. Data
reviewed included national HIV surveillance proqramrnes", clinician and laboratory
reporting of newly diagnosed HIV infections and the UAPMP, as well as other
published surveys on HIV testing in MSM29,155,156. These are all shown in Table 3.2.
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Table 3.2 Behavioural and clinical surveys of MSM measuring HIV testing rates in
Britain
Survey Source of survey sample Areas covered
Gay Men's Sexual Health Survey Self-completion PAPls at London,
(GMSHS) 2002157 Gay bars and clubs Manchester
Gay Men's Sex Survey (GMSS) Self-completion PAPI at London,
200229 Gay Pride festivals Manchester
National Survey of Sexual Attitudes National probability sample National
and Lifestyles (Natsal) 200026 face-ta-face and CASlb
interview
British Co-operative Clinical Group Structured retrospective 53 GUM clinics
(BCCG) 1998156 case-note survey of first
100 patients seen
KC60 diagnoses January to March Episode data from GUM All GUM clinics
2003158 clinics, statutory reports in England and
Wales
UA GUM survey, UAPMP 20025 MSM receiving syphilis 15 GUM clinics
serology at GUM clinic in the UK
attendance
Note. a. PAPI: pen and paper interview; b. CASI: Computer assisted self-interview.
Both community and clinic based behavioural surveys of MSM confirm the rate of HIV
testing among MSM; community surveys suggest testing rates ranging from 74% to
64% ever tested29.155, and from 37% to 38% in the last year155 (Figure 3.3). Among
GUM clinic attendees in the past year, 85%-87% had ever HIV tested. Clinical surveys
found slightly lower rates from 60-72% of all MSM attending GUM clinics being offered
and accepted an HIV test5.156 (Figure 3.3). Preliminary analysis of the January to March
2003 KC60 returns from all GUM clinics suggests that the rate of HIV testing in MSM
attending clinics is high, an estimate of 51% of MSM attending GUM clinics were
offered and accepted a HIV test. A review (using recorded KC60 codes) of all
attendees at 15 GUM clinics, receiving syphilis serology who had a HIV test at that
presentation, reveals a similar proportion HIV testing, 60% of MSM presenting with an
acute STI and 55% of MSM presenting with a non-acute condition (Figure 3.3). Overall
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there is some variation of percentages of tested MSM depending on the data source,
and when examined within the same study (e.g. Natsal) there appears to be an
association with GUM attendance. This will be explored further in Chapter six.
Figure 3.3 Behavioural and clinical surveys measuring HIV testing rates in the
UK
Behavioural surveys of MSM
Ever tested
• Natsal 2000
• GMSS 2002
• GMSHS 2002
attended GUM clinic in last year;
ever tested
Tested in last year
o 20 40 60 80 100
Percentage
Clinical surveys of MSM
Presenting with non-acute
condition had HIV test
• UA GUM survey 2002
• KC60 2003
• BCCG1998
Presenting with acute STI had HIV
test
Attending GUM clinic had HIV test
o 20 40 60 80 100
Percentage
Note. Natsal: National Survey of Sexual Attitudes and Lifestyles; GMSS: Gay Men's Sex
Survey; GMSHS: Gay Men's Sexual Health Survey; UA GUM; Unlinked anonymous
genitourinary medicine clinic survey; KC60; Statutory returns of sexually transmitted infections
diagnoses; BCCG: British Cooperative Clinical Group
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3.5 Trends in HIV and 5Tls in the UK
This section examines trends in diagnoses of HIV and other STls in MSM in England
and Wales. Data from many surveillance and survey sources have been combined to
present these trends within the context of the MSM population. In the UK, surveillance
of STls, and for the most part HIV, is based on reports from GUM clinics that provide
free, open access and confidential diagnostic services to the public. The surveillance
methods are described above in sections 3.3.1 to 3.3.55.
3.5.1 Overall Trends in HIV and STI in MSM
Since HIV/AIDS reporting began in the UK in the early 1980s, 21,401 MSM have been
diagnosed with HIV infection up to the end of 2002, of whom 11,956 have progressed
to AIDS and 7,648 have died (Figure 3.4)5. Numbers of MSM living with diagnosed HIV
infections and accessing HIV care increased from 9,244 in 1997 to 14,709 in 2002
(Figure 3.4). The number of MSM living with diagnosed HIV infection in London was
8,259 compared with 6,450 living elsewhere. Taking into account the higher numbers
of MSM living in London, this still gave a population rate of over three times more MSM
living with diagnosed HIV infection in London (7,031/100,000), compared with living
elsewhere (2,111/100,000).
Figure 3.4 Number of new HIV and AIDS diagnoses, numbers accessing care
and deaths in HIV-infected M5M, UK
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3.5.2 Trends in Acute STls in MSM 1997 to 2002
HIV was the third most commonly diagnosed acute STI in MSM in 2002 (Figure 3.5).
Between 1997 and 2002, rates of diagnoses of HIV infection increased by 26% from
478/100,000 in 1997 to 601/100,000 in 2002 (Chi-squared test for trend p<0.001)159.
The rate of diagnosis of acute STls in MSM similarly increased in England and Wales
(Figure 3.5). The biggest increases were in the rates of diagnoses of bacterial STls,
particularly between 1999 and 2001, with a doubling in gonorrhoea diagnoses between
1999 and 2001, from 661/100,000 to 1,271/100,000 (Chi-squared test for trend
p<0.001). These increases were not sustained in 2002 with gonorrhoea declining to
1,210/100,000 (Chi-squared test for trend p=0.03), but there was no decrease in men
aged 16 to 24 years old, instead rates increased by 84% from 648/100,000 in 1999 to
1,194/100,000 in 2002 (Chi-squared test for trend p<0.001). Large increases were
seen in genital chlamydia and syphilis between 1999 and 2002: rates of genital
chlamydia diagnoses in MSM increased by 144% and rates of diagnosis of syphilis
rose 616% from 19/100,000 in 1999 to 225/100,000 in 2002 (Chi-squared test for trend
p<0.001) (Figure 3.5). This has been associated with a series of large localised
outbreaks in Brighton, Manchester, Newcastle upon Tyne and London 160.
In comparison with the bacterial STls, the increases in diagnosis rates of viral STls
between 1997 and 2002 were steadier, with genital warts rising 36% from 536/100,000
to 727/100,000 (Chi-squared test for trend p<0.001) and genital herpes 16% from
1,121/100,000 to 176/100,000 (Chi-squared test for trend p<0.001).
Gonorrhoea remained the commonest STI diagnosed in MSM in England and Wales
followed by genital warts, HIV and then chlamydia. Rates of diagnosis of syphilis
overtook those of genital herpes in 2002 (Figure 3.5). Data collected between April
2001 and September 2003 from the Enhanced Syphilis Surveillance programme
indicate that 46% of MSM diagnosed with infectious syphilis in London were co-
infected with HIV161.
The distributions of rates of diagnoses of STls in London are similar to the national
picture (Figure 3.5). HIV infection was usually the second most commonly diagnosed
STI in MSM in London with an annual rate of diagnosis of around 950/100,000
between 1997 and 2000 rising to over 1,100/100,000 in 2001 and 2002 (Chi-squared
test, p=0.001). Diagnosis rates of STls however, were higher in London and
gonorrhoea rose from 1,107/100,000 in 1998, peaking at 2,088/100,000 in 2001
followed by a slight decline to 1,853/100,000 in 2002 (Chi-squared test for trend,
p<0.001). A similar pattern was seen for chlamydia, which peaked in 2001
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(938/100,000) and declined to 843/100,000 (Chi-squared test, p=0.024) in 2002.
Syphilis rose steeply by 628% from 50/100,000 in 2000 to 364/100,000 in 2002 (Chi-
squared test, p<0.001). Rates of diagnosis of genital warts were similar to HIV,
increasing by 26% from 871/100,000 in 1997 to 1,101/100,000 in 2002 (Chi-squared
test, p<0.001). Herpes rose by 47% to 313/100,000 (Chi-squared test, p<0.001) over
this period
Figure 3.5 Trends in acute 5Tls in M5M including HIV infection, rates per 100,000
population: 1997 to 2002
England and Wales
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Outside London the rate of diagnoses of all STls increased between 1997 and 2002
(Figure 3.5). Although the rates were lower than those in London, the increases
between 1997 and 2002 were of a similar magnitude, except for gonorrhoea and
syphilis where larger increases were observed. Gonorrhoea rose steeply between
1999 and 2000 (385/100,000 to 7301100,000, Chi-squared test p<0.001) followed by a
further increase to 879/100,000 in 2001 (Chi-squared test p<0.01) and levelling off to
902/100,000 in 2002. Syphilis increased from 31100,000 in 1997 to 159/100,000 in
2002 (Chi-squared test for trend p>0.001).
3.5.3 Age group specific trends in HIV in MSM
In England and Wales, the rate of HIV diagnosis was highest in MSM aged 25 to 34
years old and it increased by 18% from 527/100,000 in 1997 to 621/100,000 in 2001
(Chi-squared test for trend p=0.001) and declined to 534/100,000 in 2002 (Figure 3.6).
MSM aged 35 to 44 years had the second highest rate of diagnosis, rising by 69% from
363/100,000 in 1998 to 613/100,000 in 2002 (Chi-squared test for trend p<0.001)
overtaking the 25 to 34 years aids. MSM aged 16 to 24 years old had the lowest rate of
HIV diagnosis although it increased by 42% from 200/100,000 in 1998 to 283/100,000
in 2002 (Chi-squared test for trend p=0.004). Rates of HIV diagnosis were higher for all
age groups in London compared with elsewhere in England and Wales (Figure 3.6).
Between 2000 and 2001 rates of HIV diagnosis in MSM aged 35 to 44 years overtook
those in the 25 to 34 years age group in London, followed a year later by a similar
trend in other parts of England and Wales.
These results show that the increases in rates of HIV and other STls in MSM in
England and Wales have shown heterogeneity by type of infection and the age groups
affected over time. Rates in London were twice those seen elsewhere and had the
greatest changes over time, but the order of magnitude and the pattern of trends over
time were similar with the rest of England and Wales. Increasing numbers of MSM
living with diagnosed HIV infection may be contributing to the rising incidence of other
STls. Enhanced syphilis surveillance has shown that MSM with diagnosed HIV
infection are disproportionately represented in the emerging syphilis outbreaks
associated with metropolitan areas of England and Wales 161. In London almost half of
the MSM diagnosed with syphilis were co-infected with HIV. A large cross-sectional
behavioural survey of MSM conducted in the UK in 2002 found that diagnosed HIV
positive men reported higher numbers of sexual partners and a greater likelihood of
having been involved in HIV serodiscordant UAI compared with HIV negative and
untested men".
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Figure 3.6 Age-specific trends in HIV infection in MSM, rates per 100,000
population: 1997 to 2002
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3.5.4 Trends in undiagnosed HIV infections in MSM
The prevalence of previously undiagnosed HIV infection amongst MSM attending GUM
clinics detected through the UAPMP was 5.4% in London and 2.4% elsewhere in
England, Wales and Northern Ireland (Figure 3.7)162. Since 2000 there has been an
increase in previously undiagnosed HIV infection in MSM presenting with an acute STI
from 5.8% in 2000 to 6.5% in 2002 in London, and from 1.2% to 3.5% outside London
(Figure 3.7).
Figure 3.7 Prevalence of previously undiagnosed HIV infection" in MSM: by
clinical presentation and age group in the United Kingdom, 1993-2002
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Note. a. Excludes HIV-infected attendees who were previously diagnosed. b. Attendees at 15
GUM clinics in England, Wales, Northern Ireland (seven in London, eight elsewhere). c. Acute
STI is defined as presenting with one of the following diagnoses: infectious syphilis, gonorrhoea,
chancroid/donovanosis/LGV, chlamydia, NSU, trichomoniasis, scabies/pediculosis, HSV &HPV
first attack or molluscum contagiosum. Data source: Unlinked Anonymous Prevalence
Monitoring Programme.
The proportion of previously undiagnosed HIV infections that are diagnosed at that
clinic visit has increased, particularly in those who present with an acute STI (Figure
3.8). It is currently estimated that 62% of MSM attending GUM clinics with undiagnosed
HIV infection leave the clinic with their infection undiagnosed (Figure 3.8). This differs
by clinical presentation; 66% of previously undiagnosed HIV positive MSM presenting
with an acute STI in 2002 still remained undiagnosed after their clinic visit, and 55% of
MSM attending without an acute STI remain so. The proportion remaining undiagnosed
was higher in London (62%) compared with outside London (45%).
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Figure 3.B Proportion of HIV infections remaining undiagnosed" after clinlc'' visit
by clinical presentation": 1997-2002
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3.6 Evidence of changing sexual behaviour in MSM
Since the late 1990s, increases in STls and HIV diagnoses in MSM have been
reported from countries in Europe, North America and Australia5,117,163-166.These
increases are generally attributed to changes in the sexual behaviour of MSM, and
increases in high-risk sexual behaviour have been reported over this period in many
countries that conduct behavioural surveillance49.115.167.There have been many
explanations suggested to account for these increases in risk taking 113and in some
cases these are controversial. Treatment optimism, defined as a combination of being
less worried about HIV because there are better treatments for HIV now and a belief
that new drug therapies make people with HIV less infectious, has been offered as an
explanation for increased high-risk sexual behavtour!". Researchers in London found
similar rates of high-risk sexual behaviour reported amongst those optimistic about HIV
treatments and those who were not'", suggesting that treatment optimism alone would
not account for the increase in sexual risk taking.
Behavioural surveillance data among MSM in the UK have shown increases in rates of
UAI and, specifically, UAI involving HIV discordant or unknown status partners 157. Data
from Natsal 200026have suggested that the prevalence of male homosexual behaviour
in the general population has increased, and that some high-risk sexual behaviours
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among homosexually active men have also increased!". The reasons for this rising
risk are unclear. Society's changing attitudes towards hornosexuanty'" and treatment
optimism 172, coupled with expansions in opportunities and places that facilitate partner
acquisition (for example, the internet or saunas) 173 may all be contributing factors.
The rise in rates of diagnoses of HIV and other STls show increasing levels of sexual
ill-health in MSM in the UK. The heterogeneity in rates of diagnosis observed between
STls may relate to both differential transmission probabilities, levels of asymptomatic
infection and delays between infection and diagnosis For some acute STls the rate of
diagnosis will closely reflect the incidence of infection. This is particularly so for
gonorrhoea where the onset of clinical symptoms usually develops within a week of
infection 174. Rates of gonorrhoea are thus likely to be sensitive to changes in sexual
behaviour, although treatment failure because of shifting patterns of antimicrobial
resistance may influence trends as well. Sentinel surveillance of antimicrobial
resistance is provided by GRASP (Gonococcal Resistance to Antimicrobials
Surveillance Programme) 175. GRASP found that ciprofloxacin resistance (>= 1 mg/l) in
isolates from MSM increased from 0.8% in 2000 to 2.2% in 2001 with a further
increase to 8.5% in 2002176. Clinicians were not notified of this decrease in
susceptibility until May 2003 and so improved treatment cannot account for the
decrease in rates of diagnosis of gonorrhoea in MSM in London between 2001 and
2002.
A survey that monitored high-risk sexual behaviour in MSM attending commercial
venues and GUM clinics in London found that the proportion of men reporting UAI in
the past year increased between 1997 and 2001157• No further increase was reported
for 2002 and the proportion of men reporting UAI with partners of unknown or
discordant HIV status decreased slightly from that reported in 2001. The decrease in
rates of gonorrhoea observed in London may be explained by this reported behaviour
change. This apparent association between trends in high-risk sexual behaviour and
gonorrhoea indicates that a diagnosis of gonorrhoea may serve as a proxy marker for
high-risk sexual behaviour. This association will be investigated further in Chapters
four and five of this thesis to determine if diagnosis with an acute STI can be used as a
marker for high-risk sexual behaviour.
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Summary
No national population estimates of HIV testing are available for MSM. The Natsal was
analysed to estimate prevalence of HIV testing and factors associated with it in MSM.
HIV testing was associated with area of residence and increased numbers of sexual
partners. Other factors associated with an increased likelihood of HIV testing, were
older age, previous STI and cohabitation. HIV testing is associated with high-risk
sexual behaviour.
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This chapter explores the relationship between factors that are associated with HIV
testing in MSM. Below, in Figure 4.1 the factors and their interrelationships which will
be explored are highlighted in blue.
Figure 4.1 Conceptual framework of the relationship between HIV testing and risk
of HIV infection mediated through risk behaviour in MSM: investigation of the
association of socioeconomic status, area of residence, age, number of sexual
partners, unprotected anal intercourse, sexually transmitted infections and
perception of risk with HIV testing
Availability of HIV
testing
,,
MeOia pro-HIV
testing campaigns
HIVtest
polie>{
,
,,,
I'
Availability of
8nti..etrovirsl
therspy
,,
Changing sexual
behaviour over
tim>£!
infe.ctions ,,
Sexual pertneeship
netwOlks",
Different baOcgroundHIV '
prevalence by ares
,,
Behavioursl
intervention5
Key
o Fadors associateOwith HIV testing snd HIV inf.,dion ristth·atwill be considered in more detail in this study
_j
Fadors that ar., important but whicl1 are proxied by HIV testing numbe<s
and I or HIV infedion rist and thus lifE not furthe- considered in this study
- Diredion of influence
- - - - .. Dir.,dion of influence in
unmeasured fadors
123
POPULATION CHARACTERISTICS AND BEHAVIOURS ASSOCIATED WITH HIV TESTING
4.1 Introduction
In order to diagnose HIV infection, an individual must have a voluntary confidential HIV
test. HIV testing is common among homosexual and bisexual men and studies indicate
that the proportion of homosexual and bisexual men who have ever had an HIV test
ranges from 53-64% in the UK27,29,48,52 to 83-85%% in Ausfralla" ,54, 63% in Canada32
and 84% in the US69,177. Previous studies in the UK have shown HIV testing to be
associated with high-risk sex in both MSM and heterosexuals27,48,52,17B.
These convenience sample studies were from various settings, including recruitment of
MSM from both community and clinical, GUM and HIV testing clinic, environments.
Targeted population surveys give greater detail on populations at highest risk, where
behaviours are rare, particularly in more marginalised populations where such
behaviours are illegal or unaccepted by society. The difficulty in accessing these
populations makes probability sampling costly. More cost-effective sampling strategies
are needed; these can include advertising, snowballing, recruiting from GUM clinics
and social and commercial venues. However, these strategies may result in a sample
selection bias and decreased representativeness of results. The disadvantage of
targeted population surveys is that they are likely to be unrepresentative, given the
nature of the convenience sampling. Those accessed through this mixture of social
venues can only be representative of those using these sites. In addition, even among
venue attendees, the behaviour of study respondents may systematically differ from
that of non-respondents.
General population surveys are useful in assessing overall trends and distribution of
behaviours. These provide the most robust estimates of prevalence of behaviours, as
they largely avoid the biases inherent in most targeted population surveys. General
population surveys are usually less suitable for obtaining detailed information on
population subgroups at highest risk. These groups tend to be small, more clustered
and difficult to access and small subgroups of individuals with relatively rare risk
behaviours may not be captured in sufficient numbers. Groups of particular interest for
HIV and STI transmission include homosexual and bisexual men, IDUs, commercial
sex workers and ethnic minorities, particularly those from or who have contact with
countries with a high HIV/STI prevalence. These problems can be overcome through
adapting study designs to include oversampling and focussed enurneranon" .
The Natsal was the first ever nationally representative survey of sexual behaviours in
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Britain. It was carried out first in 1990 and repeated again in 2000. In 2000, focussed
enumeration was carried out to include an increased sample of ethnic minorities;
London was oversampled to provide an increased sample of MSM in addition to IDUs
and ethnic minorities. The main objectives of Natsal 2000 were to provide a detailed
understanding of patterns of sexual behaviour in Britain (including, for example,
number of sexual partners, frequency of different sexual practices, and homosexual
experience), to provide data for HIV projections in the UK, and to assess whether there
had been any changes in behaviour since Natsal 126. This analysis was carried out to
provide estimates of prevalence of HIV testing in a representative sample of MSM from
the general population in Britain, as there are none currently available.
In this chapter, using the Natsal 2000, the following questions were investigated
(Objectives 3 and 4, Chapter one section 1.5):
1) What are the population estimates of HIV testing patterns in MSM in Britain?
2) What behaviours and socio-demographics are associated with HIV testing?
3) Have these associations changed between 1990 and 2000?
4.2 Methods
4.2.1 Participants and survey methodology
The Natsal are stratified probability sample surveys of the general population; of
12,110 in 2000 and 13,765 in 1990 men and women aged 16 to 44 years resident in
Britain. The response rates were 65.4% and 66.8%, respectively. Participants were
interviewed using a combination of face-to-face interview and computer-assisted
interview. A similar methodology was used in both surveys although the method of
collection for the most sensitive behaviours changed from pen and paper self-
completion (PAPI) in 1990 to computer assisted self-interview (CASI) in 2000. The
details of these studies have been reported elsewhere26,179-181, Similar questions were
asked in both the 2000 and the 1990 survey, although additional questions on various
topics were included in 2000, Questions on HIV testing history were asked (if ever had
a blood test that involved testing for HIV and when the last test was), reasons for HIV
testing as well as perception of personal risk of being infected with HIV. These were
among a range of questions on sexual practices, behaviours and attitudes. Factors
associated with HIV testing in 2000 were compared with those in Natsal 1990. The
sample was broadly representative of the age, marital status, and ethnic structure of
the population in the country. The weighted population and the general population
comparison are shown in Appendix C Table C.1.
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4.2.2 Natsal sampling strategy
Natsal was a multi-stage stratified population-representative survey. Postcode sectors
were selected as the primary sampling units (PSUs), addresses within them were
selected at the second stage and, finally, one eligible adult was randomly selected at
the final stage. Natsal 1990 showed that the prevalence of many HIV risk behaviours
(such as homosexual contact and injecting drug use) was higher in London than
elsewhere in Britain, yet still reasonably rare. Thus addresses in the greater London
area were oversampled in order to increase numbers within those groups most at risk
of HIV. This would enable analysis to provide more precise estimates of the prevalence
of risky sexual behaviours. Natsal 2000 included a boost sample of black and Asian
adults. This was to enable analyses to provide some understanding on sexual health
inequalities that would otherwise not be possible due to the relatively small proportion
of ethnic minority respondents included in national general population surveys. The
core and boost samples were independently desiqned. The second sample, for the
ethnic minority boost, was multi-stage and used a combination of full screening and
focussed enumeration to determine whether addresses contained residents from the
target ethnic groups.
4.2.3 Weighting the general population sample
4.2.3.1 Selection probability weighting
Because of the unequal probabilities of selection, the Natsal sample would over-
represent residents living in London, in single dwelling addresses, and those living
alone. Three sets of weights were applied to correct for these unequal probabilities and
to make it a representative sample of the general population in Britain. The detailed
methodology is described in the technical report'",
4.2.3.2 Non-response weighting
Following weighting for selection probability weights, the distribution of the Natsal 2000
sample was compared with mid-1999 population estimates on three demographic
variables (age, sex and government office region). Women were still found to be over-
represented in the Natsal 2000 sample while men aged 25 to 29 and respondents in
London were found to be under-represented. The Natsal team concluded that these
differences could be due to differential non-response as well as random sampling
variation. To correct for these differences in age, sex and region, a non-response
weight was applied!". Following this additional weighting, the distributions of age, sex
and region for the Natsal 2000 sample were then found to be similar to those of the
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general population 180.The weighted population and the general population comparison
are shown in Appendix C Table C.1.
4.2.3.3 Weighting the ethnic minority boost sample
The ethnic minority boost sample did not have equal chances of selection for similar
reasons to the general population sample. In order to obtain representative estimates
of the four ethnic minority groups, the data were weighted to adjust for the varying
probabilities of selection. Unlike for the general population sample, there was no
additional non-response weighting for the ethnic minority sample, because the
research team stated that no reliable data to estimate differential non-response by age
and sex within ethnic minority groups were currently available at the time of the
survey180.
4.2.3.4 Weighting Natsal1990
The Natsal 1990 dataset (for those aged 16 to 44) was post-stratified to 1991 Census
estimates using similar non-response weighting as in Natsal 2000 to allow comparison
between Natsal 1990 and Natsal 2000. This corrected for any differences (due to
differential non-response and/or random sampling variation) in the age, sex and
regional distributions of Natsal 1990 respondents compared with the 1991 Census.
4.2.4 Participation biases in Natsal
The response rate was 65.4% in Natsal 2000. The Natsal research team investigated
the non-response, particularly associated with refusing the booklet (the detailed sexual
behaviour questions). They found that, among participants, after controlling for other
variables, booklet refusal was higher amongst ethnic minorities, the lower occupational
classes, people with problems of understanding, older people and those married or
single. Those who take part in the survey could be different from those who don't and
additionally those who do not answer the specific question of interest could differ in
sexual behaviour to those who do (item-response bias)182.If it is assumed that those
who take part do not differ from those who do not, then weighting results in unbiased
estimates of population parameters. This is unlikely to be the case for sexual behaviour
and differences in behaviour within participants and non-participants has been detected
in previous research 183.
As the analyses in this thesis focus on MSM, only the participation bias within this
group is relevant. The investigators found that refusal to complete the booklet was
lowest in those who reported homosexual experience (both men and women) at 1.8%
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compared with 3.3% of those who had no homosexual experience. In Natsal 2000 the
non-response on the CASI was 1% from both men and women. While the data were
weighted for non-response, this assumes that those who did not respond are similar in
sexual behaviour to those who did. The main reason for non-inclusion within the survey
was refusal or proxy refusal (27.7%). Other reasons included non-contactable after
multiple visits, no information about the address, or other reasons including not
speaking English.
Individuals with more chaotic lifestyles possibly with more marginalised behaviours
such as injecting drug use or sex workers may be more difficult to contact while having
higher HIV risk behaviours. It was noted that lower numbers of sexual partners was
associated with non-response to the booklet, and no homosexual experience. How
would it affect the conceptual framework of the relationship between HIV testing and
risk of HIV infection in this thesis? MSM were less affected by item non-response and
so, while the proportion of men estimated to be MSM may be overestimated, the
associations between sexual behaviours and HIV testing would be likely to be
unchanged. If non-responders had different sexual behaviour and HIV testing patterns
for instance, more risky behaviour but less HIV testing, or had less risky sexual
behaviour but HIV tested more, then the association between testing and behaviour
would be overestimated. Alternatively, if non-responders had more risky behaviour and
HIV tested more, then the association between behaviour and HIV testing would be
underestimated in our analysis. There is currently no way to determine how the results
may be biased. Given the strength and size of the association between sexual
behaviour and HIV testing, a reduction in the association in the MSM who were non-
responders is unlikely to diminish the association between sexual behaviour and HIV
testing to zero, and if anything may increase the association. This thesis will not use
data on sexual behaviour to infer HIV infections; instead it will use HIV testing as a
proxy variable. Thus, even if there is some bias in the reported data on the association
between sexual behaviour and HIV testing due to questionnaire non-response, these
data would still be informative.
4.2.5 Definitions
HIV testing was defined as voluntary confidential HIV testing and so blood donation
was excluded, as this constituted a screening programme rather than individuals
choosing to be tested for HIV. HIV testing was defined as an individual who had one or
more HIV test in the past 5 years. While the question asked in the 1990 survey was
'Have you ever had a blood test that involved testing for HIV', no information on when
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the test took place was collected. The period for which any HIV testing was available
was assumed to be 5 years in the 1990 survey for the comparison because the HIV
antibody test only became widely available in October 1984. Men were defined as
MSM if they had a homosexual partner in the past 5 years. A homosexual partner was
defined as genital contact with another man.
Marital status was collected as a variable in the study. This included the following
groupings: single, married, cohabiting and separated/divorcedlwidowed. Cohabiting
was defined as living with another person as a couple, included both same sex and
opposite sex cohabitation. In this sample, 90% (95% Cl 77.5 - 95.8) of the men who
were defined as cohabiting were living with another man, while the other 10% were
cohabiting with a woman. This proportion was 96.6% (95% Cl 86.2 - 99.2) cohabiting
with another man for MSM who had an HIV test.
4.2.6 Statistical analysis
Data from targeted oversampling of ethnic minorities (the Natsal ethnic minority boost)
were combined with the main survey data to increase the numbers of respondents
included in this analysis to provide more robust estimates of HIV testing and sexual
behaviours. The full analysis of the general population, including MSM, was published
and is presented in Published Papers. An analysis strategy was determined a priori
based on the conceptual framework in Chapter two of the relationship between HIV
testing and risk of HIV infection in MSM, to investigate the socio-demographic and
behavioural variables associated with HIV testing as highlighted in Figure 4.1. Due to
the small sample size, further stratification of the variables, place where last HIV test
was carried out and perception of self-risk of HIV infection by behavioural variables
was not possible. Prevalence (with 95% Cl) of HIV testing by both demographic and
behavioural characteristics was calculated. To determine what socio-demographic
characteristics and sexual behaviours are associated with HIV testing, OR were used
to compare the prevalence of behaviours and demographics associated with reporting
having had a HIV test as determined through the conceptual framework in Chapter two
(Figure 4.1). This analysis focussed on both behaviours and HIV testing in the past 5
years. Logistic regression analyses were used to calculate adjusted OR, controlling for
the other socio-demographic and behavioural variables in the model, to determine
variables independently associated with HIV testing to establish whether HIV testing
was associated with sexual behaviour, when controlling for other socio-demographic
variables. Interaction terms between social-demographic and behavioural variables
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were explored to investigate if the association of these variables with HIV testing (OR)
varied when stratified by other variables or whether risk behaviour associations remain
across all socio-demographic groups. To determine whether HIV testing patterns and
factors associated with testing have changed between 1990 and 2000, OR were used
to compare estimates of HIV testing and the behaviours and demographics associated
with it between the 2000 and 1990 surveys. Interaction terms were generated to test
whether the magnitude of change in HIV testing and associated behaviours between
the two surveys differed by each categorical variable after adjustment for region of
residence and age.
All analyses were carried out using the STATA survey analysis software (version 7.0),
accounting for stratification, clustering and weighting of the sample.
4.2.7 Ethical Approval
The study was approved by the University College Hospital and North Thames Multi-
Centre Research Ethics Committee and all the Local Ethics Committees in Britain.
4.3 Results
4.3.1 Demographic characteristics of the population sample of MSM
Natsal 2000 sampled 183 men fulfilling the criteria of MSM for this study. The weighted
sample size was 155. These men represented 2.5% of the total population of men
aged 16 to 44. History of a HIV test in the past 5 years was not answered or answered
maybe/not sure for 7.1% of the sample, and these were excluded from the sample
giving a sample of 155, with a weighted sample of 144. The demographic
characteristics of this sample are presented in Table 4.1. The demographics and
behavioural characteristics of those who did not answer were not different from those
individuals who did.
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Table 4.1 The distribution of demographic and behavioural characteristics,
percentages with their 95% confidence intervals, for men who had a homosexual
partner in past 5 years by HIV test hlstory", Natsal 2000 (column percentages are
shown)
Natsal2000 BASE 2000
% {95% Confidence Interval} {UW, WT}
HIV test in past 5 No HIV test in past 5 155, 144
years years
DEMOGRAPHICS
Age
16-24 12.1 (4.9-26.7) 25.0 (15.7 - 37.2) 27, 30
25-34 59.2 (44.0 - 72.8) 42.2 (32.8 - 53.4) 71,69
35-44 28.7 {17.4 - 43.4} 32.8 {24.1 - 41.8} 57,46
Region
Rest of Britain 75.9 (63.5 - 85.0) 65.4 (53.9- 75.3) 77,99
Greater London 24.1 {15.0 - 36.5} 34.6 {24.7 - 46.1} 78,45
Marital Status
Single 46.4 (31.5 - 62.0) 63.3 (52.0 - 72.4) 100,81
Married 0 9.5 (4.4 -19.4) 7,9
Cohabiting 49.3 (33.9 - 64.8) 24.1 (15.6 - 64.8) 42,50
Sep. I widowed I 4.3 (1.1 -15.7) 3.1 (1.2-7.8) 6,4
Divorced
Social Class
1&11 60.3 (43.9 - 74.6) 59.4 (48.2 - 69.7) 87,81
III 30.6 (17.9 - 47.1) 26.1 (18.1-35.9) 44,37
IV&V 9.2 {3.1 - 24.4~ 14.5 {7.9 - 25.2) 15, 15
Ethnicity
White 96.8 (92.3 - 98.7) 95.8 (89.9 - 98.3) 143, 139
Other 3.2 {1.3 - 7.7) 4.1 p.6-10.1) 12,5
BEHAVIOURS
Partners in past 5 years
<10 53.6 (38.4 - 68.1) 76.2 (65.9 - 84.1) 110, 102
10+ 46.44 {31.9 - 6136~ 23.8 {15.9 - 34.1) 56,42
Injected drugs in past 5
years
No 99.7 (97.6 - 99.9) 97.3 (90.5 - 99.3) 151, 143
Yes 0.3 {0.01 - 2.4~ 2.7 {0.7 - 9.5) 4,2
Paid for sex in past 5
years
No 92.1 (79.8 - 97.2) 91.4 (84.0 - 95.5) 135, 131
Yes 7.9 {2.8 - 20.2~ 8.6 {4.4 - 16.0} 19,12
Reported STI In past 5
years
No 83.9 (71.4 - 91.6) 92.0 (83.7 - 96.2) 128, 126
Yes 16.0 {8.4 - 28.6} 8.0 {3.8 - 16.3) 24, 16
New sex partners from
abroad in past 5 years
No 53.5 (38.6 - 67.9) 55.6 (43.0 - 67.5) 74, 79
Yes 46.4 {32.1 - 61.4~ 44.4 {32.5 - 57.0) 79,63
Note.a. Excludesthose who did not answeror answeredmaybe I not surewhether they hada
HIVtest in the past 5 years; b. Social classcategories I and II: professional,managerialand
technical, III; skilled non-manualandmanual, IV andV semi-skilledmanual and unskilled
manual;WT = weightedand lJW = unweightedbases.
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4.3.2 Prevalence of having an HIV test in a population sample of MSM
Over a third (36.6%) of men who had a homosexual partner in the last 5 years (MSM)
had a HIV test in the past 5 years (Table 4.2). The highest prevalence of HIV testing
was in the 25-34 year age group while only a quarter of MSM aged less than 25
reported a HIV test in the last 5 years. HIV testing was more common outside London
than in London. Those who reported more than ten partners had the highest
prevalence of testing, as did those MSM who reported an STI in the past 5 years and
'marital status' as cohabitating or separated or divorced.
4.3.3 Factors associated with HIV testing
HIV testing in the past 5 years was positively associated in univariable analyses with
marital status not being single, lower social class and increased numbers of sexual
partners. Other variables that showed an increased probability of testing were
increasing age, being resident outside London, injecting drug use and reporting an STI
in the past 5 years (Table 4.2).
MSM who reported having more than ten male sexual partners in the past 5 years were
over three times more likely to have had an HIV test compared with MSM with fewer
than ten sexual partners after adjustment for all other demographic and behaviour
variables. Cohabitation was associated with having a HIV test (OR 2.88, 95% Cl 1.10-
7.52), as was being resident outside London in the rest of Britain. Other variables
which, based on the point estimate appeared associated with having had a HIV test,
although not statistically Significant, were; increasing age (25-44 AOR 2.58 (95% Cl
0.59 - 11.48), 35-44 AOR 1.40 (95% Cl 0.32 - 6.17), non-white ethnicity (AOR 4.48,
95% Cl 0.66 - 30.29) and injecting drugs in the past 5 years (AOR 5.70,95% Cl 0.31 -
104.56).
4.3.4 Changes in prevalence of HIV testing and factors associated with HIV
testing in the past decade
There was no evidence that the prevalence of HIV testing had increased between 1990
and 2000 in MSM, age and region adjusted OR 1.01 (95% Cl 0.51 - 1.98) (Table 4.2).
While the study did not have much power to detect differences, the percentages were
similar in both surveys. The prevalence of HIV testing in MSM who reported ten or
more sexual partners appeared lower in 2000 (58.0% compared with 66.9%) although
there was limited power to detect a difference (age and region adjusted OR 0.48, (95%
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Cl 0.15 - 1.52). It appeared that the prevalence of HIV testing increased in men
reporting fewer than ten homosexual partners in the past 5 years in 2000, compared
with 1990, from 19.3% to 28.9% and there was limited power to exclude sampling
variation as an explanation of these results (age and region adjusted OR 1.49 (95% Cl
0.65 - 3.40) (Table 4.2).
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4.3.5 Time since last HIV test and perception of risk
Most individuals who had a HIV test did not perceive themselves to be at risk of HIV
infection, 87.6% of MSM stated they were 'not very much at risk' or 'not at risk at all of
HIV infection'. (Table 4.3) The perception of risk was similar for MSM who had not
tested compared with those who reported a HIV test in the past 5 years. MSM who had
not tested perceived that they were 'greatly at risk', 3.0% (95% Cl 1.0 - 8.3), compared
with 0.6% (95% Cl 0.01 - 4.2) who had a HIV test in the past 5 years.
Most respondents who reported having a HIV test in the past 5 years had it within the
past 2 years (Table 4.3). Just over 76% of MSM, who had a HIV test in the last 5 years,
had their last HIV test in the last 2 years, of whom 37% were tested in the last year
(Table 4.3).
Table 4.3 HIV testing among MSM1 in Britain, the distribution of perception of
self-risk of HIV infection and time since last HIV test, percentages with their 95%
confidence intervals, among MSM who have had a HIV test, Natsal 2000
HIV test in the past 5 yearsb
Base, unweighted, weighted
Yes
59,54
% (95% Cl)
No
96, 90
% (95% Cl)
Perception of risk of HIV infection
to self
Greatly at risk
Not very much at risk
0.6 (0.01 - 4.2) 3.0 (1.0 - 8.3)
11.1 (5.0-23.1) 13.1 (7.0-23.3)
50.2 (35.3 - 65.1) 53.0 (41.3 - 64.4)
37.4 (23.4 - 53.8) 30.8 (20.9 - 42.9)
0.6 (0.01 - 4.5) 0
Quite a lot at risk
Not at risk at all
Don't know
Time since last HIV test
In the last year 36.2 (23.5 - 51.1)
29.4 (16.7 - 46.3)
34.4 (21.5 - 50.3)
Between 1 and 2 years ago
Between 2 and 5 years ago
Note.a. Includesmenwho had 1+male sexualpartner in the past 5 years; b. A test for HIV
excludingblooddonation;c. all percentagesare column-weightedbases;Cl, confidence
intervals
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4.3.6 Reason for and place of last HIV test
Most MSM had their last HIV test due to concern, or for a general health check (68.1%,
95% Cl 51.3 - 81.2). The majority of MSM (54.2%) had their HIV test at a GUM clinic,
while 16.6% reported their last HIV test was at a GP. Place of HIV test varied by age
group 66% of MSM aged less than 25 years tested at a GUM clinic compared with 44%
of 25-34 year aids and 65% of 35-44 year aids. The proportion of MSM that tested at
GPs also varied by age; 34% of MSM aged less than 35 reported their last HIV test to
be at a GP compared with 20% of 25-34 year aids and 6% of 35-44 years olds. In
contrast, 11% and 16% of 25-34 and 35-44 year olds, respectively, tested at private
clinics, compared with no recorded tests in MSM aged less than 25 years. None of
these differences were statistically significant.
Table 4.4 Distribution of place where last HIV test was carried out, percentages
and their 95% confidence intervals, by region of residence, Natsal 2000
Percentage had a HIV London Rest of Britain Base 2000
test in the last 5 years·
% (95% Cl) % (95% Cl) UW,WT
Place of HIV testb
GP surgery 13.1 (5.7 - 27.3) 20.8 (9.0 - 42.1) 13, 13
National Health Service 55.0 (40.4 - 68.8) 52.6 (35.2 - 69.6) 48, 38
Nenereal Disease
ISexually Transmitted
Disease clinic
NHS family planning 1.2 (0.2 - 8.9) 0 1,0.3
clinic
Private clinic or doctor 13.0 (4.9 - 30.2) 9.6 (2.8 - 27.8) 8,8
Somewhere else 17.7 (8.8 - 32.3) 16.9 (6.7 - 36.6) 12, 12
Note.a. A test for HIV excludingblooddonation;b.All percentagesare column-weightedbases;
UW unweighted,WT weighted;Cl, confidenceintervals.
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4.4 Discussion
This national, probability sample study provides prevalence of HIV testing in the
population and has found that a HIV test in the past 5 years was associated with high-
risk behaviours in MSM. Some demographic characteristics were associated with an
increased probability of reporting a previous HIV test, including age, region of
residence, ethnicity, marital status and social class. There was no evidence of an
increase in the prevalence of HIV testing between the two national surveys in 1990 and
2000. Factors associated with HIV testing have remained the same over the decade.
There may be limitations to this survey; both HIV testing and sexual behaviours are
self-reported. This may lead to bias due to people's reluctance to disclose sensitive
behaviours. The cognitive interviews carried out to validate the methodology concluded
that people were happy to self-complete this sensitive behaviour question, and
because the individual's HIV status was not requested, it was not thought to be too
intrusive 180.Additionally, the response rate of 65.4% may mean that the individuals who
did respond may be different behaviourally from those who did not; the implication of
possible participation bias is discussed in section 4.2.4. Improved collection
methodology in 2000 to CASI may have led to an increased likelihood of reporting
sensitive behaviours, including HIV testing compared with the pen and paper method
used in the 1990 survey, thus making comparisons between the surveys invalid.
Although comparisons of age-related cohorts between the 1990 and 2000 surveys
indicated that this had not led to too much over-reporting 171. Because HIV status was
not collected, reported perception of risk could be confounded by an individual's
knowledge of their status. This appears to be more important in MSM; those who
reported a HIV test did not perceive themselves to be at risk of HIV infection, while a
similar analysis of heterosexuals in Natsal 2000 found that in both men and women the
prevalence of HIV testing was greater in those who perceived themselves to be at a
greater risk compared with those who perceived they were 'not at risk at all,8. This
could be due to a number of factors: firstly, that they knew that they were HIV positive
already and so were no longer at risk; secondly, that because they had recently had an
HIV test, they knew that they were negative; or, thirdly, it could be that although they
had HIV tested due to risk behaviour, post-hoc rationalisation following a negative HIV
test result had thus led them to believe that they were never at risk of HIV infection.
A further limitation of this study is the small sample size of MSM. By its nature, a
representative sample of the population will always produce a small sample size for
those behaviours that are less common, or relatively rare. Most of the behaviours and
populations of interest for HIV tend to be in more marginalised, more difficult to reach
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populations. Traditionally, convenience samples have been used to reach these
populations, although they have many limitations, most importantly in determining how
representative they are. To overcome this, the Natsal 2000 survey oversampled both
MSM and people of ethnic minorities through focussed enumeration and oversampling
in London (in particular for MSM). Population weights were then generated by the data
survey team at the National Centre for Social Research, based on the sampling
probability and the standard census population. This allowed the population to be
weighted back to the representative size, but gave a larger sample size for more
detailed analyses. However, even using the boosted population sample in these
analyses the sample size was small, which meant that there was limited power to
detect associations. It limited further analyses of the association of perception of self-
risk of HIV infection and place of last HIV test in MSM who had HIV tested. It is a
measure of the strength of the association of HIV testing with behaviour variables that
even with limited number of observations, a number of associations were detected.
Other convenience samples of MSM in the UK have found higher rates of HIV testing,
ranging between 53-64% ever tested29,155and 32% in the last year155.Of the MSM in
this study who reported that they had a HIV test in the past 5 years, a similar proportion
had one in the last year (36%). The population of MSM recruited through Natsal is a
representative sample of MSM, thus including both MSM at higher and lower
behavioural risk. Convenience sample surveys may be sampling men with higher-risk
behaviours. A comparison of the characteristics of MSM recruited through Natsal and a
convenience sample of MSM recruited through gay venues found that the community
survey MSM reported higher levels of risk behaviour and more STls 184.The proportion
of MSM in Natsal that had attended a GUM clinic in the past 5 years and had a HIV test
was similar at 73.8% (95% Cl 56.9 - 85.7) in 2000 and 75.8% (95% Cl 51.9 - 90.1) in
1990. Similar geographical differences in prevalence of HIV testing have been reported
in Canada" and Australia". These have been reported to be associated with the
differential availability of testing and service provision, and community attachment
amongst MSM. Unlike these international comparisons, within this survey the
differences in testing were higher rates in the less urban areas, and lower rates in the
capital, London. Conversely both Jin54 and Myers32found higher rates of HIV testing in
the urban centres rather than rural. This opposing result, while unexpected, is found in
some other surveillance sources within the UK. Examining HIV tests carried out in
MSM attending GUM clinics in England, Wales and Northern Ireland, as part of a UA
survey, found that overall, 60% of attendees in 2002 had a voluntary confidential HIV
test at that visit, 55% in London and 65% outside London 162.
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UAI was found to be associated with HIV testing and those who were at highest risk
were more likely to have tested in a number of surveys31,54,155.In this analysis numbers
of sexual partners was associated with HIV testing; this was an association found in
some other studies31,54,6o,69.The development of an individual potential risk index by
Sigmum and Magnus, based on the basic reproductive ratio of infection 185,found that
while the minimum number of partners needed for HIV transmission was lower than for
chlamydia as HIV is infectious for longer, the minimum intercourse frequency for
transmission is higher. While there is a correlation between number of sexual partners
and acquiring HIV infection, there is an even greater correlation between number of
sexual partners and transmitting HIV infection. The risk of acquiring HIV is more
dependent on sexual networks, and a sexual partner from the 'core-group' or higher-
risk activity group186.Studies of clusters of gonorrhoea have found it to be strongly
linked to sexual networks and core-group mixing 187-189.
Previous studies have shown that numbers of sexual partners is associated with
UAI61,63.71,73,74and in some cases directly correlated with number of unprotected sexual
partners". Thus numbers of sexual partners acts as a good proxy marker for
unprotected partners.
HIV testing was associated with higher-risk behaviours and numbers of sexual partners
was a strong predictor of HIV testing. This indicates that HIV testing is part of a
reasoned decision-making process both on the part of the individual and their health
service providers. The association with cohabitation for MSM indicates that HIV testing
may be used as a method of determining a sexual partnership strategy190. The
relationship between HIV testing and 'negotiated safety' is a more complex relationship
to understand. The term was coined by Crawford et al190in 2001, and dealt with the
context of risk taking within a stable relationship. Unprotected sex within a relationship
in which both partners are monogamous (or at least have protected sex outside the
relationship) is argued to be lower-risk behaviour, rather than the high-risk assigned to
it in behavioural surveillance. Behavioural surveillance surveys have since then
collected information on the status of partners with which the unprotected sex has
taken place with, to assign a risk. However, these arguments are governed by
assumptions, many of which rely on perceived serostatus. A number of studies in the
UK have examined perception of serostatus and found that over 25% of MSM who
report seroconcordant unprotected sexual partners have never themselves had an HIV
test52.85.155,Addinonally, perceived serostatus has been measured by Dodds et al in a
UA HIV survey of MSM and found that, of the MSM detected to be HIV positive through
UA testing, 28% perceived themselves to be HIV negative, 51% perceived themselves
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to be positive, and the remaining 21% reported they did not know their HIV status!".
No association between HIV testing and social class was found, while the sample size
may have been a limiting factor, thus a difference may have existed but the study did
not have the power to detect it. No social class difference in HIV testing was found in
the general population analysis either". While other studies have found social class
differences in HIV testing both in North America55.64.66.87.88and Australia", this implies
that differential access to HIV testing is not a problem in the UK. The social class
differences found in the US and Australia may be accounted for by other behavioural
factors already controlled for, in particular UAI. It was found that UAI varied by
education levels, with UAI associated with lower education both in the UK52.68and
Canada32.75.
4.5 Conclusions
In summary, in a UK representative survey of MSM, HIV testing was relatively common
and associated with high-risk sexual behaviour. Men who had ten or more partners
were five times more likely to have had a HIV test in the last 5 years than men who had
fewer than ten partners. HIV testing was associated with negotiated safety, Le. men
who were cohabiting with a man were three times more likely to have had a test than
men who were single. This means that interpreting the relationship between HIV testing
and risk of HIV in MSM will be complex, as testers may represent three types of
people. These are:
(1) those who test sporadically because they have high-risk behaviour,
(2) those who test routinely as part of a sexual health strategy,
(3) those who test at the establishment of a stable relationship, as part of the
decision-making process around condom use within a relationship.
The next chapter of this thesis will investigate the importance of these differences
through a cross-sectional study of MSM attending a GUM clinic in inner London. The
study will explore the predictors of HIV testing by previous HIV negative tests, repeat
tests and predictors of undiagnosed HIV infection. The study will then quantify the
association between HIV testing and HIV infection, using an unlinked anonymous
testing methodology.
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Summary
This chapter describes a cross-sectional study of MSM attending a GUM clinic in inner
London which collected additional information on past HIV testing and previous STI
diagnoses in addition to the routine UA GUM survey data. This allowed the association
between HIV testing and HIV infection to be directly measured. Ever HIV testing was
associated with age. having a previous acute STI in the past 5 years and diagnosis
with another acute STI at the survey visit. HIV test history was positively associated
with HIV serostatus. This suggests that overall, MSM who have HIV tested are at
higher risk of HIV infection compared with MSM who have not HIV tested. attending a
GUM clinic.
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5.1 Introduction
To have his HIV infection diagnosed, an individual must first choose to have an HIV
test. This decision may be influenced by a number of factors as discussed in Chapter
two and shown in Chapter four, including some demographic factors such as age and
residence, high-risk behaviours and health-seeking behaviours. Data gathered from the
results of voluntary confidential HIV testing provide important insights into the burden of
HIV infection experienced in the UK in MSM (as presented in Chapter three) 147.159.
However, these results can only apply to those seeking, or being offered, HIV testing.
While behavioural surveys show that MSM have a high rate of HIV testings.29,49,94, a
substantial proportion of MSM report not having had a HIV test.
It is difficult to assess the extent of undiagnosed HIV infection in the population. The
UA methodology approach, based on specimens routinely gathered for other reasons,
is particularly useful in contributing to the surveillance of HIV infection in all MSM,
regardless of their HIV testing behaviour. UA testing allows the measurement of HIV
prevalence both in clinically diagnosed and undiagnosed pcpulatlonsv". Several
surveys have been on-going in the UK as part of a national UA programme that began
in 1990. The surveys focus on those whose behaviour makes them more vulnerable to
HIV infection. These are in sub-populations collecting both blood specimens (including
GUM clinic attendees9o,162.191,192, pregnant women193,194, hospital patlents'", women
having terminations of pregnancy 162) and oral fluid samples through voluntary unlinked
surveys of IDUs 195, community surveys of MSM49 and, most recently, a community
survey of Africans in England196. Other UA surveys of MSM have been carried out in
the USA 197-202 and in France203,204. UA testing relies on the availability of residual
specimens collected for clinical screening purposes. These specimens are included in
surveys and tested for HIV antibodies, following anonym ising and unlinking from all
identifiers. UA testing for HIV provides an estimate of HIV prevalence and associated
risk factors in the population, free from the biases associated with being offered or
choosing to have voluntary confidential HIV testing (Figure 5.1).
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Figure 5.1 Unlinked anonymous HIV seroprevalence monitoring methodology
- -- . - .. .. . . .. .... . ..... . . . . .. . . . . . . . - _... .
····p···O:·:,p::::u··la· tlo::::n:G··:r·oi~p·:·:
,,';.::::>:, :~ ... : .:: :.: ... :.·1..>::·::',·:··,,': ::.~ ',.,>::,:" Limited
demographic
and exposure
data
Irreversible unlinking
from patient
Analysis and interpretation
Source:HPA,Departmentof HIVand SexuallyTransmittedInfections
Chapter four showed that HIV testing in MSM was associated with higher-risk
behaviours, such as increased numbers of partners, in addition to demographic
characteristics, such as area of residence. It provided denominators for the population
of MSM that had a HIV test. If the relationship between HIV testing patterns, sexual risk
behaviour and risk of HIV infection was known, then surveillance of HIV tests could
provide an estimation of the size of population at increased risk of HIV, and the total
HIV prevalence within that population could be estimated. This is displayed in Figure
5.2, and the variables that are going to be investigated in this chapter are displayed in
blue colour. The study in this chapter was designed to directly quantify the relationship
between patterns of HIV testing and risk of HIV infection.
144
UNLINKED ANONYMOUS CROSS-SECTIONAL SURVEY OF MSM ATTENDING GUM CLINIC
Figure 5.2 Conceptual framework of the relationship between HIV testing and risk
of HIV infection mediated through risk behaviour in MSM: measuring the
association between HIV testing and HIV prevalence
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This Chapter describes a cross-sectional study that used an existing survey system,
and collected additional data from MSM on their HIV testing history and previous STls
diagnosed at that clinic prior to the surveyed visit. This obtained HIV testing history and
HIV infection status (both clinically recognised infection and undiagnosed infection)
from a population of MSM attending an inner London GUM clinic. The relationship
between HIV testing history and HIV prevalence in GUM attendees was quantified
using these data.
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In this chapter the following questions are investigated (Objective 5 and Objective 6,
Chapter one, section 1.5):
1) Investigate the association between HIV testing and HIV prevalence, both
overall and undiagnosed
2) Estimate how much the overall HIV prevalence and undiagnosed HIV
prevalence is affected by HIV testing history
5.2 Methods
5.2.1 Setting
Over 50% of all HIV tests in MSM are carried out at GUM clinics8.147 (Chapter four,
section 4.3.6, Table 4.4). In the UK, in particular in London, MSM more often attend
clinics that provide more services specifically for MSM.
The survey clinic, based in inner London, sees a diverse population of attendees, but
offers specialist services, and holds separate clinics for MSM. In 2003, the Mortimer
Market Centre GUM Clinic diagnosed 12% of gonorrhoea reported as homosexually
acquired in England, and 25% diagnosed in London. It carried out 22% of all HIV tests
in MSM in England and 43% of all HIV tests in GUM clinics in London. It diagnosed
16% of chlamydia and 10% of syphilis reported as homosexually acquired in England
(32% and 26%, respectively, of London diagnoses) 158.
5.2.2 Participants and survey methodology
A UA HIV survey of GUM clinic attendees has been under way at 15 GUM clinics in
England and Wales since 1990. This collects basic demographic data and STI
diagnoses at clinic visit, with a residual blood specimen from routine syphilis screening,
which is tested for HIV, after it has been irreversibly unlinked from all patient
identifiers2os. The methodology of this study at the Mortimer Market Clinic was
developed to allow the collection of demographic data electronically. This enabled the
development of this additional short study within the on-going procedures of the survey,
collecting additional information on past HIV testing and previous STI diagnoses. This
allowed the association between HIV testing and HIV infection to be directly
investigated. Details of how the study was developed, peer-reviewed, and ethics
obtained are outlined below.
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5.2.3 Summary of main study procedures and duration
The recruitment period for the study was between January and June 2003. Specimens
from all MSM receiving syphilis tests within the study period were included. Each
individual was included only once, the first attendance within the period. The study
operated an opt-out methodology, so residual specimen and limited demographic and
behaviour data were collected from all individuals unless they stated that they did not
wish their blood specimen to be used for any other purpose or in any other research
studies. Information leaflets and posters explaining the UA survey methodology were
displayed throughout the GUM clinic. The specimens were collected from the clinic
laboratory and delivered to the HPA for storing and testing, every 3 weeks throughout
the period. Testing of specimens began when the specimens were first collected and
continued for 3 months after recruitment was completed.
Detailed explanation of the study procedures, data handling and manipulation,
laboratory procedures, ethical approval and statistical methods used for this study are
detailed below in sections 5.2.3.1-5.2.3.3 and described below in Figure 5.3. Briefly,
the clinician completed the study form during the clinic consultation and a portion of the
blood sample taken for syphilis serology was transferred to the study laboratory for
testing. An additional electronic extract of data containing information on HIV testing
history and STI history at the clinic was taken and all these data were collected in the
study database following unlinking from all patient identifiers.
5.2.3.1 Study Methodology: Consultation
The clinician completed the study form (see Appendix D) during the clinic consultation.
A unique patient-id number (assigned by the clinic) was attached to the form [1} (Figure
5.3). The form was then placed with the patient notes, which were passed to the nurse.
When the phlebotomist or nurse took a blood sample for syphilis serology, the study
form was placed with the syphilis serology request form and transported to the clinic
laboratory with the blood specimen.
At the clinic laboratory a sample of blood (about 1 ml) was taken from the specimen,
after syphilis testing was complete, and transferred into a Sarstedt tube, with the
unique patient-id number that had been placed on the syphilis request form attached
[2}. The Sarstedt tubes were kept in a bag and refrigerated. The forms were collected
together in a bag and put into a box awaiting collection.
The blood samples and survey forms were collected from the clinic laboratory on a 3-
'weekly basis and the blood was transported to the HPA Centre for Infections,
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Specialist and Reference Microbiology Division (SRMD) for HIV testing and the survey
forms sent to the CDSC for data entry.
5.2.3.2 Study Methodology: Data Management
The data management followed two stages, the first was pre-unlinking, when the data
still had patient-id attached to allow individual data on HIV testing history and STI
history to be extracted from the clinic database and combined with the survey form
data. The second was post-unlinking from all patient identifiers, and involved the linking
of the survey data to the UA specimen. These two stages are outlined below. The
process has been broken down into numbered steps, which are illustrated in Figure
5.3).
Stage one (Pre-unlinking): Patient-id and data on the form were entered into the study
database [3] (FORM 1). A download of data from the clinic database was extracted,
containing the following fields: patient-id, age (single year), gender, syphilis serology
results, date of attendance, STI diagnoses (coded as KC60 codes, (see Chapter three,
section 3.3.4 and Appendix 8» and the date of these diagnoses. This file was extracted
a month after the date of the last visit required, to ensure that all diagnoses relating to
the clinic visits had been updated on the patient records. This data file (EXTRACT 1)
was imported into the study database [4]. The two files (FORM 1 and EXTRACT 1)
were matched on patient-id and the additional data were added to the study database
[5].
A new form was generated in the laboratory containing a unique barcode number and
the patient-id label taken from the specimen (see laboratory procedures below). This
was entered into the study database (FORM 2) [6]. A duplicate of the unique barcode
number remained linked to the specimen. The barcode number when scanned was
obscured and could not be seen by the person entering the forms. This file was then
matched on patient-id with the study database, thus a barcode number was attached to
each individual record [7].
When data matching was completed, the patient-id was deleted from the database [8].
At this point the data in the study database (demographic, clinical and behavioural)
became permanently unlinked from the patient identifiers but remained linked to the
specimen though the barcode number. Each record now had a barcode number as its
unique identifier instead of the patient-id number assigned by the clinic.
Stage two (post-unlinking): The study database now contained a unique barcode
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number, the data collected on the form at the consultation and the additional fields
extracted from the clinic database.
5.2.3.3 Study Methodology: Laboratory procedures and HIV testing
The SRMD received the residual blood specimens after clinical testing was complete
[2]. The patient-id label was removed from each specimen, and it was assigned a
unique barcode number [6]. A form containing a duplicate of the barcode number
assigned to the specimen, and the patient-id label from the specimen (FORM 2) was
then sent to the data management team [7]. The unique barcode number and the
patient-id number were entered into the study database and, following matching with
the demographic data file by patient-id, the patient-id was deleted from the study
database [8] (Stage one).
Before HIV testing, each specimen was assigned a unique laboratory number [6]. This
was reported to the CDSC with barcode number for entry into the study database
(FORM 3) post-unlinking (Stage two) [9]. The study database now included for each
individual record, a unique barcode, and a laboratory number to enable the matching of
HIV test results from specimens to the demographic data, which were now unlinked
from all patient identifiers [10].
Two screening methods, GACELISA HIV 1+2 (VK61, AbbottlMurex Diagnostics,
Dartford, Kent) and GACPAT (SRMD in-house method) were used for testing the blood
samples. GACPAT, the less expensive method, was adopted as the screening assay,
and GACELISA was used to investigate reactive specimens. A small subset of
specimens that were weakly reactive in either assay, or gave discordant reactions,
were also examined by a Western blot procedure.
When HIV testing was complete, the results were reported by laboratory number
(FORM 4) and entered into the study database (Stage two) [11].
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Figure 5.3: Schema of unlinked anonymous study procedures
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5.2.4 Definitions used in the UA GUM study
The following definitions were used for the analyses within this study.
5.2.4.1 Men who have sex with men
The clinician at the survey clinic determined if an STI episode was homosexually
acquired, as defined in the KC60 data collection form (Appendix D form 1). In this study
an additional field on sexual orientation was collected on the study form, defined as
homo/bisexual. All male attendees with sexual orientation ticked as homo/bisexual
were defined as men who have sex with men (MSM). All STI episodes in any male that
had at least one homosexually acquired episode (as defined before and summarised in
Appendix B) were selected for electronic data download from the clinic database.
5.2.4.2 HIV test definition, KC60 codes and their interpretation
Definitions for KC60 codes defining clinic episodes were described in Chapter three,
section 3.3.4 and are presented in Appendix B. These were coded into acute and non-
acute STI presentations.
5.2.4.3 Definition of clinically recognised HIV infection and undiagnosed HIV
infection as measured through UA testing
The definitions of clinically recognised HIV infection and undiagnosed HIV infection as
measured through the UA GUM study are described below in Box 5.1.
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Box 5.1 Definition of HIV status in UA GUM study
HIV status Specimen Study form KC60 diagnoses recorded with visit
HIV test
result
Clinically HIV Known HIV 'Asymptomatic HIV infections,
recognised HIV positive positive subsequent presentation'
infection or
'HIV infection with symptoms,
subsequent presentation'
or
'AIDS - subsequent presentation'
Undiagnosed HIV HIV Not known Not recorded as previously clinically
infection positive to be HIV recognised infection
positive
1) Undiagnosed HIV Not known Not recorded as previously clinically
HIV infection- positive to be HIV recognised infection
new diagnosis positive and
HIV test recorded at the survey visit
Or
KC60 diagnosis 'asymptomatic HIV
infection - first presentation' recorded
2) Undiagnosed HIV Not known Not recorded as previously clinically
HIV infection positive to be HIV recognised HIV infection,
positive and
who did not have a HIV test at this
visit
and
did not have a new diagnosis of HIV
infection recorded at this visit
These definitions of HIV infection status by HIV testing history collected through the
recorded history of HIV tests are illustrated below in Figure 5.4.
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Figure 5.4 Flow chart of HIV infection status by HIV test history: Clinically
recognised infection, New diagnosis and Undiagnosed HIV infection
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5.2.5 Statistical analyses
An analysis strategy was determined a priori based on the conceptual framework in
Chapter two of the relationship between HIV testing and risk of HIV infection in MSM,
to investigate the socio-demographic and HIV testing variables associated with HIV
prevalence as highlighted in Figure 5.2.
Three HIV testing variables were constructed for these analyses, (i) previous HIV
positive test and (ii) previous HIV negative test, were constructed based on the HIV
testing algorithm shown in Figure 5.4. Natsal collected information on whether MSM
had a previous HIV test; but no information on the result of this test was collected.
Thus, a third variable, (iii) Ever HIV tested (including both positive and negative tests),
was constructed, which included all MSM who had a previous HIV test, including both
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positive and negative tests, before the survey visit, to measure the HIV prevalence in a
comparable group to the Natsal denominator.
To describe the demographics of MSM attending a GUM clinic in inner London,
prevalence (with 95% Cl) of HIV testing and HIV prevalence (overall positive and
undiagnosed) by both demographic and STI diagnoses characteristics were calculated.
A 95% Cl was calculated in each case using a binomial exact distribution. Differences
between groups were compared using the Chi-squared test and Chi-squared test for
trend. Age-specific prevalence of HIV testing by each testing variable was calculated.
To determine what demographic characteristics are associated with previous HIV
testing, OR were used to compare the prevalence of STI diagnoses and demographics
associated with HIV test history through the conceptual framework in Chapter two
(Figure 5.2), controlling for the other socio-demographic and STI variables in the
model. This was to investigate variables independently associated with HIV testing and
to establish whether STI diagnoses were independently associated with HIV testing
when controlling for other demographic variables. Interaction terms between
demographic and STI variables were explored to investigate if the association of these
variables with HIV testing (OR) varied when stratified by other variables. Two individual
analyses were undertaken: the first looked at demographic and behavioural factors
associated with ever HIV tested with never as the reference, and the second looked at
never HIV tested with ever HIV tested as the reference. One set of results is the
inverse of the other; both were done to provide ratios for untested MSM for the
adjustment factor calculated in Chapter seven.
A second series of analyses were undertaken to quantify how much HIV prevalence
varied by HIV test history, to produce an adjustment factor for the estimation model in
Chapter seven. To determine what demographic characteristics, STI diagnoses and
HIV testing variables are associated with HIV prevalence (overall prevalence and
undiagnosed prevalence), OR were used to compare the prevalence of HIV testing
behaviour, STI diagnoses and demographics associated with being HIV positive, both
diagnosed and undiagnosed. Logistic regression analyses were used to calculate
adjusted OR, controlling for the other socio-demographic and STI diagnoses variables
in the model, in order to establish whether HIV testing were independently associated
with HIV prevalence, when controlling for other demographic variables. Interaction
terms between demographic and STI variables were explored to investigate if the
association of these variables with HIV prevalence (OR) varied when stratified by other
variables. The importance of STI diagnoses was relevant to determine whether
previous STI could be used as a proxy for UAI in surveillance systems; as it is a clinical
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diagnosis, it would not be subject to reporting bias and would be routinely available
through clinical records. Three individual analyses were undertaken, each one
including a different variable on HIV testing examined in section 5.3.3. The first
examined factors associated with HIV prevalence, both overall and undiagnosed and
included the HIV testing variable, time since last HIV negative test. The second
analysis included the HIV testing variable, total numbers of HIV negative tests and the
third included ever HIV tested, regardless of the result. Factors from the conceptual
framework associated with both HIV testing and HIV prevalence were summarised to
determine factors for inclusion in the HIV estimation model in Chapter seven.
All analyses were performed using STATA 7.0.
5.2.6 Ethics of unlinkedanonymousHIVtesting
As part of the UA programme, the survey was carried out in a setting where voluntary
confidential HIV testing was readily available to all participants. Posters and leaflets
were displayed at the clinic, which informed the clinic attendees that the residual of the
specimens they give might be used for additional research. If any individual did not
want the residual blood left after clinical testing to be used in research, they could
express an objection, and their specimen was excluded from the study. If a patient
objected, this information was collected on FORM 1. In this case the demographic data
were examined so that a comparison between objectors and those included in the
study could be made.
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5.3 Results
5.3.1 Demographic characteristics of a cross-sectional survey of MSM
attending an inner London GUMclinic
Overall, 2,210 MSM were surveyed between 1 January 2003 and 30 June 2003. The
majority (73.7%) were aged between 25 and 44; 13.0% of MSM were aged less than
25 and 13.3% aged over 45. Overall, 60.0% of attendees had an HIV test at the survey
visit (Table 5.1). The age distribution of HIV testers differed from those attendees who
did not have a HIV test. There were 18% of HIV testers aged less than 25, but most
non-testers (94%) were aged 25 years or more. Non-testers were more likely to be 35
years or older and 19% of non-testers were aged 45 or over, compared with only 10%
of testers (see Table 5.1). MSM aged over 25 were less likely to test at the survey visit
compared to 16 to 24 year aids; OR 0.46 (95% Cl 0.33 - 0.64) for 25 to 34 year olds,
OR 0.23 (95% Cl 0.47 - 0.33) for 35-44 year aids and OR 0.18 (95% Cl 0.12 - 0.26).
Almost a quarter of non-testers were diagnosed with an acute STI at the survey visit.
MSM diagnosed with an acute STI were 30% less likely to have an HIV test at the
survey visit (OR 0.79, 95% Cl 0.64 - 0.97). A higher proportion of MSM who did not
have a HIV test at this visit had previously had an acute STI diagnosed (26.0%)
compared with current HIV testers (18.9%). MSM who had previously had an acute STI
diagnosed were 40% less likely to test at the survey visit (OR 0.66, 95% Cl 0.54 -
0.81). In particular if this previous STI diagnosis was gonorrhoea it was associated with
not testing at this survey visit, OR 0.48 (95% Cl 0.35 - 0.67).
5.3.2 HIV testing patterns in MSMattending GUMclinic
Overall, 37.4% of MSM surveyed had never HIV tested. Just over a quarter, 26.6%,
had a previous HIV test in the past 12 months, 16.0% between 24 and 59 months ago,
and 4.3% 60 or more months ago. Whether an HIV test was carried out at the survey
visit was associated with previous HIV testing history (Table 5.1). Sixty-four per cent of
non-testers had never tested and MSM who had tested 60 or more months ago were
75% less likely to test at the survey visit compared with MSM who had never previously
tested negative (OR 0.23, 95% Cl 0.18 - 0.29). One third of MSM who HIV tested at
the survey visit had a previous HIV test in the past 12 months and a further 34% HIV
tested in the past 59 months. Just 17% of non-testers at the survey visit had HIV tested
in the past 12 months, and 15% between 12 and 59 months ago. Fewer than 5% of
both HIV testers and non-testers had a previous HIV test more than 5 years ago.
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Overall, 33.3% of MSM had one previous HIV test recorded, 16.8% had two tests,
6.4% had between three and four previous tests and 1.2% had five or more tests
previously. Numbers of previous HIV negative tests was associated with a HIV test at
this visit (Table 5.1). Approximately two thirds of MSM who tested at the survey visit
had one or more previous HIV negative tests before this visit while only a third of MSM
who did not choose to test at the survey visit had had a previous test (Table 5.1). MSM
who had never previously tested negative were less likely to HIV test at the survey visit,
when compared with MSM who had one previous negative test, OR 0.25 (95% Cl 0.20
- 0.31). MSM who had two previous tests had an increased likelihood to have a HIV
test at the survey visit compared with MSM who had just one previous test (OR 1.34,
95% Cl 0.99 -1.79).
Table 5.2 The distribution of HIV testing variables (column percentages and 95%
confidence intervals) for MSM· attending an inner London GUM clinic January -
June 2003; Time since last negative HIV test by total number of negative HIV
tests
Total number of Time since last negative
HIV negative HIV test
tests
<12 months Between 12 Between 24 60 or more
and 23 and 59 months
months months
% (95% Cl) % (95% Cl) % (95% Cl) % (95% Cl)
Number surveyed 587 354 236 96
1 previous 52.2 51.2 66.9 87.5
negative test (48.1 - 56.3) (46.9 - 57.6) (60.6 - 72.9) (79.2 - 93.4)
2 35.9 30.8 17.4 10.4
(32.0 - 39.9) (26.0 - 35.9) (12.8 - 22.8) (5.1 - 18.3)
3-4 9.4 14.4 14.0 2.1
(7.1-12.0) (10.9 - 18.5) (9.8-19.1) (0.3- 7.3)
5-10 2.4 2.5 1.7 0
(1.3 - 4.0) (1.2-4.8) (0.5 -4.3)
a. Excludes936 MSMwho had no recordedpreviousnegativeHIVtest
The total numbers of recorded previous HIV negative tests were associated with time
since last HIV negative test. This has been cross-tabulated in more detail in Table 5.2.
Most MSM who had tested previously had their last HIV negative test in the past 23
months. MSM with increasing numbers of HIV tests were more likely to have had their
last HIV test in the past 23 months compared with men with only one HIV test (Chi-
squared test for trend p<0.001). Eighty-eight per cent of MSM who had their last test
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60 or more months ago only had one previous test compared with 52% of those who
had their last test in the past 12 months.
When these HIV testing variables were stratified by age group to allow for the
association between increasing age and time since last HIV test, a similar pattern was
seen in each age group. Tables of each HIV testing variable by age group have been
included in Appendix D, Table D.1. MSM aged greater than 35 were less likely to have
tested in the past year compared with MSM aged less than 25; OR 0.59, 95% Cl 0.44 -
0.79, for 35 to 44 year aids and OR 0.31,95% Cl 0.20 - 0.46 for MSM aged 45 or more
years old (Table 5.3). MSM age 25 to 34 years old were more likely to have tested
between 12 and 23 months ago compared with MSM aged less than 25, OR 1.52, 95%
Cl 1.04 - 2.24. They were more likely to have tested between 24 and 59 months ago
(OR 1.76, 95% Cl 1.08 - 2.86). MSM aged more than 25 were more likely to have
tested 60 or more months ago compared with less than 25 year aids. MSM aged 25 to
34 were 12 times more likely OR 11.76, 95% C11.60 - 86.24),34 to 44 year aids were
eighteen times (OR 18.58, 95% C12.55 - 135.4) and over 45 year aids fifteen times
more likely to have tested 59 or months ago compared with MSM aged less than 25
(OR 15.49, 95% Cl 2.03 - 118.02).
The distribution of the numbers of total previous negative HIV tests was similar. MSM
aged 25-34 years old were less likely to have no negative tests recorded compared to
MSM aged less than 25, OR 0.67,95% Cl 0.51 - 0.88. MSM aged over 35 were less
likely to have one negative HIV test recorded than MSM aged less than 25; OR 0.56,
95% Cl 0.42 - 0.75 in 35-44 years aids and OR 0.41, 95% Cl 0.29 - 0.59 in MSM aged
45 or more. MSM aged over 35 were between four and six times more likely to have
three to four negative tests than MSM aged less than 25 (OR 4.37, 95% 1.73 - 11.04,
and OR 6.46,95% Cl 2.47 - 16.89, for 35-44 and 45 or more years respectively, Table
5.3).
When a testing variable that encompassed all HIV tests MSM had, including both those
that were HIV positive and HIV negative was examined, three quarters of MSM had
ever HIV tested (75%). This varied by age and the likelihood of ever testing was higher
in each age group relative to MSM aged less than 25 years old: OR 2.40 (95% Cl 1.81
- 3.17) in MSM aged 25-34, OR 2.96 (95% Cl 2.20 - 3.97), for 35-44 years old and OR
2.84 (95% Cl 1.97 - 4.09) in MSM aged 45 or more. This is detailed further in the next
section.
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The frequency and distribution of the demographic and behavioural characteristics of
all MSM by ever having had an HIV test previous to the survey visit (HIV testing
history) are shown in Table 5.4. The proportions that are found to be important in the
model in Table 5.5 will be used for the HIV estimation model in Chapter seven. The
distribution of age and diagnosed with a previous acute STI varied by whether MSM
had ever had an HIV test or not. Results for the association between having had an
HIV test, age, and STI diagnosis can be found in Table 5.5.
Table 5.4 The distribution of demographic and behavioural characteristics by HIV
testing history (column percentages and 95% confidence intervals) for MSM
attending an Inner London GUM clinic, January-June 2003
Total Ever HIV tested;
surveyed Including both
positive and
negative tests
Never HIV tested
All respondents, n 1666 544
% (95% Cl) % (95% Cl)
Age group
16-24 288 9.9 (0.85 - 11.4) 22.3 (19.2 -26.4)
25-34 889 40.7 (38.3 - 43.0) 38.8 (34.7 - 43.0)
35-44 740 35.5 (33.2 - 37.8) 27.4 (23.7 - 31.3)
45+ 293 13.9 (12.3 - 15.7) 11.2 (8.7 - 14.2)
Diagnosed gonorrhoea
at survey visit
No 2096 95.1 (94.0 - 96.1) 93.9 (91.6 - 95.8)
Yes 114 4.9 (3.9 - 6.0) 6.1 (4.2 - 8.4)
Diagnosed syphilis at
sUNey visit
No 2186 98.9 (98.3 - 99.4) 98.9 (97.6 - 99.6)
Yes 24 1.1 (0.6- 1.7) 1.1 (0.4 - 2.4)
Diagnosed other acute
STI at sUNey visif
No 1888 86.0 (84.3 - 87.6) 83.6 (80.3 - 86.7)
Yes 322 14.0 (12.4 - 15.7) 16.4 (13.3 - 19.7)
Previous acute STI in
past 5 years
No 1729 74.7 (72.5 -76.7) 89.2 (86.2 - 91.6)
Yes 481 25.3 (23.3 - 27.5) 10.8 (8.4 - 13.8)
Note. a. proportion used for estimation model in Chapter seven.
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In univariable analysis ever having had an HIV test was associated with being older,
and having a previous acute STI in the past 5 years. There was no evidence of an
association between any acute STI at the surveyed visit and ever having had an HIV
test in MSM. However, MSM who had ever HIV tested were almost three times more
likely to have had a previous acute STI compared with MSM who had never HIV tested
before this survey visit (OR 2.79, 95% Cl 2.08 - 3.73). In multivariable analysis,
following adjustment for all demographic and behavioural variables, increasing age
remained statistically associated with ever HIV tested. MSM presenting with another
acute STI other than gonorrhoea or syphilis were less likely to have ever HIV tested
while MSM with a previous history of acute STls were more likely to have ever HIV
tested.
163
o
Z:::;
o
~
:::l
(,!)
(,!)
zs
Z
LIJ
~«
~
(Jl
~
u,o
>-
~
Cl::
:::l
(Jl
..J
~o
i=o
LIJ
(Jl
~o
Cl::o
(Jl
:::lo
~zoz«
c
LIJ
le:
Z:::;
Z
:::l
('t')
('t')
o
II
CL
I
00
~«!
e.
'"it
N
......
No
IIa.
I
0('1)
~ex>o-
('I)
('I)
o
II
CL
I
0('1)
~It')o-..-
ex>o
......
No
II
CL
I
ON
~It')o-m......o
..-
..-
-Nm
..-
<0
N
-o
N
............
o
II
CL
-......m
N
I
010.'"it..- .o-
<0
~
o
II
CL
-m
It')
N
I
00
,....:~
o-
......
":o
II
CL
-ex>
'"it
N
Iom
""':('1)o-
<0mo
II
Q.
10..-.....
N
~..-
......
ex>o
OJmo
('I)
N
'"itoo
II
CL
0 .....
·0......
~oo
II
CL
I
Oco,....:mo-10
N
('I)
~
o
II
CL
-mmo
I
0 ......
""':10o-
~oo
II
CL
I
0 .....
,....:CC!
o-o
ex>o
-10......
.....
..-
I
..-ooo
ov
CL
..--
-('t')co
..- ..-oooov
CL
.....
..-
oooov .....
CL
..... .....oooov
CL
UNLINKED ANONYMOUS CROSS-SECTIONAL SURVEY OF MSM ATTENDING GUM CLINIC
5.3.3 Descriptive analysis of HIV prevalence, clinically recognised and
undiagnosed HIV infections
Overall, 24.6% (95% Cl 22.8 - 26.5) of MSM sampled were HIV positive, 19.8% had
their HIV infection clinically recognised prior to this visit, and 4.8% were undiagnosed
prior to this clinic visit (Table 5.6). HIV prevalence was highest in older men, and just
over a quarter of men aged over 25 were HIV positive compared with 5% of 16-24 year
olds. The majority of HIV positive MSM aged over 35 had their HIV infection clinically
recognised prior to this clinic visit (84.6%, 95% Cl 80.4 - 88.1). This was a higher
proportion than of men aged under 35 (Chi-squared test p=0.001) although the majority
of HIV positive men aged less than 35 years old also had their HIV infection clinically
recognised (72.9%, 95% Cl 65.9 - 79.1) prior to this clinic visit. MSM diagnosed with
an acute STI were less likely to be HIV positive and have clinically recognised HIV
infection. However, MSM diagnosed with syphilis were more likely to be HIV positive
and there was no evidence of a difference in overall HIV prevalence in MSM presenting
with gonorrhoea, although a higher proportion had undiagnosed HIV infection. MSM
presenting with another acute STI were less likely to be HIV positive, and to have
clinically recognised HIV infection prior to that visit. MSM who had a previous acute STI
diagnosed in the past 5 years had no difference in HIV prevalence.
Forty-two per cent of MSM with no previously recorded HIV negative test had clinically
recognised HIV infection and 7% had undiagnosed HIV infection. The remainder were
HIV negative. While overall HIV prevalence was higher in MSM who had ever had a
HIV test (including both positive and negative), undiagnosed HIV infection was higher
in MSM who had never HIV tested.
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5_3.4 Factors associated with overall HIV prevalence and undiagnosed HIV
prevalence
5.3.4.1 Factors associated with overall HIV prevalence
In univariable analysis, overall HIV prevalence was associated with increasing age,
being diagnosed with syphilis at that visit, not being diagnosed with another acute STI
at that visit. There was no evidence of a difference in HIV prevalence in MSM who
were diagnosed with gonorrhoea at the surveyed visit or a previous acute STI in the
past 5 years. Overall HIV prevalence was associated with and increased likelihood of
having a previous HIV negative test more than 5 years ago, (OR 1.25, 95% Cl 0.58 -
2.66) and never testing HIV negative previously (OR 13.04, 95% Cl 10.1 - 16.9)
compared with testing in the past 5 years (Table 5.7). However, MSM who had never
HIV tested were less likely to be HIV positive than those who had ever HIV tested when
both previous HIV positive and negative tests were included (OR 0.34, 95% Cl 0.25 -
0.44).
In multivariable analysis, following adjustment for age, previous STI, current STI and
HIV testing variables (interval since last negative test, total number of previous
negative tests, and ever test previously (including both positive and negative tests»,
increasing age remained associated with overall HIV prevalence in each model.
Gonorrhoea diagnosis was associated with being HIV positive although only borderline
associated in Model 1, which included the HIV testing variable time since last negative
HIV test. A diagnosis of syphilis was associated with being HIV positive in crude
analysis and attenuated in Model 3 when adjusted for ever HIV tested (including both
positive and negative tests). While in Model 1 or 2, adjusting for time since last
negative tests and number of negative tests showed less marked attenuation. This is
due to the positive confounding effects of ever HIV tested (including both positive and
negative) which was strongly associated with syphilis (see Table 5.7). MSM presenting
with another acute STI other than gonorrhoea or syphilis were less likely to be HIV
positive compared with MSM with no other acute STI in each model. A previous history
of acute STls while not associated with being HIV positive in crude analysis, attenuated
in Model 1 and Model 2 when adjusting for time since last negative tests, and number
of negative tests, while in Model 3 when adjusting for ever HIV tested (including both
positive and negative tests) showed less marked attenuation. This is due to the
negative confounding effects of number of negative HIV tests and the interval between
them which was strongly associated with previous acute STls (see Table 5.7).
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In multivariable analysis, after controlling for demographic and other behaviour
variables, never having a previous negative HIV test was independently associated
with testing HIV positive in both Model 1 and Model 2. MSM who had no previous
negative HIV test recorded at that clinic were more likely to be HIV positive (adjusted
OR 14.91, 95% Cl 11.31 - 19.66) compared with men who had a previous negative
test recorded in the past 5 years (Model 1). MSM who had no previous HIV negative
test recorded were more likely to be positive than MSM who had one previous negative
test in Model2 (OR 12.10, 95% Cl 8.85 - 16.55). In Model3, which included MSM who
have tested positive at first HIV test, MSM who never HIV tested had a decreased risk
of being HIV positive (OR 0.37, 95% Cl 0.28 - 0.50).
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5.3.4.2 Factors associated with undiagnosed HIV infection
In univariable analysis, undiagnosed HIV infection was associated with increasing age,
being diagnosed with syphilis or gonorrhoea at that visit and not being diagnosed with
another acute STI at that visit. In the HIV testing variables, undiagnosed HIV infection
was associated with never having a previous negative HIV test for each of the HIV test
variables: firstly, compared with having a negative HIV test in the last 2 years,
secondly, compared with having one previous negative HIV test and, finally, compared
with ever having a previous HIV negative test (Table 5.8).
In multivariable analysis, following adjustment for all demographic and behavioural
variables, there was an increase in OR of undiagnosed HIV infection with increasing
age. Diagnosis with gonorrhoea was associated with an increased likelihood of
undiagnosed HIV infection compared with MSM not presenting with this diagnosis in
each of the Models. Presenting with another acute STI other than gonorrhoea or
syphilis was associated with a lower likelihood of undiagnosed HIV infection in each
Model compared with MSM not presenting with another acute STI. This proportion
(shown in Table 5.8) will be used in the final estimation model in Chapter seven.
MSM who had never tested negative previously were more likely to have undiagnosed
HIV infection compared with those who had tested less than 5 years ago in Model 1
(OR 4.65, 95% Cl 3.00 - 7.22) (Table 5.8), and compared with MSM who had one
previous negative test in Model2 (OR 4.17,95% Cl 2.56 - 6.79). Similarly, MSM who
had never HIV tested, this time just including previous HIV negative tests (as
undiagnosed excludes all MSM with clinically recognised HIV infection), had a higher
AOR of having undiagnosed HIV infection prior to this visit (OR 4.70, 95% Cl 3.07 -
7.20).
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5.3.5 Factors associated with both HIV testing and risk of HIV infection
The factors that were associated with both HIV testing and risk of HIV infection are
summarised in Table 5.9. The variables that were associated both with HIV testing and
HIV prevalence are in italic and variables associated with either HIV testing or risk of
HIV infection are highlighted in bold. This section first looks at variables associated with
HIV testing, then with HIV infection and finally variables associated with both HIV
testing and HIV infection.
Increasing age group and a previous diagnosis with an acute STI were positively
associated with previous HIV testing. Being diagnosed with an acute STI (other than
gonorrhoea or syphilis) at survey visit was negatively associated with previous HIV
testing.
Non-linear increasing age (peak at 35-44 years) and a diagnosis of gonorrhoea at
survey visit were positively associated with HIV infection. Being diagnosed with an
acute STI (other than gonorrhoea or syphilis) at survey visit was negatively associated
with HIV infection.
Increasing age group was positively associated with previous HIV testing and HIV
infection. Diagnosis with another acute STI (other than gonorrhoea or syphilis) at the
survey visit was associated with a reduced odds of ever HIV testing and of HIV
infection compared with no other acute STI.
MSM who had an STI other than gonorrhoea or syphilis were less likely to have had a
previous HIV test and had lower odds of being HIV positive than MSM without another
acute STI. Hence, it was important to distinguish between types of STI in the estimation
model. Being diagnosed with gonorrhoea or syphilis at the clinic visit, while both
strongly associated with risk of HIV infection, provided no evidence of an association
with HIV testing at the same visit. Previous HIV testing history was associated with a
HIV test at survey visit. Two thirds of MSM who did not test at survey visit, had never
previously HIV tested, while over a half of those who tested, had tested previously in
the past 2 years. Surveillance methods collect concurrent HIV test with STI diagnosis,
not past HIV test history.
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Table 5.9 Odds ratios with their 95% confidence intervals for variables which are
associated with HIV testing, HIV infection and undiagnosed HIV infection in MSM.
Results for different logistic regression models for each outcome are shown in
se~arate columns
Variables Number AOR (95% CI)a
(%) of
MSM
Ever HIV Tested HIV infection Undiagnosed HIV
(known and infection
unknown}
Age group
<25 288(13.0) 1.0 1.0 1.0
25-34 889(40.2) 2.22 (1.67 - 2.94) 4.11 (2.37 - 7.15) 3.76(1.56- 9.04)
35-44 740(33.5) 2.58 (1.91 - 3.48) 8.76 (5.05-15.18) 6.13 (2.54-14.81)
45+ 293(13.3) 2.62 (1.81 - 3.79) 8.89 (4.97- 15.90) 1.66 (0.52 - 5.33)
Diagnosed with
gonorrhoea at
survey visit
No 2096 1.0 1.0 1.0
Yes 114 (5.2) 0.81 (0.53 - 1.24) 1.83 (1.18 - 2.84) 2.90 (1.50 - 5.59)
Diagnosed with
syphilis at
survey visit
No 2186 1.0 1.0 1.0
Yes 24 (1.1) 0.87 (0.34 - 2.24) 3.15 (1.34 - 7.43) 3.67 (0.95-14.10)
Diagnosed with
other acute STI
survey visit
No 1888 1.0 1.0 1.0
Yes 322(14.6) 0.75 (0.57 - 0.99) 0.45 (0.31- 0.63) 0.42 (0.21 - 0.86)
Diagnosed with
previous acute
STI in last 5
years
No 1729 1.0 1.0 1.0
Yes 481(21.8) 2.61 (1.94 - 3.51) 0.81 (0.64 - 1.04) 1.31 (0.79-2.18)
Note. a. For variables that were associated with both HIV testing and HIV infection OR for the
associations are highlighted in italic, for variables associated with either HIV testing or HIV
infection OR for the associations are highlighted in bold; b. each OR was adjusted for all the
variables within the models presented in Table 5.5, Table 5.7, Table 5.8, these included, age,
diagnosed STls, previous STls and HIV testing variables; AOR, adjusted odds ratio; Cl,
confidence intervals.
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5.4 Discussion
5.4.1 Factors associated with overall and undiagnosed HIV prevalence
Three quarters of MSM attending the GUM clinic had ever HIV tested. Previous HIV
testing was associated with increasing age, previous acute STls and not presenting
with another acute STI.
Overall HIV prevalence was high in this population of MSM attending an inner London
GUM clinic, at 24.6%. Older MSM were more likely to be HIV positive than MSM aged
less than 25. Overall HIV prevalence in MSM varied according to clinical presentation
at the clinic, and by previous HIV testing patterns within MSM. Undiagnosed HIV
prevalence, Le. HIV infection detected in specimens from attendees without clinically
recognised HIV infection before this clinic visit, was also high: 4.8% of the sample had
undiagnosed HIV infection. MSM aged 35-44 years were most likely to have
undiagnosed HIV infection. Undiagnosed HIV prevalence showed a similar pattern of
associations as overall HIV prevalence and varied by clinical presentation of STls and
by previous HIV test history.
A large proportion (42%) of HIV positive MSM are diagnosed at the first HIV test. HIV
prevalence increased with time since last HIV negative test. If MSM who have never
tested negative (including those diagnosed HIV positive at first test) were compared
with MSM with a previous negative test then they were fifteen times more likely to be
HIV positive than MSM who had tested in the past 5 years, and 12 times more likely to
be HIV positive than MSM with one previous negative test. This was in contrast to the
hypothesis that MSM who had previously tested were at higher risk of HIV infection
compared with MSM who had not HIV tested. However if known HIV positive MSM with
no prior negative HIV test were included into the analysis as 'ever HIV tested'. then the
overall HIV prevalence was higher for MSM who had ever HIV tested than in MSM who
had never tested. Indeed non-testers were 70% less likely to be HIV positive compared
with ever HIV testers.
When looking at undiagnosed HIV infection, these HIV positive MSM with no previous
negative tests are excluded, Le. looking at the sub-population of MSM who've had past
negative HIV tests and compare them with the MSM who have never tested, then
never tested MSM were more likely to have undiagnosed HIV infection. Similar to
overall HIV prevalence, the prevalence of undiagnosed HIV infection increased with
time since the last negative test.
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5.4.2 HIV testing as a proxy for sexual behaviour
When each event occurs in a timeline it is difficult to assess through cross-sectional
studies which happened first; this survey did show that HIV testing at the clinic visit was
associated with new STI diagnoses, and thus associated with UAI. MSM presenting
with another acute STI other than gonorrhoea or syphilis were less likely to be HIV
positive than those not. This may reflect documented outbreaks of syphilis and
gonorrhoea in MSM with clinically recognised HIV infection 161or the sexual networks in
which both HIV infection and syphilis and gonorrhoea are circulating. Thus, MSM who
present with syphilis and gonorrhoea may be at a higher level of risk behaviour
compared with MSM who present with other acute STls such as genital warts or
chlamydia. Being HIV positive was associated with a new diagnosis of gonorrhoea and
with previous negative HIV tests more than 5 years ago. This may be because
diagnosed HIV positive MSM attended a GUM clinic for an STI and did not disclose
their HIV status to the clinician or these may be new incident HIV infections. It is
difficult to determine this; but these results reinforce the need for MSM attending GUM
clinics with acute gonorrhoea to be offered and recommended HIV testing as the
national standards set in the National Strategy for Sexual Health and HIV state 151.
Sexual behaviour was not collected in this survey, but if HIV testing is thought to be a
proxy for sexual behaviour then its association with HIV infection must be similar to the
association of UAI with HIV infection. Clearly an individual's HIV infection status is an
important determinant of future sexual behaviour. It has been shown that some MSM
are using HIV testing to determine their HIV status in order to make decisions about
their sexual behaviour within relationships based on their test results79.190.206.This has
been termed 'negotiated safety'. However, two studies within Britain have shown that
between 16% and 25% of MSM surveyed who stated that they had only had UAI with
men of the same serostatus, have never had an HIV test49.52.In addition, other studies
have shown that of men who were practising negotiated safety, many of the partners
with whom they had UAI were casual partners of unknown status". Regular testing is
described as part of healthy behaviour, for responsible MSM, who choose to test
annually or biannually as part of a sexual health check". These associations do not
hold true in the UK where the overwhelming reason for HIV testing seems to be
associated with risk and even MSM who test regularly may be prompted by an event
which causes them to doubt their negative status, and re-test. A case control study of
repeat HIV testers in the UK found that among men engaging in high-risk sexual
behaviour, negative HIV tests contributed to reduced risk perceptions and continued or
increased risk-taking78. Qualitative interviews of HIV seroconverters found that HIV
negative test results gave the MSM a sense of immunity. They also reassured them
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that the UAI which had prompted them to have a HIV test was not as risky for HIV
infection as they had thoughfe.
There was no difference in the prevalence of HIV testing in MSM by an individual's
perception of self-reported perceived risk of HIV infection in Natsal 2000, although a
third of men who reported same-sex partners had been tested in the past 5 years", The
majority of MSM recruited through a community survey in London reported 'not putting
themselves at risk' as the reason for not HIV testing in the last year (34%) 157. However,
of these men 29% reported UAI in the last year. Behavioural surveys in the UK found
that men that reported HIV testing in the past year were likely to report both an STI,
and UAI in the past year'". HIV testing was associated with increasing numbers of
sexual partners in Natsal (Chapter three, Table 3.2). So HIV testing may denote many
different types of behaviour and there are many reasons for having an HIV test. The
overall evidence suggests that those who have ever HIV tested have higher
behavioural risk than those who haven't tested.
HIV testing at the clinic must be a combination of both offering and decision making by
the MSM, as some of the attendees who have not tested at this visit haven't tested
before either, even if they have had previous visits and previous episodes of STI.
5.4.3 Limitations of the UA GUM survey
A major strength of this survey was that it enabled the direct measurement of HIV
status associated with HIV testing. However, some limitations to the interpretation of
the results should be noted. While the UA methodology minimises participation bias
within the setting, it is possible that those MSM with lower HIV risk who do not have a
HIV test were less likely to seek treatment at GUM clinics. Thus, this survey of GUM
clinic attendees provides prevalence and associations with both overall HIV infection
and undiagnosed HIV infection for a higher-risk population of MSM. In addition the men
surveyed through this survey are only those who have been screened for syphilis at
their visit. This may represent a higher-risk population, if only higher-risk MSM who
have been at behavioural risk get screened for syphilis at the clinic. The current syphilis
testing policy for GUM attendees remains unchanged for many years and recommends
screening of all GUM attendees at first visit, and subsequently according to risk207.2oe.
Outbreaks of syphilis among MSM since 1997, particularly among HIV positive
MSM160,161,209,have led to recommendations in 2003 to test all MSM attending GUM
clinics, regardless of HIV status, as HIV positive men attending specialist HIV services
at the clinics were not always routinely tested210, This should have led to the testing of
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all GUM attendees, thus making the sample surveyed in this clinic more representative
of all MSM attending the clinic.
There are limitations to interpretations of UA programme data. There is an assumption
that prevalence in the residual specimens and the patient group are equivalent to the
population it is taken to represent; that is, that HIV prevalence in MSM attending GUM
clinic is representative of all MSM (Figure 5.1). It also assumes that the HIV
seroprevalence estimates measured in centres included in the surveys are
representative of seroprevalence in all centres within that geographic region. This
survey only represents MSM at one inner London clinic and may not be representative
of the population of MSM attending other GUM clinics in England.
A further limitation to this study is that it involves only one GUM clinic in inner London.
This clinic could be different from other clinics. However, the GUM clinic surveyed, the
Mortimer Market Clinic, serves a diverse population of MSM, with one-third born
abroad, and they have a broadly similar age distribution to the Natsal national sample
of MSM17O• HIV test history was collected in this survey for all HIV tests previously
carried out at the clinic or reported last negative HIV test recorded on the survey card
for attendees without clinically recognised HIV infection. This may lead to an under-
reporting of true HIV test history, as not all MSM will have had previous negative HIV
tests at this clinic, and may not provide information to their clinician on all previous
negative HIV tests carried out at other GUM clinics. This would lead to an
underestimate of past HIV testing. Overall, 59% reported a previous negative HIV test
and a further 16% had previously tested HIV positive without a recorded HIV negative
test. Of MSM surveyed through Natsal overall, 35% reported a previous HIV test, and
74% of MSM who had attended a GUM clinic in the past 5 years also had a HIV test in
that pertod'". Other convenience samples of MSM surveyed through community
surveys gave the following results: of MSM recruited in bars, clubs and saunas, 76%
reported a previous HIV test (69% for whom it was negative), 83% of gym attendees
surveyed and 55% of gay pride attendees reported ever having a previous HIV
test94.157.211.HIV status of these previous tests was not collected in the latter two
studies.
The survey clinic may have more HIV positive MSM attending although, as long as
their previous HIV testing history was recorded, the association with HIV testing could
still be measured. If the clinic had more drop-in visits from MSM not disclosing their
clinical HIV diagnosed positive status as they require testing for an STI and don't want
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to be told to alter their sexual behaviour and so decline HIV testing. A social-desirability
effect could systematically bias the study leading to a high undiagnosed HIV
prevalence misclassified as undiagnosed. If the HIV testing policy was different at this
clinic from others, then the association between testing and risk of HIV infection
measured from this study would not be generalisable to the general population of MSM
attending GUM clinics.
This study does not collect sexual behaviour data, thus making it difficult to draw
associations between high-risk sexual behaviour, HIV testing and HIV infection.
However, it did collect biological outcomes, which are robust laboratory-confirmed
diagnoses rather than self-reported STI and HIV diagnoses and thus give it a strong
reliability .
How would bias in the clinic population affect the association between HIV testing and
risk of HIV infection? The possible biases, the mechanism by which they might be
introduced, and the effect it would have on the association between HIV testing and
HIV prevalence in the study are summarised below in Table 5.10. The HIV prevalence
for this study was only for one clinic. This was compared with the survey prevalence in
the national study and while the prevalence differed, there was no evidence to suggest
that the association between risk of infection in untested compared with tested might
differ in London overall. Outside London, this might not be the case, because the
background HIV prevalence is lower, and HIV testing prevalence is higher, as seen
from Chapter three. The proportion of HIV infections that remain undiagnosed are high
outside London compared with in London, based on the national UAPMP GUM survey
results.
Differences between the population in the study clinic and the population of all MSM
would lead to a lack of generalisability of the study results. Further adjustments to the
model would need to be made to take account of some of these possible differences.
Whether such differences exist are explored in a formal fashion in Chapter six and then
allowed for in the estimation model as detailed in Chapter seven. This will be done in
Chapter seven through sensitivity analyses factoring in the range of possible variations.
Finally, while the overall sample size for the survey was high, when stratified, small
sample size in some sub-groups may have led to loss of power with resulting inability
to detect associations.
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Table 5.10 Possible biases in UA GUM study and how it would affect the
association between HIV testing and HIV prevalence
Bias Mechanism Effect on the association
between previous HIV testing
and HIV prevalence
Selection of people at low-
risk of HIV into the survey.
Underestimation of the
association
Selection of people at
high-risk of HIV into the
survey.
Misclassification bias
Selection of a
predominately young
and/or educated
population which
introduces associations
not seen in the total
population
If MSM with less risk
behaviour HIV test
more and have a
decreased risk of HIV
infection compared with
the general population
ofMSM
If GUM clinic population
had more STls and
increased risk of HIV
infection as resident in
inner London, and
higher HIV testing rates
as HIV testing is
promoted in GUM clinic
If MSM not disclosing
diagnosed HIV status,
this would lead to an
increase in newly
diagnosed HIV
infection, or (if they
refuse a test at this
occasion) a decrease in
HIV testing and an
increase in
undiagnosed HIV
infection
If people attending a
GUM clinic are more
likely to be a different
SES and/or age from
the rest of MSM
Overestimation of the
association
Underestimation of the
association
This would lead to an
association of HIV testing with
age or SES which might not be
there in the rest of the
population, or to not detecting
an association with age and
SES that was there in the total
population (negative
confounding)
5.5 Conclusions
In summary, MSM who had a HIV test recorded at the GUM clinic visit were more likely
to have a history of testing previously. Ever HIV testing was assoclateo with age,
having a previous acute STI in the past 5 years and being diagnosed with another
acute STI at the survey visit. Overall HIV prevalence was positively associated with
increasing age. HIV prevalence was higher in those with syphilis and gonorrhoea
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diagnoses when compared with MSM who were diagnosed with an acute STI other
than these. The interval since last negative HIV test was associated with having an
undiagnosed HIV infection and the adjusted OR were twice that for MSM who have HIV
tested more than 5 years ago compared with MSM who have HIV tested in the past 2
years. The adjusted OR of having undiagnosed HIV infection were six times higher for
MSM attending a GUM clinic who have never HIV tested before, compared with MSM
who had a negative HIV test in the past 2 years. The peak age of undiagnosed HIV
infection was in MSM aged 35-44 years old.
HIV prevalence was associated with HIV test history in MSM and thus HIV test history
could be used to estimate how much undiagnosed HIV infection there currently is
within a population of MSM.
This study surveyed the sub-population of MSM who attend GUM clinics. These men
may not be representative of all MSM, and may have a higher HIV prevalence than
MSM who do not attend GUM clinics, as they are diagnosed with STls which put them
at higher risk of HIV infection. It is likely that they have more HIV tests than MSM who
do not attend GUM clinics since most HIV tests in Britain are carried out at GUM
clinics". To test the hypothesis that lower-risk MSM do not HIV test as often and are
less likely to be HIV positive, HIV prevalence in a sample of MSM not attending GUM
clinics is needed. However, these are not a population routinely captured through
surveillance programmes. A community survey of MSM attending bars and clubs in
inner London was carried out in 2001. Chapter six will assess HIV prevalence in MSM
recruited as GUM attendees and HIV prevalence in non-GUM recruited MSM using
results from this bar- and club-recruited survey.
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HOW DO GUM ATTENDEES COMPARE WITH ANOTHER
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Summary
This study compared HIV prevalence in MSM recruited through a GUM clinic with MSM
recruited though bars and venues in the community (both standardised to an external,
national population of MSM) to compare HIV prevalence estimates in these two
populations. HIV prevalence was higher in the community-recruited population, of
whom a sub-set may be at higher risk of HIV compared with the GUM-recruited group.
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6.1 Introduction
The study in chapter five provided an estimate of the risk of HIV infection by testing
patterns in MSM attending a GUM clinic. It showed that overall HIV prevalence was
higher in MSM who had ever tested compared with those who had not. In contrast,
undiagnosed HIV prevalence was higher in MSM who had not HIV tested when
compared to people who had ever tested HIV negative before. These findings were
conditional on attending a GUM clinic, and thus may not be generalisable. This Chapter
investigated the differences in HIV prevalence between MSM recruited through GUM
clinics and MSM recruited through a community-based survey to provide a further
estimate of risk of HIV infection for non-GUM attendees.
This chapter investigates the following question:
1. How does HIV prevalence in MSM recruited through a GUM clinic compare with
the general population of MSM?
Combined with results from Chapter five, this will answer objective 5 (Chapter one,
section 1.5), model the association between HIV testing and HIV prevalence, and HIV
testing and sexual behaviour in the general population of MSM. The variables that will
be investigated in this chapter are highlighted in blue in the conceptual graph below
(Figure 6.1).
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Figure 6.1 Conceptual framework of the relationship between HIV testing and risk
of HIV infection mediated through risk behaviour: Measuring the association
between HIV testing and HIV prevalence
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6.2 Methods
HIV prevalence measured in MSM being tested for syphilis from seven GUM clinics in
London as part of the UA GUM survey (described in Chapter five) 192 was compared
with that in a community-recruited sample of MSM (recruited from 54 venues including
bars, clubs and saunas in inner London) as part of the GMSHS155. Both studies will be
described below.
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6.2.1 Setting
The UA GUM survey recruited all MSM attending seven London GUM clinics who were
screened for syphilis. The GMSHS recruited MSM in the community from 54 venues
attending a variety of bars, clubs and saunas in Inner London.
6.2.2
6.2.2.1
Participants and survey methodology
Unlinked Anonymous Genitourinary Medicine Clinic survey
A national Unlinked Anonymous Prevalence Monitoring Programme (UAPMP) has
been on-going since 1990. Its primary aim is monitoring the prevalence of HIV and
associated risk factors in England and Wales avoiding the bias associated with
voluntary confidential HIV testing. The programme relies on the availability of residual
specimens, collected for clinical testing. Several surveys are carried out as part of the
programme. These are in sub-populations collecting blood specimens including MSM
and heterosexual men and women attending GUM clinics and pregnant women. Blood
samples taken for clinical screening purposes in these populations were unlinked from
personal identifiers before being tested for HIV antibody.
The UA GUM survey in London recruited all attendees that had blood taken for syphilis
serology at seven participating GUM clinics. The detailed methodology of this survey
has been described elsewhere9o,191,192 and is described in Chapter five, section 5.2.
Briefly, following clinical testing, a residual specimen was collected unlinked and
anonymised from all personal identifiers, and tested for antibodies to HIV. A survey
form completed by the clinician at the clinical consultation and collected with the
specimen, included information on sexual orientation, age group, gender, previous HIV
test history, if the individual was known to be HIV positive (Le. had clinically recognised
HIV infection), and STI diagnoses (list of STI groupings in Appendix B) at the survey
visit. This survey form was returned by the clinician to the survey team at the HPA,
Centre for Infections, and linked through a barcode to the residual specimen. The
residual specimen was tested for antibodies to HIV at the HPA Centre for Infections,
using an in-house assay for screening and a commercially available ELISA
(GACELISA HIV 1 and 2, Abbott Laboratories, Maidenhead, UK) for confirmatory
testing of reactive specimens, and a Western blot (Genelabs HIVblot 2.2) where
discordant results were obtained by an established algorithm212.213.
6.2.2.2 Limitations to interpretation of unlinked anonymous genitourinary
medicine clinic survey
There are limitations to the interpretation of UA programme data. UA testing relies on
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the availability of residual specimens, collected for clinical testing for other reasons.
The UA GUM survey, which includes seven of the 34 GUM clinics in London, assumes
that the HIV seroprevalence estimates measured in clinics included in the surveys are
representative of seroprevalence in all clinics within that geographic region. The GUM
clinics were not selected randomly, although the selection of the clinics was based on
the size of the population attending each clinic within each region, to include large,
medium and small clinics from each region214. While the UA methodology minimises
participation bias within its setting, it is possible that MSM who do not attend GUM
clinics have a different behavioural association between HIV testing and risk of HIV
infection. MSM who attend GUM clinics are likely to be at higher behavioural risk of HIV
than MSM who do not attend GUM clinics99; MSM recruited from the community also
were at higher behavioural risk of HIV if they reported GUM attendance'". Clinically
diagnosed HIV infection may not be disclosed by MSM attending a GUM clinic for
treatment of an STI, thus leading to an overestimate of undiagnosed HIV prevalence.
Thus, this population may overestimate HIV prevalence in the general population of
MSM, Le. may not be generalisable. Although prevalence may be overestimated when
generalised from GUM clinics to the general population, GUM data may still yield
information on trends, provided that behavioural factors associated with GUM clinic
attendance and HIV testing remained constant over time.
6.2.2.3 Gay Men's Sexual Health survey
The GMSHS was a community survey of MSM men attending bars, clubs and saunas
in Inner London recruited in a 3-week period annually. All men in the venue for over a
1-hour period are handed a questionnaire. The sampling time within the evening varied
by venue, as did the exact method of sampling. Some MSM were sampled while
queuing at the door to be admitted to the club, while others within a particular area of
the bar or club were sampled. The detailed methodology of this survey has been
described elsewhere 155. A sampling frame was constructed by compiling a list of all
venues used by MSM in London including GUM clinics, bars, clubs, community groups
and saunas. The survey selected 71 recruitment venues from this sample frame of all
commercial gay venues (bars, clubs and saunas) and GUM clinics within inner London.
A response rate of 68% was calculated based on a total of 2,426 questionnaires being
handed out and 1,644 cornpleted'". Not all respondents completed the saliva test and
the response rate including the saliva test was 58% (1,409/2,426).
Sites at which questionnaires were to be distributed were selected to be representative
by geography and type of site. Outdoor public-sex environments were not included in
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the study following a pilot study which found a poor response rate of questionnaires at
these sltes!". A sample of a short 20-item self-completion questionnaire covering
topics including demographics, sexual behaviour, HIV testing history and perceived
HIV status was collected. An oral fluid sample was collected using an Orasure™
(Orasure Technology Ins, Bethlehem PA, USA) collection device, and linked to the
questionnaire via a barcode. This specimen was tested for anti-HIV at the HPA Centre
for Infections using GACELISA HIV1 and 2 (Abbott Laboratories, Maidenhead, UK).
Specimens reactive in the GACELISA assay were also examined by a Western blot
test (Genelabs HIV blot 2.2)216,217.
In 2001 an additional question was added to the self-completion questionnaire asking
whether the individual had a test for syphilis in the last year. This was used as a proxy
for GUM attendance, to allow a direct comparison with the UA GUM survey, since the
residual blood samples tested in the UA GUM survey were from samples taken for
syphilis serology.
6.2.2.4 Participation biases in Gay Men's Sexual Health Survey
The GMSHS survey is not representative of the general population of MSM, but of a
higher-risk more sexually active group. A comparison of the survey with Natsal 2000
has been published by the survey investigators184. They found that while MSM
surveyed in the GMSHS had a broadly similar proportion reporting sex in the past year
to Natsal 2000, they had higher levels of HIV risk behaviour, were more likely to report
previous STls and HIV testing than the Natsal population. The investigators concluded
that the GMSHS was likely to overestimate levels of risk behaviour if taken to reflect all
MSM.
A number of possible sources of bias exist for this study. Sexual behaviour research is
subject to some biases that may affect the representativeness of results!". While
random population based survey sampling could overcome some of self-selection
biases it would still not fully protect against non-participation bias. In addition targeted
population surveys are a useful adjunct to these general population surveys as they
give greater detail on populations at highest risk". The disadvantage of targeted
surveys is that they are likely to be unrepresentative of the general population of MSM,
given the nature of the convenience sampling. Those accessed through this mixture of
social venues can only be representative of MSM using these sites, and the sites
selected to be in the survey may not be the same as those that were not included. In
addition, even among venue attendees the behaviour of study respondents may
systematically differ from non-respondents. The GMSHS had a participation rate of
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58%; MSM who complete the questionnaire and give a saliva sample for HIV testing
may be behaviourally different, or have a different HIV serostatus from those who did
not participate. Studies have shown that volunteers in sexual behaviour studies can
tend to be more sexually experienced, and have more relaxed sexual attitudes and
behaviours than those randomly selected from the general population219,22o. Behaviours
that are thought to be not socially acceptable may not be reported (reporting bias). As
the GMSHS was carried out via a self-completion form it should reduce the social-
desirability bias that might be more likely in a face-to-face interview. The survey was
not weighted to adjust for non-response as it is not attempting to be representative of
the general population. In order to overcome this problem, a number of targeted
surveys from a range of settings are needed, in order to ensure a better overview on
whether associations found in one study remain consistent in a different setting.
6.2.3 Definitions of HIV status
An individual was defined as having undiagnosed HIV infection when the specimen
tested positive for antibodies to HIV but the survey respondent was not known to have
clinically diagnosed HIV infection when the survey form was completed. In the UA
GUM survey this was defined as when the individual was not reported as having
clinically recognised HIV infection (known to be HIV positive) by the clinician
completing the survey form but the residual specimen tested HIV positive (see Box
6.1).
In the GMSHS this was defined as when the individual either reported never having
had an HIV test or reported HIV status as being negative but the saliva specimen
tested HIV positive (see Box 6.1).
6.2.4 Statistical analyses
The GMSHS was stratified into three groups: (i) the overall community-recruited
sample, (ii) only those individuals who reported undergoing syphilis testing in the last
year (indicating GUM attendance), and (iii) those MSM who did not report syphilis
testing in the last year (indicating non-GUM attendance).
The two populations (UA GUM survey and GMSHS) were standardised to an external
reference population (the Natsal proportion of national MSM multiplied by the census
population of men) to provide comparable undiagnosed HIV prevalence estimates in
these two groups, and prevalence ratios were calculated to compare both populations.
This comparison was used for providing a lower and higher behavioural risk adjustment
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for the estimation model in Chapter seven. This is described in more detail below.
Age-specific overall HIV prevalence was calculated from the total number of HIV
positive specimens in each age group divided by the total number of specimens tested
in that age group. Age-specific undiagnosed HIV prevalence was calculated from the
total number of HIV positive specimens that were defined as undiagnosed in each age
group divided by the total number of specimens tested in that age group; 95%
confidence intervals were calculated for each proportion.
Box 6.1 Definition of HIV status in surveys
Survey Reported status in survey Specimen HIV status
HIV test
result
UAGUM Clinician Not known to be HIV HIV positive Undiagnosed HIV
survey report positive infection
Known to be HIV HIV positive Diagnosed HIV infection
positive
GMSHS Self-report Never had an HIV HIV positive Undiagnosed HIV
test infection
Reported HIV status HIV positive Undiagnosed HIV
negative infection
Reported HIV status HIV positive Diagnosed HIV infection
positive
Age-standardised HIV prevalence was calculated using the direct standardisation
method221. The Natsal 2000 population of MSM (defined in Chapter four, section 4.2.1)
was used as an external reference population. Natsal 2000 estimated the proportion of
men, aged 16 to 44 years, reporting sex with another man in the past 5 years to be
5.5% (4.2 - 7.2) in Greater London". This point prevalence was applied to the 2000
mid-year census estimate of males aged 16 to 44 years 144 to obtain estimates of the
numbers of MSM living in London for specific age groups, based on the UA GUM
survey age-group categories. These were 16 to 24 years, 25 to 34 years and 35 to 44
years old. To standardise the two populations, the HIV prevalence calculated from
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each survey was applied to Natsal estimate of numbers of MSM in that age group, and
this gave the expected numbers of HIV infections, if the survey had the same age
structure as the Natsal population. This expected number of HIV infections within each
age group was added to give the total numbers of expected HIV infections. This was
divided by the Natsal total population of MSM, to give the age-standardised HIV
prevalence. This was calculated for both survey populations.
A prevalence ratio was then calculated, with the UA GUM population as the reference.
This was to compare the measured overall and undiagnosed HIV prevalence, having
accounted for differing age structures within the surveys. This was calculated for the
following sub-populations; (1) the overall GMSHS survey population, (2) for the
GMSHS respondents who reported that they had a syphilis test in the last year (as a
proxy for GUM attendance) , and (3) for those who reported that they did not have a
syphilis test in the last year (a proxy for non-GUM attendance). All analyses were
carried out in STATA (version 7.0) (STATA corp., Statistical software, TX, USA).
6.3 Results
6.3.1 Comparison of crude overall HIV prevalence in UA GUM survey with
GMSHSsurvey
When examining associations with age in each study separately, there was some
evidence for increased prevalence of HIV with increasing age. Within the UA GUM
survey, overall HIV prevalence was higher in MSM aged 25-34 compared with under
25 year olds (12.2% v 7.0%) and MSM aged over 35 (21.2% v 7.0%). Within the
GMSHS overall, overall HIV prevalence was higher in MSM aged 25-34 years old
compared with the under 25 age group (11.8% v 3.0%), and no evidence of a
difference between the 25-34 year olds and the over 35 age groups (11.8% v 14.2%).
When stratifying the GMSHS survey by whether they had tested for syphilis in the past,
there were similar trends of HIV prevalence by age in both groups.
Crude unadjusted HIV prevalence appeared higher in MSM recruited through the UA
GUM survey compared with the GMSHS (Table 6.1). When stratifying the GMSHS
survey by whether they had tested for syphilis in the past, overall crude HIV prevalence
increased to 20.3% in the group with past syphilis tests compared to 7.3% in those
without syphilis tests (Table 6.1).
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6.3.2 Age-adjusted comparison of overall HIV prevalence in GMSHS survey
with UA GUM survey
The age-adjusted overall HIV prevalence for both surveys following direct
standardisation to the Natsal 2000 MSM population in London is presented in Table
6.1. The HIV prevalence ratio of having HIV infection in the community-recruited survey
compared with the UA GUM survey, following adjustment of the population age
structures through direct standardisation, is presented in Table 6.1. The age-adjusted
prevalence ratio of overall HIV prevalence when compared with the UA GUM survey for
the GMSHS overall was 0.77 (95% Cl 0.74 - 0.81). When the GMSHS syphilis-testers
sample was compared with the UA GUM survey, the age-adjusted HIV prevalence ratio
was 1.35 (95% Cl 1.30 - 1.40). The age-adjusted HIV prevalence ratio in the non-
syphilis sample (i.e. MSM who did not attend a GUM clinic), compared with in the UA
GUM survey, was 0.50 (95% Cl 0.48 - 0.52). This means that there was evidence for
effect modification, i.e. HIV prevalence ratio of GMSHS relative to UAGUM differed by
syphilis testing.
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6.3.3 Comparison of crude undiagnosed HIV prevalence in UA GUM survey
with GMSHS survey
When examining crude undiagnosed HIV prevalence in different age-groups within the
surveys, undiagnosed HIV prevalence was higher in MSM aged over 35 within the UA
GUM survey compared with under 25-34 year olds (21.2% v 12.2%) There appeared
to be no difference in prevalence between MSM aged less than 25 and the 25-34 year
olds recruited through the UA GUM survey. Within the GMSHS overall, crude
undiagnosed HIV prevalence was higher in the 25-34 year olds compared with the
under 25 year old age group (9.9% v 2.0%) and there appeared to be no difference
between the 25-34 year olds and the over 35 age groups. When stratifying the GMSHS
by previous syphilis testing, the was evidence for higher undiagnosed HIV prevalence
in 25-34 year olds compared with MSM aged less than 25; syphilis testers: 9.2% v
3.8% and non-syphilis testers: 5.8% v 1.3%. There was no further increase in
prevalence in ages 35 and above with patterns across ages looking broadly similar
within the two groups (albeit higher undiagnosed HIV prevalence in syphilis testers).
Crude undiagnosed HIV prevalence of 4.5% was detected in MSM through the UA
GUM survey and 5.7% in the community-recruited survey of MSM (GMSHS) in 2001
(Table 6.2). When stratifying the GMSHS survey by whether they had tested for
syphilis in the past, crude undiagnosed HIV prevalence increased to 7.7% in the group
with past syphilis tests compared to 4.7% in those without syphilis tests (Table 6.2).
6.3.4 Age-adjusted comparison of undiagnosed HIV prevalence In UA GUM
survey with GMSHS survey
The age-adjusted undiagnosed HIV prevalence for both surveys following direct
standardisation to the Natsal2000 MSM population in London is presented in Table 6.2
below. The prevalence ratio of undiagnosed HIV infection in the UA GUM survey
compared with in the community-recruited survey following adjustment of the
population age-structures through direct standardisation is presented in Table 6.2. The
age-adjusted prevalence ratio of having undiagnosed HIV infection in the GMSHS
overall was 1.29 (95% Cl 1.21 - 1.38) when compared with the UA GUM survey. Again
there was evidence of effect modification by prior HIV test history. The undiagnosed
HIV prevalence ratio was 1.74 (95% Cl 1.63 - 1.84) when comparing the GMSHS
sample of men with prior syphilis tests to the MSM in the UA GUM survey. The age-
adjusted prevalence ratio of having undiagnosed HIV infection in MSM without syphilis
tests in GMSHS (i.e. MSM who did not attend a GUM clinic) compared with the UA
GUM survey was 1.09 (95% Cl 1.02 - 1.16).
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6.4 Discussion
In this study MSM recruited through a GUM clinic were compared with MSM recruited
through a community survey to investigate how representative the GUM-recruited
survey population are of all MSM. The study showed that there were sub-populations of
MSM amongst the GMSHS with different HIV prevalences when compared to the GUM
survey, and that ignoring the existence of these differences based on past syphilis
testing may lead to misleading conclusions.
Although the crude prevalence of overall HIV infection showed a higher HIV prevalence
in MSM recruited through GUM clinics compared with the community-recruited sample,
the overall HIV prevalence was higher in the community-recruited sample with past
syphilis tests when compared to GUM attenders. The HIV prevalence was lowest for
those community-recruited MSM who had not reported a syphilis test (indicating non-
GUM attendance). These differences all remained once the prevalence had been
standardised to account for the different age structure in the two survey populations
(Table 6.2).
When comparing undiagnosed HIV prevalence, a similar picture emerged with a
pronounced higher undiagnosed HIV prevalence in those with past syphilis tests in the
GMSHS when compared with the UA GUM survey. The age-adjusted prevalence ratio
for having undiagnosed HIV infection was slightly higher in MSM in the GMSHS who
had not had past syphilis test when compared to the UA GUM survey. This meant that
once the prevalence had been standardised to account for the different age structure in
the two survey populations the prevalence of undiagnosed HIV infection was higher for
a" community-recruited MSM, both syphilis tested in the past year and non-syphilis
tested when compared to the UA GUM survey but to a different extent.
Higher-risk behaviours are reported in individuals attending GUM clinics compared with
individuals who have not attended in other surveys99.222,223and so one might expect the
population recruited through the GUM clinic to have overall higher rates of HIV infection
than MSM recruited through a community survey. However, even men recruited
through the community who had not attended a GUM clinic in the past year had a
higher undiagnosed HIV prevalence than MSM recruited through the UA GUM clinic
survey, This difference could be due to several factors: men recruited from the
community survey could represent a core group of MSM at higher risk of HIV than
other MSM, even when compared with a similar population of MSM who received
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syphilis testing in a GUM clinic. Their social behaviours and the source of their
recruitment, gay bars, clubs and saunas in London, may indicate different sexual
behaviour and higher numbers of sexual partners and acquisition of new partners than
other MSM71.99.17O.Previous studies have found that how connected MSM are to the
gay scene, measured as frequency of attendance at bars and clubs, may be
interpreted in two ways. In the US it has been found to improve health-seeking
behaviour because it provides a forum for sexual health education and information
about services and treatments and an increased awareness and improved self-
efficacy". Indeed sexual health prevention was found to be successful through a
'buddy system' and peer-influence system in the US224.However, a similar prevention
method was not found to be effective in England22s.226.Attendance at gay bars and
clubs has been associated with meeting new sexual partners":", In Canada bar and
club attendance was associated with increased STI and number of sexual partners".
Outbreaks of syphilis, gonorrhoea and HIV seroconversion have all been associated
with bars, saunas and bath houses in the past among MSM116.227and again more
recently in the US103.119.228-230.Convenience samples of MSM recruited from different
types of venues may therefore capture and measure behaviour in MSM with different
levels of risk behaviour. Surveys have found that MSM recruited through the internet
differ demographically from those recruited offline: they tend to be younger, less
educated and more likely to be from an ethnic minority group211.They are behaviourally
different; less likely to only have sex with men, less likely to have ever tested for HIV,
less likely to be exposed to health promotion messages and more likely to report
higher-risk sexual behaviour94.211.When this population of internet-recruited MSM in
England was age-standardised and compared with the Natsal2000 survey, the authors
found that MSM recruited from the internet, while broadly similar in social and
demographic characteristics and equally likely to have HIV tested, were more likely to
report an STI in the past year (16.9% v 4.8%, adjusted odds ratio 4.14,95% Cl 1.76 to
9.74), and UAI in the past 3 months (45% v 36.6%; p = 0.064)231.However, few if any
studies have compared HIV prevalence as a biological outcome from samples of MSM
recruited through two different methods. Thus, this study is unique and has strength in
the robustness of the outcome measures.
Some limitations should be noted in the interpretation of these results. HIV clinical
diagnosis status was determined differently in the two studies: through clinical notes in
the UA GUM survey while knowledge of HIV status was self-reported in the GMSHS
community survey. This could lead to an under-reporting of clinically recognised HIV
infections in the GMSHS community survey. Survey forms were completed out in the
field, and individuals may prefer not to report that they are HIV positive on these forms,
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even though they are anonymous. However, the overall measured HIV prevalence
(both diagnosed and undiagnosed) of MSM being tested for syphilis in the last year
was higher in the community-recruited sample when compared with the UA GUM
sample. Thus, the differences in HIV prevalence could be a real difference rather than
due to misclassification. Alternatively, it could be hypothesised that MSM with clinically
diagnosed HIV infection may report themselves as HIV negative when recruited out in
the community, due to issues of privacy and social acceptability, rather than HIV
negative men misclassifying themselves as HIV positive. This differential
misclassification would lead to an overestimate of undiagnosed HIV infections in the
community compared with MSM recruited in the clinic and the findings in the study
could be seen as consistent with such a mechanism. In addition to selective
misreporting of HIV status there is the issue of non-response bias. The population of
MSM recruited through the GMSHS community survey may be skewed towards HIV
positive men. HIV positive MSM may be more likely to take part in the survey that is
carried out to provide information to improve sexual health services for MSM. Altruism
can be a strong motivator particularly amongst MSM who are already HIV positive. A
similar community survey of sexual behaviour and HIV prevalence, carried out among
Africans in London, Luton and the West Midlands in 2004196, found through qualitative
interviews paralleling the quantitative survey that a need to help the community was a
primary reason for participation amongst those recruited 232. How would participation
bias affect the associations between HIV testing and risk of HIV infection? If non-
responders had a lower HIV prevalence but had HIV tested more, only analysing
responders would lead to an overestimate of the association between HIV testing and
risk of HIV infection. Alternatively, if the non-responders had higher HIV prevalence
and had HIV tested more, then analyses of the responders would underestimate the
association between HIV testing and risk of HIV infection. Again, given the strength of
the association between HIV testing and HIV infection, while the magnitude of the
association may be altered, depending on the direction of the bias, it would be unlikely
to be reduced to zero. Thus, bounds of uncertainty should be considered when using
estimates from this study.
The discussion in Chapter five, section 5.4.3 in Table 5.10 summarised some possible
biases in the UA GUM survey. How these biases might affect the association between
previous HIV testing and HIV prevalence if the population of the study clinic were
different from the population of all MSM was discussed. Some of these biases were
investigated through this comparative study. Whether there was selection bias through
recruitment of high- or low-risk MSM compared to all MSM was addressed.
Comparison with the community-recruited survey has shown that the sub-population of
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MSM recruited through the GUM survey were not at higher risk of HIV infection
compared to the MSM who were recruited through bars and clubs who had also being
syphilis tested in the previous year. Thus the association between HIV prevalence and
HIV testing will not be overestimated using the UA GUM survey results. MSM recruited
through the UA GUM survey had a higher overall HIV prevalence and so were not at
lower risk than the community-recruited MSM who had not attended a GUM. This
indicates that there is unlikely to be an underestimation of the association between HIV
testing and HIV prevalence when using UA survey results in the estimation model in
Chapter seven. Undiagnosed HIV prevalence was higher in the community-recruited
MSM, once HIV prevalence was age-standardised. This indicates that misclassification
bias through non-declaration of clinical diagnosis status in the GUM survey may not be
a problem, at least compared with the community-recruited MSM.
These two surveys provide samples from two different sub-populations of sexually
active MSM: one who is potentially at higher risk of undiagnosed HIV infection,
attending bars, clubs and saunas, and a second population attending GUM clinics,
which may represent the broader population including MSM at both high and
intermediate risk of HIV infection. To fully understand these differences, comparable
sexual behaviour variables would need to be collected through the UA GUM survey.
The strength of these individual surveys is in their ability to provide estimates of ranges
of HIV prevalence and the uncertainty surrounding them.
6.5 Conclusions
Combining results from surveys recruiting MSM from a number of different types of
sites and venues and through different methodologies would provide a more accurate
and representative overall estimate of behaviour and HIV prevalence within different
populations of MSM. This analysis provides plausible ranges by which the estimates of
total HIV infections in Chapter seven might be adjusted to account for population and
differences of associations within selected sub-groups.
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Summary
Based on numerical results from the investigations presented in Chapters four, five and
six, this chapter describes a parametric model that is based on the conceptual
framework described in Chapter two, to enable the estimation of total HIV infections in
the general MSM population, including undiagnosed HIV infections. Sensitivity
analyses and comparison with estimates of prevalent infections derived from other
methods were carried out.
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7.1 Introduction
Total prevalent HIV infections are represented below in Figure 7.1, as a combination of
diagnosed HIV infections and undiagnosed HIV infections, but within a population of
MSM who have both previously tested HIV negative and never HIV tested. HIV
negative MSM combine MSM who have never HIV tested and MSM who have
previously tested negative. HIV positive MSM are a combination of MSM who have
clinically diagnosed HIV infection (i.e. they have had a positive HIV test), undiagnosed
HIV positive MSM, who have had a previous negative HIV test, and undiagnosed MSM
who have never tested. Thus, MSM can be divided into two groups, those who have
HIV tested, and those who have never tested. Those who have tested will be both HIV
positive and HIV negative, as will those who have never tested.
Figure 7.1 Total prevalent HIV infections in MSM; clinically diagnosed and
undiagnosed HIV infections by previous HIV negative test status
HIV negative; never
previously HIV tested
HIV negative; previously
HIV tested
Clinically recognised
HIV infection
Undiagnosed
HIV infection;
previous HIV
negative test
HIV positive MSM Undiagnosed
HIV infection;
never HIV
tested
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The current direct method to estimate total HIV infections in the UK was described in
Chapter one, Figure 1.4. Briefly, this method estimates total HIV infections through
combining data from multiple sources: estimating undiagnosed HIV infections using
undiagnosed HIV prevalence from UAPMP surveys and applying this to sub-
populations at risk d·erived from Natsal and adding these to the total diagnosed
infections to give total prevalent HIV infections. The Estimating Undiagnosed from the
Observed Method that will be described in this Chapter uses aspects of the direct
estimation, in that it adds up diagnosed and undiagnosed HIV infections in different
strata to produce a total of HIV infections, Z. This novel method also uses aspects of
the indirect estimation method (which estimates total prevalent HIV infections through
combining diagnosed HIV infections with the proportion who have HIV tested), Le. by
working out what the undiagnosed HIV infections may have been, given what is known
about the diagnosed infections and the differences between testers and non-testers.
The ultimate aim is to estimate the total HIV infections, Z. A method that relies on data
in those who have tested needs to take account of differences in behaviour and risk of
HIV infection for testers when compared to MSM who have not tested. Hence, the
method needs to adjust estimated undiagnosed HIV infections (using an indirect
approach) for the prevalence ratio of HIV infection between MSM who have previously
HIV tested and MSM who have not HIV tested. As HIV testing is not taking place on an
annual basis, MSM who have previously tested HIV negative may still have
undiagnosed HIV infection, as they may have become HIV infected since their last HIV
test. In order to take account of this, undiagnosed HIV infections are estimated in two
components. The first component estimates the undiagnosed HIV infections in MSM
who have tested previously, but have undiagnosed HIV infections, while the second
component estimates the undiagnosed HIV infections in untested MSM.
The total number of prevalent HIV infections in MSM is equal to the total number of
diagnosed HIV infections and the total number of undiagnosed HIV infections.
Throughout this section, the number of diagnosed infections will be represented by Y
with different suffixes representing the behavioural category g, age group i, and region
r. The undiagnosed (unobserved) HIV infections will be denoted by X, again where
suffixes represent the behavioural category g, age group i, and region r. The
behavioural categories g will become a more complex set of variables, i.e. whether
individuals have HIV tested or not, whether they have an STI or not, and within STI
categories, whether that STI was gonorrhoea or syphilis, or not. The model will be split
into components according to these behavioural categories. The true burden of HIV
infections, Z, will then be the sum of all diagnosed and undiagnosed HIV infections
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within the different strata of age, region and behavioural categories. The entity Z is not
actually observed, since the number of undiagnosed HIV infections is unknown.
(1)
.1(=1 r=1 i=1 .1(=1 r=1 1=1
Total HIV infections have been estimated through indirect estimation from the total
diagnosed HIV infections (y) as the proportion of the sub-population that has had an
HIV test. For example, if only 50% of MSM have tested, and the total diagnosed HIV
infections Y represents the proportion of those testers that were positive, then the total
number of HIV infections would be twice the total diagnosed HIV infections (2:..).
0.5
Hence, the method assumes that the proportion of the population that have not HIV
tested (for example 50% of the total population) has the same probability of being HIV
infected as the proportion that has tested. Clearly this is a very strong assumption to
make. Only with universal annual testing would this hold true and in fact the results of
HIV testing would equal annual HIV incidence. Analyses in Chapter four showed that
MSM who had HIV tested in the past 5 years had higher numbers of sexual partners
than MSM who had not HIV tested and results in Chapter five show that HIV
prevalence in MSM differed by previous HIV testing history.
The method that will be introduced in this chapter is based on the principle that if Y is
multiplied by an adjustment factor to estimate X, then knowing Yand X will in turn allow
the calculation of Z. This adjustment factor relates to prevalence ratio of being HIV
infected in MSM who have not HIV tested to MSM who have HIV tested. Hence, the
adjustment factors will be derived based on findings from previous chapters which
showed that choice of testing and risk of HIV infection given a test, differed by
behavioural category, circumstances of testing, age, region and other factors.
The total number of HIV infections, Z, is unknown in the total population of MSM;
however, existing survey data can give an indication of how big Z is relative to Y
(diagnosed HIV infections). Survey data from Chapters four, five and six will provide
information on how this relationship of Z to Y varies by the type of population studied.
Thus, this leads us to choose a model where type of behaviour is looked at first
(whether HIV tested or not and within that, diagnosed with an acute STI or not). Then
within behavioural categories, the model is further stratified by region, and within
region, stratified by age group. The observed numbers, Y and p (the proportion HIV
tested) are region and age-specific. The unobserved numbers X are calculated within
behavioural category, region and age-specific strata. Different adjustment factors were
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applied within the model for HIV test status, acute STI status, and region before
stratifying by age.
7.2 Definitionof the model
This section will define and describe a model to estimate the numbers of total HIV
infections in MSM from the numbers of total diagnosed HIV infections in MSM and the
proportion of MSM who have HIV tested. Thus, it will estimate the numbers of
undiagnosed HIV infections in both MSM who have previously tested HIV negative, and
in MSM who have never HIV tested as shown above in the smaller pie chart in Figure
7.1. This section describes the model in general, and the detail of how it works across
the strata of region and age will be explained later in sections 7.3 and 7.4.
Assuming there was no difference between MSM choosing to have an HIV test and
those who don't, the total number of prevalent HIV infections in those tested (Y, i.e.
diagnosed HIV infections) would be equal to the total HIV infections, Z, multiplied by
the proportion p of MSM who have had an HIV test.
y =Z.p (2)
Still assuming that those who have not tested have the same prevalence of HIV
infections as those who have tested, and then the total number of HIV infections equals
z =!: and it follows that X = !- y
p p
x = Y(l-p) = yt not tested)
p n tested
(3)
Hence, this would assume that the undiagnosed infections are equal to the diagnosed
infections times the odds of not having had an HIV test. However, the data shown in
previous chapters suggest that this assumption cannot be made about HIV prevalence
in MSM who are not tested. MSM with previous tests have different risk behaviour
when compared to those who do not test. Hence, the number of undiagnosed HIV
infections, X, will be different from (!:- Y). If it is expanded (3) to include an adjustment
p
a for the prevalence ratio of HIV infection in MSM who have not HIV tested to tested
MSM, this gives
(4)
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Xgri is calculated in this case for g, r, and i based on Yri, Pri, and ayr. Behavioural
categories are derived for X only. If it is assumed that the prevalence ratio of HIV
infection in MSM who have not HIV tested relative to MSM who have tested (zr) is
known then
a = tt = HIV prevalence in MSM without HIV tests/HIV
prevalence in MSM with prior tests. (5)
Generally it can be assumed that alpha is smaller than one because this thesis has
shown that MSM who test are self-selected to a higher risk population. However,
knowing the 'truth', i.e. 1t, is not equally possible for all settings and the mechanism of
self-selection to HIV test may differ by setting. Hence, this model derives adjustment
factors aGUMyr and aGPgr by setting in which HIV testing can occur: GUM clinics and
GP. This model assumes that total prevalent HIV infections among MSM are the sum
of MSM who have tested positive, either at GUM clinics or their GPs. The importance
of each setting is dependent on geographical location and availability of services and
this may vary between regions of the country. This study used data from the UA GUM
survey and thus focused on HIV testing in the GUM setting. It is assumed that the
factors associated with testing HIV positive at GUM clinics are similar to those of
testing positive at the GP surgery, and thus assumed that aGUMgr = aGPgr and Z is
calculated using only aGUMgr'
To test if this assumption is valid, a sensitivity analysis will be carried out in section
7.6.3. This will estimate by how much the estimates would change if the OR of having
HIV infection differed in MSM HIV tested at GPs compared with MSM tested at GUM
clinics. This will test different assumptions on the proportions testing at GPs, and focus
on the possibility that these proportions and risks may change over time.
Apart from setting, the model will take into account whether MSM had a previous HIV
test or not. This is shown in Figure 7.2, together with the source of data to be used to
inform each parameter. If the proportion of MSM who have tested is used to estimate
the total HIV infections, Z, and if MSM who have tested have a different HIV prevalence
from MSM who have not tested, then the MSM who have previously HIV tested
negative, but now have undiagnosed HIV infections, U must be accounted for. This is
derived from the UA GUM survey carried out in Chapter five. In order to do this,
undiagnosed HIV infections are estimated in two components based on the behavioural
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category 'HIV tested'. The first component estimates the undiagnosed HIV infections in
MSM who have tested previously, but have undiagnosed HIV infections, while the
second component estimates the undiagnosed HIV infections in untested MSM.
Figure 7.2 Overall outline of the estimation model
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in MSMmen
who have
never HIV
tested
i = age group
r = area of residence
t = 0, not HIV tested
t= 1, HIV tested
g=behavioural category
The central part of the figure is the unobserved quantity Xgri, the number of
undiagnosed HIV infections, shown as an ellipsoid, and according to equation (4). The
observed inputs Vir and PiT are derived from the Natsal and SOPHID datasets. The
adjustment factor agT differs depending on whether the individual has had a previous
HIV test (Le. t=1, Component One) or not (Le. t=O,Component Two).
The following will explain the derivation of Components One and Two separately, as
shown in Figures 7.3 and 7.4.
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7.3 Component One: Estimating undiagnosed HIV infections in MSM who
have previously HIV tested
Figure 7.3 Structure of model to estimate the numbers of undiagnosed HIV
infections in MSM who have ever HIV tested (Component One)
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The first component estimates the numbers of undiagnosed HIV infections in MSM who
had ever HIV tested. Not aU HIV infected MSM who have HIV tested now have
diagnosed HIV infection. If the adjustment factor was applied to diagnosed HIV
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infections to indirectly estimate total numbers of all HIV infections, the proportion of
MSM that had previously had a negative HIV test but whose HIV infection remains
undiagnosed, would not be accounted for. This would lead to an underestimate of the
undiagnosed HIV infections. An additional adjustment factor (0) accounting for these
undiagnosed HIV infections as described in equation 6 below was added. The key
difference is that these MSM have previously tested, and so the correction factor alpha
in this subgroup needs to correct the numbers back to those in 'testers' using 0.
The estimation of undiagnosed people with prior tests was stratified by the proportion
of MSM presenting with an acute STI, as undiagnosed HIV infection was independently
associated with an acute STI. While this was reflecting current outbreaks of STls
among MSM and may be changeable over time, the adjustment was important in 2003
and this factor was included in the adjustment. This is shown above in Figure 7.3.
As in the previous figure the central part is estimating the quantity X of undiagnosed (or
unobserved) infections in those who have had a previous HIV test, but not at the
current time. In a GUM clinic, this quantity will differ dependent on whether a person is
attending because of an acute STI (those with acute STI have different HIV infection
risk compared with those without STI), for example, by stratifying by other acute STI.
Being diagnosed with another acute STI (other than gonorrhoea or syphilis) at the
surveyed GUM clinic visit was associated with a reduced odds of ever HIV testing. It
was associated with lower odds of HIV infection. An adjustment factor was calculated
through analyses in Chapter five based on the OR of undiagnosed HIV infection in
MSM with other acute STls relative to no acute STls and the proportions of MSM that
had other acute STls. These were included in the model as illustrated in equation 6 and
shown in Figure 7.3.
In mathematical terms for each category included in the model, an adjustment will be
calculated for the proportion of MSM that have HIV tested within that category. For all
parts of component one, the model has to use an a. that takes account of the
proportion of testers with undiagnosed HIV infection (Lf) and a correction factor that
cancels out the odds of not having had an HIV test when estimating X=Y(odds of not
having had an HIV test). This is done by using:
9 = odds ratio for undiagnosed HIV infection in MSM who have ever HIV tested
relative to untested
U = proportion of undiagnosed HIV infections in MSM that have previously HIV tested
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Estimation of undiagnosed HIV infections are stratified by presence or absence of other
acute STI
S = proportion of MSM with other acute STI, 1 - S = proportion without other acute STI
'I'u;J = odds ratio for undiagnosed HIV infection in MSM with other acute STI relative to
no acute STI
then the adjustment for MSM who have HIV tested but who have undiagnosed HIV
infection, taking the behavioural categories, previous HIV testing and previous acute
STI infection into account, is
at=1 = ((u. 0.5. f/JU=1) + Cu.0. (1 - 5))) (6)
For example to calculate the undiagnosed HIV infections in MSM in London aged less
than 25, who have ever tested, this would be done separately by STI diagnosis, first for
those who have an acute STI (s=1), and then for those who don't have an acute STI
(s=O).
Xr=LondonJ=<25,t=1, = Xr=LondonJ=<25,t=1,S=1 + Xr=London,;=<25,t=1,S=O
In a first step the total numbers of diagnosed HIV infections in MSM in London, aged
less than 25 would be divided by the proportion of MSM in London aged less than 25
that have HIV tested. The diagnosed numbers would then be subtracted to give the
d' t d t' t d d' d HIV' ~ tl (Yr-londoni-<2s v )una JUse es Ima e un lagnose Inlec Ions, - ',- - 'r=london,i=<25 .
Pr=London,I=<2S
To derive the numbers of undiagnosed infections in men with acute STI the unadjusted
estimate would then be multiplied by the proportion of MSM that have an acute STI
(other than gonorrhoea or syphilis) S, It would then be multiplied by the adjustment
factor f/JU=1 to account for the OR of undiagnosed HIV infection in this group relative to
those without an acute STI. This would be followed by multiplying by the proportion
tested with undiagnosed HIV infection U. Finally it would be multiplied by the
adjustment factor 0 to take account of the OR of undiagnosed HIV infection in MSM
who are tested relative to untested.
To estimate the numbers of undiagnosed HIV infections without an acute STI, the
unadjusted estimated undiagnosed HIV infections would be multiplied by the proportion
who did not have an acute STI (1-5) followed by U and 0. These estimated numbers of
undiagnosed HIV infections are then added together to give the total estimated number
of undiagnosed HIV infections in MSM aged less than 25 in London who have ever
tested,
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X - (Yr=IOndOn.i=<25 v ) V 0 S +r=London.i=<25.t=1 - . - Ir=london.i=<25 . . . . <{JU=l
Pr=London.r=<25
(
Yr=london.i=<25 v ) V 0 (1 S). - Ir=london,i=<25 . .. -
Pr=London.r=<25
(7)
This would be repeated for the other age-groups, 25-34, 35-44 and 45 or more years,
giving the total estimated number of undiagnosed HIV infections in MSM in London
who have ever tested.
The model needs to take account of the difference in prevalence of HIV infection in
MSM who have HIV tested outside London relative to MSM in London due to
differential uptake of HIV testing, different rates of diagnosis of HIV infections and
different background HIV prevalence. The study in Chapter five was only in one clinic in
London. It was assumed that the adjustment factor Ut=l was correct for all MSM in
London and PR=l = 1 when r =1= London. To estimate the regional adjustment factor
for MSM resident outside London, the UAPMP GUM survey (Chapter three) provided
values for the HIV diagnosis ratio (e) and the HIV prevalence ratio (Il) while the Natsal
study in Chapter four provided a value for the OR of HIV testing outside London
relative to London (0). The HIV diagnosis ratio (f) was calculated from the proportion
of HIV infections detected through unlinked anonymous testing, that were clinically
diagnosed through voluntary confidential HIV testing at GUM clinics outside London,
compared to the proportion diagnosed in London.
PR=O = (the proportion of HIV infections diagnosed outside London I proportion of HIV
infections diagnosed in London) I «OR HIV testing outside London) x (HIV prevalence
outside London I HIV prevalence London»
E
PR=O = 9.p. (8)
This model uses numbers of diagnosed HIV infections in individuals (observed) and
estimates undiagnosed (unobserved) based on these. Total HIV infections in the model
is by region, and total HIV infections are calculated by using observed infections, and
because odds and prevalence ratios are used to correct numbers, the differences in
population sizes have been indirectly captured and so no additional adjustment for the
relative sizes of the MSM population outside London compared to London is needed.
Then equation 6 becomes
at=l = Pr=l (V. 0.S. lPU=l) + (V.0. (1 - S)))
+Pr=o(V, 0.S. <{JU=l)+ (V.0. (1- s))) (9)
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Thus to calculate the number of undiagnosed HIV infections for outside London, similar
to above in equation 7, undiagnosed HIV infections within each individual age group
would be estimated, from diagnosed HIV infections and proportions tested outside
London, with the additional regional adjustment Pr=o added to the other adjustments as
shown in equation 9.
The study in Chapter five was of MSM attending a GUM clinic and the Chapter six has
shown that results from UA GUM may be not entirely representative. Hence, the study
estimated a range of plausible values for undiagnosed infections using results from
Chapter six. This included a lower and an upper 'behavioural range' HIV prevalence
ratio of undiagnosed HIV infection in untested relative to tested. An upper behaviour
range factor was calculated taking account of the results that people who have
attended GUM clinics in the past may be people who have had higher-risk sexual
behaviours. A lower behavioural range factor took account of the fact that UA GUM
users may be at a higher risk of HIV when compared to a person who does not engage
in high-risk sexual behaviours. The problem is that UA GUM attendees are a mix of
people from both ends since the reasons for prior HIV testing may vary. This was
discussed in Chapters four and five. The lower behavioural adjustment factor 0L was
the standardised HIV prevalence ratio in community-recruited MSM who had not
attended a GUM clinic relative to HIV prevalence in MSM within the UA GUM study -Bn,
multiplied by the OR of undiagnosed HIV infection in tested MSM relative to untested,
0. This entered equation 10 for a lower-risk adjustment factor at=1L as follows to
provide a lower range for X.
at=1L = Pr=1' (CU. 0L·S·CPU=1) + (U. 0L• Cl - S)))
+Pr=o' (CU. 0L·S·CPU=1) + (U. 0L• Cl - S))) (10)
Similarly an upper behavioural range factor 0H was calculated in Chapter six from a
higher-risk population of sexually active MSM attending bars, clubs and saunas. This
was the standardised HIV prevalence ratio in the GMSHS survey relative to the
prevalence in the UA GUM survey, -Bm, multiplied by 0. This entered the equation for
at=1H to provide a higher-risk adjustment factor shown in equation 11 to give an upper
range for X.
at=lH = Pr=1' (CU. 0H·S·l{JU=1) + (U. 0H. (1- S)))
+Pr=o.CCU.0H.S.l{JU=1) + (U.0H.Cl- S))) (11)
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7.4 Component Two: Estimating undiagnosed HIV infections in MSMwho
have never had a HIV test
Figure 7.4 Structure of model to estimate the numbers of undiagnosed HIV
infections in MSMwho have never HIV tested (Component Two)
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The second component will estimate the numbers of undiagnosed HIV infections in
MSM who have never HIV tested. The diagnosed population of HIV positive MSM will
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be stratified by each of the categories included in the model and an adjustment factor
for each category will be calculated. The equation (4) will be extended for each of the
relevant parameters that are calculated. The odds ratio of HIV infection in untested
MSM relative to tested 0, was calculated from Chapter five with an upper and lower
behavioural range calculated from Chapter six which enters the formula for the final
adjustment factor for untested MSM, at=o, in the model. This is illustrated in equation
(12) below.
As in the previous figure, the central part of Figure 7.4 is estimating the quantity X of
undiagnosed (or unobserved) infections in those who have never tested. In a GUM
clinic, this quantity will differ dependent on whether a person is attending because of an
acute STI (those with acute STI have different HIV infection risk compared with those
without STI), for example by stratifying by other acute STI. Being diagnosed with
another acute STI (other than gonorrhoea or syphilis) at the surveyed GUM clinic visit
was associated with a reduced odds of ever HIV testing and of HIV infection. An
adjustment factor for acute STI will be included, and was calculated through analyses
in Chapter five based on the prevalence of HIV infection amongst MSM that had (or
had not) acute STls as illustrated in equation (12) and shown in Figure 7.4
In mathematical terms for each category included in the model, an adjustment factor
will be calculated for the proportion of MSM that have never HIV tested within that
category. If for example stratifying by other acute STI:
If 8 = OR of HIV infection in MSM who have not HIV tested relative to tested
1 - U = proportion of undiagnosed HIV infected MSM that have not HIV tested:
because undiagnosed HIV infections in those with prior tests have already been
counted in component one, these can't be counted again.
S = proportion of MSM with other acute STI, 1-S = proportion without other acute STI
'1/ u=o =OR of HIV infection for MSM with other acute STI relative to no acute STI
then the adjustment factor for MSM who have not tested and have undiagnosed HIV
infection, taking previous acute STI infection into account, is
at=o = «(1 - U). 0.S.({Ju=o) + (1 - U). 0. (1 - S))) (12)
As explained previously for component one, to estimate undiagnosed HIV infections in
untested MSM aged <25 in London, the following would be applied
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X - (Yr=IOndOn.i=<25 v ) (1 U) 1: S +r=LondonJ=<25.t=O - . - Ir=london.i=<25· - . u. .CfJu=o
Pr=London.I=<25
(
Y r=london.i=<25 v ) (1 U) 1: (1 S)- Ir=london,i=<25' - . u. -
Pr=London.i=<25
(13)
This would be repeated again for each of the age groups, and the estimated numbers
of undiagnosed HIV infections in untested MSM would be added together.
The prevalence ratio of HIV infection in MSM who have not HIV tested outside London
will differ from MSM in London due to differential uptake of HIV testing, different rates
of HIV diagnosis and different background HIV prevalence. The same regional
adjustment factor P as described for component one will be applied. Again it is
assumed that at=o is correct for London and P = 1 when r = 1=London. This is shown
in equation (14).
If Pr=o = (the proportion of HIV infections diagnosed outside London I proportion of
HIV infections diagnosed in London) I «OR HIV testing outside London) x (HIV
prevalence outside London I HIV prevalence London» or Pr=o = -9£.u
then
at=o = Pr=l' (c(1- U). D.S.CfJu=o) + ((1- U). D. (1- s)) )
+ Pr=o, (((1- U).O.S.({Ju=o) + ((1- U).o.(l- S))) (14)
Thus to calculate the undiagnosed number of HIV infections for outside London, similar
to equation (13), undiagnosed HIV infection within each individual age group would be
estimated, from diagnosed HIV infections and proportions tested from outside London,
with the additional regional adjustment Pr=o added as shown in equation (14).
The study in Chapter five was of MSM attending a GUM clinic. A lower behavioural
range for the prevalence ratio of HIV infection in untested relative to tested in MSM, OL,
was calculated through analyses in Chapter six. This was obtained through calculating
the standardised prevalence ratio of HIV prevalence in community-recruited MSM who
had not attended a GUM clinic relative to the UA GUM study (t9n). This was multiplied
by the OR adjustments 0 to calculate OL' a lower range factor, which provided a lower-
risk adjustment factor at=OL shown in equation (15) and a lower range for X.
at=OL = Pr=l' ( ((1- U). 0L' s. CfJu=o) + ((1- U). 0L' (1- S)))
+ Pr=o, (((1- U). OL'S, CfJu=o) + ((1- U).OL' (1- S))) (15)
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Similarly an upper behavioural range for the prevalence ratio of HIV infection in
untested relative to tested adjustment, OH' was calculated in Chapter six from a higher-
risk population of sexually active MSM, attending bars, clubs and saunas. This was the
standardised HIV prevalence ratio in the GMSHS survey relative to the UA GUM
survey Om. This was multiplied by the OR adjustments 0 to calculate OH, an upper
range factor, which provided a higher-risk adjustment at=OH shown in equation (16) and
a higher range for X.
at=OH = Pr=l. (( (1 - U). OH.S. qJu=o) + ((1 - U). OH. (1 - S)))
+Pr=o.(((l- U).OH.S.qJU=o) + ((1- U).oH.(l-S))) (16)
7.5 Estimating total HIV infections in MSM
The number of undiagnosed HIV infections in MSM in the general population X was
estimated using a model consisting of two separate components as outlined above
(Figure 7.2). Component One (Figure 7.3) estimated the numbers of undiagnosed HIV
infections in MSM who have tested negative previously but had undiagnosed HIV
infection. Component Two estimated the numbers of HIV infections in MSM who have
never HIV tested and had undiagnosed infection (Figure 7.4). The number of total HIV
infections Z was estimated by adding X to Y, diagnosed HIV infections, represented by
prevalent diagnosed individuals receiving care through the SOPHID surveillance
survey as described in Chapter three, section 3.3.3. Table 7.1 lists all parameters by
model component, and the subsequent section describes how the parameters were
estimated and which results were used in the final model.
Analyses in Chapters four, five and six showed the factors that affected HIV testing and
risk of HIV infection in MSM and were summarised in Table 5.9, Chapter 5; section
5.3.5. These included age group and being diagnosed with an acute STI. These factors
were therefore included in the model to extrapolate HIV diagnoses to all HIV infected
MSM using HIV testing prevalence. Since both HIV testing and HIV infection risk were
associated with age, all analyses and modelling was age-specific. Overall adjustment
factors, at=l, and at=o, were calculated that combine the effects of all the relevant
variables. The odds ratios for the adjustment factors to be applied by age group and
region were derived based on analyses in Chapter five with adjustments according to
GUM attendance derived from Chapter six and these are shown in Table 7.1. The
diagnosed population of HIV positive MSM was stratified by each of the categories
included in the model and an adjustment factor for each category was calculated.
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The regional adjustment f3r=o C ~.Il) was calculated. The UAPMP GUM survey
(Chapter three, section 3.5.4) provided values for the diagnosis ratio; the proportion of
HIV infections detected through unlinked anonymous testing in HIV positive MSM that
were clinically diagnosed outside London relative to London, which was ( E = 0.45 =
0.62
0.72). The prevalence ratio in MSM attending GUM clinics outside London relative to
London was again provided by the UAPMP GUM survey and was CIl = ~::= 0.44).
Finally the Natsal study in Chapter four (Table 4.2a) provided the value for OR of HIV
testing if outside London relative to London CO = _1_ = 3.03).
0.33
Total numbers of prevalent diagnosed HIV infections, Y, in MSM resident in Britain
were used as described in Chapter three, section 3.3.3. These were then adjusted for
cross-boundary flow between regions for care and for non-attendance for care in a
year, based on the 3 previous years 143. Deaths in HIV infected MSM within the year
2003, received from the Office of National Statistics (ONS), were age-stratified and
subtracted from the 2003 total to give total numbers living with diagnosed infections.
This provided London, outside London, Scotland and Wales, age-specific numbers of
MSM with diagnosed HIV infections Yri. Numbers of total diagnosed HIV infections for
Northern Ireland were the total number of HIV infections diagnosed up to the end of
2003 minus all deaths up to the of 2003 from the ONS. Prevalence rates of HIV testing
in MSM, Pri' were derived from Natsal 2000 in Chapter four. Uncertainties regarding
assumptions made throughout the modelling analyses were explored in sensitivity
analyses. All estimates were rounded to the nearest ten.
The adjustments (1) and {j were derived based on analyses in Chapter five with
adjustments cp and S, according to acute STI diagnoses, and an upper and lower range
adjustment aL' aH derived from Chapter six. These are shown below in Table 7.2.
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Table 7.2 Estimation of adjustment factors for Component One and Component
Two; adjustment for prevalence of HIV infection in MSM
Acute STI adjustment (Lower, upper)
status" Equation adjustment
a aLaH
at=l
London Other acute STI U.0. S. lPu=l· f3r=l 0.00538 (0.00256,
0.00717)
No acute STI U. 0. fJr=l. (1 - S) 0.06994 (0.03481,
0.09448)
Rest of Other acute STI U. 0. S. lPu=l· fJr=o 0.00269 (0.00128,
UK 0.00359)
No acute STI U.0·fJr=o·(1-S) 0.03497 (0.01740,
0.04724)
at=o
London Other acute STI (1 - U). 8. S. lPu=o·f3r=l 0.0138 (0.00688,
0.01870)
No acute STI (1 - U). 8. f3r=l. (1 - S) 0.19274 (0.09592,
0.26004)
Rest of Other acute STI (1- U).8.S.lPu=o.f3r=o 0.00692 (0.00344,
UK 0.00935)
No acute STI (1 - U). 8. f3r=o,(1 - S) 0.09637 (0.04796,
0.13019)
Note.a. Other acuteSTI definedas presentingwith one of the followingdiagnoses: chancroid/
donovanosis/LGV,chlamydia,NSU, trichomoniasis,scabies/pediculosis,HSV&HPVfirst attack
or molluscumcontagiosum.
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7.6 Results
This section presents results of the estimates of Z, total numbers of HIV infections in
MSM in the UK using the Estimating Undiagnosed from the Observed Method
developed in this chapter, adjusting for prevalence of HIV in those who were untested.
A comparison of by how much the estimates changed because of the adjustment factor
was made, followed by sensitivity analyses testing the assumptions made within the
model. Finally, the estimations produced by the model were compared with results from
other estimation methods.
7.6.1 Numbers of HIV infections in MSM in the general population.
Estimates of total numbers of HIV infections amongst MSM (Z) are presented in Table
7.3. A range of estimates are provided giving a higher and lower estimate based on the
higher-risk MSM recruited through the GMSHS and lower-risk MSM who have not
attended a GUM clinic in the past year. In 2003 an estimated 24,800 MSM were living
with HIV, of whom 8,460 (34%) were unaware of their infection.
Table 7.3 Estimated number of prevalent HIV infections in MSM in the UK 2003;
estimating undiagnosed from the observed method
Diagnosed Undiagnosed (Rangea) Total HIV (Range)
infections infections infections
london
<25 220 320 (160 -430) 540 (380 - 650)
25-34 2,650 1,380 (690 -1,860) 4,030 (3,330 - 4,030)
35-44 5,320 4,370 (2,170 - 5,900) 11,050 (7,490 - 11,220)
45+ 880 730 (360 - 980) 1,860 (1,240 - 1,860)
9,070 6,790 (3,380 - 9,170) 15,860 (12,440- 18,240)
Outside london
<25 500 220 (110 - 300) 720 (610 - 800)
25-34 2,110 300 (150 - 410) 2,410 (2,260 - 2,530)
35-44 3,370 830 (410-1,120) 4,200 (3,790 - 4,500)
45+ 1,290 320 (160- 430) 1,610 (1,450 - 1,720)
Total 7,270 1,670 (830 - 2,260) 8,940 (8,110- 9,550)
Outside
London
Total 16,340 8,460 (4,210 -11,430) 24,800 (20,560 - 27,790)
UK
Note. a. Range calculated from the adjustment factors aH.•aL'
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7.6.2 Comparison of the Undiagnosed from the Observed Method with
unadjusted indirect method estimations
To investigate the importance of adjusting the estimates of undiagnosed HIV infections
with the adjustment factor (a), the unadjusted indirect method estimate was compared
with the Estimating Undiagnosed from the Observed Method estimate in Table 7.4. The
Estimating Undiagnosed from the Observed Method estimate was found to be 52.4%
lower (24,800 compared with 52,120). This showed that not adjusting the indirect
estimation method would lead to overestimation of the numbers of undiagnosed HIV
infections, X. The reduction in estimated undiagnosed HIV infections, X, was similar in
London and the rest of the UK.
Table 7.4 Comparison of estimates from Estimating Undiagnosed from the
Observed Method with unadjusted indirect estimations
Estimating Unadjusted % reduction in
Undiagnosed indirect estimate estimates through
from Observed (range) adjustment
Method estimate
{range-}
London 15,860 33,150 -52.2%
(12,440 -18,240) (16,500 - 44,780)
Outside London 8,940 18,970 -52.9%
(8,110 - 9,550) (9,440 - 25,630)
Total 24,800 52,120 -52.4%
(20,550 - 27,790) (25,940 - 70,410)
Note.a. rangecalculatedfrom the adjustmentfactors aH"aL'
7.6.3 Sensitivity analyses
Sensitivity analyses were undertaken in areas of uncertainties surrounding the model
to determine how sensitive the outcome, estimates of numbers of undiagnosed HIV
infections, may be to the behavioural-risk gradient defined through the adjustment
factors at=1 and at=o. This was carried out through describing plausible ranges of key
variables and examining the robustness of particular assumptions. Four different
scenarios were considered.
1. Effect of changes in OR of HIV infection, 6, 0, in HIV untested MSM relative to
tested due to changes in HIV testing in HIV positive and HIV negative MSM
2. Effect of changes in the estimate of proportions of HIV infections in MSM who have
HIV tested and have undiagnosed infection U
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3. Effects of changes in GUM attendance patterns
4. Effects of changes in place of HIV test, leading to a higher proportion of MSM
testing at GPs
7.6.3.1 Effect of changes in OR of HIV infection, 0, ~ in untested MSM relative
to tested MSM due to changes in HIV testing in HIV positive and HIV negative
MSM
HIV testing information used in the model was gathered through two surveys - (1) the
Natsal survey of all MSM analysed in Chapter four and (2) the survey of MSM
attending a GUM clinic analysed in Chapter five. Three scenarios were explored that
would affect three possible directions of the relationship between HIV infection and HIV
testing. These are shown below in Figure 7.5.
The first scenario (A) assumed that MSM who HIV test have higher risk of HIV infection
then MSM who do not test, thereby applying the adjustment factors at=l. at=o shown in
Table 7.2 to all MSM who have tested, and producing estimates as shown in Table 7.3.
The second scenario (8) assumed that HIV testing is related to MSM being in a
monogamous relationship and thus testers have lower-risk of HIV infection than
untested MSM, assuming a similar but opposite OR of HIV infection 0,0 in untested
MSM relative to tested MSM leading to an adjustment factor opposite to that found in
scenario A.
The third scenario (C) considered MSM who tested annually regardless of their
behaviour with changing HIV test policies whereby these MSM were assumed to revert
to having the adjustment factors at=l and at=o of 1.0.
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Figure 7.5 Sensitivity analyses of the effect of changes in the adjustment factor
a between HIV positive and HIV negative MSM: three scenarios
45000
~ 40000
o~ 35000
~ 30000
~ 25000
::E:'0 20000
le 15000
Cl)
~ 10000
~ 5000o ~~ ~ __ -L ~ __~ ~ __
Scenario A Scenario B
n Undiagnosed Infections
C Diagnosed HIV infections
Scenario C
The total HIV infections, Z, for 2003 were adjusted, assuming the above scenarios, and
results are presented in Figure 7.5. If it is assumed that untested MSM have lower HIV
prevalence than MSM who tested (A) and an adjustment is made to the indirect
method, the numbers of HIV infections, Z, estimated in the population would be 24,800
(8,460 undiagnosed). If, however, HIV testing was assumed to be related to MSM
being in a monogamous relationship (8), and untested men had, for example, 30%
higher prevalence of HIV, then estimates of undiagnosed HIV infections increased to
40,460 (23,720 undiagnosed). If annual testing was undertaken unrelated to risk (C),
then 35,520 MSM would be estimated to be living with HIV, of whom 18,970 (53.4%)
had undiagnosed HIV infection. This undiagnosed proportion would not remain at this
high level since the proportion of MSM tested would be expected to increase over time.
In the event of annual HIV testing, numbers diagnosed would begin to equal HIV
incidence over time and the proportion undiagnosed (U) would decrease. Scenario A
leads to the lowest estimates of undiagnosed HIV infections, scenario 8 the highest,
and scenario C while higher now, would eventually through successful diagnoses lead
to a decrease in undiagnosed HIV infections. This is assuming that all MSM would test
annually, including men at increased risk of HIV infection.
7.6.3.2 Effect of changes in the estimate of proportions of HIV infections in
MSMwho have HIV tested and have undiagnosed infection U
If the proportion of HIV infections in MSM who have tested negative and have
undiagnosed HIV infections (U) changed, for instance due to more regular systematic
HIV testing rather than HIV testing relating to risk behaviour, this proportion would be
expected to decline annually. The effect of a range of either a decrease or an increase
(although this is an unlikely scenario) in this proportion is illustrated in Table 7.5
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(assumption 1). This change is unlikely to take place independently of the never tested
proportion (1-p) of MSM. It would be expected that this proportion might decline
simultaneously. The Estimating Undiagnosed from the Observed Method model was
recalculated for assumption 3 and 4, Table 7.5, assuming the proportion of MSM with
undiagnosed infection, V, who tested previously HIV negative was reduced to zero,
and a decrease in the proportion of people who have not had HIV tests (1-p) by 39%
and 80%, respectively. All recalculated estimates were compared with estimates
produced from the Estimating Undiagnosed from the Observed Method model (Table
7.3). These are presented in Table 7.5.
Table 7.5 Range of estimates of HIV infections based on range of assumptions
about the proportion of HIV infections in MSM who have ever HIV tested and
have undiagnosed infections
Estimated total HIV
infections
(rangea)
Estimated total
undiagnosed HIV
infections (range)
%HIV
infections
undiagnosed
Estimating Undiagnosed from
the Observed Method model:
assuming V=0.39b
Assumption 1: assuming
V=0.80, all else unchanged
Assumption 2: assuming V=O,
all else unchanged
Assumption 3: assuming v=o
and a corresponding 39%
decrease in (1- p)
Assumption 4: V= 0 and a
corresponding 80% decrease
in (1- p)
24,800
(20,550 - 27,790)
23,010
(19,660 - 25,350)
26,490
(21,390 - 30,050)
22,430
(19,370 - 24,430)
20,070
(18,190 - 21,370)
8,460
(4,210- 11,430)
6,670
(3,320 - 9,010)
10,150
(5,050 -13,710)
6,090
(3,030 - 8,230)
3,720
(1,850 - 5,030)
34.1%
29.0%
38.2%
27.2%
18.5%
Notea. Rangecalculatedfrom the adjustmentfactors aL,aH; b. Themeasuredproportionof
MSMwith undiagnosedHIV infectionthat hadever HIV tested in UAGUMsurveyChapterfive.
Table 5.8.
The OR of undiagnosed HIV infection in MSM who have ever tested, 0, was lower
compared with untested MSM (Table 7.1). When the proportion of previously HIV
negative MSM with undiagnosed infection, V, was increased in the model (assumption
1, Table 7.5), the overall estimated numbers of undiagnosed HIV infections, X,
decreased. Increasing V to 80% (assumption 1, Table 7.5) decreased the estimated
numbers of undiagnosed HIV infections by 21% and decreasing V to 0% (assumption
2, Table 7.5), increased the estimated numbers of undiagnosed HIV infections, X, by
20%. Assuming a corresponding drop in the proportion of HIV untested MSM overall
(1 - p), led to further declines in estimated numbers of undiagnosed HIV infections. A
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39% decrease (assumption 3, Table 7.5) produced a 16% decline in estimated
numbers of undiagnosed HIV infections. Finally, an 80% decrease (assumption 4,
Table 7.5) in the proportion untested, resulted in a 56% lower estimate of undiagnosed
HIV infections when compared with the baseline Estimating Undiagnosed from the
Observed method model (Table 7.5).
7.6.3.3 Effects of changes in GUM attendance patterns on estimates of
unobserved HIV infections
The effect of changing assumptions about GUM attendance patterns was explored.
GUM attendance could change for various reasons. The first most likely change might
be if MSM were to attend a GUM clinic specifically for a HIV test, unrelated to risk, due
to a change in HIV test promotion and policy. This would lead to a reduction in 8, the
prevalence ratio in untested MSM attending the GUM clinic. The proportion of MSM
without previous HIV tests (1- p) would become smaller as the total number attending
the GUM clinic increased. This would affect the adjustment factors, at=o, and at=o
would move towards 1.0. With increased HIV testing, undiagnosed HIV infections
would decrease, assuming HIV positive MSM were equally like to test as HIV negative
MSM, and as the proportion untested (1- p) becomes smaller it would have less
impact on the model.
To investigate how Z, the estimate of number of total HIV infections in MSM, would
change if GUM clinic attendance changed, different outputs using a plausible range of
key variables were calculated. All comparisons were made to estimates produced from
the Estimating Undiagnosed from the Observed Method model, Table 7.3. The ranges
of probable changes due to increased HIV testing resulting in a changed OR of HIV
infection in non-testers, 8, are shown below in Table 7.6.
As HIV testing increases, the proportion of untested MSM (1 - p) decreases, thus
resulting in a lower estimate of X (undiagnosed HIV infections), as in assumptions 1
and 2, Table 7.6 below. If it is assumed that the OR 8 moves towards 1.0 when MSM
HIV test more routinely unrelated to risk behaviour, then X increases as in assumption
3, Table 7.6. However, as the corresponding proportion of untested MSM (1- p)
decreases, so too does X (assumption 4, Table 7.6). Thus, if the prevalence ratio 8
was not changed within the model when the clinic population who are undergoing HIV
testing changed, then the Estimating Undiagnosed from the Observed Method model
would underestimate the true numbers of undiagnosed HIV infections.
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Table 7.6 Range of estimates of total HIV infections in MSM through Estimating
Undiagnosed from the Observed Method model based on varying assumptions
about changing GUM clinic attendance due to increased HIV testing and
corresponding changes in the OR of HIV infection 8 in untested MSM
Estimated total HIV Estimated total
infections Z undiagnosed HIV
(ranqe") infections X
(range)
%HIV
infections
undiagnosed
Estimating Undiagnosed from
the Observed Method
estimate:
Assumption 1: an increase in
MSM attending GUM clinic for
HIV test only, by 50%, all else
remains the same"
Assumption 2: an increase in
MSM attending GUM clinic for
HIV test only, by 100%, all
else remains the same"
Assumption 3: an increase in
MSM attending GUM clinic for
HIV test only, by 50%, and a
50% decrease 8c
Assumption 4: an increase in
MSM attending GUM clinic for
HIV test only, by 100%, and a
75% decrease 8c
24,800
(20,550 - 27,790)
20,700
(18,480 - 22,260)
18,770
(17,550 -19,630)
19,150
(20,140 - 20,140)
18,340
(17,340 -18,340)
8,460
(4,210- 11,430)
34.1%
4,430
(2,200 - 5,990)
21.4%
2,430
(1,210 - 3,284)
12.9%
2,810
(1,400 - 3,800)
14.7%
2,000
(990 - 2,700)
10.9%
Note.a. Rangecalculatedfrom the adjustmentfactors aL, aH; b. Assumesthe proportion
presentingwith anotheracute STI S, andOR of HIV in non-testers,6, undiagnosedtesters, 0,
and otheracuteSTls qJ remainthe same; c. Assumesthat the proportionpresentingwith
anotheracuteSTI S, the OR of undiagnosedHIV in undiagnosedtesters 0 and in otheracute
STI qJ remainthe same
A second change to GUM attendance could arise during an outbreak of an acute STI,
for example syphilis or gonorrhoea. This could lead to an increased proportion of MSM
who might be HIV positive, or newly HIV infected MSM attending the GUM clinic. This
would result in an increase in HIV diagnosis in higher-risk MSM, thus increasing the
OR of HIV infection 0 in non-testers relative to testers and it would move towards zero.
If this change was not taken into account in the adjustment factor at=o, the Estimating
Undiagnosed from the Observed Method model would overestimate X (undiagnosed
HIV infections).
To investigate how Z, the estimate of number of total HIV infections in MSM, would
change if GUM clinic attendance changed due to new outbreaks of STls, different
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outputs using a plausible range of key variables were calculated. All comparisons were
made to estimates produced from the Estimating Undiagnosed from the Observed
Method model, Table 7.3. The ranges of probable changes due to new outbreaks of
STls resulting in changed OR of HIV infection in non-testers () are shown below in
Table 7.7.
Table 7.7 Range of estimates of total HIV infections in MSM through the
Estimating Undiagnosed from the Observed Method based on varying
assumptions about changing GUM clinic attendance due to outbreaks of STls
and corresponding changes in ORof HIV infection 6 in non-testing MSM
Estimated total Estimated total
HIV infections Z undiagnosed HIV
(range8) infections X (range)
%HIV
infections
undiagnosed
Estimating Undiagnosed from 24,800 8,460
the Observed Method estimate: (20,550 - 27,790) (4,210 -11,430)
34.1%
Assumption 1: an increase in 24,600 8,260 33.6%
MSM attending GUM clinic for (20,450 - 27,500) (4,110-11,160)
Acute STls (e.g. gonorrhoea or
syphilis) and HIV test, by 25%,
and no change {)b
Assumption 2: an increase in 24,410 8,070 33.6%
MSM attending GUM clinic for (20,360 - 27,240) (4,020 - 10,900)
STls (e.g. gonorrhoea or
syphilis) and HIV test, by 50%,
and no increase in tic
Assumption 3: an increase in 23,090 6,750 29.2%
MSM attending GUM clinic for (19,700 - 25,460) (3,360 - 9,11O)
Acute STls (e.g. gonorrhoea or
syphilis) and HIV test, by 25%,
and a 25% increase in ()
Assumption 4: an increase in 21,450 5,110 23.8%
MSM attending GUM clinic for (18,890 - 23,250) (2,540 - 6,900)
STls (e.g. gonorrhoea or
syphilis) and HIV test, by 50%,
and a 50% decrease in tic
Note.a. Rangecalculatedfrom the adjustmentfactors aL' aH; b. Assumesthe proportion
presentingwith anotheracute STI 5, andOR of HIV infectionin non-testers8, undiagnosed
testers (1) and otheracute 5Tls qJ remainthe same;c. Assumesthat the proportionpresenting
with anotheracuteSTI 5, ORof undiagnosedHIV infectionin testers (1) and in other acuteSTI qJ
remainthe same
Estimated numbers of X, undiagnosed HIV infections, decreased as the proportion of
MSM HIV tested p, increased (assumptions 1 and 2, Table 7.7). If the increased
proportion of MSM HIV tested were at higher risk of HIV infection, then the OR of HIV
infection in untested relative to tested (), would get larger and move towards zero. The
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model is sensitive to changes in 0, combined with increased HIV tested proportion p,
as shown in assumptions 3 and 4, Table 7.7 above. The estimated numbers of
undiagnosed HIV infections X, reduced by 40% when both the proportion untested
(1 - p) and the OR of HIV infection in untested relative to tested 0, were reduced by
50%. The model would produce overestimates of undiagnosed HIV infections if the
profile of MSM having HIV tests changed to an increased proportion of MSM with
higher risk of HIV infection, if the adjustment factor at=o was not updated.
7.6.3.4 Effects of changes in place of HIV test, leading to a higher proportion
of MSM testing at GPs
Finally the effect of changes in place where MSM attend for an HIV on X, the estimated
numbers of undiagnosed HIV infections from the model, was investigated.
The proportion of MSM who reported their last HIV test at a GP was 16.6% (Chapter
four, Table 4.4). A sentinel survey of first HIV tests between 1990 and 2000 found that
overaIl2.9% of all first tests took place at GPs, while the rest took place at GUM clinics
(Chapter 3, Table 3.1). A higher proportion of first tests in MSM at GPs within London
were HIV positive (15.6% compared with 8.5%) although this was still a low number of
MSM tested (141 compared with 13,734). There was no evidence of a difference in
positivity outside London (3.7%, 4.1%) (Chapter 3, Table 3.1).
HIV testing practice could change with more MSM attending GPs for an HIV test
instead of a GUM clinic. This would be more likely to take place as part of the initiative
to normalise HIV testing and encourage annual HIV testing, rather than attending a GP
through illness and a HIV test being undertaken as part of treatment and diagnosis. In
the former case, one would hypothesise that MSM testing at GPs were lower risk, while
HIV testing continuing at GUM clinics would be higher-risk MSM, attending for
diagnosis and treatment for other STls. In this case, since the model only monitors
GUM clinic testers, the OR of HIV infection adjustments for both undiagnosed tested
MSM, 0, and untested MSM, 0, would increase towards zero. The untested proportion
(1 - p) would be expected to decline over time. Therefore, if the OR of HIV infection
adjustments 0,6 in the model were not increased to account for this change in MSM
HIV testing at GUM clinics, the model would overestimate undiagnosed HIV infections.
This would have the same effect on the estimate as shown in Table 7.7 and discussed
in Section 7.6.3.3, final paragraph. An alternative method of estimating total HIV tests
outside the GUM clinic would be needed to update the total proportion of MSM HIV
tested. Effectively an aGP would need to be calculated, and be applied to the total
diagnosed HIV infections over time. A surveillance system that monitors HIV tests at
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GPs would be necessary to undertake this new addition to the model and monitor it
over time for changes.
7.6.3.5 Multiple Imputation methods
Multiple imputation is a general approach to the problem of missing data in large
datasets. These methods are used in single data-sets, and are not used to combine a
range of data from different sources (which is what this thesis did). Multiple imputation
allows for the uncertainty about the missing data by creating several different plausible
imputed datasets in which the observed data set limits on the unobserved and
combining results obtained from each of them to create a new dataset without rnissinq
data233. This method is otten used for randomised controlled trials where every
observation is important. This model is based on a series of different datasets. There is
one similarity - as in multiple imputation it is assumed that missing data were missing
at random, that is any systematic differences between the observed and missing data
can be explained by the observed, and that the reasons for the missing data are
unrelated to unobserved outcomes. The premise of this thesis and multiple imputation
methods are similar in that there are data that allow us to make assumptions about
people who are not taking part, Le. for whom it is known that they exist but a directly
observed measurement is not available. However, to determine plausible ranges for
the unobserved, no multiple imputations were undertaken within the multiple data sets
used in Chapters four to six.
7.6.4 Comparison of HIV estimates from the Estimating Undiagnosed from
the Observed Method model with results from other estimation methods
The model has provided a point estimate of the numbers of HIV infections in MSM in
the UK in a given year using diagnosed HIV infections and the proportion of MSM HIV
tested. The other UK method used to estimate total HIV infections, Z, in 2003, the
direct estimates method was published in 2006 by McGarrigle et a125. This method was
described in Chapter one, section 1.2.3. Briefly, it produces estimates of undiagnosed
HIV infections by multiplying undiagnosed HIV prevalence estimates from UA surveys
in behavioural groups by the population in that group. The undiagnosed infections are
then added to the diagnosed to give total prevalent HIV infections. It estimated 24,500
prevalent HIV infections in MSM in the UK in 2003, of whom 6,400 (26%) were
undiagnosed. This Estimating Undiagnosed from the Observed Method provided
estimates that were close to the national published estimates, although the proportions
undiagnosed were higher from the Estimating Undiagnosed from the Observed Method
model (34%).
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Further estimates of Z, total HIV infections, for 2003 were produced using the direct
estimate method but through Bayesian MPES and published by Goubar et al234.This
method is explained briefly in Chapter one, section 1.6 and further in section 7.7 below.
They estimated a total of 19,400 (17,200 to 22,300) prevalent HIV infections in MSM
aged 15-44 in England and Wales, of whom 8,200 (6,100 to 11,100) (42.3%) were
undiagnosed. Estimates for MSM in England and Wales aged 15-44 using this
Estimating Undiagnosed from the Observed Method model, using the adjustment factor
and the same numbers of diagnosed HIV infections, were 18,430 (17,110 to 22,270), of
whom 7,230 (3,600 to 9,760) (39.2%) were undiagnosed. The model described in this
chapter provides estimates of HIV infection in MSM very similar to those provided by
the MPES method.
HIV testing in MSM has increased since the beginning of the implementation of an opt-
out HIV test policy throughout the GUM clinics following recommendations in 2006235 in
England and Wales, and the Scottish sexual health strategy in 2005236. To further test
the model, estimates of Z, total numbers of HIV infections, were calculated for 2009,
using available data, and then compared with estimates for 2009 produced by the
MPES method. To update the Estimating Undiagnosed from the Observed Method
model to 2009 some assumptions were made, since the model used the proportions
HIV tested p from Natsal 2000 and there is no current update for these proportions. To
approximate the population increases in HIV testing in MSM to p, the proportionate
increases in HIV testing seen in MSM attending GUM clinics taken from the UAPMP
GUM survey between 2003 and 2008, were examined. The UAPMP GUM survey was
carried out at 17 GUM clinics nationally and the increases in HIV testing measured
were assumed to be equal to the proportionate population increases. Thus, an increase
in HIV testing of 36% in London and 39% outside London were applied to p in the
Estimating Undiagnosed from the Observed Method model. It was assumed that these
increases to p were equal across the age groups. These results are presented below in
Table 7.8.
The Estimating Undiagnosed from the Observed Method model estimated results
similar overall to the MPES method although the estimated numbers of undiagnosed
HIV infections were closer in London than the outside London numbers. This may be
due to changes in prevalence of HIV infection when comparing London and Outside
London since 2003. Given the large changes in HIV testing policy and practice
implemented at GUM clinics since 2003, the adjustment factor for OR of HIV infection
in untested MSM 8 is likely to have changed since 2003, The Estimating Undiagnosed
from the Observed Method model was recalculated, this time assuming a reduction in
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the OR of HIV infection amongst untested MSM Ii relative to tested, and with no
adjustment factor for outside London. It was assumed that untested MSM at GUM
clinics would be even less at risk of an undiagnosed HIV infection, given the increase in
HIV offering and testing at GUM clinics. The adjustment for London was removed as
there was no evidence to update this adjustment. The second estimate produced
numbers of undiagnosed HIV infections more similar to the MPES method.
Table 7.8 Comparisons of estimates of total HIV infections In MSM (Z) 2009
through Estimating Undiagnosed from the Observed Method· model using 2009
diagnosed HIV infections (Y) with published estimates produced through MPES
method
Estimated total Estimated total %HIV
HIV infections Z undiagnosed HIV infections
{rangeb} infections X {range} undiagnosed
Assuming all adjustments in
at=1 , at=o are equal to 2003
Estimating Undiagnosed from
the Observed Methode 19,030 6,330 33.3%
London (15,850 - 21,250) (3,150 - 8,550)
Rest of UK 15,030 1,680 11.2%
(14,190-15,620) (840 - 2,270)
Total UK 34,060 8,010 23.5%
(30,040 - 36,8801 (3,990- 10,8201
Adjustment to 6, {J
Estimating Undiagnosed from
the Observed Methodd London 18,100 5,400 29.8%
(15,390 - 20,000) (2,690 - 7,300)
Rest of UK 16,200 2,840 17.5%
(14,770 -17,200) (1,420 - 3,840)
Total UK 34,300 8,250 24.0%
(30,160- 37,1901 (4,100- 11,1401
MPES Methode
London 18,020 5,320 29.5%
(15,980 - 21,660) (3,330 - 8,940)
Rest of UK 17,050 3,670 21.5%
(16,440 - 17,470) (3,110 - 4,080)
Total UK 34,070 8,990 26.4%
(32,420 - 39, 130) (6,440 - 13,0201
Note.a. p increasedby 36% in Londonand 39%outsideLondon,from UAPMPGUMsurvey
increasein testingat GUMclinics; b. Rangecalculatedfrom adjustmentfactors aL, aH; c.
Assumedthat ORof HIV infection8 , (1) and outside Londonadjustment {J remainedthe same
as 2003;d. Assumedthat OR of HIV infection Ii reducedby 20%and no {J adjustment;e.
Resultsreproducedfrom methodby Presaniset a1234updatedand publishedby HPA,2011.
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7.7 Discussion
The Estimating Undiagnosed from the Observed Method model, using an adjustment
factor (at=lo at=o) produced estimates of numbers of undiagnosed HIV infections (X)
similar to other published estimates for 2003. The model was sensitive to changes in
the OR of HIV infection in untested MSM relative to tested, 8, and the proportion of
MSM with undiagnosed HIV infection that have tested, U. The estimates produced by
the model for 2009 showed some deviations from published estimates. The OR of HIV
infection 0 and 8 may have changed since 2003, given the changes to the proportions
of MSM that have HIV tested. An update of the key parameters used to produce the
adjustment factor (at=l, at=o) may produce a more accurate estimate for 2009, e.g.
OR of HIV infection for untested MSM, 8, the proportion presenting with other acute
STls, S, and the OR of HIV infection, lp, for this group, and the proportion of MSM, U,
and OR of undiagnosed HIV infection in tested MSM, 0. Additionally, over the
intervening period, large increases in the offer and uptake of HIV tests at GUM clinic
have been seen through the UK. A review of factors associated with offering and
accepting an HIV test to MSM at GUM clinics, carried out between January 2003 and
May 2005; found that similar factors were associated with both the offer and uptake of
HIV testing as were found in this thesis237.The offer of a test was associated with not
attending with symptoms of an STI, more sexual partners, and previously HIV tested237.
While MSM accepting a test was associated with decreasing age, no symptoms of an
STI, risk from UAI, no previous HIV test in addition to less time to wait for results237.
Many clinics changed their HIV testing policy over this time period, moving to an opt-
out rather than an opt-in HIV testing policy. This would lead to an increase in HIV
testing, regardless of risk behaviour, and should ultimately lead to the OR of HIV
infection in untested MSM relative to tested, 8, moving towards 1.0.
This Estimating Undiagnosed from the Observed Method does have limitations. The
main limitation is that the HIV adjustment factors at=l and at=o were calculated based
on data from one inner London GUM clinic. MSM attending this clinic may differ
behaviourally and in testing history from MSM attending other GUM clinics nationally.
Outside London risks may be different from London, and the model did show some
divergence when estimating undiagnosed HIV infections (X) outside London when
compared with estimates from other methods. Additiona"y HIV testing histories were
only collected within the clinic. MSM may test at many different clinics, and not report
this HIV testing to their care provider at GUM consultation. This could underestimate
the proportion of MSM HIV tested, and bias the results.
The model estimated undiagnosed HIV infections, X, based on data from MSM
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attending a GUM clinic. While adjustments were made for MSM not attending GUM
clinics, and represented as the lower range of the estimate, the method could be
strengthened by including an additional component, aGP, that included MSM who HIV
test at sites other than GUM clinics, and in particular at GPs. New national guidelines
on HIV testing were produced jointly by the British Association of Sexual Health and
HIV (BASHH), the British HIV Association and the British Infection Society in 2008, with
wide representation from other relevant bodies and parties across the UK238.These
guidelines recommend the expansion of HIV testing beyond antenatal and GUM clinic
settings and advocate the routine offer of an HIV test to all adults registering in GP and
all general medical admissions in higher prevalence areas. As HIV testing increases in
settings outside GUM clinics, this additional component would become increasingly
important to produce accurate estimates.
There were missing data within each of the datasets, and multiple imputation
methodology could have been carried out to improve the estimations. In the future,
more rigorous methods of handing missing data (e.g. multiple imputation) could be
used. This could be done by assuming a range of values for each of the missing
variables in the individuals, assuming them to be distributed across the missing as they
were in the complete cases. This could either confirm or refute whether any additional
variable not found in this analysis was associated with both HIV testing and risk of HIV
infection and, if so, whether it should be added as an additional strata to the model.
The importance of collecting this variable though surveillance would then need to be
communicated to the data providers. An audit of why it is not collected completely at
clinic level would need to be carried out.
Finally, this method does not have statistical limits, Le. it does not allow for sampling
variation of the adjustment factors which were based on estimates from different
datasets. The estimates of HIV infections derived from this Estimating Undiagnosed
from the Observed Method were compared with estimates produced by the MPES
method. The MPES method developed a Bayesian framework for synthesis of
surveillance and other information, carried out through Markov chain Monte Carlo
methods, and thus takes account of sampling variation in the original estimates. The
MPES method is very similar to the method in this chapter, namely a 'direct' approach
in that the population is split into risk groups, and estimates of risk group size and of
risk group prevalence and diagnosis rates (to produce undiagnosed HIV prevalence)
are combined to derive estimates of the number of undiagnosed infections, X, and of
the overall number of infected individuals, Z. In the direct method each parameter was
informed by a single item of evidence, and it is assumed that each item is unrelated. It
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was not possible to produce meaningful statistical limits around the direct method
estimates. However, the MPES model incorporated a hierarchical structure to spread
information more evenly over the parameter space, thus each source of evidence
contributes to each parameter. This method allowed a quantification of the uncertainty
within the estimate and a range to be produced for the estimate. The schematic
diagram of influence from the Goubar et al publication 12 is represented below in Figure
7.B.
Figure 7.6 Bayesian multiparameter evidence synthesis of surveillance to
estimate HIV infections, taken from Goubar et al J. R. Statist. Soc. A (2008)
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and the six types of data: 9 indicates a risk group and N is the population size
The novel, and computationally much simpler method presented in this chapter uses
similar data sources and does not rely on the population risk group sizes (Natsal and
ONS), instead it uses the numbers of diagnosed HIV infections, Y, from SOPHID and
the proportion of MSM who have HIV tested p (Natsal), and indirectly estimates the
undiagnosed HIV infections from the diagnosed HIV infections. This Estimating
Undiagnosed from the Observed Method model did not produce any confidence limits;
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although the range for the estimates produced based on higher- and lower-risk
behavioural groups were similar to the ranges produced by the Bayesian MPES
method.
7.8 Conclusions
In summary the Estimating Undiagnosed from the Observed Method, with the newly
developed adjustment factor provided estimates for total HIV infections in MSM, Z,
using total number of diagnosed HIV infections and information on HIV testing. This
provided an easily calculated method for estimating undiagnosed HIV infections, X,
based on existing available surveillance data. The adjustment factor calculated was a
useful adjunct to this method as it reduced the previous overestimations associated
with the method and yet still provides a cost-effective and easy method to estimate
prevalent HIV infections. Sensitivity analyses showed how the adjustment factor for
untested MSM might change according to some factors over time. These factors would
need to be prospectively monitored through surveillance systems to detect the changes
which could then be accounted for in the future models.
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Summary
This chapter contains the conclusions of the thesis and recommendations for policy
and future surveillance systems. Key findings are described, including clarification in
areas where some anomalies were found. Recommendations for policy changes based
on the conclusions of this thesis are made. This is followed by recommendations for
surveillance mechanisms that would enable the prospective monitoring of factors
associated with the outcomes of the estimation model.
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The aims and objectives of the thesis set out in sections 1.4 and 1.5 were met by the
original studies conducted within this thesis. A systematic review investigated the
relationship between HIV testing and risk of HIV infection in MSM and a conceptual
framework of the relationship was developed (Chapter two). The trends of HIV, STI,
and HIV testing in MSM in the UK were described (Chapter three). The first national
study estimating the size and characteristics of the population of MSM HIV testing and
their associated sexual behaviours was carried out (Chapter four). The association
between HIV testing and HIV infection was modelled in different behavioural groups of
MSM (Chapter five and six). Finally a model to estimate total HIV infections in MSM
was developed using this relationship between HIV testing and HIV infection (Chapter
seven).
8.1 Key Findings
This thesis investigated and measured the relationship between HIV testing and risk of
HIV infection, through risk behaviours. It identified and described the factors that affect
both HIV testing and risk of HIV infection: age, area of residence, and acute STls
diagnosed. It reviewed the literature which provided compelling evidence that these
variables proxy unobserved high-risk behaviours and thus allow estimating HIV
infections at a population level.
At the time of this thesis, nationally over a third of MSM (36.6%) reported an HIV test,
and this was associated with increasing numbers of sexual partners (AOR 3.26, 95%CI
1.09 - 19.78) (Chapter four). Measuring HIV infection through UA testing of specimens,
found that increasing age was associated with ever HIV testing and HIV infection
(Chapter five). Being diagnosed with an acute STI, other than gonorrhoea or syphilis,
was associated with a reduced likelihood of ever HIV testing and with lower HIV
infection relative to no other acute STI. While diagnosis with gonorrhoea and syphilis
were strongly associated with HIV infection, they were not associated with HIV testing
(Chapter five). MSM recruited through the community to studies had a higher risk of
HIV infection, and GUM clinic attendance was associated with higher risk of HIV
infection (Chapter six). A model that estimated numbers of total prevalent HIV
infections in MSM, using surveillance data on diagnosed HIV infections and proportions
of MSM HIV tested, was developed. This built on previous work by developing an
adjustment factor for untested MSM compared with HIV tested MSM. In 2003 an
estimated 24,800 (range: 20,550 - 27,790) MSM were living with HIV, of whom 8,460
(range: 4,210- 11,430) (34%) were unaware of their infection (Chapter seven).
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The next section provides some clarification in areas where some anomalies were
found within the thesis.
8.2 Diagnosis of Gonorrhoea or Syphilis and HIV testing
Because of the rising trends in gonorrhoea in MSM (section 3.5.2), it was expected to
be a marker for high-risk behaviour, and therefore useful in the model. A new diagnosis
of gonorrhoea and previous negative HIV tests more than 5 years ago were associated
with being HIV positive (section 5.3.5). The reason for this could be twofold. This may
be because diagnosed HIV positive MSM attended a GUM clinic for diagnosis and
treatment of an STI and did not disclose their HIV status to the clinician (social-
desirability bias). Alternatively, these may be new incident HIV infections. It is difficult to
determine which scenario is true. However, gonorrhoea diagnosis was not found to be
associated with HIV testing (section 5.3.5). These results reinforce the need for MSM
attending GUM clinics with acute gonorrhoea to be offered and recommended HIV
testing as the national standard set in the National Strategy for Sexual Health and HIV
state'". A follow-up audit of clinical practice at GUM clinics in England and Wales in
2004 carried out by the BASHH and the HPA to inform new HIV test guidelines, also
found this failure to HIV test MSM presenting with an acute STI. The most often cited
reason for not receiving voluntary counselling and testing (VeT) was deferral because
of concerns relating to the accuracy of HIV testing shortly after exposure. The rate of
re-attendance for the second test was 10w237•
8.3 HIV testing and undiagnosed HIV Infections
While previous HIV testing was associated with higher risk of HIV infection,
undiagnosed HIV infections occurred in those who never had an HIV test when all
clinically recognised HIV infections were excluded (section 5.3.4.2). This was because
most of HIV infections were diagnosed at first HIV test (88.1%). Overall HIV prevalence
was higher in men who had attended a GUM clinic compared with men who had not.
However, the proportion of HIV infections that were undiagnosed was higher in the
non-GUM attending sample (64.6% compared with 38.1% in the community sample
and 28.8% in GUM-recruited sample) (section 6.3.3). Targeted prevention is necessary
to reach this group of MSM and provide opportunities for their HIV infection to be
diagnosed. Alternative testing sites outside the GUM clinics have been proposed and
currently evaluations are being carried out of where the best sites for HIV testing might
be to allow access to HIV testing to aIl239-241. If barriers to HIV testing exist, further
research is needed to understand what they are and if they are with the provider or the
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individual. Voluntary confidential HIV testing is an important strategy for facilitating the
management of HIV infection in the individual and reducing the likelihood of onward
transmission through behavioural change and decreased viral load through
antiretroviral treatment.
The reasons for not HIV testing in MSM in the UK are multi-factorial and change over
time. The majority of MSM recruited through a community survey in London in 2002
reported 'not putting themselves at risk' as the reason for not HIV testing in the last
year (34%)157. While the majority of MSM in the Natsal study who did not test in the
past 5 years perceived themselves to be either 'not very much at risk' or 'not at risk at
all' of HIV infection (84%f Research in Scotland found that fear of a positive result,
along with HIV-related stigma and discrimination within the gay community,
discouraged HIV testing107.108.However service provision and clinic policy are also
important factors in HIV testing decisions. A national study of testing in MSM attending
GUM clinics found that MSM attending for the treatment of an STI were less likely to be
offered an HIV test, and lower uptake of tests following offer was associated with
symptomatic STI infection, increasing age, no previous HIV test and the time to wait for
results?".
While there has been some normalisation of HIV testing over the previous decade, with
an increase in HIV testing, associated with lower-risk behaviours, this has not been
substantial and much of the MSM surveyed in 2000 did not report a HIV test in the past
5 years. While HIV testing was associated with risk behaviours, and reported STI, the
opportunities to offer and recommend HIV testing to those at increased risk of infection,
should be acted upon. National standards for HIV testing have been set in the National
Strategy for Sexual Health and HIV151,including an increase in the offer and uptake of
HIV and STI testing.
8.4 Limitationsof estimationmethodology
The following section discusses some of the limitations of the research design and
methodology from the knowledge that was acquired while undertaking the research.
Some alternative or additional approaches that might be pursued are outlined for the
future.
The validity of the project depends upon how representative the MSM surveyed were of
all MSM in the UK. The calculation of the adjustment factor was based on data from the
study in Chapter four in an inner London GUM clinic, assuming that they are
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representative of all MSM. To test the model within changing parameters, it was
updated with data from 2009 and this highlighted some concerns with the model
estimation for outside London. Further development of the model is needed and a
study investigating the differences in untested and tested MSM outside London would
provide a more representative sample. The addition of an extra regional stratum for
MSM may help, as HIV prevalence in MSM outside London is not uniform. Areas such
as Brighton and the South east, and Manchester have been shown through syphilis
and gonorrhoea outbreaks to be higher-risk areas for MSM161.
The relationship between HIV testing and risk of HIV infection is a complicated one,
which will vary on an individual level. It was difficult to collect all the relevant
behavioural information within existing disease surveillance mechanisms and not all
factors associated with HIV testing and HIV infection could be measured. This thesis
was working within the constraints of available surveillance data, as this was the
principle aim of the project which was to provide estimates within existing HIV
surveillance systems242.
This model is country-specific; because the estimates and relationships are all within
the context of the UK service provision and demographic and behavioural factors within
MSM in the UK. However, these parameters could be generated for other countries,
with some sentinel survey data in MSM to inform the adjustments. Finally the
associations between HIV testing and behaviour are changing over time, and this
requires closer monitoring in order to reproduce accurate estimates for future years.
Currently the model does not include a component for MSM tested at GPs. As testing
practice changes and expands outside of GUM clinics, the model would need to be
updated accordingly.
Further limitations of the thesis were in missing data and selection and measurement
biases and these were discussed within each chapter study. Even within these
limitations, this thesis provides a unique contribution to estimations of numbers of total
prevalent HIV infections in the UK as each parameter can be subjected to sensitivity
analyses.
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8.5 Was the conceptual framework for measuring the association between
HIV testing and risk of HIV infection correct?
After the analyses and estimation model carried out in this thesis, the conceptual
framework from Chapter two can be reviewed again (Figure 8.1). The conceptual
framework does have limitations. The graph doesn't look at location of HIV testing (e.g.
GUM clinics versus GP). The associations between the factors within the graph may be
different by place of HIV test. There is some evidence arising from this thesis that
sexual behaviours lead to different associations (e.g. UA GUM survey and GMSHS
comparison in Chapter six). If the associations are the same, regardless of place of
test, then the framework will still be correct. If the associations are different, the white
boxes in the graph which weren't measured (HIV test policy, availability of testing),
become more important as they may relate to place of HIV test. These may imply
different associations between sexual behaviour and HIV testing in each location. The
differences in HIV prevalence in UA GUM and GMSHS may be related to sexual
partnership networks, and changing sexual behaviour within sub-groups within the
population of MSM. Again these were factors not measured within the model.
These issues could be clarified by collecting additional information on UAI and number
of sexual partners within existing surveillance systems in addition to developing
surveillance of HIV tests carried out in alternative locations to GUM clinics.
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Figure 8.1 Conceptual framework of the relationship between HIV testing and risk
of HIV infection mediated through risk behaviour
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Drug and alcohol use were not included in the framework. These have been shown to
be linked to increased risk behaviour which has led to HIV seroconversion in the
UK42.78. While these are undoubtedly important when considering HIV transmission and
HIV prevention, they are outside the scope of current surveillance data, and so have
not been considered for this model.
8.6 Implications for policy and practice
This section makes recommendations for policy changes based on the conclusions of
the thesis. In Chapter four, the first national study of HIV testing and demographic and
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behavioural factors associated with HIV testing in MSM was reported. The full
population analysis was published in a peer-reviewed journal to inform the public health
planning of HIV test policy. This thesis contributed to the growing evidence of
differential risk of HIV infection in MSM who test compared with untested MSM. Its
contribution lies not only in the identification of factors associated with HIV testing and
HIV infection, but provides national figures of HIV testing in MSM, and estimations of
total numbers of HIV infections. The European Working Group on HIV Prevalence
Estimations has encouraged countries to develop multiple estimation methods to help
develop the understanding of the strengths and weaknesses of the various methods 17.
This thesis demonstrated that HIV testing was associated with higher risk of HIV
infection, and that MSM presenting with new gonorrhoea or syphilis infections were not
routinely HIV tested. The prevalence of undiagnosed HIV infection in MSM attending
GUM clinics in England and Wales is high. Even though HIV testing rates are already
high in MSM, two-thirds of MSM with undiagnosed HIV infection leave the GUM clinic
with their HIV infection still undiagnosed (section 3.5.4). The opportunity to diagnose
these men is being missed under the current HIV testing policy. The benefits of earlier
diagnosis are twofold. Firstly, the opportunity to monitor HIV infection and initiate
prompt treatment in the individual is increased. Secondly, the likelihood of further
transmission is reduced through both behavioural change and the reduction in
infectivity brought about by controlling viral load with antiretroviral treatment. This
thesis supports the recommendations for increasing HIV testing in MSM to a more
regular, annual event as part of a general sexual health screening, moving away from a
solely risk-based model.
Increased offering and recommendation of HIV testing would reduce the proportion of
undiagnosed HIV infections in MSM attending GUM clinics. The implications of a
change in policy need consideration. Some have argued that promoting HIV testing
could cause increased psychological worry for individuals who perceive themselves to
be at risk and reinforce high-risk sexual behaviours in individuals that test
negative33.6o.77.There is currently little evidence to support the hypothesis that possible
adverse effects of test promotion could outweigh the benefits of earlier HIV diagnosis.
A policy change to increase the offer of HIV testing to MSM may have little impact on
clinic workload, since this may standardise already existing heterogeneous clinic
practices.
The English National Strategy for Sexual Health and HIV has prioritised the uptake of
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HIV testing as a core HIV prevention intervention with two main aims 137. The first is to
reduce the number of HIV infected individuals who remain undiagnosed after attending
a GUM clinic. The second is to encourage HIV testing of people at a wider range of
sites including primary care and general medical settings 137. This has been proposed at
the European level243. On-going surveillance of HIV testing will provide a key
mechanism for monitoring progress on these goals. Alongside increased offers of HIV
testing, this thesis supports the need for targeting groups at high risk of HIV infection
with HIV testing interventions, including MSM presenting with acute STI such as
gonorrhoea and syphilis. Such focussed promotion of HIV testing will be more cost-
effective than testing of individuals at lower risk, as fewer HIV tests are needed to
diagnose one HIV infection. Implementing an annual offer and recommendation of HIV
test to all MSM attending GUM clinics would reach the objective of reducing
undiagnosed HIV infections in MSM through HIV testing in GUM clinics. This strategy
would build on the existing policy but, in addition, ensure that all MSM are actively
offered and recommended an annual HIV test throughout their GUM clinic attendance
career. This would ensure earlier HIV diagnoses among asymptomatic MSM
presenting at GUM services. The policy has the advantage of being targeted at MSM
who are at Significantly higher behavioural and STI transmission risk.
Following recommendations for annual HIV testing in the annual report 2003244, the
Department of HIV and STI at the HPA were invited to present evidence for it to the
Expert Advisory Group on AIDS (EAGA). The policy recommendation, of which I was
lead author, was presented in 2004, and is included in Appendix E. This was followed
by an audit of clinical practice and policy carried out by BASHH and HPA, with
represented to the EAGA In 2006. This formed the basis of the national guidelines on
HIV testing produced in 2008. The BASHH guidelines (2008)238recommend that all
patients should be offered VCT on their first clinical attendance including patients
presenting with STI. It was recommended that all MSM should HIV test annually, or
more often, if clinical symptoms are suggestive of seroconversion or on-going risk
exposure238. Finally, following invited commentary from key stakeholders some clinical
and voluntary organisations thought the proposal didn't go far enough, but that opt-out'
HIV testing as part of a sexual health screen for MSM at first visit and additionally
according to risk should be considered, given the proven success in increased offer
and uptake from the antenatal testing model. An audit covering 83% of GUM clinics in
2004237ascertained that about half of clinics operated an opt-out HIV test policy and
i Opt-out testing policy:A HIV test forms part of a sexual health screen and is routinely offered
and carried out unless the patient declines. The patient must actively refuse a test (informed
consentvia leaflet or discussionis presumed).
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half an opt-in", This is supported by evidence from the UK and the US and other
countries which has shown an increase in test uptake and a decrease in undiagnosed
infections following opt-out test policies245-248.
8.7 Recommendation for future work
As HIV testing expands out of GUM clinics to alternative settings, in particular GPs, an
additional component to the indirect model to be developed would be HIV testing at
GPs. The adjustment factor in the estimation model would need to include an additional
adjustment for the proportion of HIV tests that will be carried out at GPs in the future,
as testing practice will change over the next decade and become normalised. HIV
surveillance systems will collect information on HIV tests through sentinel surveillance
mechanisms; however, some measure of the risk of being HIV positive in these men
would need to be estimated.
This model can be used to estimate total HIV infections in cost-constrained countries
where limited surveillance data are available, but recent sentinel estimates of HIV
testing exist. The size and overall direction of the relationship is likely to differ in
populations differing in development, culture and epidemiological patterns that
characterise the transmission of HIV. If these were considered within the available
surveillance and epidemiological data, the model could be adapted for use in other
countries and other population groups such as heterosexuals.
8.8 Recommendations for future surveillance mechanisms
The following section makes recommendations for surveillance mechanisms that would
enable the prospective monitoring of factors associated with the outcomes of the
estimation model.
Disease surveillance provides information for action. The need for detailed surveillance
data has been previously emphasised in the UK Department of Health publication
'Getting ahead of the curve,249and this thesis highlighted the limited range of datasets
available, together with the problems associated with interpretation. Accurate estimates
of numbers of total prevalent HIV infections are important for public health planning,
iI Opt-in testing policy:A HIV test is offered to a patient on its own or as an optional additionto a
sexualhealthscreen (SHS).The patientmustactivelyagree to the test as an 'extra' to the SHS.
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they inform public health interventions and the targeting of sexual health promotion and
disease control strategies. Estimates of HIV prevalence from MSM attending GUM
clinics are readily accessible, and current estimation methods use these together with
estimates of the population of MSM12.25.However, diagnosed HIV infections include
MSM tested both at GPs and GUM clinics, and so a method that estimates total
numbers of HIV infections from all MSM is a useful addition to the fielc".
This thesis was written at a time of increasing STI diagnoses in MSM. Behavioural
change is a key factor in the primary prevention of HIV infection. Potential modifiable
risk factors and determinants of HIV infection that could be targeted through
educational campaigns to reduce the probability of disease occurrence were identified
through this study. Sexual behaviour remains the key determinant of STI and HIV
transmission. Not all factors could be measured in the model as only available
surveillance data were used. Factors that were important but were not available
included sexual behaviours such as UAI and numbers of sexual partners (section 2.11,
Figure 2.13). Current surveillance systems collect limited data on the behavioural
determinants of STI transmission and while they are good for monitoring trends, they
do not provide information on the sexual behaviours or mixing patterns that may be
underlying this trend'. Where data on UAI and numbers of sexual partners exist they
are often limited to facilitate ease of completion by busy clinical staff, and there are
issues about non-response in particular in the area of sexual health. Hence, there is a
trade-off between the information that can be collected reliably and in complete fashion
on large numbers of people and information that may be very detailed but which may
be not representative and generalisable. Most systems rely on methods more focused
on disease outcome, practicality, uniformity, and speed rather than on obtaining full
demographic and behavioural details so that representative data can be collected.
Generally, the additional data collected are minimal (typically age, sex, sexual
orientation). However, the enhanced KC60 surveillance system will not only allow more
risk factor information to be collected on an individual basis, but will allow rates of co-
infection and re-infection of STI to be examined and core groups to be more accurately
described250.251.
Public health surveillance of sexual behaviour is needed to measure risk behaviours
that will allow the monitoring of the effectiveness of prevention programmes and may
provide early warning signs for the spread of HIV and STls or help determine which
areas are in need of greater efforts252,253. Behavioural surveillance programmes have
enabled the description of population patterns of risk behaviours for STI and HIV
transmission and aid in the understanding of how epidemics of STI are generated. The
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triangulation of a small set of core measures selected from surveillance data and other
complementary sources can strengthen the interpretation of these data because the
relationship between sexual behaviour and STI transmission is complex. This has been
accomplished in many other countries including some in Asia254-257,Africa258,Europe259,
and the United States260.Behavioural surveillance generally aims to monitor trends in
two broad groups of indicators: firstly, those that allow the identification of population
subgroups at increased risk, for example, age, sex, sexual orientation, and ethnlcity:
and secondly, those behaviours that are amenable to change, for example number and
type of sexual partnerships, condom use, UAI. The validity and reliability of sensitive
data on behaviour are critical as they are self-reported and cannot be directly
measured!". National population surveys, while useful for creating a national picture,
are unable to produce robust local data and thus there are limitations to local decision
making.
The World Global Programme on AIDS (GPA) and UNAIDS, in collaboration with
national and international partners have developed a standard set of HIV prevention
indicators for this purpose261.262.The GPA developed ten prevention indicators of
health, knowledge and behaviour that are central to HIV prevention. These range from
indicators of population knowledge of preventative practices, reported sexual behaviour
and use of condoms in the general population, through STI service evaluation, to
indicators of the impact of the programme. The indicators are meant to be simple,
relatively easy to measure and interpret and operationally useful. In aggregate, the
prevention indicators are intended to provide evidence that overall prevention efforts
are reducing HIV incidence rather than evaluate specific prevention projects.
Behavioural surveillance programmes have now been implemented in the United
States260.263,SWitzerland259, Australia264, and Hong Kong265.Standardised behavioural
indicators for Europe have been developed recently through a European working
group, organised by the European Centre for Disease Prevention and Control, which
had an individual group to focus on indicators for MSM266.267.Such a coherent system
for monitoring indicators uses data resources more efficiently, allows comparison of
indicators internationally and reduces duplication of effort.
Prevention indicators have been developed in the past in England and Wales derived
from HIV and STI surveillance data205.The indicators used have been limited by the
fact that they were not comparable with international prevention indicators and they
have not been tied into the outcomes set out in the HIV prevention framework for MSM
in England and Wales268. In the past, quantitative surveys have been limited in their
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collection of non-standardised demographic, behavioural and outcome indicators that
restrict comparability between them. A move to more standardised indicators would aid
cross-comparability between surveys7,28. A number of annual surveys of MSM
attending social venues48,52.269, GUM cllnics'", and Gay Pride events270 are currently
carried out in the UK. These use a stable set of behavioural indicators that can be
monitored repeatedly. The example given in this thesis, namely the three surveys
which developed and used a common set of core behaviour questions that allow
comparisons of the three populations of MSM gave simple methods to deal with the
issue of generalisability and allowing for ranges of HIV prevalence in different
behavioural risk groups7.
As shown in this thesis, prevention indicators should therefore investigate trends of
infection alongside trends in behaviour that may lead to infection240,or proxies thereof.
Triangulation of surveillance, programme evaluation and research data can help to
substantiate the link between interventions and observed behaviour changes. They
have been instrumental in helping to refine public health interventions and inform the
targeting of sexual health promotion and disease control strategies. The formalisation
and coordination of behavioural surveillance in the UK could optimise our ability to
measure the impact of interventions and health promotion strategies on behaviour. This
will be particularly useful for monitoring the progress towards specific disease control
targets set in the Department of Health's new Sexual Health and HIV Strategy.
Additionally, they would prospectively monitor the factors most closely associated with
risk of HIV infection and HIV testing and could feed into the estimation model
developed in this thesis.
A combination of approaches could be used in the UK. In association with key external
partners, the HPA can collate data derived from on-going local and national sexual
behavioural surveillance and research programmes both within and outside the HPA.
A streamlining of current behavioural data collection through existing surveillance
systems is needed". Collaborative partnerships with academic and research institutions
involved in behavioural research should be established to define and collate key
behavioural indicators relevant to HIV and other STI transmission. These indicators will
include sexual behaviours such as number of sexual partners, types of sexual
intercourse (vaginal, anal, and oral), and potentially preventative behaviours such as
condom use and health service use for HIV and other STI screening. This would give
an overview of behaviours at the population level in both the general population and in
those with disease. A surveillance system. which will allow the prospective monitoring
of the important risk indicators, could then be established.
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8.9 Conclusion
It was proposed that HIV test policy should be changed to recommend annual HIV
testing as part of a sexual health screen in MSM. Future surveillance should include
centralised collation of behavioural surveillance indicators that include numbers of
sexual partners and UAI. In conclusion, this thesis has provided a unique methodology
to estimate HIV infections in MSM in the UK which can easily be adapted to allow for
changes in assumptions, and thus is useful in addition to the existing estimation
methods.
250
REFERENCES
REFERENCE LIST
1. De Angelis 0, Day N, Gill ON. Acquired immune deficiency syndrome
projections in England and Wales: interplay of methodology and data. J R
Statist Soc A 1998;161 :167-76.
2. Aalen 00, Farewell VT, De Angelis 0, Day N, Gill ON. New Therapy explains
the fall in AIDS incidence with a substantial rise in number of persons on
treatment expected. AIDS 1999;13:103-8.
3. Bellocco R, Marschner IC. Joint analysis of HIV and AIDS surveillance data in
back-calculation. Stat Med 2000 Feb 15;19(3):297-311.
4. Hoover DR. The effects of long term zidovudine therapy and Pneumocystis
carinii prophylaxis on HIV disease. A review of the literature. Drugs 1995
Jan;49(1):20-36.
5. Brown AE, Sadler KE, Tomkins SE, McGarrigle CA, LaMontagne OS, Goldberg
0, et al. Recent trends in HIV and other STls in the United Kingdom: data to the
end of 2002. Sex Transm Infect 2004 Jun;80(3):159-66.
6. Gill ON, Adler MW, Day NE. Monitoring the prevalence of HIV. BMJ 1989 Nov
25;299:1295-8.
7. McGarrigle CA, Fenton KA, Gill ON, Hughes G, Morgan 0, Evans B.
Behavioural surveillance: the value of national coordination. Sex Transm Infect
2002 Dec;78(6):398-405.
8. McGarrigle CA, Mercer CH, Fenton KA, Copas AJ, Wellings K, Erens B, et al.
Investigating the relationship between HIV testing and risk behaviour in Britain:
National Survey of Sexual Attitudes and Lifestyles 2000. AIDS 2005;19(1):77-
84.
9. Nicoll A, Gill ON, Peckham C, Ades A.E., Parry J, Mortimer P, et al. The Public
Health Application of Unlinked Anonymous Seroprevalence Monitoring for HIV
in the United Kingdom. Int J EpidemioI2000;29:1-10.
10. Heptonstall J, Gill ON. The legal and ethical basis for unlinked anonymous HIV
testing. CDR 1989;48:3-6.
11. Presanis AM, De Angelis 0, Spiegelhalter DJ, Seaman S, Goubar A, Ades AE.
Conflicting evidence in a Bayesian synthesis of surveillance data to estimate
human immunodeficiency virus prevalence. J R Statist Soc 2008;171:915-37.
12. Goubar A, Ades AE, De Angelis 0, McGarrigle CA, Mercer CH, Tookey PA, et
al. Estimates of human immunodeficiency virus prevalence and proportion
diagnosed based on Bayesian multiparameter synthesis of surveillance data. J
R Statist Soc A 2008;171(3):541-80.
13. Ades AE, Cliffe S. Markov chain Monte Carlo estimation of a multiparameter
decision model: consistency of evidence and the accurate assessment of
uncertainty. Med Decis Making 2002 Jul;22(4):359-71.
14. Sommen C, Alioum A, Commenges D. A multistate approach for estimating the
incidence of human immunodeficiency virus by using HIV and AIDS French
surveillance data. Stat Med 2009 May 15;28(11):1554-68.
15. Wand H, Van P, Wilson 0, McDonald A, Middleton M, Kaldor J, et al. Increasing
HIV transmission through male homosexual and heterosexual contact in
Australia: results from an extended back-projection approach. HIV Med 2010
Jul 1;11(6):395-403.
16. Hall HI, Green TA, Wolitski RJ, Holtgrave OR, Rhodes P, Lehman JS, et al.
Estimated future HIV prevalence, incidence, and potential infections averted in
the United States: a multiple scenario analysis. J Acquir Immune Defic Syndr
2010 Oct 1;55(2):271-6.
17. Working Group on Estimation of HIV Prevalence in Europe. HIV in hiding:
methods and data requirements for the estimation of the number of people
living with undiagnosed HIV. AIDS 2011 May 15;25(8):1017-23.
18. Walker N, Stover J, Stanecki K, ZaniewskLA.E., Grassly NC, Garcia-Calleja JM,
et al. The workbook approach to making estimates and projecting future
251
REFERENCES
scenarios of HIV/AIDS in countries with low level and concentrated epidemics.
Sex Transm Infect 2004;80 SuppI1:i10-i13.
19. Lyerla R, Gouws E, Garcia-Calleja JM, Zaniewski E. The 2005 Workbook: an
improved tool for estimating HIV prevalence in countries with low level and
concentrated epidemics. Sex Transm Infect 2006;82(Suppllll):iii41-iii44.
20. Ghys PO, Brown T, Grassly NC, Garnett G, Stanecki KA, Stover J, et al. The
UNAIDS Estimation and Projection Package: a software package to estimate
and project national HIV epidemics. Sex Transm Infect 2004;80 Suppl1 :i5-i9.
21. Hughes G, Porter K, Gill ON. Indirect methods for estimating prevalent HIV
infections: adults in England and Wales at the end of 1993. Epidemiol Infect
1998 Aug;121(1):165-72.
22. Archibald CP, Jayaraman GC, Major C, Patrick DM, Houston SM, Sutherland D.
Estimating the size of hard-to-reach populations: a novel method using HIV
testing data compared to other methods. AIDS 2001 Apr;15 Suppl 3:S41-848.
23. Giesecke J, Johnson A, Hawkins A, Noone A, Nicoll A, Wadsworth J, et al. An
estimate of the prevalence of human immunodeficiency virus infection in
England and Wales by using a direct method. J R Statist Soc 1994;157:89-103.
24. Petruckevitch A, Nicoll A, Johnson AM, Bennett D. Direct estimates of prevalent
HIV infection in adults in England and Wales for 1991 and 1993: an improved
method. Genitourin Med 1997;73:348-54.
25. McGarrigle CA, Cliffe S, Copas AJ, Mercer CH, De Angelis D, Fenton KA, et al.
Estimating adult HIV prevalence in the UK in 2003: the direct method of
estimation. Sex Transm Infect 2006;82:78-86.
26. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al.
Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours.
lancet 2001 ;358(9296): 1835-42.
27. Norton J, Elford J, Sherr l, Miller R, Johnson MA. Repeat HIV testers at a
london same-day testing clinic. AIDS 1997;11 :773-81.
28. Nardone A, Frankis JS, Dodds JP, Flowers PN, Mercey DE, Hart GJ. A
comparison of high-risk sexual behaviour and HIV testing amongst a bar-going
sample of homosexual men in London and Edinburgh. Eur J Public Health 2001
Jun;11(2):185-9.
29. Hickson F, Weatherburn P, Reid D, Stephens M. Out and about. Findings from
the United Kingdom Gay Men's Sex Survey 2002. London: Sigma Research;
2003.
30. Hart GJ, Williamson lM, Flowers P, Frankis JS. Gay men's HIV testing
behaviour in Scotland. AIDS Care 2002;14(5):665-74.
31. Van de Yen P, Prestage G, Knox S, Kippax S. Gay men in Australia who do not
have HIV test results. Int J STD AIDS 2000 Jul;11(7):456-60.
32. Myers T, Godin G, Lambert J, Calzavara l, locker D. Sexual risk and HIV-
testing behaviour by gay and bisexual men in Canada. AIDS Care
1996;8(3):297-309.
33. Mamas I, Helal H, Pretet S, Marsal l, Poinsard R. Demographic and behavioral
predictors of knowledge and HIV seropositivity: results of a survey conducted in
three anonymous and free counselling and testing centers. Eur J Epidemiol
1997 Apr; 13(3):255-60.
34. Strathdee SA, Martindale Sl, Cornelisse PG, Miller ML, Craib KJ, Schechter
MT, et al. HIV infection and risk behaviours among young gay and bisexual
men in Vancouver. CMAJ 2000 Jan 11;162(1):21-5.
35. Weber AE, Chan K, George C, Hogg RS, Remis RS, Martindale S, et al. Risk
Factors Associated with HIV Infection Among Young Gay and Bisexual Men in
Canada. JAIDS 2001 ;24:81-8.
36. Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, et al. Risk
factors for HIV infection among men who have sex with men. AIDS 2006 Mar
21;20(5):731-9.
37. Buchbinder SP, Vittinghoff E, Heagerty PJ, Celum Cl, Seage GR, III, Judson
FN, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated
252
REFERENCES
with HIV seroconversion in men who have sex with men in the United States. J
Acquir Immune Defic Syndr 2005 May 1;39(1):82-9.
38. Ostrow DG, DiFranceisco WJ, Chmiel JS, Wagstaff DA, Wesch J. A case-
control study of human immunodeficiency virus type 1 seroconversion and risk-
related behaviors in the Chicago MACS/CCS Cohort, 1984-1992. Multicenter
AIDS Cohort Study. Coping and Change Study [published erratum appears in
Am J Epidemiol 1996 Jan 1;143(1):104]. Am J Epidemiol 1995 Oct
15;142(8):875-83.
39. McFarland W, Kellog T, Dilley J, Katz MH. Estimation of human
immunodeficiency virus (HIV) seroincidence among repeat anonymous testers
in San Francisco. Am J EpidemioI1997;146:662-4.
40. Thiede H, Jenkins RA, Carey JW, Hutcheson R, Thomas KK, Stall RD, et al.
Determinants of Recent HIV Infection Among Seattle-Area Men Who Have Sex
With Men. Am J Public Health 2009;99:S157-S164.
41. Williams DI, Stephenson JM, Hart GJ, Copas A, Johnson AM, Williams IG. A
case control study of HIV seroconversion in gay men, 1998-1993: what are the
current risk factors? Genitourin Med 1996;72:193-6.
42. Macdonald N, Elam G, Hickson F, Imrie J, McGarrigle CA, Fenton KA, et al.
Factors associated with HIV seroconversion in gay men in England at the start
of the 21st century. Sex Transm Infect 2007;84:8-13.
43. Kippax S, Campbell 0, Van de Ven P, Crawford J, Prestage G, Knox S.
Cultures of sexual adventurism as markers of HIV seroconversion: a case
control study in a cohort of Sydney Gay men. AIDS Care 1998;10:677-88.
44. McKusick L, Coates TJ, Morin SF, Pollack L, Hoff C. Longitudinal predictors of
reductions in unprotected anal intercourse among gay men in San Francisco:
the AIDS Behavioral Research Project. Am J Public Health 1990
Aug;80(8):978-83.
45. Binson 0, Woods WJ, Pollack L, Paul J, Stall R, Catania JA. Differential HIV
risk in bathhouses and public cruising areas. Am J Public Health
2001 ;91(9):1482-6.
46. Harrison LH, do LR, Friedman RK, Rodrigues J, Santos EM, de Melo MF, et al.
Incident HIV infection in a high-risk, homosexual, male cohort in Rio de Janeiro,
Brazil. J Acquir Immune Defic Syndr 1999 Aug 15;21(5):408-12.
47. Dodds JP, Johnson AM, Parry JV, Mercey DE. A Tale of three cities: persisting
high HIV prevalence, risk behaviour and undiagnosed infection in community
samples of men who have sex with men. Sex Transm Infect 2007;83:392-6.
48. Dodds JP, Nardone A, Mercey DE, Johnson AM. Increase in high risk sexual
behaviour among homosexual men, London 1996-8; cross sectional,
questionnaire study. BMJ 2000;320:1510-1.
49. Dodds JP, Mercey DE, Parry JV, Johnson AM. Increasing risk behaviour and
high levels of undiagnosed HIV infection in a community sample of homosexual
men. Sex Transm Infect 2004 Jun;80(3):236-40.
50. Nardone A, Dodds JP, Mercey DJ. Active surveillance of sexual behaviour
among homosexual men in London. Commun Dis Public Health 1998;1:197-
201.
51. Povinelli M, Remafedi G, Tao G. Trends and predictors of human
immunodeficiency virus antibody testing by homosexual and bisexual
adolescent males, 1989-1994. Arch Pediatr Adolesc Med 1996 Jan;150(1):33-8.
52. Hart GJ, Flowers P, Der GJ, Frankis JS. Homosexual men's HIV related sexual
risk behaviour in Scotland. Sex Transm Infect 1999 Aug;75(4):242-6.
53. Stolte IG, de Wit JBF, Kolader ME, Fennema HSA, Coutinho RA, Dukers
NHTM. Low HIV-testing rates among younger high-risk homosexual men in
Amsterdam. Sex Transm Infect 2007;83:387-91.
54. Jin FY, Prestage G, Law MG, Kippax 5, Van d, V, Rawsthorne P, et al.
Predictors of recent HIV testing in homosexual men in Australia. HIV Med 2002
Oct;3(4):271-6.
55. Sumartojo E, Lyles C, Choi K, Clark L, Collins C, Guenther Grey C, et al.
253
REFERENCES
Prevalence and correlates of HIV testing in a multi-site sample of young men
who have sex with men. AIDS Care 2008;20(1):1-14.
56. Dawson J, Fitzpatrick R, McLean J, Hart G, Boulton M. The HIV test and sexual
behaviour in a sample of homosexually active men. Soc Sci Med
1991;32(6):683-8.
57. Do TO, Hudes ES, Proctor K, Han CS, Choi KH. HIV testing trends and
correlates among young Asian and Pacific Islander men who have sex with
men in two U.S. cities. AIDS Educ Prev 2006 Feb;18(1):44-55.
58. Flores SA, Bakeman R, Millett GA, Peterson JL. HIV Risk Among Bisexually
and Homosexually Active Racially Diverse Young Men. Sex Transm Dis
2009;36(5):325-9.
59. Myers T, Orr KW, Locker D, Jackson EA. Factors Affecting Gay and Bisexual
Men's Decisions and Intentions to Seek HIV Testing. Am J Public Health
1993;83:701-4.
60. Hays RB, Paul J, Ekstrand M, Kegeles SM, Stall R, Coates TJ. Actual versus
perceived HIV status, sexual behaviors and predictors of unprotected sex
among young gay and bisexual men who identify as HIV-negative, HIV-positive
and untested. AIDS 1997 Oct;11(12):1495-502.
61. Kelly JA, Murphy DA, Roffman RA, Solomon LJ, Winett RA, Stevenson LY, et
al. Acquired immunodeficiency syndrome/human immunodeficiency virus risk
behavior among gay men in small cities. Findings of a 16-city national sample.
Arch Intern Med 1992 Nov;152(11):2293-7.
62. Ruiz J, Facer M, Sun RK. Risk Factors for Human Immunodeficiency Virus
Infection and Unprotected Anal Intercourse Among Young Men Who Have Sex
With Men. Sex Transm Dis 1998;25:100-7.
63. Choi KH, Han CS, Hudes ES, Kegeles S. Unprotected sex and associated risk
factors among young Asian and Pacific Islander men who have sex with men.
AIDS Educ Prev 2002 Dec;14(6):472-81.
64. Phillips KA, Paul J, Kegeles S, Stall R, Hoff C, Coates TJ. Predictors of repeat
testing among gay and bisexual men. AIDS 1995;9:769-75.
65. Leaity S, Sherr L, Wells H, Evans A, Miller R, Johnson M, et al. Repeat HIV
testing: high-risk behaviour or risk reduction strategy? AIDS 2000 Mar
31; 14(5):547-52.
66. MacKellar DA, Valleroy LA, Secura GM, Bartholow BN, McFarland W, Shehan
0, et al. Repeat HIV testing, risk behaviors, and HIV seroconversion among
young men who have sex with men: a call to monitor and improve the practice
of prevention. J Acquir Immune Defic Syndr 2002 Jan 1;29(1):76-85.
67. Kalichman SC, Schaper PE, Belcher L, Abush-Hirsch T, Cherry C, Williams E,
et al. It's like a regular part of gay life: repeat HIV antibody testing among gay
and bisexual men. AIDS Educ & Preven 1997;9(3 Suppl):41-51.
68. Dawson JM, Fitzpatrick RM, Reeves G, Boulton M, McLean J, Hart GJ, et al.
Awareness of sexual partners' HIV status as an influence upon high-risk sexual
behaviour among gay men. AIDS 1994;8:837-41.
69. Roffman RA, Kalichman SC, Kelly JA, Winett RA, Solomon LJ, Sikkema KJ, et
al. HIV antibody testing of gay men in smaller US cities. AIDS Care
1995;7(4):405-13.
70. Elford J, Leaity S, Lampe F, Wells H, Evans A, Miller R, et al. Incidence of HIV
infection among gay men in a London HIV testing clinic, 1997-1998. AIDS 2001
Mar 30; 15(5):650-3.
71. Osmond DH, Pollack LM, Paul JP, Catania JA. Changes in Prevalence of HIV
infection and Sexual Risk Behaviour in Men Who Have Sex With Men in San
Francisco: 1997-2002. Am J Public Health 2007;97:1677-83.
72. Hart GJ, Williamson LM. Increase in HIV sexual risk behaviour in homosexual
men in Scotland, 1996-2002: prevention failure? Sex Transm Infect
2005;81(367):372.
73. Ekstrand ML, Stall RD, Paul JP, Osmond OH, Coates TJ. Gay men report high
rates of unprotected anal sex with partners of unknown or discordant HIV
254
REFERENCES
status. AIDS 1999;13:1525-33.
74. Schwarcz S, Scheer S, McFarland W, Katz M, Valleroy L, Chen S, et al.
Prevalence of HIV Infection and Predictors of High-Transmission Sexual Risk
Behaviours Among Men Who Have Sex With Men. Am J Public Health
2007;97:1067-75.
75. Strathdee SA, Hogg RS, Martindale SL, Cornelisse PG, Craib KJ, Montaner JS,
et al. Determinants of sexual risk-taking among young HIV-negative gay and
bisexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998 Sep
1;19(1):61-6.
76. Tao G, Remafedi G. Economic evaluation of an HIV prevention intervention for
gay and bisexual male adolescents. J Acquir Immune Defic Syndr Hum
Retrovirol1998 Jan 1;17(1):83-90.
77. Molitor F, Truax SR, Ruiz JD, Sun RK. Association of methamphetamine use
during sex with risky sexual behaviors and HIV infection among non-injection
drug users. West J Med 1998 Feb; 168(2):93-7.
78. Elam G, Macdonald N, Hickson FCI, Imrie J, Power R, McGarrigle CA, et al.
Risky sexual behaviour in context: qualitative results from an investigation into
risk factors for seroconversion among gay men who test for HIV. Sex Transm
Infect 2008;88:473-7.
79. Wortley PM, Chu SY, Diaz T, Ward JW, Doyle B, Davidson AJ, et al. HIV
testing patterns: where, why, and when were persons with AIDS tested for HIV?
AIDS 1995;9:487-92.
80. Kippax S, Noble J, Prestage G, Crawford JM, Baxtor 0, Cooper DA. Sexual
negotiation in the AIDS era: negotiated safety revisited. AIDS 1997;11 :191-7.
81. Marks G, Crepaz N. HIV-positive men's sexual practices in the context of self-
disclosure of HIV status. J Acquir Immune Defic Syndr 2001 May 1;27(1):79-85.
82. Dougan S, Evans BG, Elford J. Sexually transmitted infections in Western
Europe among HIV-positive men who have sex with men. Sex Transm Dis 2007
Oct;34( 10):783-90.
83. Velter A, Bouyssou-Michel A, Arnaud A, Semaille C. Do men who have sex with
men use serosorting with casual partners in France? Results of a nationwide
survey (ANRS-EN17-Presse Gay 2004). Euro Surveill 2009 Nov
26;14(47):19416.
84. Truong HM, Kellogg T, Klausner JD, Katz MH, Dilley J, Knapper Kt et al.
Increases in sexually transmitted infections and sexual risk behaviour without a
concurrent increase in HIV incidence among men who have sex with men in
San Francisco: a suggestion of HIV serosorting? Sex Transm Infect 2006
Dec;82(6):461-6.
85. Elford J, Bolding Gt Maguire M, Sherr L. Sexual risk behaviour among gay men
in a relationship. AIDS 1999 JuI30;13(11):1407-11.
86. Helms OJ, Weinstock HS, Mahle KC, Bernstein KT, Furness BW, Kent CK, et
al. HIV Testing Frequency Among Men Who Have Sex With Men Attending
Sexually Transmitted Disease Clinics: Implications for HIV Prevention and
Surveillance. J Acquir Immune Defic Syndr 2009;50(3):320-6.
87. MacKellar DA, Valleroy LA, Anderson JE, Behel S, Secura GM, Bingham T, et
al. Recent HIV testing among young men who have sex with men: correlates,
contexts, and HIV seroconversion. Sex Transm Dis 2006 Mar;33(3):183-92.
88. Fernandez MI, Perrino T, Bowen GS, Royal S, Varga L. Repeat HIV testing
among Hispanic men who have sex with men--a sign of risk, prevention, or
reassurance? AIDS Educ Prev 2003 Feb;15(1 Suppl A):105-16.
89. Dao H, Lehman JS, Wortley P, Lansky lA, Hecht FM. Human immunodeficiency
virus (HIV) testing history and risk behavior among persons at risk for HIV:
results from the HIV testing survey. Natl HIV Prev Conf. [abstract no. 193]. 29-
8-1999.
90. Simms I, Rogers P, Catchpole M, McGarrigle CA, Nicoll A. Trends in
undiagnosed HIV-1 infection among attenders at genitourinary medicine clinics,
England, Wales, and Northern Ireland: 1990-6. Sex Transm Infect 1999
255
REFERENCES
Oct;75(5):332-6.
91. Valleroy LA, MacKellar DA, Karon JM, Rosen OH, McFarland W, Shehan DA, et
al. HIV prevalence and associated risks in young men who have sex with men.
Young Men's Survey Study Group. JAMA 2000 JuI12;284(2):198-204.
92. Wells H, Sherr l, Norton J, Miller R, Johnson MA, Elford J. Age and sexual risk
behaviour. Sex Transm Infect 1998;74:74-5.
93. Mansergh G, Marks G. Age and risk of HIV infection in men who have sex with
men. AIDS 1998;12:1119-28.
94. Elford J, Bolding G, Davis M, Sherr l, Hart G. Trends in sexual behaviour
among london homosexual men 1998-2003: implications for HIV prevention
and sexual health promotion. Sex Transm Infect 2004;80:451-4.
95. de Wit JB. The epidemic of HIV among young homosexual men. AIDS
1996;SuppI3(0269-9370):S21-S25.
96. Bolding G, Davis M, Hart G, Sherr l, Elford J. Gay men who look for sex on the
Internet: is there more HIV/STI risk with online partners? AIDS 2005 Jun
10;19(9):961-8.
97. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis
infections in the United Kingdom 2001. london: Department of Health; 2002.
98. Paget WJ, Zwahlen M, Eichmann AR, the Swiss Network of
Dermatovenereology Policlinics. Voluntary confidential HIV testing of STD clinic
patients in Switzerland, 1990-5: HIV test refusers cause different biases on
prevalences in heterosexuals and homo/bisexuals. Genitourin Med
1997;73:444-7.
99. Fenton KA, Mercer CH, Johnson AM, Byron Cl, McManus 5, Erens B, et al.
Reported sexually transmitted disease clinic attendance and sexually
transmitted infections in britain: prevalence, risk factors, and proportionate
population burden. J Infect Dis 2005 Feb 1;191(SuppI1):S127-S138.
100. Webster RD, Darrow WW, Paul JP, Roark RA, Taylor RA, Stempel RR.
Community planning, HIV prevention, and a needs assessment for men who
have sex with men: the South Beach Health Survey. Sex Transm Dis 2005
May;32(5):321-7.
101. Choi KH, McFarland W, Neilands TB, Nguyen S, louie B, Secura GM, et al. An
opportunity for prevention: prevalence, incidence, and sexual risk for HIV
among young Asian and Pacific Islander men who have sex with men, San
Francisco. Sex Transm Dis 2004 Sep;31 (8):475-80.
102. Page-Shafer K, Veuglers PJ, Moss AR, Strathdee S, Kaldor J, van Greinsven
GJP. Sexual risk behavior and risk factors for HIV-1 seroconversion in
homosexual men participating in the tricontinental study, 1982-1994. Am J
EpidemioI1997;146:531-41.
103. Paz-Bailey G, Meyers A, Blank S, Brown J, Rubin S, Braxton J, et al. A Case-
Control study of Syphilis Among Men Who Have Sex With Men in New York
City. Association With HIV Infection. Sex Transm Dis 2004;31(10):581-7.
104. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al.
Impact of improved treatment of sexually transmitted diseases on HIV infection
in rural Tanzania: randomised controlled trial. Lancet 1995 Aug
26;346(8974):530-6.
105. Hayes RJ, Schulz KF, Plummer FA. The cofactor effect of genital ulcers on the
per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg
1995 Feb;98(1):1-8.
106. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The Causal Role for
Genital Ulcer Disease as a Risk Factor for Transmission of Human
Immunodeficiency Virus. An Application of the Bradford Hill Criteria. Sex
Transm Dis 1996;23(5):429-50.
107. Flowers P, Duncan B, Knussen C. Re-appraising HIV testing: an exploration of
the psychosocial costs and benefits associated with learning one's HIV status in
a purposive sample of Scottish gay men. Br J Health Psychol 2003 May;8(Pt
2):179-94.
256
REFERENCES
108. Flowers P, Knussen C, Church S. Psychosocial factors associated with HIV
testing amongst Scottish gay men. Psychology Health 2003; 18(6):739-52.
109. Centres for Disease Control and Prevention. HIV Testing - United States, 1996.
MMWR 1999;48:52-5.
110. CDC. Increases in unsafe sex and rectal gonorrhea among men who have sex
with men - San Francisco, California, 1994-1997. MMWR 1999;48(3):45-8.
111. Adams AL, Becker TM, Lapidus JA, Modesitt SK, Lehman JS, Loveless MO.
HIV infection risk, behaviors, and attitudes about testing: are perceptions
changing? Sexually Transmitted Diseases 2003 Oct;30(10):764-8.
112. Wohl AR, Johnson DF, Lu S, Frye D, Bunch G, Simon PA. Recent increase in
high-risk sexual behaviors among sexually active men who have sex with men
living with AIDS in Los Angeles County. J Acquir Immune Defic Syndr 2004 Feb
1;35(2):209-11.
113. Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JB. Homosexual men
change to risky sex when perceiving less threat of HIV/AIDS since availability of
highly active antiretroviral therapy: a longitudinal study. AIDS 2004 Jan
23;18(2):303-9.
114. Van de Ven P, Rawstorne P, Crawford J, Kippax S. Increasing proportions of
Australian gay and homosexually active men engage in unprotected anal
intercourse with regular and with casual partners. AIDS Care 2002
Jun;14(3):335-41.
115. Van de Ven P, Prestage G, French J, Knox S, Kippax S. Increase in
unprotected anal intercourse with casual partners among Sydney gay men in
1996-98. Aust N Z J Public Health 1998 Dec;22(7):814-8.
116. Katz MH, McFarland W, Guillin V, Fenstersheib M, Shaw M, Kellog T.
Continuing high prevalence of HIV and Risk behaviours among young men who
have sex with men: The young men's survey in the San Francisco bay area in
1992 to 1993 and in 1994 to 1995. J Acquired Immun Def Syndr & Hum Retr
1998;19:178-81.
117. Calzavara L, Burchell AN, Major C, Remis RS, Corey P, Myers T, et al.
Increases in HIV incidence among men who have sex with men undergoing
repeat diagnostic HIV testing in Ontario, Canada. AIDS 2002 Aug
16;16(12):1655-61.
118. Sullivan PS, Hamouda 0, Delpech V, Geduld JE, Prejean J, Semaille C, et at
Reemergence of the HIV epidemic among men who have sex with men in North
America, Western Europe, and Australia, 1996-2005. Ann Epidemiol 2009
Jun;19(6):423-31.
119. Centres for Disease Control and Prevention. Trends in primary and secondary
syphilis and HIV infections in men who have sex with men--San Francisco and
Los Angeles, California, 1998-2002. MMWR Morb Mortal Wkly Rep 2004 Aug
9;53(26):575-8.
120. Buchacz K, Greenberg A, Onorato I, Janssen R. Syphilis epidemics and human
immunodeficiency virus (HIV) incidence among men who have sex with men in
the United States: implications for HIV prevention. Sex Transm Dis 2005
Oct;32( 10 Suppl):S73-S79.
121. Jin F, Prestage GP, Kippax SC, Pell CM, Donovan BJ, Kaldor JM, et al.
Epidemic syphilis among homosexually active men in Sydney. Med J Aust 2005
Aug 15;183(4):179-83.
122. Simms I, Fenton KA, Ashton M, Turner KM, Crawley-Boevey EE, Gorton R, et
al. The re-emergence of syphilis in the United Kingdom: the new epidemic
phases. Sex Transm Dis 2005 Apr;32(4):220-6.
123. van der Snoek EM, de Wit JB, Mulder PG, van der Meijden WI. Incidence of
sexually transmitted diseases and HIV infection related to perceived HIV/AIDS
threat since highly active antiretroviral therapy availability in men who have sex
with men. Sex Transm Dis 2005 Mar;32(3):170-5.
124. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk
behavior: a meta-analytic review. JAMA 2004 JuI14;292(2):224-36.
257
REFERENCES
125. Wilson DP, Regan DG, Heymer KJ, Jin F, Prestage GP, Grulich AE.
Serosorting may increase the risk of HIV acquisition among men who have sex
with men. Sex Transm Dis 2010 Jan;37(1):13-7.
126. Cassels S, Menza TW, Goodreau SM, Golden MR. HIV serosorting as a harm
reduction strategy: evidence from Seattle, Washington. AIDS 2009 Nov
27;23(18):2497-506.
127. Eaton LA, Kalichman SC, Cain ON, Cherry C, Stearns HL, Amaral CM, et al.
Serosorting sexual partners and risk for HIV among men who have sex with
men. Am J Prev Med 2007 Dec;33(6):479-85.
128. Eaton LA, Kalichman SC, O'Connell DA, Karchner WD. A strategy for selecting
sexual partners believed to pose little/no risks for HIV: serosorting and its
implications for HIV transmission. AIDS Care 2009 Oct;21(10):1279-88.
129. Philip SS, Yu X, Donnell 0, Vittinghoff E, Buchbinder S. Serosorting is
associated with a decreased risk of HIV seroconversion in the EXPLORE Study
Cohort. PLoS One 2010 Sep 9;5(9):e12662.
130. Nicoll A, Hughes G, Donnelly M, Livingstone S, De Angelis D, Fenton K, et al.
Assessing the impact of national anti-HIV sexual health campaigns: trends in
the transmission of HIV and other sexually transmitted infections in England.
Sex Transm Infect 2001 ;77:242-7.
131. Danziger R. HIV testing for HIV prevention: a comparative analysis of policies in
Britain, Hungary and Sweden. AIDS Care 1998;10:563-70.
132. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research.
Epidemiology 1999 Jan;10(1):37-48.
133. Miller PMC, Wilson MJ. A dictionary of social science methods. Chicester:
Wiley; 1983.
134. Keogh P, Weatherburn P, Henderson L, Reid 0, Dodds C, Hickson F. Doctoring
gay men: exploring the contribution of General Practice.London: Sigma
Research; 2004.
135. Department of Health. On the state of the public health. The annual report of
the Chief Medical Officer of the Department of Health for the Year 1991. 1992.
136. British Co-operative Clinical Group. Survey of human immunodeficiency virus
infection and sexually transmitted diseases in homosexual and bisexual men
attending genitourinary medicine clinics in the UK during 1986-88. The British
Cooperative Clinical Group. Genitourin Med 1990 Oct;66(5):387-92.
137. Department of Health. The national strategy for sexual health and HIV. Crown
Copyright; 2001. p. 1-53.
138. Griffith R, Mandalia S, Beck EJ. HIV media campaigns and HIV-1 testing trends
at london genitourinary medicine clinics, 1985-1993. AIDS 1995;9:1367-72.
139. De Cock KM, Johnson AM. From exceptionalism to normalisation: a reappraisal
of attitudes and practice around HIV testing. BMJ 1998 Jan 24;316:290-3.
140. Mortimer JY, Salathiel JA. 'Soundex' codes of surnames provide confidentiality
and accuracy in a national HIV database. Commun Dis Rep CDR Rev 1995
Nov 10;5(12):R183-R186.
141. Evans BG, McCormick A. Completeness of reporting cases of acquired immune
deficiency syndrome by clinicians. J R Statist Soc 1994;157:105-14.
142. Molesworth AM. Results of a survey of diagnosed HIV infections prevalent in
1996 in England and Wales. Commun Dis Public Health 1998;1(4):271-5.
143. Rice BD, McHenry A, Sinka K, Payne L, Baster K, Patel B, et al. Prevalent
diagnosed HIV in England, Wales and Northern Ireland: adjusted totals 1996 to
2001 and extrapolations to 2004. AIDS 2004;18(6):927-32.
144. Office Of National Statistics. Census 2001: First Results on Population for
England and Wales. London: TSO; 2002.
145. Waight PA, Rush AM, Miller E. Surveillance of HIV infection by voluntary testing
in England. Commun Dis Rep Rev 1992 JuI17;2(8):R85-R90.
146. McGarrigle CA, Gill ON. UK HIV testing practice. By how much might the
infection diagnosis rate increase through normalisation? In: Moatti JP,
Souteyrand Y, Prieur A, Sandfort T, Aggleton P, editors. AIDS in Europe. New
258
REFERENCES
challenges for the social sciences. London: Routledge; 2000. p. 223-34.
147. Chadborn TR, McGarrigle CA, Waight PA, Fenton KA, on behalf of the HIV
Testing Surveillance Collaborative Group. Trends in, and determinants of, HIV
testing at genitourinary medicine clinics and general practice in England, 1990-
2000. Sex Transm Infect 2004;(80):145-50.
148. Public Health Laboratory Service, OHSS&PS, and the Scottish ISO(0)5
Collaborative group. Sexually Transmitted Infections in the UK. New episodes
seen at Genitourinary Medicine Clinics, 1991 to 2001. London: Public Health
Laboratory Service; 2002.
149. Ross JOC, Goldberg OJ. Patterns of HIV Testing in Scotland: A General
Practitioner Perspective. Scot Med J 1997;42:108-10.
150. PHLS, OHSS & PS, and the Scottish ISD(D)5 Collaborative group. Trends in
Sexually Transmitted Infections in the United Kingdom, 1990 to 2000. London:
Public Health Laboratory Service; 2001.
151. Department of Health. The national strategy for sexual health and HIV:
Implementation Action Plan. Crown Copyright; 2002.
152. Sinclair M, Bor R, Evans A, Glass 0, Levitt 0, Johnson MA. The
sociodemographic profile, risk categories and prevalence of HIV infection
among people attending a London same-day testing clinic, 2000-2001. Int J
STD AIDS 2004 Jan;15(1):33-7.
153. Fennema JS, van Ameijden EJ, Coutinho RA, van Doornum GJ, Cairo I, van
den Hoek A. HIV surveillance among sexually transmitted disease clinic
attenders in Amsterdam, 1991-1996. AIDS 1998 May 28;12(8):931-8.
154. Schwarcz S, Kellogg T, McFarland W, Louie B, Kohn R, Busch M, et al.
Differences in the temporal trends of HIV seroincidence and seroprevalence
among sexually transmitted disease clinic patients, 1989-1998: application of
the serologic testing algorithm for recent HIV seroconversion. Am J Epidemiol
2001 May 15;153(10):925-34.
155. Dodds JP, Mercey D. London Gay Men's survey: 2001 results. London: Royal
Free & University College Medical School; 2002.
156. British Co-operative Clinical Group. Screening for HIV infection in genitourinary
medicine clinics: a lost opportunity? British Co-operative Clinical Group. Sex
Transm Infect 2000 Aug;76(4):307-10.
157. Dodds JP, Mercey D. Sexual Health Survey of gay men - London 2002:
summary of results. London: Royal Free and University College Medical
School; 2003.
158. Health Protection Agency Centre for Infections. Trends in Sexually Transmitted
Infections, England, Wales and Northern Ireland. KC60. http://www hpa org
uklinfectionsltopics_azlhiv_and_sti/epidemiology/sti_data_1995-2004_Final xis
2005.
159. Macdonald NO, Dougan S, McGarrigle CA, Baster K, Rice BD, Evans BG, et al.
Recent trends in diagnoses of HIV and other sexually transmitted infections in
England and Wales among men who have sex with men. Sex Transm Infect
2004;80:492-7.
160. Doherty L, Fenton KA, Jones J, Paine TC, Higgins SP, Williams 0, et al.
Syphilis: old problem, new strategy. BMJ 2002 JuI20;325(7356):153-6.
161. Fenton KA. Sexual health and HIV positive individuals: emerging lessons from
the recent outbreaks of infectious syphilis in England. Commun Dis Public
Health 2002 Mar;5(1):4-6.
162. Health Protection Agency, SCIEH, ISO, National Public Health Service for
Wales, CDSC Northern Ireland, UASSG. Renewing the focus. HIV and other
Sexually Transmitted Infections in the United Kingdom in 2002. London: Health
Protection Agency; 2003.
163. Dukers NH, Spaargaren J, Geskus RB, Beijnen J, Coutinho RA, Fennema HS.
HIV incidence on the increase among homosexual men attending an
Amsterdam sexually transmitted disease clinic: using a novel approach for
detecting recent infections. AIDS 2002 JuI5;16(10):F19-F24.
259
REFERENCES
164. Centres for Disease Control and Prevention. Increases in HIV diagnoses - 29
States, 1999-2002. MMWR Morb Mortal Wkly Rep 2002;52(47):1145-7.
165. SemailleC.CazeinF.LotF.Pilionel J, Le VS, Le SY, et al. Recently acquired
HIV infection in men who have sex with men (MSM) in France, 2003-2008. Euro
Surveill2009 Dec 3;14(48):19425.
166. National Centre in HIV Epidemiology and Clinical Research (NCHECR).
HIV/AIDS, viral hepatitis and sexually transmitted infections in Australia: Annual
Surveillance Report 2003. Sydney: NCHECR, University of NSW; 2003.
167. Wolitski RJ, Valdiserri RO, Denning PH, Levine WC. Are we headed for a
resurgence of the HIV epidemic among men who have sex with men? Am J
Public Health 2001 Jun;91 (6):883-8.
168. International Collaboration on HIV Optimism. HIV treatments optimism among
gay men: an international perspective. J Acquir Immune Defic Syndr 2003 Apr
15;32(5):545-50.
169. Elford J, Bolding G, Sherr L. High-risk sexual behaviour increases among
London gay men between 1998 and 2001: what is the role of HIV optimism?
AIDS 2002 Aug 26;16(11):1537-44.
170. Mercer CH, Fenton KA, Copas AJ, Wellings K, Erens B, McManus S, et al
Increasing prevalence of male homosexual partnerships and practices in Britain
1990-2000: evidence from national probability surveys. AIDS 2004 Jul
2; 18(10):1453-8.
171. Copas AJ, Wellings K, Erens B, Mercer CH, McManus S, Fenton KA, et al. The
accuracy of reported sensitive sexual behaviour in Britain: exploring the extent
of change 1990-2000. Sex Transm Infect 2002 Feb;78(1):26-30.
172. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, et a!.
Attitudes towards highly active antiretroviral therapy are associated with sexual
risk taking among HIV-infected and uninfected homosexual men. AIDS 2002
Mar 29; 16(5):775-80.
173. McFarlane M, Bull SS, Rietmeijer CA. The Internet as a newly emerging risk
environment for sexually transmitted diseases. JAMA 2000 JuI26;284(4):443-6.
174. Holmes KK, Sparling PF, MtJrdh P-A, Lemon SM, Stamm WE, Piot P,
Wasserheit IN, editors. Sexually Transmitted Diseases. 3rd ed. USA: McGraw-
Hill; 1999.
175. Paine TC, Fenton KA, Herring A, Turner A, Ison C, Martin I, et al. GRASP: a
new national sentinel surveillance initiative for monitoring gonococcal
antimicrobial resistance in England and Wales. Sex Transm Infect
2001 ;77(6):398-401.
176. Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, et al.
Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in
2002. Lancet 2003;361:1867-9.
177. Kellerman SE, Lehman JS, Lansky A, Stevens MR, Hecht FM, Bindman AB, et
al. HIV testing within at-risk populations in the United States and the reasons for
seeking or avoiding HIV testing. J Acquir Immune Defic Syndr 2002 Oct
1;31(2):202-10.
178. Fenton KA, Chinouya M, Davidson 0, Copas A. HIV testing and high risk sexual
behaviour among London's migrant African communities: a participatory
research study. Sex Transm Infect 2002;78:241-5.
179. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K,
et al. Sexual behaviour in Britain: reported sexually transmitted infections and
prevalent genital Chlamydia trachomatis infection. Lancet
2001 ;358(9296): 1851-4.
180. Erens B, McManus S, Field J, Korovessis C, Johnson AM, Fenton K, et al.
National survey of sexual attitudes and lifestyles II: technical report. London:
National Centre for Social Research; 2001.
181. Johnson AM, Wadsworth J, Wellings K, Field J, Bradshaw S. Sexual attitudes
and lifestyles. Oxford: Blackwell Scientific Publications; 1994.
182. Copas AJ, Johnson AM, Wadsworth J. Assessing participation bias in a sexual
260
REFERENCES
behaviour survey: implications for measuring HIV risk. AIDS 1997;11(6):785-9.
183. Berrios DC, Hearst N, Coates TJ, Stall R, Hudes ES, Turner H, et al. HIV
antibody testing among those at risk for infection. The national AIDS
behavioural surveys. JAMA 1993;270:1576-80.
184. Dodds JP, Mercer CH, Mercey DE, Copas AJ, Johnson AM. Men who have sex
with men: a comparison of a probability sample survey and a community based
study. Sex Transm Infect 2006;82:86-7.
185. Stigum H, Magnus P. A Risk Index for Sexually Transmitted Diseases. Sex
Transm Dis 1997;24:102-8.
186. Renton A, Whitaker L, Ison C, Wadsworth J, Harris JRW. Estimating the sexual
mixing patterns in the general population from those in people acquiring
gonorrhoea infection: theoretical foundation and empirical findings. J Epidemiol
Community Health 1995;49:205-13.
187. Ghani AC, Ison CA, Ward H, Garnett GP, Bell G, Kinghorn GR, et al. Sexual
Partner Networks in the Transmission of Sexually Transmitted Diseases. An
analysis of Gonorrhoea Cases in Sheffield, UK. Sex Transm Dis 1996;23:498-
503.
188. Ghani AC, Swinton J, Garnett GP. The Role of Sexual Partnership Networks in
the Epidemiology of Gonorrhoea. Sex Transm Dis 1997;24:45-56.
189. Garnett GP, Hughes JP, Anderson RM, Stoner BP, Aral SO, Whittington WL, et
al. Sexual Mixing Patterns of Patients Attending Sexually Transmitted Diseases
Clinics. Sex Transm Dis 1996;23:248-57.
190. Crawford JM, Rodden P, Kippax S, Van d, V. Negotiated safety and other
agreements between men in relationships: risk practice redefined. Int J STD
AIDS 2001 Mar;12(3):164-70.
191. McGarrigle CA, Nicoll A. Prevalence of HIV-1 among attenders at sexually
transmitted disease clinics: analyses according to country of birth. Sex Transm
Infect 1998 Dec;74(6):415-20.
192. Catchpole MA, McGarrigle CA, Rogers PA, Jordan LF, Mercey D, Gill ON.
Serosurveillance of prevalence of undiagnosed HIV-1 infection in homosexual
men with acute sexually transmitted infection. BMJ 2000 Nov
25;321 (7272):1319-20.
193. Ades AE, Parker S, Berry T, Holland FJ, Davison CF, Cubitt D, et al.
Prevalence of maternal HIV-1 infection in Thames Regions: results from
anonymous unlinked neonatal testing. Lancet 1991;337:1562-5.
194. Nicoll A, McGarrigle C, Brady AR, Ades AE, Tookey P, Duong T, et al.
Epidemiology and detection of HIV-1 among pregnant women in the United
Kingdom: results from national surveillance 1988-96. BMJ 1999 Jan
24;316:253-7.
195. Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, et al. HIV
prevalence among injecting drug users in England and Wales 1990 to 2003:
evidence for increased transmission in recent years. AIDS 2005 Jul
22;19(11):1207-14.
196. Sadler KE, McGarrigle CA, Elam G, Ssanyu-Sseruma W, Davidson 0, Nichols
T, et al. Sexual behaviour and HIV infection in black-Africans in England: results
from the Mayisha II survey of sexual attitudes and lifestyles. Sex Transm Infect
2007;83:523-9.
197. Centers for Disease Control. National HIV serosurveillance summary. Results
through 1992. U S Department of Health and Human Services, Public Health
Service 1993;HIV/NCID/11-93/036.
198. Weinstock H, Dale M, Linley L, Gwinn M. Unrecognized HIV infection Among
Patients Attending Sexually Transmitted Disease Clinics. Am J Public Health
2002;92(2):280-3.
199. Koblin BA, Torian LV, Guilin V, Ren L, MacKellar DA, Valleroy LA. High
prevalence of HIV infection among young men who have sex with men in New
York City. AIDS 2000 Aug 18;14(12):1793-800.
200. Harawa NT, Douglas J, McFarland W, Thiede H, Kellogg TA, Vorhees K, et al.
261
REFERENCES
Trends in HIV Prevalence Among Public Sexually Transmitted Disease Clinic
Attendees in the Western Region of the United States (1989-1999). J Acquir
Immune Defic Syndr 2004 Oct 1;37(1}:1206-15.
201. Bluthenthal RN, Kral AH, Gee L, Lorvick J, Moore L, Seal K, et al. Trends in HIV
Seroprevalence and Risk Among Gay and Bisexual Men Who Inject Drugs in
San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr 2001 ;28:264-9.
202. Harawa NT, Greenland S, Bingham TA, Johnson DF, Cochran SD,
Cunningham DG, et al. Associations of Race/Ethnicity With HIV Prevalence and
HIV-Related Behaviours among Young Men Who Have Sex With Men in 7
Urban Centers in the United States. J Acquir Immune Defic Syndr
2004;35(5}:526-36.
203. Couturier E, Brossard Y, Larsen C, Larsen M, Du MC, Paris-Uado J, et al. HIV
infection at outcome of pregnancy in the Paris area, France. Lancet 1992
Sep;340(8821 }:707-9.
204. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS
Surveillance in Europe. Quarterly report 1997 Sep 30;55.
205. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis
infections in the United Kingdom 2000.London: Department of Health; 2001. p.
1-45.
206. Davidovich U, de Wit JB, Stroebe W. Assessing sexual risk behaviour of young
gay men in primary relationships: the incorporation of negotiated safety and
negotiated safety compliance. AIDS 2000 Apr 14;14(6}:701-6.
207. Carne CA, Foley E, Rowen D, Kell P, Maw R. Variation in clinical practice in
genitourinary medicine clinics in the United Kingdom. Sex Transm Infect 2003
Jun;79(3}:240-2.
208. Carne CA, McClean H, Sullivan AK, Menon-Johansson A, Gokhale R, Sethi G,
et al. National audit of asymptomatic screening in UK genitourinary medicine
clinics: clinic policies audit. Int J STD AIDS 2010 Jul;21(7}:512-5.
209. Pugh RN, Laverty 5, Simms I, Morrall lA, Chandramani 5, Joseph AT, et al.
Syphilis clusters in Walsall: case profiles and public health implications.
Commun Dis Public Health 2004 Mar;7(1}:36-8.
210. Rogstad KE, Simms I, Fenton KA, Edwards S, Fisher M, Carne CA. Screening,
diagnosis and management of early syphilis in genitourinary medicine clinics in
the UK. Int J STD AIDS 2005 May ;16 (5):348 -52 2005 May;16:348-52.
211. Hickson F, Reid D, Weatherburn P, Stephens M, Nutland W, Boakye P. HIV,
sexual risk, and ethnicity among men in England who have sex with men. Sex
Transm Infect 2004 Dec;80(6):443-50.
212. Parry JV, Mortimer PP. An immunoglobulin G antibody capture particle-
adherence test (GACPAT) for antibody to HIV-1 and HTLV-1 that allows
economical large-scale screening. AIDS 1989;3:173-6.
213. Parry JV, Mahoney A, Mortimer PP. Laboratory methodology for anonymised
testing for anti-HIV in dried blood, serum and urine specimens. Report to the
Medical Research Council PHLS Virus Reference Division 1992.
214. Unlinked Anonymous HIV Surveys Steering Group. Unlinked Anonymous HIV
Prevalence Monitoring Programme: England and Wales, Data to the end of
1996. Department of Health, Public Health Laboratory Service, Institute of
Child Health (London); 1997.
215. Nardone A, Mercey DE, Johnson AM. Surveillance of sexual behaviour among
homosexual men in a central London health authority. Genitourin Med 1997
Jun;73(3): 198-202.
216. Connell JA, Parry JV, Mortimer PP, Duncan J. Novel assay for the detection of
immunoglobulin G antihuman immunodeficiency virus in untreated saliva and
urine. J Med Virol 1993;41: 159-64.
217. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva:
and alternative tests to serum. Lancet 1987;ii:72-5.
218. Fenton KA, Johnson AM, McManus S, Erens B. Measuring sexual behaviour:
methodological challenges in survey research. Sex Transm Infect 2001 ;84-92.
262
REFERENCES
219. Dunne MP, Martin NG, Bailey JM, Heath AC, Bucholz KK, Madden PAF, et al.
Participation bias in a sexuality survey: psychological and behavioural
characteristics of responders and non-responders. Int J Epidemiol 1997;26:844-
54.
220. Strassberg OS, Lowe K. Volunteer bias in sexuality research. Arch Sex Behav
1995;24:369-82.
221. Armitage P. Statistical Methods in Medical Research. Oxford: Blackwell
Scientific Publications; 1971.
222. Wadsworth J, Hickman M, Johnson AM, Wellings K, Field J. Geographic
variation in sexual behaviour in Britain: implications for sexually transmitted
disease epidemiology and sexual health promotion. AIDS 1996;10(2):193-9.
223. Catchpole M, Connor N, Brady A, Kinghorn G, Mercey 0, Band B, et al.
Behavioural and demographic characteristics of attenders at two genitourinary
clinics in England. Genitourin Med 1997;73(6):457-61.
224. Kelly JA, Murohy DA, Sikkema KJ, McAuliffe TL, Roffman RA, Solomon LJ, et
al. Randomised, controlled, community-level HIV-prevention intervention for
sexual-risk behaviour among homosexual men in US cities. The Lancet
1997;350: 1500-5.
225. Elford J, Bolding G, Sherr L. Peer education has no significant impact on HIV
risk behaviours among gay men in London. AIDS 2001 Mar 9;15(4):535-8.
226. Elford J, Hart G, Sherr L, Williamson L, Bolding G. Peer led HIV prevention
among homosexual men in Britain. Sex Transm Infect 2002 Jul;78(3):158-9.
227. Archibald CP, Schechter MT, Craib KJ, Le TN, Douglas B, Willoughby B, et al.
Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS
Study. J Acquir Immune Defic Syndr 1990;3 SuppI1:S18-S23.
228. Woods WJ, Sabatino J, Bauer PL, Adler B, Dilley JW, Binson D. HIV testing in
gay sex clubs. Int J STD AIDS 2000 Mar;11(3):173-5.
229. Chen SY, Gibson S, Katz MH, Klausner JD, Dilley JW, Schwarcz SK, et al.
Continuing increases in sexual risk behavior and sexually transmitted diseases
among men who have sex with men: San Francisco, Calif, 1999-2001, USA.
Am J Public Health 2002 Sep;92(9):1387-8.
230. Van Beneden CA, O'Brien K, Modesitt S, Yusem S, Rose A, Fleming D. Sexual
behaviors in an urban bathhouse 15 years into the HIV epidemic. J Acquir
Immune Defic Syndr 2003;30:522-6.
231. Evans AR, Wiggins RD, Mercer CH, Bolding GJ, Elford J. Men who have sex
with men in Great Britain: comparison of a self-selected internet sample with a
national probability sample. Sex Transm Infect 2007;83:200-5.
232. Sadler KE, McGarrigle CA, Elam G, Ssanyu-Sseruma W, Othenio G, Davidson
0, et al. Mayisha II:Pilot of a community-based survey of sexual attitudes and
lifestyles and anonymous HIV testing within African communities. AIDS Care
2006; 18(4):398-403.
233. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al.
Multiple imputation for missing data in epidemiological and clinical research:
potential and pitfalls. BMJ 2009 Jun 29;338:b2393.
234. Presanis AM, Gill ON, Chadborn TR, Hill C, Hope V, Logan L, et al. Insights into
the rise in HIV infections, 2001 to 2008: a Bayesian synthesis of prevalence
evidence. AIDS 2010 Nov 27;24(18):2849-58.
235. Rogstad KE, Rooney G. United Kingdom national guidelines on HIV testing
2006: Clinical Effectiveness Group. British Association for Sexual Health and
HIV; 2006.
236. Scottish Executive. Respect and responsibility: strategy and action plan for
improving sexual health. Edinburgh: Scottish Executive; 2005.
237. Munro HL, Lowndes CM, Daniels DG, Sullivan AK, Robinson AJ. National study
of HIV testing in men who have sex with men attending genitourinary clinics in
the United Kingdom. Sex Transm Infect 2008 Aug;84(4):265-70.
238. British HIV Association, British Association of Sexual Health and HIV, British
Infection SOCiety.UK National Guidelines for HIV Testing 2008.London: BHIVA;
263
REFERENCES
2008.
239. Bailey AC, Roberts J, Weatherburn P, Hickson FC, Reid OS, Fisher M, et al.
Community HIV testing for men who have sex with men: results of a pilot
project and comparison of service users with those testing in genitourinary
medicine clinics. Sex Transm Infect 2009 Apr;85(2):145-7.
240. MacNeil JM, Hogle J. Applying social, behavioral and evaluation research to
developing country HIV prevention programs. AIDS 1998;12 SuppI2:S99-108.
241. Health Protection Agency. Time to test for HIV: Expanded Healthcare and
community HIV testing in England. Interim report. London: Health Protection
Agency; 2010.
242. Diaz T, Garcia-Calleja JM, Ghys PO, Sabin K. Advances and future directions in
HIV surveillance in low- and middle-income countries. Curr Opin HIV AIDS
2009 Jul;4(4):253-9.
243. European Centre for Disease Prevention and Control. HIV testing: IncreaSing
uptake and effectiveness in the European Union. Stockholm: ECDC; 2010.
244. The UK Collaborative Group for HIV and STI Surveillance. Focus on
Prevention. HIV and other Sexually Transmitted Infections in the United
Kingdom in 2003. London: Health Protection Agency Centre for Infections;
2004.
245. Madge S, Smith C, Evans A, Clewley G, Johnson MA, Geretti AM. Patterns of
HIV testing at a London teaching hospital between 2004 and 2007. Int J STD
AIDS 2011 Mar;22(3):151-4.
246. Lorenc T, Marrero-Guillamon I, Aggleton P, Cooper C, Llewellyn A, Lehmann A,
et al. Promoting the uptake of HIV testing among men who have sex with men:
systematic review of effectiveness and cost-effectiveness. Sex Transm Infect
2011 Jun;87(4):272-8.
247. McDaid LM, Hart GJ. Increased HIV testing and reduced undiagnosed infection
among gay men in Scotland, 2005-8: support for the opt-out testing policy? Sex
Transm Infect 2011 Apr;87(3):221-4.
248. Heijman RL, Stolte IG, Thiesbrummel HF, van LE, Coutinho RA, Fennema JS,
et al. Opting out increases HIV testing in a large sexually transmitted infections
outpatient Clinic. Sex Transm Infect 2009 Aug;85(4):249-55.
249. Department of Health. Getting ahead of the curve. London: Department of
Health; 2002.
250. Hughes G, Catchpole M, Fenton K, Rogers P, Brady A, Kinghorn G, et al.
Comparison of risk factors for four sexually transmitted infections: results from a
study of attenders at three genitourinary medicine clinics in England. Sex
Transm Infect 2000;76(4):262-7.
251. Hughes G, Brady A, Catchpole MA, Fenton KA, Rogers P, Kinghorn G, et al.
Characteristics of those who repeatedly acquire sexually transmitted infections:
a retrospective cohort study of attendees at three urban sexually transmitted
disease clinics in England. Sex Transm Dis 2001 ;28(7):379-86.
252. National AIDS Programes: a guide to monitoring and evaluation.Geneva: Joint
United Nations Programme on HIV/AIDS; 2000. p. UNAIDS/00.17E, Internet
communication, 24 November 2000 at
http://www.unaids.org/publicationsldocuments/epidemiology/surveiliance/JC427
-Mon&Ev-Full-E. pdf.
253. Grassly NC, Garnett GP, Schwartlander B, Gregson S, Anderson RM. The
effectiveness of HIV prevention and the epidemiological context. Bull World
Health Organ 2001;79(12):1121-32.
254. Kitsiripornchai S, Markowitz LE, Ungchusak K, Jenkins RA, Leucha W,
Limpitaks T, et al. Sexual behavior of young men in Thailand: regional
differences and evidence of behavior change. J Acquir Immune Defic Syndr
Hum Retrovirol 1998 Jul 1;18(3):282-8.
255. Mills S, Benjarattanaporn P, Bennett A, Pattalung RN, Sundhagul 0,
Trongsawad P, et al. HIV risk behavioral surveillance in Bangkok, Thailand:
sexual behavior trends among eight population groups. AIDS 1997 Sep;11
264
REFERENCES
Suppl1 :S43-S51.
256. Gorbach PM, Sopheab H, Phalla T, Leng HB, Mills S, Bennett A, et al. Sexual
bridging by Cambodian men: potential importance for general population spread
of STD and HIVepidemics. Sex Transm Dis 2000 Jul;27(6):320-6.
257. Lau JT, Wong WS. Behavioural surveillance of sexually-related behaviours for
the cross-corder traveller population in Hong Kong: the evaluation of the overall
effectiveness of relevant prevention programmes by comparing the results of
two surveillance surveys. Int J STD AIDS 2000;11(11):719-27.
258. Asiimwe-Okiror G, Opio AA, Musinguzi J, Madraa E, Tembo G, Carael M.
Change in sexual behaviour and decline in HIV infection among young pregnant
women in urban Uganda. AIDS 1997 Nov 15;11(14):1757-63.
259. Dubois-Arber F, Jeanin A, Spencer B. Long term evaluation of a national AIDS
prevention strategy: the case of Switzerland. AIDS 1999;13(18):2571-82.
260. Rugg DL, Heitgerd JL, Cotton DA, Broyles S, Freeman A, Lopez-Gomez AM, et
al. CDC HIV prevention indicators: monitoring and evaluating HIV prevention in
the USA. AIDS 2000;14(13):2003-13.
261. Mertens TE, Carael M. Evaluation of HIV/STD prevention, care and support: an
update on WHO's approaches. AIDS Educ Prev 1997 Apr;9(2):133-45.
262. Mertens T, Caraet M, Sato P, Cleland J, Ward H, Smith GO. Prevention
indicators for evaluating the progress of national AIDS programmes. AIDS
1994;8:1359-69.
263. Reitmeijer CA, Lansky A, Anderson JE, Fichtmer RR. Developing standards in
behavioral surveillance for HIV/STD prevention. AIDS Educ Prev
2001; 13(3):268-78.
264. Dare GJ, Kaldor JM. Sexually transmitted diseases surveillance in Australia:
towards a coordinated national system. Commun Dis InteIl1998;22(4):49-52.
265. Lau JTF, Siah PC. Behavioural surveillance of sexually-related risk behaviours
of the Chinese male general population in Hong Kong: a benchmark study.
AIDS Care 2001;13(2):221-32.
266. Editorial team. Workshop on European behavioural indicators for men who
have sex with men. Euro Surveill2008;13(15):18853.
267. Dubois-Arber F, Jeannin A, Spencer B, Gervasoni J, Graz B, Elford J, et al.
Mapping HIV/STI behavioural surveillance in Europe. BMC Infectious Diseases
2010;10(290).
268. Hickson F, Nutland W, Doyle T, Burbidge N, Burnell C, Cadette M, et al. Making
it count. A collaborative planning framework to reduce the incidence of HIV
infection during sex between men. London: Sigma Research; 2000.
269. Elford J, Bolding G, Sherr L. Seeking sex on the Internet and sexual risk
behaviour among gay men using London gyms. AIDS 2001;15:1409-15.
270. Hickson F, Reid D, Weatherburn P, Stephens M, Brown D. Time for more.
Findings from the National Gay Men's Sex Survey 2000. London: Sigma
Research; 2001.
265
APPENDIX A
APPENDIX A Studies excluded from review and a tabulated summary of factors
associated with HIV testing and UAI from reviews in Chapter two
Table A.1 Studies excluded from review of factors associated with HIV testing
and UAI
Study Reason for Exclusion
Abdullah ASM, Hedley AJ, Fielding R, Ebrahim SH.
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Risk, and Attitudinal Correlates. JAIDS 2003;32:534-541
Chesney MA, Chambers DB, Kahn, JO. Risk Behaviour for
HIV Infection in Participants in Prevetive HIV Vaccine Trials:
A Cautionary Note. Journal Of Acquired Immune Deficiency
Syndromes and Human Retrovirology 1997;16:266-271
DolILS, O'Malley PM, Pershing AL, Darrow'NW, Hessol
NA, lifson AR. High-Risk Sexual Behaviour and Knowledge
of HIV Antibody Status in the San Francisco City Clinic
Cohort. Health Psychology 1990;9:253-256
Elford J, Bolding G, Davis M, Sherr L, Hart G. Web-Based
Behavioural Surveillance Among Men Who Have Sex With
Men: A Comparison of Online and Offline Samples in
London, UK. J Acquir Immune Defic Syndr 2004; 35:421-
426
Fernyak SE, Page-Shafer K, Kellog TA, McFarland W, Katz
MH. Risk behaviours and HIV incidence Among Repeat
Testers at Publicly Funded HIV Testing Sites in San
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Spain. AIDS Education and Prevention, 18(3),227-242,
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Bookye. HIV, sexual risk, and ethnicity among men in
England who have sex with men. Sex Transm Infect
2004;80:443-450
Houston S, Archibald CP, Strike C, Sutherland D. Factors
associated with HIV testing among Canadians: results of a
No separate results presented
for MSM
No separate results presented
for MSM
No separate results presented
forMSM
No separate results presented
for MSM
No measure of association with
HIV testing or UAI, only
investigates impact of test and
counselling on subsequent
sexual behaviour
No measure of association with
HIV testing or UAI, only for
mode of recruitment, online or
offline
No separate results presented
for MSM, included with injecting
drug users
No measure of association with
HIV testing or UAI only by
knowledge of status and
subsequent behaviour
No measure of association with
HIV testing or UAI, only by
knowledge of status and
subsequent behaviour
No measure of association with
HIV testing or UAI, only by
ethnicity
No separate results presented
forMSM
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population based survey. International Journal of STD and
AIDS 1998;9:341 - 346
Kellog TA, McFarland W, Perlman JL, et al. HIV incidence
Among Repeat Testers at a County Hospital, San Francisco,
California, USA. JAIDS 2001;28:59-64
Knussen C, Flowers P, Church S. The intentions of gay men
in taking a HIV test. Culture, Health and Sexuality
2004;6:45-59
Kelly JA, Amirkhanian YA, McAuliffe TL, et al. HIV Risk
Behaviours and Risk-Related Characteristics of Young
Russian Men Who Exchange Sex for Money or Valuables
From Other Men. AIDS Education and Prevention
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Journal of STD & AIDS 2003;14:132- 138
Maguen S, Armistead LP, Kalichman S. Journal of
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Manning SE, Thorpe LE, Ramaswamy C, Hajat A, Marx MA,
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years--New York City, 2002. J Urban Health. 2007
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Miller lG, Simon PA, Miller ME, long A, Yu El, Asch SM.
High-Risk Sexual Behaviour in los Angeles: Who Receives
Testing for HIV. JAIDS 1999;22:490-497
Molitor F, Truax SR, Ruiz JD, Sun RK. Association of
Methamphetamine Use During Sex With Risky Sexual
Behaviours and HIV Infection Among Non-Injection Drug
Users. West J Med 1998;168:93-97
Mamas I, Helai H, Pretet S, Marsal L, Poinsard R.
Demographic and behavioural predictors of knowledge and
HIV seropositivity: Results of a survey conducted in three
anonymous and free counselling and testing centers.
European Journal of Epidemiology1997;13:255-260
Ni H, Hedberg K, Torok J, Dubickas SH, Fleming D. Trends
in HIV Counseling and Testing of Clients Attending a Public
Sexually Transmitted Disease Clinic in Portland, Oregan,
1989-1995. Journal of Acquired Immune Deficiency
Syndromes and Human Retrovirology 1997;15:151-156
Peterman TA, Zaidi AA, Wroten J. Decreasing prevalence
hides a high HIV incidence: Miami. AIDS 1995;9:965-970
Remafedi G. Predictors of Unprotected Intercourse Among
Gay and Bisexual Youth: Knowledge, Beliefs and Behaviour.
Pediatrics 1994;94:163 -168
Roffman RA, Kalichman SC, Kelly JA, Winett RA, Solomon
LJ, Sikkema KJ, et al. HIV antibody testing of gay men in
smaller US cities. AIDS Care 1995;7(4):405-13
No separate results presented
for MSM, included with Injecting
Drug Users
Measures of association for
intention to test only, not actual
HIV testing
No measure of association with
HIV testing or UAI, only with
exchanging sex for money
No separate results presented
for MSM
No separate results presented
for MSM
No measures of association for
HIVtesting
No separate results presented
for MSM
No measure of association with
HIV testing or UAI, only with
methamphetamine use
No separate results presented
forMSM
No separate results presented
forMSM
No separate results presented
forMSM
No separate results presented
for MSM, included with injecting
drug users
No measure of association
between HIV testing and UAI
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Sinclair M, Bor R, Evans A, Glass D, Levitt D, Johnson MA.
The socia-demographic profiles, risk categories and
prevalence of HIV infection among people attending a
London same-day testing clinic, 2000-2001. International
Journal of STD & AIDS 2004; 15: 33-37
Skolnik HS, Phillips KA, Binson D, Dilley JW. Deciding
Where and How to Be Tested for HIV: What Matters Most?
JAIDS 2001;27:292 - 300
Stumoiler F, Penna TL, Vieria de Souza CT, Lambert Jon
behalf of the Oswaldo Cruz Foundation STD/HIV Prevention
Group. Int J Infect Dis 2002;6:259-265
Suliugoi B, Giuliani M, Galai N, Balducci M and the STD
Surveillance Working Group. HIV incidence among repeat
HIV testers with sexually transmitted diseases in Italy. AIDS
1999;13:845 - 850
Schwarcz SK, Spitters C, Ginsberg MM, Anderson L, Kellog
TM, Katz MH. Predictors of Human Immunodeficiency Virus
Counselling and Testing Among Sexually Transmitted
Disease Clinic Patients. Sex Trans Dis.1997;24:347-352
Van de Ven P, Prestage G, French J, Knox S, Kippax S.
Increase in unprotected anal intercourse with casual
partners among Sydney gay men in 1996-98. Aust N Z J
Public Health 1998 Dec;22(7):814-8
Webster RD, Darrow WW, Paul JP, Roark RA, Taylor RA,
Stempel RR. Community planning, HIV prevention, and a
needs assessment for men who have sex with men: the
South Beach Health Survey. Sex Transm Dis 2005
May;32(5):321-7
Wortley PM, Chu SY, Diaz T, et al. HIV Testing pattems:
where, why, and when were persons with AIDS tested for
HIV. AIDS 1995;9:487-492
Xia Q, Osmond DH, Tholandi M, Pollack LM, Zhou W, Ruiz
JD, Catania JA. HIV prevalence and sexual risk behaviours
among men who have sex with men: results from a state-
wide population-based survey in Califomia. J Acquir Immune
Defic Syndr. 2006 Feb 1;41(2):238-45
No separate results presented
for MSM
No separate results presented
for MSM
No measure of association for
HIV testing or UAI
No separate results presented
for MSM
No separate results presented
for MSM
No measure of association for
HIV testing or UAI just trend
overtime
No measure of association for
HIV testing and UAI
No separate results presented
forMSM
No measure of association for
HIV testing or UAI
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Table A.2 Studies excluded from review of factors associated with HIV testing
and age
Study Reason for Exclusion
Hightow LB, Miller WC, Leone PA, Wahl DA, smurzynski No separate measures of
M, Kaplan. Predictors of Repeat Testing and HIV association for MSM
Seroconversion in a Sexually Transmitted Disease
Clinic Population. Sex Transm Dis 2004;31(8):455-459
Huhn GO, Mcintyre, AF, Broad JM, Holmes SW,
Studzinski A, Rabins C, Dworkin MS Factors Associated
With Newly Diagnosed HIV Among Persons With
Concomitant Sexually Transmitted Diseases. Sex
Transm Dis 2008; 35(8):731-737
Lau JTF, Wang M, Tse YK, Gu J, Tsui HY, Zhang Y,
Wang Y, Cheng F. MSM in China.HIV-related behaviors
among men who have sex with men in China: 2005-
2006. AIDS Educ Prev 2009;21(4):325-339
Melbye M, Biggar RJ. Interactions between Persons at
Risk for AIDS and the General Population in Denmark.
Am. J. Epidemiol. (1992) 135(6): 593-602
Sandfort TGM, Nel J, Rich E, Reddy V, Yi H. HIV
testing and self-reported HIV status in South African
men who have sex with men: results from a community-
based survey. Sex Transm Infect 2008;84:425--429
Sinclair M, Bor R, Evans A, Glass D, Levitt D, Johnson
MA. The sociodemographic profile, risk categories and
prevalence of HIV infection among people attending a
London same-day testing clinic,2000-2001. Int J STD &
AIDS 2004;15:33-3
Thomas S, Mimiaga MJ, Menon S, Chandrasekaran V,
Murugesan P, Swaminathan S, Mayer KH,Safren SA.
MSM in India unseen and unheard: predictors of sexual
risk behaviour and HIV infection among men who have
sex with men in Chennai, India. AIDS Educ Prev
2009;21(4);372-383
Williamson LM, Flowers P, Knussen C, Hart GJ.HIV
testing trends among gay men in Scotland, UK (1996-
2005): implications for HIV testing policies and
prevention. Sex Transm Infect 2009 85: 550-554
Xia Q, Osmond OH, Tholandi M, Pollack LM, Zhou W,
Ruiz JD, Catania JA. HIV prevalence and sexual risk
behaviors among men who have sex with men: results
from a statewide population-based survey in Califomia.
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):238-45
Xu JJ, Zhang M, Brown K, Reilly K, Wang H. Hu Q, Ding
H, Chu Z, Bice T, Shang H. Syphilis and HIV
Seroconversion Among a 12-Month Prospective Cohort
of Men Who Have Sex With Men in Shenyang, China.
Sex Transm Dis 2010;37(7):432-443
No measures of association with HIV
testing for MSM separately
Outside inclusion criteria. Carried
out after 2002
No separate data for MSM
Out of Inclusion criteria carried out
Nov 2003-2005
No measure of association for HIV
testing or UAI
Outside inclusion criteria. Carried
out after 2002
Outside criteria, includes tests 2003-
2005 which include opt-out policy
No measure of association for HIV
testing or UAI
Outside inclusion criteria. Carried
out in 2006
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Table A.3 Studies excluded from review of factors associated with HIV testing
and area
Study Reason for Exclusion
Clark JL, Konda KL, Segura ER, Salvatierra HJ, Leon
SR, Hall ER, Caceres CF, Klausner JD, Coates TJ.
Risk factors for the spread of HIV and other sexually
transmitted infections among men who have sex with
men infected with HIV in Lima, Peru. Sex Transm Infect
2008;84:449-454
Dodds JP, Mercey DE, Parry JV, Johnson AM.
Increasing risk behaviour and high levels of
undiagnosed HIV infection in a community sample of
homosexual men. Sex Transm Infect 2004
Jun;80(3):236-40
Dodds JP, Johnson AM, Parry JV, Mercey DE. A tale of
three cities: persisting high HIV prevalence, risk
behaviour and undiagnosed infection in community
samples of men who have sex with men.Sex Transm
Infect. 2007 Aug;83(5):392-6. Epub 2007 May 1
Dougan S, Elford J, Chadborn TR, Brown AE, Roy
K, Murphy G, Gill ON; Group Investigating Rising HIV
Diagnoses Among MSM in UK. Does the recent
increase in HIV diagnoses among men who have sex
with men in the UK reflect a rise in HIV incidence or
increased uptake of HIV testing? Sex Transm
Infect. 2007 Apr;83(2):120-5; discussion 125. Epub
2006 Nov 7
McGarrigle CA, Mercer CH, Fenton KA, Copas AJ,
Wellings K, Erens B, et al. Investigating the relationship
between HIV testing and risk behaviour in Britain:
National Survey of Sexual Attitudes and Lifestyles
2000. AIDS 2005;19(1):77-84
Roffman RA, Kalichman SC, Kelly JA, Winett RA,
Solomon LJ, Sikkema KJ, et al. HIV antibody testing of
gay men in smaller US cities. AIDS Care 1995;7(4):405-
13
Outside inclusion criteria, carried out
May 2007
No outcome measure for area
No outcome measure for area
Not about HIV testing
No separate outcome measure for
MSM
No outcome measure for area of
residence
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Table A.4 Studies excluded from review of factors associated with HIV testing
and SES
Study Reason for Exclusion
Choi KH, Han CS, Hudes ES, Kegeles S. Unprotected No measure of association between
sex and associated risk factors among young Asian and HIV testing and SES
Pacific Islander men who have sex with men. AIDS
Educ Prev 2002 Dec;14(6):472-81
Clark JL, Konda KL, Segura ER, Salvatierra HJ, Leon
SR, Hall ER, Caceres CF, Klausner JD, Coates TJ.
Risk factors for the spread of HIV and other sexually
transmitted infections among men who have sex with
men infected with HIV in Lima, Peru. Sex Transm Infect
2008;84:449-454
Hart GJ, Williamson LM. Flowers P, Frankis JS, Der GJ.
Gay men's HIV testing behaviour in Scotland. AIDS
Care 2002 Oct;14(5):665-74
Hays RB, Paul J, Ekstrand M, Kegeles SM, Stall R,
Coates TJ. Actual versus perceived HIV status, sexual
behaviors and predictors of unprotected sex among
young gay and bisexual men who identify as HIV-
negative, HIV-positive and untested. AIDS 1997
Oct;11(12):1495-502
Lemcke A, Kjoller M, Ekholm 0, Smith E. HIV testing in
the Danish population: a national representative survey,
2000. Scand J Public Health 2007;35(6):631-9
McKusick L. Coates TJ, Morin SF, Pollack L, Hoff C.
Longitudinal predictors of reductions in unprotected
anal intercourse among gay men in San Francisco: the
AIDS Behavioral Research Project. Am J Public Health
1990 Aug;80(8):978-83
Sandfort TJM, Nel J, Rich E, Reddy V, Vi H. HIV testing
and self-reported HIV status in South African men who
have sex with men: results from a community-based
survey. Sex Transm Infect 2008;84:425-429
Webster RD, Darrow WVII, Paul JP, Roark RA, Taylor
RA, Stempel RR. Community planning, HIV prevention,
and a needs assessment for men who have sex with
men: the South Beach Health Survey. Sex Transm Dis
2005 May;32(5):321-7
Outside inclusion criteria, carried out
May 2007
No measure of association between
HIV testing and SES or education
reported
No measure of association between
HIV testing and SES
No separate outcome measures for
MSM
No measure of association between
HIV testing and SES
Outside inclusion criteria, carried out
Nov 2003-2005
No measure of association between
HIV testing and SES
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Table A.5 Studies excluded from review of factors associated with HIV testing
and number of sexual partners
Study Reason for Exclusion
Cribier B, Schmitt MP, Le Coz C, Grosshans E. Changes in No separate measure of association for
sexual behaviour of patients attending an HIV testing MSM
centre: a prospective study 1988-1994. Genitourin Med
1996; 72: 37-42.15
Do TO, Chen S, McFarland W, Secura GM, Behel SK,
MacKellar DA, et al. HIV testing patterns and unrecognized
HIV infection among young Asian and Pacific Islander men
who have sex with men in San Francisco. AIDS Educ Prev
2005 Dec;17(6):540-54
Hart GJ, Williamson LM, Flowers P, Frankis JS, Der GJ.
Gay men's HIV testing behaviour in Scotland. AIDS Care
20020ct;14(5):665-74
Heckman TG, Kelly JA, Roffman RA, Sikkema KJ, Perry
MJ, Solomon LJ, et al. Psychosocial differences between
recently HIV tested and non-tested gay men who reside in
smaller US cities. Int J STD AIDS 1995 Nov;6(6):436-40
Johnson EH, Jackson LA, Hinkle Y, Gilbert 0, Hoopwood
T, Lollis CM, et al. What is the significance of black-white
differences in risky sexual behavior? J Natl Med Assoc
1994 Oct;86(10):745-59
Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley
JW, Gibson S, et al. Impact of highly active antiretroviral
treatment on HIV seroincidence among men who have sex
with men: San Francisco. Am J Public Health 2002
Mar;92(3):388-94
Lau RK, Jenkins P, Caun K, Forster SM, Weber IN,
McManus TJ, et al. Trends in sexual behaviour in a cohort
of homosexual men: a 7 year prospective study. Int J STD
AIDS 1992 Jul;3(4):267-72
Manning SE, Thorpe LE, Ramaswamy C, Hajat A, Marx
MA, Karpati AM, Mostashari F, Pfeiffer MR, Nash D.
Estimation of HIV prevalence, risk factors, and testing
frequency among sexually active men who have sex with
men, aged 18-64 years--New York City, 2002. J Urban
Health. 2007 Mar;84(2):212-25
Osmond OH, Pollack LM, Paul JP, Catania JA. Changes in
Prevalence of HIV infection and Sexual Risk Behaviour in
Men Who Have Sex With Men in San Francisco: 1997-
2002. Am J Public Health 2007;97:1677-83
Roark RA, Webster RD, Darrow WW, Stempel RR. HIV
testing among men who have sex with men: how often
should one test? J Public Health Manag Pract 2005
Jan;11(1):18-2
Sanchez T, Finlayson T, Drake A, Behel S, Cribbin M,
Dinenno E, et al. Human immunodeficiency virus (HIV) risk,
prevention, and testing behaviors-United States, National
HIV Behavioral Surveillance System: men who have sex
with men, November 2003-April 2005. MMWR Surveill
Summ 2006 Jul 7;55(6):1-16
Larger study including this data
published 2006 and included
No association between HIV testing
and number of sexual partners once
other factors were controlled for.
This study was included already in
Roffman et al 1995
This study was included already in
Roffman et al 1995
No measures of association for HIV
testing
No measures of association for HIV
testing
No measures of association for HIV
testing
No measures of association for HIV
testing or UAI
Duplicate publication of Webster et al
Sex Transm Dis 2005 May;32(5):321-
ioo
Outside inclusion criteria, carried out
after2002
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Strathdee SA, Martindale SL, Cornelisse PG, Miller ML,
Craib KJ, Schechter MT, et a!. HIV infection and risk
behaviours among young gay and bisexual men in
Vancouver. CMAJ 2000 Jan 11;162(1):21-5
No association between HIV testing
and numbers of sexual partners
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Table A.6 Studies excluded from review of factors associated with HIV testing
and STI
Study Reason for Exclusion
Binson D, Woods WJ, Pollack L, Paul J, Stall R,
Catania JA. Differential HIV risk in bathhouses and
public cruising areas. Am J Public Health
2001 ;91(9):1482-6
No outcome measure for HIV testing
and STI
Bolding G, Davis M, Hart G, Sherr L, Elford J. Gay men No outcome measure for HIV testing
who look for sex on the Internet: is there more HIV/STI and STI
risk with online partners? AIDS 2005 Jun 10;19 (9):961
-8 2005 Jun 10;19:961-8
Choi KH, Han CS, Hudes ES, Kegeles S. unprotected No outcome measure for HIV testing
sex and associated risk factors among young Asian and and STI
Pacific Islander men who have sex with men. AIDS
Educ Prev 2002 Dec;14(6):472-81
KH, McFarland W, Neilands TB, Nguyen S,Louie B, No outcome measure for HIV testing
Secura GM, et al. An opportunity for prevention: and STI
prevalence, incidence, and sexual risk for HIV among
young Asian and Pacific Islander men who have sex
with men, San Francisco. Sex Transm Dis 2004
Sep;31 (8):475-80
Dilley JW, Woods WJ, Sabatino J, Lihatsh T, Adler B, Not about behaviour before HIV test
Casey S, et al. Changing sexual behavior among gay
male repeat testers for HIV: a randomized, controlled
trial of a single-session intervention. J Acquir Immune
Defic Syndr 2002 Jun 1;30(2):177-86
Do TO, Hudes ES, Proctor K, Han CS, Choi KH. HIV No outcome measure for HIV testing
testing trends and correlates among young Asian and and STI
Pacific Islander men who have sex with men in two U.S.
cities. AIDS Educ Prev 2006 Feb; 18(1):44-55
Flores SA, Bakeman R, Millett GA, Peterson JL. HIV No outcome measure for HIV testing
risk among bisexually and homosexually active racially and STI
diverse young men. Sex Transm Dis 2009
May;36(5): 325-9
Hays RB, Paul J, Ekstrand M, Kegeles SM, Stall R, No outcome measure for HIV testing
Coates TJ. Actual versus perceived HIV status, sexual and STI
behaviors and predictors of unprotected sex among
young gay and bisexual men who identify as HIV-
negative, HIV-positive and untested. AIDS 1997
Oct; 11(12):1495-502
Hickson F, Reid 0, Weatherburn P, Stephens M, No outcome measure for HIV testing
Nutland W, Boakye P. HIV, sexual risk, and ethnicity and STI
among men in England who have sex with men. Sex
Transm Infect 2004;80:443-50
Jin FY, Prestage G, Law MG, Kippax S, Van d, V, No outcome measure for HIV testing
Rawsthorne P, et al. Predictors of recent HIV testing in and STI
homosexual men in Australia. HIV Med 2002
Oct;3(4):271-6
Kalichman SC, Schaper PE, Belcher L, Abush-Kirsh T, No outcome measure for HIV testing
Cherry C, Williams EA, et al. It's like a regular part of and STI
gay life: repeat HIV antibody testing among gay and
bisexual men. AIDS Educ Prev 1997 Jun;9(3 Suppl):41-
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Kelly JA, Murphy DA, Roffman RA, Solomon LJ, Winett
RA, Stevenson LY, et al. Acquired immunodeficiency
syndrome/human immunodeficiency virus risk behavior
among gay men in small cities. Findings of a 16-city
national sample. Arch Intern Med 1992
Nov;152(11):2293-7
Lattimore S, Thornton A, Delpech V, Elford J. Changing
patterns of sexual risk behavior among London gay
men: 1998-2008. Sex Transm Dis 2011 Mar;38(3):221-
9
McKusick L, Coates TJ, Morin SF, Pollack L, HoffC.
Longitudinal predictors of reductions in unprotected
anal intercourse among gay men in San Francisco: the
AIDS Behavioral Research Project. Am J Public Health
1990 Aug;80(8):978-83
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
Nardone A, Frankis JS, Dodds JP, Flowers PN, Mercey
DE, Hart GJ. A comparison of high-risk sexual
behaviour and HIV testing amongst a bar-going sample
of homosexual men in London and Edinburgh. Eur J
Public Health 2001 Jun; 11(2): 185-9
Phillips KA, Paul J, Kegeles S, Stall R, Hoff C, Coates No outcome measure for HIV testing
TJ. Predictors of repeat testing among gay and bisexual and STI
men. AIDS 1995;9:769-75
Schwarcz SK, Spitters C, Ginsberg MM, Anderson L,
Kellog T, Katz MH. Predictors of Human
Immunodeficiency Virus counseling and testing among
sexually transmitted disease clinic patients. Sex Transm
Dis 1997;24:347-52
Schwarcz SK, Kellogg TA, McFarland W, Louie B,
Klausner J, Withum DG, et al. Characterization of
sexually transmitted disease clinic patients with recent
human immunodeficiency virus infection. J Infect Dis
2002 Oct 1;186(7): 1019-22
Sumartojo E, Lyles C, Choi K, Clari< L, Collins C,
Guenther Grey C, et al. Prevalence and correlates of
HIV testing in a multi-site sample of young men who
have sex with men. AIDS Care 2008;20(1):1-14
Thiede H, Jenkins RA, Carey JW, Hutcheson R,
Thomas KK, Stall RD, et al. Determinants of Recent
HIV Infection Among Seattle-Area Men Who Have Sex
With Men. Am J Public Health 2009;99:S157-S164
Torian LV, Makki HA, Menzies IB, Murrill CS, Weisfuse
lB. HIV infection in men who have sex with men, New
York City Department of Health sexually transmitted
disease clinics, 1990-1999: a decade of
serosurveillance finds that racial disparities and
associations between HIV and gonorrhea persist. Sex
Transm Dis 2002 Feb;29(2):73-8
Truong H.M., Kellogg T, Klausner JD, Katz MH, Dilley J,
Knapper K, et al. Increases in sexually transmitted
infections and sexual risk behaviour without a
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
Ecological analysis. No measures of
association
275
APPENDIX A
concurrent increase in HIV incidence among men who
have sex with men in San Francisco: a suggestion of
HIV serosorting? Sex Transm Infect 2006;82(461):466
Van de Yen P, Prestage G, Knox S, Kippax S. Gay men
in Australia who do not have HIV test results. Int J STD
AIDS 2000 Jul; 11(7):456-60
Webster RD, Darrow WVII, Paul JP, Roark RA, Woods
WJ, Stempel RR. HIV infection and associated risks
among young men who have sex with men in a Florida
resort community. J Acquir Immune Defic Syndr 2003
Jun 1;33(2):223-31
Williamson LM, Hart GJ, Flowers P, Frankis JS, Der GJ.
The Gay Men's Task Force: the impact of peer
education on the sexual health behaviour of
homosexual men in Glasgow. Sex Transm Infect 2001
Dec;77(6):427 -32
Xia Q, Osmond DH, Tholandi M, Pollack LM, Zhou W,
Ruiz JD, et al. HIV prevalence and sexual risk
behaviors among men who have sex with men: results
from a statewide population-based survey in California.
J Acquir Immune Defic Syndr 2006 Feb 1;41(2):238-45
Strathdee S, Hogg R, Martindale S, et al. Determinants
of Sexual Risk-Taking Among Young HIV-Negative Gay
and Bisexual Men. Journal of Acquired Immune
Deficiency Syndromes & Human Retrovirology
1998;19:61-6
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
Study not about HIV testing
No outcome measure for HIV testing
and STI
No outcome measure for HIV testing
and STI
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Table A.7 Summary chart of factors associated with HIV testing from reviews in Chapter
two
Socio-demoqraohic variables Behavioural variables Biological
I/)
iii
~:::I- :::I Xc: 16 s c: :eQ) - 0 I/)E I/) 8 'j!! 0>- 0 a.
0 'e c: - I/) Q) I/)IS. Q) 0 Q) > .a
E 0 :2 I/) c: .l!!c: III 0
~
c: ~ 8 I!? I!? I!? c: e0 Cl.. Q) q> - m~ E 0 0 ~Q) '6 ll! ll!
Q) :::I 8 'g m E€ > ~Cl "C I!? « :::1m i= :I:-c w .5 Cl) -c :::> za. Cl) z:
HIV testing
UK
Dawson et al (1991) ". -:
Dodds et al (2004) __i
Hart et al (1999) _'J_
Hart et al (2002) " " _'J_Macdonald et al (2007) v
Nardone et al (1998) " " " "Nardone et al (2001) "Williams et al (1996 _i
Other EuroDe
Paget et al (1997) "u -.f
Stolte et al (2007) " " "-United States "Choi et al (2002) "Do et al (2006) "Flores et al (2009) v
Helms et al (2009) "Hays et al (1997) ns"
Kelly et al (1992) "Mackellar et al (2006) " " " _"Povenelli et al (1996) " " "Roffman et al(1996) j"_
Ruiz et al (1998) ,,-
Sumartoio et al (2008) " " "Canada
Myers et al (1993) " "Myers et al 1996) " " "Australia
Jin et al (2002) " __i " _'J_Van de Ven et al (2000) " ns "Repeat HIV testing
UK
Elford et al (2001 -r
Leaitv et al (2000) va _'J_
Norton et al (1997) ". v
US
Fernandez et al (2003) " " , "Kalichman et al (1997) ns· ";.
MacKellar et al (2002) " " nsu ,Philips et al (1995 " " «
Ns. Not statistically significant. a. Univariable analysis only. b. associated with not UAI
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Table A.8 Summary chart of factors associated with UAI from reviews in Chapter
two
Socio-demographic variables Behavioural Biological
variables
Iii
::J
~III X::J 5119 c :-20 IIIIII a 0u 'i!! a.
'f c - Cl) IIICl) 0 ! > .a0 '0 cStudies c: 'iii 0 8 J!!c 0 !!! I!? I!? c III0 U Cl e e:p Cl) <p -r3 0 ,8(1) IV 51 51E 0 IV E C '6Cl) ::J 8 '0 !!! ::J1:: i= > >Cl '0
E 0 zl! J: J:-c w Cl) -c Cl)
UK
Dawson et al (1994) "Dodds et al (2004) "Dodds et al (2007) "Elford et al (1999) " - "Hart et al (1999) " "Macdonald et al (2007) "Nardone et al (2001) "Wells et al (1998) "a
Williams et al (1996) "United States
Binson et al (2001) "Buchbinder et al (2005) "Choi et al (2002) "Ekstrand et al (1999) "Kelly et al (1992) " "Koblin et al (2006)
McKusick et al (1990) " nsMacFarland et al (1997) "Ostrow et al (1995) "Ruiz et al (1998) " "Schwarcz et al (2007) " " "Thiede et al (2009) "Canada
MacKellar et al (2006) j_
Myers et al (1996) " "Strathdee et al (1998) " oJ"Weber et al (2001) ,,-Australia
Kippax et al (1998) "South America
Harrison et al (1999) "
Note, Ns, Not statistically significant; a, Univariable analysis only; b. associated with not UAI.
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APPENDIX B KC60 codes for acute STls
Table B.1 KC60 Codes Diagnosed coded as acute STls
Code, Condition Acute STI
A1, A2 Infectious syphilis
A3 Early latent syphilis
A4, A5, A6 Latent syphilis
A7, A8 Congenital syphilis
A9 Epidemiological treatment of syphilis
B1, B2 Uncomplicated gonorrhoea
B3 Gonococcal ophthalmia neonatorum
B4 epidemiological treatment of suspected
gonorrhoea
Gonococcal complications
Chancroid/LGVlDonovanosis
Uncomplicated chlamydial infection
Complicated chlamydial infection
Epidemiological treatment of chlamydia
Uncomplicated non-gonococcal , non-
specific urethritis in males
Epidemiological treatment of non-specific
genital infection
Complicated infection (non-
chlamydial/non-gonococcal) excluding
PlO and epididymitis
Trichomoniasis
Anaerobic /Bacterial vaginosis and
anerobic balanitis
Other vaginosislvaginitis/balanitis
Anogenital candidosis
Epidemiological treatment of C6 and C7
Scabies/Pediculosis pubis
Anogenital herpes simplex, first attack
Anogenital herpes simplex: recurrence
Anogenital warts infection, first attack
Anogenital warts infection: recurrence
Anogenital warts infection: Re-registered
cases
Molluscum contagiosum
Antigen positive viral hepatitis
Other viral hepatitis
Urinary tract infection
Other conditions requiring treatment
Asymptomatic HIV infection - First
presentation
HIV infection with symptoms (not AIDS)
- first presentation
Subsequent HIV presentation (not AIDS)
AIDS first presentation
AIDS: subsequent presentation
B5
C1,C2,C3
C4A,C4C
C4B
C4E
C4H
C41
C5
C6A
C6B
C6C
C7a
C7B
C8,C9
C10A
C10B
C11A
C11B
C11C
C12
C13
C14
D2A
D2B
E1A
E2A
E1B,E2B
E3A
E3B
Yes
Yes
No
No
No
Yes
No
Yes
No
Yes
Yes
No
Yes
Yes
Yes
No
Yes
No
No
No
No
Yes
Yes
No
Yes
No
No
Yes
No
No
No
No
No
No
No
No
No
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APPENDIX C Table C.1 Comparison of Natsal 2000 general population sample
lth I·WI popu atlon estimates
(a) Natsal 2000 Sample (c) Natsal2000 Sample
after selection weighting (b) Population estimates after final weighting
Age group Men Women All Men Women All Men Women All
% % % % % % % % %
16-19 13.6 11 12.1 12.2 12 12.1 12.1 12 12
20-24 14.3 13.4 13.8 14.5 14.4 14.4 14.6 14.4 14.5
25-29 15.6 17.1 16.5 17.6 17.4 17.5 17.6 17.4 17.5
30-34 19.6 20.7 20.2 19.8 19.8 19.8 20 19.9 19.9
35-39 18.6 20 19.4 19.4 19.5 19.4 19.3 19.4 19.4
40-44 18.2 17.8 17.9 16.4 16.9 16.7 16.5 16.9 16.7
Row% 43.5 56.5 51.0 49.0 50.9 49.1
Government Office
Region Men Women All Men Women All Men Women All
% % % % % % % %
North East 5.7 5.4 5.5 4.3 4.4 4.4 4.4 4.5 4.5
North West 11.4 12.7 12.1 11.7 11.7 11.7 11.7 11.7 11.7
Yorkshire &
Humberside 9.2 9.1 9.2 8.7 8.6 8.6 8.8 8.6 8.7
East Midlands 7.8 7.9 7.9 7.1 7.1 7.1 7.1 7.1 7.1
West Midlands 8.7 8.1 8.4 9.0 9.0 9.0 9.1 9.0 9.0
South West 9 7.8 8.3 7.8 7.8 7.8 7.9 7.8 7.8
Eastern 8 9.7 9 9.2 9.2 9.2 9.1 9.2 9.1
Inner London 4.7 4.3 4.5 6.1 6.1 6.1 5.9 6.0 6.0
Outer London 7.1 7.4 7.2 8.5 8.3 8.4 8.5 8.3 8.4
South East 14.1 13.6 13.8 13.9 13.9 13.9 14 13.9 14
Wales 5.0 5.0 5.0 4.8 4.8 4.8 4.6 4.7 4.7
Scotland 9.3 9.0 9.1 8.9 9.2 9.0 8.9 9.1 9.0
Marital status Men Women All Men Women All Men Women All
% % % % % % % %
Single 39.5 28.2 33.1 38.8 31.3 35.2 39.3 29.9 34.7
Married 40.1 45.7 43.3 42.4 45.7 44.1 39.8 44.2 42
Separated 1.5 2.8 2.2 1.9 3.1 2.5 1.6 2.8 2.2
Divorced 2.8 4.7 3.9 2.6 5.5 4 2.8 4.6 3.7
Widowed 0.1 0.3 0.2 0.1 0.5 0.3 0.1 0.3 0.2
Cohabiting 16 18.2 17.3 14.1 13.8 14 16.5 18.2 17.3
Social Class· Men Women All Men Women All Men Women All
% % % % % % % %
Professional 7.2 3.3 5 6.2 2.7 4.5 7.5 3.3 5.5
Managerial and
technical 28.8 27.3 28 26.2 22.8 24.6 29.2 27.2 28.2
Skilled non-manual 13.2 37.8 26.9 14.5 38.5 26.1 13.3 38 25.1
Skilled manual 30.9 8.5 18.5 30 7.6 19.2 30.5 8.4 19.9
Partly skilled
manual 15 18.3 16.9 17.1 22.4 19.6 14.7 18.3 16.4
Unskilled manual 4.8 4.8 4.8 6.0 6.1 6.0 4.9 4.7 4.8
% in households:" % % %
With no children 46.1 51.4 48.2
With children 53.9 48.6 51.8
'Estimates based on the 1998 Health Survey for England. Source: National survey of sexual attitudes and
lifestyles. Technical report
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APPENDIX D Examples of forms used in unlinked anonymous survey of MSM
attending a GUM clinic
Ever injected drugs: Yes D Not asked D
FORMl
UNLINKED ANONYMOUS SEROPREVALENCE SURVEY
Sexual Orientation: Homo/bisexual D Heterosexual D
Date of last negative HIV test: Mth/year, ...!. .. Date not known D
Never tested: D (tick if yes)
Known HIV positive: D (tick if yes)
Patient spontaneously objects D (tick if yes)
FORM2
I
Patient-id Barcode
I 01008678 I ......................
I 00007898
1 ..................
199076548
1 ~ ..................
I '\
I -,
"" The
...........................•
FORM3
Barcode Laboratory no
GOI 165
GOI 166
GOI 167
Labels
rI~tflr.h~rI
........................... ~
mm!
se
barcode
numbers are
matching
Laboratory no HlV Result
FORM4
GOl165
GOl166
GOI 167
HIV negative
HIV negative
HIV positive
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APPENDIX E
APPENDIX E Paper prepared for the Expert Advisory Group in AIDS
H IV tesiing in men wt10 have sex _th men.
Recommendation for annual HIV testing of men who havil sex witt! men
attending genitourinary medicine clinics in England aoo Wales
Paper prepared for the Expert Advisory Group on AIDS. 19 February 2004
HIV and Sexually Transmitted Infections DepMment:
Health Protection Agency Communicable Disease Surveilance Centre
1 Background
1.1 One of the primary aims of the National strategy for Sexual Health and HIV( 1)
is 10 reduce the tnnm1ission of HIV and STls, with a national goal of achievng
a 25% reduction in the number of newly 8CXJuired HIV infections ~ 2007. To
achieve this goal, national standards for HIV testing have been set, indudilg
an increase in the offer" and uptake of HIV and sn testing. This is to be
achieved through offering aI genittuinary medicine (GUM) dinic atlendees an
HIV test on their first screenng for sns, and sWsequently according to risk.
12 Since 1999 there has been an itcrease in new diagooses of HIV in men who
have sex with men (MSM), 1617 new diagnoses in 2002 have been reported
so _. and .. is likely to rise as delayed reports are received (Figure 1 )(2).
Those currently being ciagnosed .appear to be a mix of old and new infections.
However the lack of chan.ge in CD4 cell count and median age at diagnosis
suggests Ihat a similar number of new infections are oa:urring as are
ciagnosed each year (Figure 2). In addition, estimates of annual incidence
among MSM attending GUM clnics receiving syptilis seroIoav between 1995
and 2002 showed a stable incidence of between 2-3.5%(3).
2 Evidence fot" policy change
2.1 The prev.alenc:e of previously undagnoeed HIV infedion amongst MSM
attendilg GUM dines detecled through the unlinked MOI1YfOOUS surveilance
programme was 5.4% in London and 2.4% ebewtIere in En!Jland, Wales and
Nathem lretand (FlQure 3)(2). Silce 2000 there has been a significant
increase in previously unciagnosed HIV infection in MSM presenting with an
acute sn from 5.8% in 2000 to 6.5% in 2002 in London, and from 1.2% 10
3.5% outside london (Figlre 3). The proportion of previously unciagnoaed HIV
infections that are diagnDsed at that clinic visit has inc:reued, particua.ty it
those who present with an acute S11 (Figwe 4).
22 However, we currently estimate that 62% of MSM aUencmg GUM dinies with
mdiB!JlDSed HIV infection leave the dinic wiIh their infection undiagnosed
(Figwe 4). This diffenl by clinical preaenlation; 66% of previously undiagnoeed
HIV positive MSM presenting with an acute STI in 2002 slil remained
mdiagnosed after theW"clinic visit, InC! 55%of MSM· allending without .-! acute
STI remain 80. The proportion remaining undiagnoeed was h~r in London
(62%) ~ to outside london (45%).
2.3 The current rate of HIV testing it MSM attending GUM dines is already high.
Behaviocnl surveys of MSM all indicale simiar HlV testing rates, of MSM
attendilg bars .-!d dubs in 2002, 74% had ever 1etted, and 38'lI(, in the last
year (51% of aU that had eII'ef tested)(4). Of MSM who had aftended a GUM
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clinic in the past year, 85% had ever HIV 1ested, a significant ilcrease in
2001(4). Of MS.. !UVe}Ied at ·Pride festivals" 64.2% repot1ed that they had
ever had a HIV tesI(5). The National survey of sexual allitudesand lifestyles
(Natsal 2000) found 36.7% of MSM reported that they had a HIV test in the
past 5 years, 36.6% of whom had it in the last year. However 86.6% of MSM
who had attended a GUM d ... ic in the past 5 years had 8 HIV Ie1It ... that pefiod
and 50.7% attending in the past year reported a HIV test ... the past year(6).
2.4 A survey of HIV lest policy and practice canied out thfOlJ!tl the British Co-
operative Clinical Group ... 1998 found that 72% of all sexLJ811y active
homosexual men aUencing GUM clinics had a HIV test at !hat visit. 97% of
those requesting a test and 36'% of those who cfld not ~ a test were
offered and accepted a test(7).
2.5 NUlMers of first HIV tests ... MSM coIlecied through laboratDfy surveiiance
have remained similar over recent years (Figure 5)(8). Prelimin.y analy1lis of
the J... ary.March 2003 KC60 retlms from III GUM dinicssuggests that the
rate of HIV testing in MSM attending cina is high, an estimate of 51'% of MSM
attendilg GUM dnics were offered and accepted a HIV tesl A review of all
attenders at 15 GUM clinics, receiving syphilis serology who had a HIV test at
that presenlation, (utilising recorded KOSO codes) reveals a similar propoftion
HIV testing, 60% of MSM presenting with an 8CLJte STI and 55% of MSM
presenting with a non-acute concition (Figure 6).
3 Policy objective
3.1 The fiBt stnliegic aim of the IsIest Comroority HIV .-.cl AIDS Prevention
Strategy (CHAPS), 'Making it CoIJTIt 2003' (9) for MSM is k> reduce the average
time between HIV infection .-.cl HIV ciagnosis in men who become infected.
The benefits of earty ciagnosis are the oppOOunity 10 rnIIIl8ge HIV infection ...
the individual and reduce the likeihood of onward transmission through
behllVioural change and decreased viral load through antiretrovirBl tre&Iment
Increased offering and reconmendation of HIV testing would reduce the
PIoportion of undagnosed HIV infedions ... MSM attend.-.g GUM clinics.
3.2 The irJ1llications of a change ... poiey need oonlideration. These ...dLJde the
impact on wol"kload and cost in GUM clinics, increued psychological wony for
MSM and ,potential reinforcement of high-risk sexual behaviou"s in individuals
that lest negative. ~ver there is currently little evidence to support these
latter hypo1l1eses of adverse affects and these are outweighed by the proven
benefits of HIV diagnosis. A policy change 10 increase the after of HIV tesmg
10 MSN may have lillie in1Jact on dinic wcrtdoad, since this may slandardise
exismg dinic practices as evidenced by the SUNellance data.
" Ways of achieving objectives
To achieve the objective of redumg undiagnosed HIV mections in MSM through HIV
lesting in GUM clini.cs, a oomber of "legies may be 1XIflIIidered:
1) Increasing the coverage of HIV tests being offered to MSII at their first
visit to a GUM clinic. This recommendation aims 10 i~e the
2
284
APPENDIX E
HIV testing in men who have sex .. th men.
implementation of the anent recommendation. However, the main problem
with this strategy is that as the meOan age at HIV seroconversion for MSM is
likely to be higher than the median age at first GUM attendance, this policy is
likely to miss HIV serocooversions occming after the tnt GUM HIV test.
2) Annual ofter and reoommendattor"l of HIV test to all MSI' attendiRg at
subsequent GUM visits. This policy wcUd buik! on objec:tiYe 1, but in
addition ensure that all MSM attending GUM services are actively offered .m
recommended an annual HIV tesL This wtdd ensure earlier HIV dia~
among asyrT1)1cmalic MSM presenting at GUM services. The policy has the
advantage of being targeted at MSM who are at significantly higher
behavioural and sn transmission risk than non- GUM clinic attenders.
3) Recommend that all se.xually active MS.. have annual tests. This more
general policy has the advantage of raising ...-eness of the need for HIV
testing among sliMS... and would berefev·ant to !hose in contact with and
those not accessing GUM services. A potential problem with this slnltegy is
the oon.specific nature of the recommendation (so those at highest risll: may
not feel the message is meant for them or those at low risk may test
repeatedly and unnecessarily). This recommendation also removes the
responsibility for active intervention by nealh care providers in contact with
MS"', and places the onus on MSM 10 get their annual HIV tests.
5 Policy Recommendations
5.1 Based on the evidence of the extent of undiagnosed HIV infection EAGA are
asked to consider that the standard of care for HI ...SM attending GUM dinios
shouk! include the offer and recorrrnendalion of a HIV test annuHly as part of a
sexual healtl1 screen.
3
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Figure 1: Number of new HIV and AIDS diagnoses
and deaths ill those illfect.ed by sex between men
by year of diagflOiSisJoccunreDce. UK data
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Investigating the relationship between H IV testing
and risk behaviour in Britain: National Survey of
Sexual Attitudes and Lifestyles 2000
Christine A. McGarriglea, Catherine H. Mercer", Kevin A. Fentona,b,
Andrew J. Copas", Kaye WellingsC, Bob Erensd and Anne M. Iohnson''
Objectives: To estimate the prevalence of, and identify factors associated with, HIV
testing in Britain.
Design: A large, stratified probability sample survey of sexual attitudes and lifestyles.
Methods: A total of 12 110 16-44 year aids completed a computer-assisted face-to-
face interview and self-interview. Self-reports of HIV testing, i.e. the timing, reasons for
and location of testing, were included.
Results: A total of 32.4% of men and 31.7% of women reported ever having had an HIV
test, the majority of whom were tested through blood donation. When screening for
blood donation and pregnancy were excluded, 9.0% of men and 4.6% of women had
had a voluntary confidential HIV test (VCT) in the past 5 years. However, one third of
injecting drug users and men who have sex with men had a VCT in the past 5 years. VCT
in the past 5 years was significantly associated with age, residence, ethnicity, self-
perceived HIV risk, reporting greater numbers of sexual partners, new sexual partners
from abroad, previous sexually transmitted infection diagnosis, and injecting non-
prescribed drugs for men and women, and same-sex partners (men only). Whereas
sexually transmitted disease clinics were important sites for VCT, general practice
accounted for almost a quarter of VCT.
Conclusion: HIV testing is relatively common in Britain; however, it remains largely
associated with population-based blood donation and antenatal screening pro-
grammes. In contrast, VCT remains highly associated with high-risk (sexual or drug-
injecting) behaviours or population sub-groups at high risk. Strategies to reduce
undiagnosed prevalent HIV infection will require further normalization and wider
uptake of HIV testing. \Cl 2005 lippincott Williams & Wilkins
AIDS 2005, 19:77-84
Keywords: HIV, HIV risk, HIV testing, probability survey, sex survey, sexual
behaviours
Introduction were undiagnosed [1]. In England, a goal of the National
Strategyfor Sexual Health and HIV [2J is to reduce the
prevalence of undiagnosed HIV infection by 50% within
the next 4 years. The implementation of the strategy has
In 2002, an estimated 49 500 individuals in the United
Kingdom were living with HIV infection, 31% of whom
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encouraged the promotion of HIV testing at sexually
transmitted disease (STD) clinics in addition to well-
established antenatal and blood donation screening
programmes. A further refinement of the strategy to
encourage the uptake of HIV testing, especially among
men who have sex with men (MSM) has been identified
as a priority by the Chief Medical Officer (England) [3].
The motivation behind HIV testing is complex, and an
individual's decision to be tested may be affected by a range
of factors including HIV testing policy, the effectiveness
and availability of medication, the availability of testing,
and health education messages promoting HIV testing.
Studies have shown that HIV testing is common among
MSM, ranging from 37-64% in the UK [4-8] to 83-85%
in Australia [9,10], 63% in Canada [II], and 84% in the
United States [12,13]. Previous studies, including both
general population probability sample and convenience
sample studies undertaken in community, STD clinic and
HlV testing clinic settings in the United Kingdom, have
shown strong associations between HIV testing uptake and
high-risk sexual behaviours in both MSM and hetero-
sexual individuals [4,6,7,14,15]. However there are no
current estimates of the prevalence of HIV testing in the
general population in Britain. In this paper we report
population estimates of HIV testing patterns and associated
behaviours from the second British National Survey of
Sexual Attitudes and Lifestyles (Natsal 2000).
Methods
Participants and survey methodology
Natsal 2000 and its additional ethnic minority boost
sample is a stratified probability sample survey of the
general population of 12110 men and women aged 16-
44 years resident in Britain. The study was undertaken
between 1999 and 2001, and the response rate was 65.4%.
Participants were interviewed using a combination of
computer-assisted face-to-face interview and computer-
assisted self-interview for collecting more sensitive
questions including questions on HIV testing. The
methodological details and outcomes related to high-risk
behaviours have been reported elsewhere [16-18]. In
addition to a range of questions on sexual practices,
behaviours and attitudes, we asked all respondents about
their HIV testing history (if they had ever had a blood test
that involved testing for HIVand when the last test was),
the reasons for HIV testing, as well as the self-perception
of personal risk of being infected with HIV.
Statistical analysis
Data from targeted over-sampling of ethnic minorities
(the Natsal ethnic minority boost) were combined with
the main survey data to increase the numbers of
respondents included in this analysis. Natsal 2000 data
Were weighted to account for differential selection
probabilities in the survey, and then post-stratified to
British population estimates of the age, sex and region
distribution from mid-1999, as previously described
[16-18]. Odds ratios were used to measure the associa-
tion of behavioural, demographic and risk perception
factors with reporting a voluntary HIV test in the past
5 years, i.e. excluding HIV testing through blood
donation and antenatal screening. Logistic regression
analyses were used to calculate adjusted odds ratios
(AOR), to identify factors independently associated with
HIV testing in this time frame. We performed all analyses
using the survey analysis software Stata (version 8.0;
Stata Corp., College Station, TX, USA), accounting for
stratification, clustering and weighting of the sample.
The study was approved by the University College
Hospital and North Thames Multi-Centre Research
Ethics Committee and all the Local Ethics Committees in
Britain.
Results
Prevalence of and reason for HIV testing
Overall, 32.4% [95% confidence interval (Cl) 30.8-34.1]
of men and 31.7% (95% Cl 30.5-33.0) of women
reported ever having had an HIV test (Table I). Just under
a quarter reported an HIV test in the past 5 years: 23.8%
(95% Cl 22.3-25.2) of men and 23.5% (95% Cl 22.3-
24.7) of women. The majority of both men and women
were tested through blood donation, whereas 16.5% of
women who had ever been tested, and 17.0% who had
been tested in the past 5 years, reported pregnancy as the
main reason for their last HIV test (Table 1). A greater
proportion of men reported both a 'general health check'
and 'concern of risk to self' as a reason for their last HIV
test than women, both ever and in the past 5 years. These
reasons accounted for a quarter of all HIV tests in men,
although because men are not routinely screened as a
result of pregnancy these differences are expected.
As both antenatal screening for HIV (pregnancy given as
the main reason for an HIV test in women) and blood
donation constitute screening programmes rather than
individuals choosing to be tested for HIV, blood donation
and antenatal screening were excluded from further
analyses of demographic and behavioural factors asso-
ciated with voluntary confidential HIV testing (VCT).
Table 1 shows the prevalence ofVCT in the past 5 years,
with adjusted odds ratios (AOR) associated with having
an HIV test by demographic, social and behaviour
variables. Overall, 9.()O/c)(95% Cl 8.1-10.0) of men and a
significantly lower proportion of women, 4.6% (95% Cl
4.0-5.2), chose to have an HIV test in the past 5 years.
In univariate analysis having an HIV test in the past 5 years
was associated with being aged 25 - 34 years and being of a
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higher social class in men, and living in Greater London,
not having been married, and being black Caribbean,
blackAfrican, and of other ethnicity for men and women.
Greater numbers of sexual partners, reporting a previous
sexually transmitted infection (STI), acquiring new sexual
partners from abroad, and increasing numbers of same-sex
partners were all associated with HIV testing in the past
5 years for both men and women. Nearly one third of
injecting drug users had had an HIV test in the past
5 years.
In multivariable analysis, after adjustment for all demo-
graphic and behavioural variables, the demographic
variables remaining statistically associated with having
had an HIV test in the past 5 years were similar for both
men and women. Men aged 25 years and over were more
likely to have been tested than men aged under 25 years,
whereas there was no difference in testing by age for
Women. Individuals living in Greater London had a
significantly greater AOR of having had an HIV test
compared with those resident in the rest of Britain (AOR
1.58 for men and 1.79 for women). The odds of HIV
testing varied by ethnicity even after adjustment, with
men of black African and 'other' ethnicity more likely to
be tested compared with white men (AOR 3.45 and
2.51), whereas in women there was no difference, after
adjustment (Table 2).
In multivariable analysis, after controlling for demo-
graphic and other behaviour variables, the magnitude of
the associations of HIV testing with each behavioural
variable reduced, but a significant association remained.
The likelihood of having had an HIV test in the past
5 years increased with increasing numbers of sexual
partners. Women who had had 10 or more sexual partners
in the past 5 years, had an AOR of 4.15 of reporting an
HIV test, compared with women who had had at most
HIV testing in Britain, Natsal 2000 McGarrigle et al. 81
one partner, whereas men with 10 or more sexual
partners had an AOR of 2.30. Acquiring new sexual
partners abroad was also independently associated with
HIV testing in the past 5 years, as well as reported STI in
the past 5 years and injecting drug use for both men and
women. Men who reported having more than 10 male
sexual partners in the past 5 years had an AOR of5.08 of
having an HIV test compared with men who had no male
partners.
Time since last HIV test and perception of risk
The prevalence of reported HIV testing varied according
to an individual's perception of their self-perceived risk of
HIV infection (Table 3). The prevalence of HIV testing
was greater in all men who stated that they were 'not very
much at risk' or 'greatly or quite a lot at risk' compared
with those who perceived that they were 'not at risk at all'
after adjustment for age (P < 0.0001). In women, the
prevalence of testing by self-perceived risk was also
greater in those who perceived themselves to be at a
greater risk after adjustment for age. Both men and
women who reported that they 'don't know' if they were
at risk of HIV infection were more likely to have had an
HIV test than those who reported that they were 'not at
risk at all'. There was no difference in the prevalence of
HIV testing in MSM by risk perception (P = 0.6385),
although one third of men who had same-sex partners
had been tested in the past 5 years.
Over half the respondents who reported choosing to have
an HIV test in the past 5 years (i.e. excluding blood
donation and antenatal screening) tested within the past 2
years; 28.3% (95% Cl 23.8-33.3) of men and 25.4% (95'Yc.
Cl 20.2-31.4) of women reported their last HIV test in
the past year, and 25.7% (95% Cl 21.4-30.5) and 25.9%
(95% Cl 20.8-31.8), respectively, between one and
2 years ago. Among MSM, two thirds tested within the
Table 3. Relationship between perception of self-risk of HIV infection and voluntary HIV testing" (age-adjusted odds
ratio and 95% confidence interval) by sex and sexuality.
Perception of risk of HIV
infection to self
% (95% Cl) of reporting an
HIV test in past 5 years Base (UW, WT)
Age adjusted OR
(95% Cl) P value
All men
Not at all at risk
Not very much at risk
Greatly/quite a lot at risk
Don't know
All women
Not at all at risk
Not very much at risk
Greatly/quite a lot at risk
Don't know
Men who have sex with men"
Not at all at risk/don't know
Not very much at risk
Greatly/quite a lot at risk
Don't know
7.7 (6.7-8.9)
10.5 (8.9-12.4)
13.4 (9.6-18.3)
26.3 (11.0-50.6)
3.8 (3.3-4.5)
6.0 (4.8-7.5)
8.2 (4.8-13.8)
7.7 (14.7-32.0)
40.6 (25.8-57.3)
35.14 (24.2-47.8)
30.6 (14.9-52.7)
<0.0001 2659,3382
1596, 1799
270, 262
21,19
1.0
1.51 (1.19-1.91)
2.17 (1.41-3.32)
4.40 (1.54-12.62)
1.0
1.51 (1.11-2.06)
2.34 (1.30-4.24)
2.49 (0.39-15.72)
0.0051 4223, 3746
1689,1396
207, 150
37, 29
1.0
0.66 (0.27 - 1.61)
0.80 (0.21-3.02)
0.6385 48,52
96,79
26,21
Cl. Confidence interval; OR, odds ratio; WT, weighted; UW, unweighted.
"Excludes testing through blood donation and antenatal screening.
bMen who reported a same-sex partner in the past 5 years.
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Table 4. Place where last HIV test was carried out by sex and sexuality (excluding blood donation and antenatal
screening).
Place of HIV testa
All men
% (95% Cl)
All women
% (95% Cl)
Men who have
sex with men
% (95% Cl)
GP surgery
STD clinic
NHS family planning clinic
Private clinic or doctor
Somewhere else
Base", unweighted, weighted
28.5 (24.0-33.6)
34.1 (29.1-39.5)
2.8 (1.6-4.8)
14.4 (11.0-18.6)
20.1 (16.1-24.8)
498, 488
20.0 (15.1-25.6)
44.0 (37.8-50.3)
3.0 (1.8-5.3)
13.1 (9.6-17.5)
19.9 (15.2-25.6)
346,241
18.4 (8.4-35.8)
52.0 (36.3-67.4)
0.5 (0-3.9)
11.3 (4.5-25.6)
17.7 (7.9-35.0)
62, 56
Cl, Confidence interval; GP, general practitioner; NHS, National Health Service; STD, sexually transmitted
diseases.
"Al] percentages are of column-weighted bases.
"Excludes those who did not have an HIV test, did not answer or answered maybe/not sure whether they had had
an HIV test in the past 5 years.
past 2 years; 37.8% (95% Cl 24.7-53.0) in the past year
and 28.6% (95% Cl 16.5-44.8) between one and 2 years
ago.
Place of last H IV test
The most commonly reported place where an HIV test
was carried out was at an STD clinic for women (44.0%)
and men (34.1%). General practice was also commonly
reported for men (28.5%) and women (20.0%) (Table 4).
Twenty per cent of men and women had had an HIV test
'somewhere else'. The majority ofMSM (52.0%) had had
their HIV test at an STD clinic. whereas 18.4% reported
that their last HIV test was at a general practitioner's
surgery.
Discussion
Natsal 2000, a national probability sample survey,
provides estimates of the prevalence of HIV testing in
the general population, and has found that overall over a
third of British men and women have tested for HIV in
their lifetime, the majority of whom have been tested
through blood donation. When HIV screening through
blood donation and pregnancy are excluded, testing for
HIV in the past 5 years was associated with high-risk
behaviours in both men and women. We also found
reported HIV testing to be associated with certain
demographic characteristics, including older age, resi-
dence in London, and black-African ethnicity. These may
reflect both lifetime opportunity for HIV testing, self-
perceived risk of HIV infection, and individual attitudes
towards HIV testing. With the exception of older age,
many of these characteristics are also associated with a
greater burden of STI [1.17) and an increased likelihood
of attending an STD clinic.
Robust prevalence estimates of HI V testing uptake in the
general population are not available in many countries. In
the USA, the general population prevalence of HIV
testing was greater at 45.6%, whereas this excluded blood
donors, it included testing through other screening
programmes such as military service, immigration.
marriage licence and occupational exposure. which
together accounted for 45.2'){, of all HIV tests in men
and 27.8% in women [19J. Canadian estimates of general
population voluntary HIV testing are also greater than the
UK, at 17.8% of men and 15.6% of women [20J.
Convenience samples of MSM in the UK have reported
greater rates of HIV testing, ranging between 53-64%,
ever tested [5,2lJ and 32% in the past year [2lJ. However,
of the MSM in our study who reported that they had had
an HIV test in the past 5 years, a similar proportion
reported an HIV test in the past year (36%). MSM
recruited through Natsal include both MSM at higher
and lower behavioural risk. as Natsal is a probability
survey of the general population. In contrast. convenience
sample surveys may be sampling men with higher risk
behaviours. Nonetheless, the proportion of those MSM
from Natsal 2000 who had attended an STD clinic in the
past 5 years and had also had an HIV test has been found to
be similar to other studies at 74% [8J. Geographical
differences in the prevalence of voluntary HIV testing in
both MSM and the general population have been
reported in the USA [19J, Canada (11). and Australia
(10). These have been associated with the differential
availability of testing and service provision. and com-
munity attachment among MSM [10,11 J. Unprotected
anal intercourse, and HIV-positive partners were also
found to be associated with HIV testing in MSM, and
those who were at greatest risk were more likely to have
been tested [1OJ.
Our study has some limitations, as non-respondents
may be different from those who chose to participate;
however, the direction of this bias is unknown.
Probability sample surveys. by their nature, do not
achieve large samples of high-risk populations, although
this was addressed in this survey through oversampling in
London, and the focussed enumeration of ethnic
minorities to achieve larger sample sizes in these groups,
which were then weighted to correct for unequal
selection probabilities. As both HIV testing and sexual
behaviours were self-reported in Natsal 2000, this may
lead to bias because of individual's reluctance to disclose
sensitive behaviours. However, the cognitive interviews
carried out to validate the methodology for Natsal 2000
concluded that individuals were happy to report their
HIV testing behaviours, and as the respondent's HIV
status was not requested, this subject was not considered
to be too intrusive [18]. Improved data collection
methodology in 2000 with the use of computer-assisted
self-interview (CASI) may have further facilitated the
reporting of sensitive behaviours, including HIV testing.
Comparisons of age-related cohorts between the 1990
and 2000 surveys indicated that it is possible that there has
been a change in the willingness to report some
experiences, perhaps in particular for those that are most
socially sensitive [22]. Because HIV status was not
collected in our survey, the reported self-perception of
risk could be informed by an individual's knowledge of
his or her own HIV status. This appears to be more
important in MSM as there was no evidence of a
difference in the likelihood of reporting an HIV test in the
past 5 years in those who did not perceive themselves to
be at risk of HIV infection. However, in all men and
women, the probability of reporting an HIV test in the
past 5 years was greater in those who perceived themselves
to be at risk or did not know if they were at risk.
HIV testing was associated with higher risk behaviours
and numbers of sexual partners, and the numbers of same-
sex partners for men. This suggests that HIV testing
largely remains part of a reasoned decision-making
process both on the part of the individual and their health
service providers. Although HIV testing was associated
With risk behaviours, and reporting STI diagnoses, the
opportunities to offer and recommend HIV testing to
those at increased risk of infection should be encouraged.
A substantial number of HIV tests were reported to have
taken place outside the STD clinic setting. If barriers to
HIV testing exist, further research is needed to under-
stand what they are and if they are with the provider or the
individual. Voluntary confidential HIV testing is an
important strategy for facilitating the management of
HIV infection in the individual and reducing the
likelihood of onward transmission through behavioural
change and decreased viral load through antiretroviral
treatment. National standards for HIV testing have been
set in the National Strategy for Sexual Health and HIV
[2], including an increase in the offer and uptake of HI V
and STI testing. In order to decrease undiagnosed
HIV infections, care should also be taken to ensure that
HIV testing is available to all.
~knowledgements
The study was supported by a grant from the Medical
Research Council with funds from the Department of
HIV testing in Britain, Natsal 2000 McGarrigle et al. 83
Health, the Scottish Executive and the National Assembly
for Wales.
The authors would like to thank all the study participants,
the team of interviewers and the operations and
computing staff from the National Centre for Social
Research who carried out the interviews.
References
1. Brown AE, Sadler KE, Tomkins SE, McGarrigle CA,
LaMontagne DS, Goldberg D, et al. Recent trends in HIV
and other STls in the United Kingdom: data to the end of
2002. Sex Transm Infect 2004,80:159-166.
2. Department of Health. The national strategy for sexual health
and HIV: Implementation Action Plan. London: Department of
Health; 2002.
3. Chief Medical Officer. Health check. On the state of public
health. Annual Report of the Chief Medical Officer 2003.
London: Department of Health; 2004.
4. Dodds J, Nardone A, Mercey 0, Johnson A. Increase in high
risk sexual behaviour among homosexual men, London 1996-
1998: cross sectional, questionnaire study. BMI 2000,
320:1510-1511.
5. Hickson F, Weatherburn P, Reid 0, Stephens M. Out and
about. Findings from the United Kingdom Gay Men's Sex
Survey 2002. London: Sigma Research; 2003.
6. Hart GJ, Flowers P, Der Gl, Frankis JS.Homosexual men's HIV
related sexual risk behaviour in Scotland. Sex Transm Infect
1999, 75:242-246.
7. Norton J, ElfordI, Sherr L,Miller R, Johnson MA. Repeat HIV
testers at a London same-day testing clinic. AIDS 1997,
11:773-781.
8. Mercer CH, Fenton KA, Copas A], Wellings K, Erens S,
McManus S, et al. Increasin~ prevalence of male homosexual
partnerships and practices In Britain 1990-2000: evidence
from national probability surveys. AIDS 2004, 18: 1453-1458.
9. Van de Ven P, Prestage G, Knox S, Kippax S. Gay men in
Australia who do not have HIV test results. Int J STD AIDS
2000, 11 :456-460.
10. [in FY, Prestage G, Law MG, Kippax S, Van de Ven p,
Rawsthorne P, et al. Predictors of recent HIV testing
in homosexual men in Australia. HIV Med 2002, 3:271-276.
11. Myers T, Godin G, Lambert J, Calzavara L, Locker D. Sexual
risk and HIV.testing behaviour by gay and bisexual men in
Canada. AIDS Care 1996, 8:297-309.
12. Roffman RA,Kalichman SC, KellyJA,Winett RA,Solomon LL
Sikkema KLet al. HIV antibody testing of gay men in smaller
US cities. AIDS Care 1995, 7:405-413.
13. Kellerman SE, Lehman JS, LanskyA, Stevens MR, Hecht FM,
Sindman AB, et al. HIV testing within at·risk populations
in the United States and the reasons for seeking or avoiding
HIV testing. J Acquir Immune Oefic Syndr 2002, 31:202-
210.
14. Fenton KA,Chinouya M, Davidson 0, Copas A. HIV testing
and high risk sexual behaviour among London's migrant
African communities: a participatory research study. Sex
Transm Infect 2002, 78:241-245.
15. Johnson AM, Wadsworth L Wellings K, Field J, Bradshaw S.
Sexual attitudes and lifestyles. Oxford: Blackwell Scientific
Publications; 1994.
16. Johnson AM, Mercer CH, Erens B, Copas AL McManus S,
Wellings K, et al. Sexual behaviour in Britain: partnerships,
practices, and HIV risk behaviours. Lancet 2001, 358: 1835-
1842.
17. Fenton KA, Korovessis C, Johnson AM, McCadden A,
McManus S, Wellings K, et al. Sexual behaviour in Britain:
reported sexually transmitted infections and prevalent genital
Chlamydia trachomatis infection. Lancet 2001, 358: 1851-
1854.
18. ErensB,McManus S, FieldL KorovessisC, Johnson AM,Fenton
K, et al. National survey of sexual attitudes and lifestyles II:
AIDS 2005, Vol 19 No 1
technical report. london: National Centre for Social Research;
2001.
19. Centers for Disease Control and Prevention. HIV testing -
United States, 2001. MMWR 2003; 52:540-545.
20. Houston S, Archibald CP, Strike C. Sutherland D. Factors
associated with HIV testing among Canadians: results of
a population-based survey. Int J STD AIDS 1998, 9:341-346.
21. Dodds JP,Mercey D. London Cay Men's survey: 2001 results.
London: Royal Free and University College Medical School;
2002.
22. Copas AI. Wellings K, ErensB, Mercer CH, McManus S, Fenton
KA, et sl. The accuracy of reported sensitive sexual behaviour
in Britain: exploring the extent of change 1990-2000, Sex
Transm Infect 2002, 78:26-30.
ORIGINAL ARTICLE
145
Trends in, and determinants of, HIV testing at genitourinary
medicine clinics and general practice in England, 1990-
2000
T RChadbom, C A McGarrigle, P A Waight, KA Fenton, on behalf of the HIVTesting Surveillance
Collaborative Group
...............................................................................................................................
Sex Transm Infect 2004;80:145-150. doi: 10.1136/sli.2003.006288
Objectives: To describe the trends in and determinants of HIV testing and positivity at genitourinary
medicine (GUM) clinics and in general practice (GP) in England between 1990 and 2000.
Methods: Data on 011 ~rst HIV specimens from GUM and GP clinics and tested at seven sentinel
laboratories were related to key demographic, clinical, and behavioural variables.
Results: During the observation period, 202 892 eligible ~rst HIV tests were reported. 90% (182 746) of
specimens were from GUM clinics, of which 55% were from heterosexuals, 12% from men who have sex
with men (MSM), and 3% from injecting drug users (IOU). In contrast, only 3% of GP specimens were from
MSM and 13% from IDUs. The total number of ~rst HIV tests increased threefold between 1990 and 2000.
Overall, 1.6% of GUM and 0.9% of GP ~rst testers were diognosed HIV positive. In GUM clinics, HIV
positivily was highest among heterosexuals who have lived in Africa (11.7%), MSM (6.9%), and IDUs
(2.8%) and lowest among heterosexuals with no other speci~ed risk (0.3%). Consistenrly lower prevalences
were observed in GP settings. HIV positivity among GUM ~rst testers declined in MSM, from 13.6% in
1990 to 5.2% in 2000 (p<O.OI), and in IDUs, from 7.5% in 1990 to 2.0% in 2000 (p .. 0.03). Prevalence
remained constont in the groups heterosexually exposed to HIV infection.
Conclusions: HIV testing in GUM settings increased over the decade, with a concomitant reduction in HIV
positivily among MSM and IDUs. Increased testing among heterosexual ~rst testers overall was not
associated with declining positivily.
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By the end of June 2002, over 4400 HIV infections newlydiagnosed in the United Kingdom in 2001 had beenreported to the Communicable Disease Surveillance
Centre (CDSC) with 26635 HIV infected individuals reported
as being seen for care during that year in the United
Kingdom.' Two decades of intensive HIV health promotion
have seen gradual and sustained increases in HIV testing
among GUM attendees in the United Kingdom. Statutory
returns made by GUM clinics in England (form KC60) show
that the number of episodes of HIV counselling and testing
increased by 35% in the last year, 56% in the past 3 years, and
by 90% in the past 6 years to 201 347 in 2001.' Nevertheless,
substantial numbers of HIV infected individuals in the
United Kingdom still do not know their HIV status' and
therefore cannot receive appropria te care, notify their
partners, or be guided in safer sexual behaviour in knowledge
of their status.'
In an effort to reduce the number of undiagnosed HIV
infections in the population and to reduce HIV transmission,
testing promotion has been prioritised by the Department of
Health's National Strategy for Sexual Health and HIV for
England.' Key strategies include the provision of clear
information to the public about HIV with the aim of
encouraging the demand for voluntary HIV testing while
improving access to GUM services and increasing the offer of
HIV testing. At the same time, there is a growing acknow-
ledgement of the need to remove the exceptionalism and
stigma associated with HIV testing by providing these
services outside traditional GUM and antenatal settings ..
Currently, there is little information on HIV testing trends in
general practice in England' or in other settings where
individuals at increased risk may be seen (for example,
termination of pregnancy clinics).
This study aimed to explore trends in HIV testing in GUM
clinics and the comparative trends in GP practices using data
derived from an existing sentinel laboratory surveillance
programme.' In this paper we focus on changes in HIV
testing over time by exposure category and sex, and compare
the numbers of HIV tests and HIV positivity across risk
groups.
METHODS
Study description
The denominator study was set up in 1986 by the Public
Health Laboratory Service (PHLS) to monitor trends and
determinants of voluntary HIV testing in England through
the sentinel surveillance of 18 laboratories.' Seven sentinel
laboratories in England (three in London and four outside
London) were selected to continue after 1998 on the basis of
their ability to provide complete electronic records of their
HIV tests to Communicable Disease Surveillance Centre
(CDSC). They were not a randomly selected sample of
laboratories and cannot be assumed to reflect all HIV testing
in England. However, these sentinel laboratories accounted
for 16%of all HIV tests reported from English GUM clinics in
2000 and areas outside London were well represented. All
laboratories participated in a national external quality
assurance scheme for HIV (NEQAS). There is no evidence
to suggest that any differences in the sensitivity of HIV tests
for different SUbtypes would have a significant effect on
detected HIV positivity between exposure categories or over
time" Enhanced epidemiological data on exposure, reasons
for testing, and HIV related symptoms at the time of test have
been routinely collected at these centres on all HIV test
request forms, which collected the same core dataset.
www.s~ioumal.com
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Variations between sites were accommodated by regrouping
data into broader categories for this analysis.
Data extraction
First tests of individuals were identified on each laboratory
database in the laboratory by matching on either GUM
number or name and date of birth. All patient identifiers
were then removed before extracts of all first tests were sent
to CDSCfor addition to a central database. Variables collected
on each patient included date and final result of test, source
of specimen, age, sex, reported risk factors, nature of contact
involved in the HIV transmission risk, reasons for testing,
and symptoms at the time of test. Specimens referred to
participating laboratories from other laboratories for con-
firmatory testing were excluded.
Data preparation
For this analysis all first HIV tests performed between I
January 1990 and 31 December 2000 in the seven sentinel
sites were selected. HIV tests from hospital wards and other
clinics were excluded leaving only those tests requested by
GUM clinics and GPs. We excluded individuals recorded as
known to be HIV positive (because this would not have been
their first test), those with unknown or equivocal test results,
and people aged less than 15 or of unknown age. We also
excluded individuals whose HIV test was clearly prompted by
some other reason than a perception of HIV risk: pregnant
women, organ/tissue donors, and individuals with either
antiretroviral treatment or special survey reported as the
reason for their test. Exposure categories were assigned to the
individuals tested according to their reported risk factors and
the nature of contact through which HIV may have been
transmitted. This allocation used a hierarchical algorithm
(fig I): men who have sex with men (MSM); injecting drug
users (IOU); recipients of blood/blood products or tissues
(Blood); heterosexuals with high risk partners (HET HRP);
heterosexuals who have lived in Africa (HET LA); hetero-
sexuals with no other specified risk (HET OT). Those with no
identified risk behaviour and those with other risk beha-
viours reported were grouped as such. For each centre, data
were checked for evidence of inconsistent data entry. This
identified HIV tests for which the source of test had been
Chadborn, McGarrigle, Waight, et al
systematically misclassified over a period of time at one
laboratory. Tests were reallocated to the GUM clinic.
Statistical analysis
Stata 7.0 software was used for statistical analyses of the
data. Differences in proportions were tested by Pearson's l
method and Fisher's exact test where appropriate. Point
estimates and exact confidence intervals for odds ratios were
calculated for comparison of the odds of testing positive by
exposure, source, and sex. Trends were analysed using linear
regression using ordinary least squares.
RESULTS
Overall description of somple
A total of 206 782 first HIV specimens were tested at the
seven sentinel sites over the to year period; 98% were eligible
for inclusion in this study. Two laboratories, both in London
and with more than 50 000 tests each, accounted for over
50% of the tests. Ninety per cent (182 746/202 892) of the
eligible tests were requested from GUM clinics. The majority
of tests (77%) were performed on samples from hetero-
sexuals with no other specified risk and individuals with no
identified risk (50% and 28% respectively at GUM clinics and
17% and 56% respectively at GPs). MSM accounted for 11.2%
(22685/202892) of individuals tested for HIV, with the
proportion ranging from 3.8% (522/13 8(7) to 19.5% (II 1111
56 916) across sites.
HIV testing by source of specimen
More first HIV tests from GUM clinics than from GPs were
reported in each exposure category, both within and outside
London (table I). Overall, in GUM clinics 12% of HIV tests
were for MSM and only 3% for IDUs. In contrast, 3% of tests
requested by GPs were for MSM and 13% for mus. Overall, a
higher proportion of individuals tested at GUM clinics (55%)
were heterosexuals than those tested at GPs (22%) (p<O.OI).
In contrast, individuals with no identified risk accounted for
28% of the individuals tested at GUM clinics and 56% of
those tested at GP (p<O.OI).
Significant sex differences in HIV testing were observed
between exposure categories. Females accounted for over
70% (4082 of 5164 overall) of heterosexuals with high risk
partners in both GUM clinics and at GP practices, both within
Other No info
Figure 1 Algorithm for the
hierarchical calegorisation of
exposures. The patient risk has
decreasing hierarchy from MSM to
Other/NK. MSM - men who have sex
with men, IOU - injecting drua. user,
Blood - haemophiliac or transfusion/
transplant recipient, MP - mul~ple
heterosexual partners, HET -
heterosexual, OT - no other specified
risk, LA - lived in Africa, HRP - high
risk partner.
-------------_;;,oo~-iA~'''fl i~t:~K:~IA,,;;J iiD~""'J:No ,'"
Female Male ·Portner-
MSM,IOU,
blood
Homosexual Heterosexual
www.s~journal.carn
HIV testing in England 147
Table 1 Number and percentage of HIVtests by source and exposure cotegory"
London Outside London
Exposure caIegofy GP IoIaI (%l GUM IoIaI (%l GP IoIal (%) GUM IoIaI (%l
Sex between men 141 (2) 13734 (15) 520 (4) 8290 (9)
Injecting drug use 981 (15) 2273 (3) 1556 (111 2408 (3)
Blood or tissue. 33 (1) 352 (0) 114 (I) 303 (0)
Hetel'Olexual:
High risk partner 89 (I) 2196 (2) 430 (3) 2470 (3)
lived in Africa 146 (2) 3642 (4) 254 (2) 1008 (I)
Other 660 (l0) 41744 (46) 2829 (21) 49669 (54)
No identmed ri.k 3887 (61) 25419 (28) 7310 (53) 25645 (28)
Other ri.k 479 (8) 1619 (2) 717 (5) 1974 (2)
Total 6416 (lOO) 909791100) 13730 (lOO) 9t767 (lOO)
'Include. people 01 unknown sex. GP • general practice; GUM • genitourinary medicine.
and outside London (table 2), but 30% or less of tested IDUs
at all sources (data not shown). Among heterosexuals who
have lived in Africa, men accounted for 61% (609 of 1003) of
tests at GUM clinics and 69% (176 of 254) of tests at GPs
outside London (with a more even balance in London).
The overall modal age group for each exposure category
was 25-29 years of age except for the female heterosexuals
with high risk partners who were generally younger (table 2).
MSM and IDUs tested outside London were younger than
those tested in London. Male heterosexuals with no other
specified risk were younger than females except at GUM
clinics within London.
Trends in HIV testing
The annual number of first tests increased from 8328 in 1990
to 26 389 in 2000. There was a linear increase from 1996 to
2000 (p<O.OI) averaging 1932 tests per year. The total
contribution of HIV tests from GUM clinics increased from
6398 in 1990 to 23 923 in 2000 (p<O.OI). There was no
significant linear change in the total number of tests at GPs
(1930 in 1990 to 2466 in 2000, p = 0.58).
At GUM clinics, HIV tests increased from all exposure
groups except heterosexuals with high risk partners, the
recipients of blood/blood products or tissues and those with
other risk behaviours. Heterosexuals with no other specified
Table 2 Distribution of HIVprevalence within exposure categories by source and region
London Outside Landon
GP GUM 011* (95% en GP GUM OR' (95% en Toeal
Homosexual and bisexual men
Total number Ie.ted 141 13734 520 8290 22685
HIV prevalence 15.6% 8.5% 1.98 (1.20-3.16) 3.7% 4.1% 0.89 (0.53 ta 1.44) 6.8%
Modal age groop 25-29 25-29 20-24 20-24 25-29
Injecling drug UI8r5
Total number tested 981 2273 1556 2408 7175
HIV prevalence 1.3% 404% 0.29 (0.15 100.52) 0.5% 1.3% 0.38 (0.15 100.85) 2.1%
Modal age groop 30-34 25-29 20-24 20-24 25-29
Female hetel'Olexuall:
Total number Ie,ted (%) 472 (100) 26289 (100) 1654 (lOO) 26670 (lOO) 55085 (lOO)
HIV prevalence 2.5% 1.6% 1.64 (0.83 102.92) 0.4% 0.3% 1.45 (0.56 10 3.1A) 0."'
Moda) age groop 20-24 20-24 20-24 20-24 20-24
High riak partner
Total number Ie,ted (%) 7A (16) 1740 (7) 311 (19) 1957 (7) 4082 (7)
HIV prevalence 0.0% 0.6% n/a 0.0% 0.2% n/a 0.3%
Moda) age groop 20-24 25-29 25-29 20-24 20-24
INed in Africa
Total number tested (%) 65 (14) 1754 (7) 78 (5) 394 (I) 2291 (A)
HIV prevalence 16."' 16.1% 1.06 (0.50-2.09) 7.7% 9.1% 0.83 (0.28 la 2.09) 14.6"-
Modal age group 25-29 25-29 25-29 25-29 25-29
Other
Total number tested (%) 333 (71) 22795 (87) 1265 (76) 24319 (91) '-'712 (88)
HIV prevalence 0.3% 0.5% 0.57 (0.01 la 3.25) 0.1% 0.2% 0.49 (0.01 102.92) 0.3"-
Modal age group 25-29 25-29 25-29 25-29 25-29
Male '-roaexuala:
Total number tested (%) 399 (lOO) 21129 (lOO) 1854 (lOO) 26340 (lOO) 49722 (lOO)
HIV prevalence 3.8% 1.4"- 2.71 (1 .48 la 4.60) 0.2% 0.3% 0.68 (0.18 la 1.80) 0.8%
Moda) age group 25-29 25-29 20-24 20-24 25-29
High riak partner
Talai number tested (%) 13 (3) 446(2) 118 (6) 505 (2) 1082 (2)
HIV prevalence 0.0% 1.6% n/a 0.0% 0.6"- n/a 0."'
Madal age group 25-29 25-29 25-29 20-24 25-29
INed in Africa
Total number tested (%) 76 (19) 1869 (9) 176 (9) 609 (2) 2730 (5)
HIV prevalence 13.2% 10.0% 1.37 (0.62 la 2.74) 1.7% 6.2% 0.26 (0.05 la 0.84) 8.7%
Modal age group 25-29 25-29 35-39 25-29 25-29
Other
Total number tested (%) 310 (78) 18814 (89) 1560 (84) 25226 (96) 45910 (92)
HIV prevalence 1.6% 0.6% 2.87 (0.91 106.97) 0.1% 0.2% 0.38 (0.01 la 2.21) 0.3%
Modal age group 20-24 25-29 20-24 20-24 25-29
'Odd. ratio. compare HIV prevalence 01 GP la GUM (GP • general practice; GUM • genitourinary medicinel.
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Figure 2 Trends in (AI HIV testing and (BI HIV prevalence among first
testers at GUM clinics. MSM = men who hove sex with men; IOU =
injecting drug users; HET HRP = heterosexuals with high risk partners;
HET lA = heterosexuals who hove lived in Africa; HET OT =
heterosexuals with no ather specified risk; Unknawn = no identified risk
reported.
risk and people with no identified risk accounted for most of
the overall increase (fig 2A). Consequently, the proportion of
HIV tests among MSM declined from 23% in 1990 to 10% in
2000 (p = 0.01), from 4% to 2% (p = 0.02) among lDUs, and
from 5% to 1% (p = 0.00) among heterosexuals with high risk
partners.
At GPs, the proportion of tests requested by IDUs increased
over time (4% (84/1930) in 1990 to 21 % (524/2466) in 2000,
p<O.OI), which contributed to the gradual declines in the
proportion of tests requested from MSM (p<O.OI), hetero-
sexuals with high risk partners (p<O.O I), heterosexuals who
have lived in Africa (p = 0.02), and heterosexuals with no
other specified risk (p<O.OI).
HIV prevalence
Marked geographic heterogeneity in HIV posrnvity was
observed in those being tested for the first time. Sites in
London had generally higher positivity than those outside
(2.6% compared to 0.7%, p<O.OI). At GUM clinics, HIV
prevalence was generally significantly higher in all exposure
categories in London compared to outside London (table 2).
This was also the case at GPs except where the numbers
tested or the numbers tested positive were small.
Overall, HIV positivity was high in heterosexuals who have
lived in Africa (11.4%, 572 of 5021), in MSM (6.8%, 1550 of
22 685) and in recipients of blood/blood products or tissues
(4.3%, 34 of 794). HIV positivity was 0.4% (23 of 5164) in
heterosexuals with high risk partners and 0.3% (317 of
94 622) in heterosexuals with no other specified risk. HIV
positivity in female heterosexuals who have lived in Africa
was higher overall than that in males in the same exposure
category (14.6% v 8.7%; odds ratio (OR) 1.80 (95% Cl 1.50 to
2.16)) (table 2). This contrasts with a higher prevalence in
male heterosexuals with high risk partners than in females
(0.9% v 0.3%, OR 2.92 (1.l4 to 7.23)).
Within London, HIV positivity was higher among MSM
tested at GPs than in those tested at GUM elinics (15.6% v
www.stijournal.com
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8.5%, OR 1.98 (1.20 to 3.16)). A similar difference was weakly
significant for male heterosexuals with no other specified risk
(1.6% v 0.6%, OR 2.87 (0.91 to 6.97)). In contrast, prevalence
was lower among !DUs tested at GPs than at GUM elinics
( 1.4% v 4.4%, OR 0.30 (0.15 to 0.54)). HIV positivity was also
lower at GPs than at GUM elincs outside London among
IDUs and among male heterosexuals who have lived in Africa
(0.5% v 1.3%, OR 0.38 (0.15 to 0.85) and 1.7% v 6.2%, OR 0.26
(0.05 to 0.84) respectively) .
Trends in HIV prevalence at GUM clinics
Linear regression analysis in MSM showed significant
decreases in HIV prevalence over time overall (p<O.OI)
(fig 2B) and both within London (p<O.OI) and outside
London (p = 0.02). A significant decline was also seen for
IDUs tested in London (p = 0.02) but there was no evidence
of a decline outside London (p = 0.22). No other strongly
significant trends were observed. However, H IV prevalence
among heterosexuals with no other specified risk decreased
from 0.43% in 1990 to 0.16% in 1996 and then increased to
0.57% in 2000. Similar trends were seen in both heterosexual
males and females, both within and outside London. The
numbers of individuals first tested at GPs in each year were
not large enough for analysis of trends within exposure
groups.
DISCUSSION
Between 1990 and 2000 the number of voluntary HIV tests
undertaken at these seven sentinel sites more than tripled.
GUM clinics accounted for the majority of this increase with
a near quadrupling of tests while little overall change was
seen in the number of HIV tests undertaken at GPs. The
increased HIV testing at GUM clinics was observed among all
exposure groups except heterosexuals with high risk partners
and occurred over a period when new attendances at these
sites doubled. ro Our data confirm that much of the increase
was due to testing among low risk heterosexuals. This may
have been a direct response to sexual health promotion
messages throughout the 1990s although other factors such
as changing clinic policies regarding the offer of routine HIV
testing may also have contributed."
Trends in HIV positivity among first time testers varied
considerably by exposure category. The HIV positivity among
heterosexuals who have lived in Africa (11.4%) and among
MSM (6.8%) in our study were similar to those found
among testers attending a same day testing service at a large
inner London hospital in 2000-1" (11.2% and 6.2% respec-
tively), although the positivity found there among low risk
heterosexuals (1.8% in males and 1.4% in females) were
much higher than in our study. Our study suggests that
equivalent numbers of heterosexual men and women who
have lived in Africa were tested for HIV in England during
the past decade, consistent with other community based
studies in England. [j Despite this, our study documents a
significantly lower HIV positivity among males who have
lived in Africa compared with females and may help to
explain why men account for less than 40% of black Africans
reported to the national surveillance scheme of newly
diagnosed HIV patients since 1995.'
The data provide evidence of a continual decline in HIV
prevalence among MSM and !DU first testers at GUM clinics
between 1990 and 2000. This could not be accounted for by
changes in the age distribution of first testers and trends in
HIV prevalence were similar in alJ age groups. Decreasing
trends in HIV prevalence in the United Kingdom have been
reported among male homosexual and bisexual GUM clinic
attcnders tested for syphilis between 1993 and 2000 that
were not previously diagnosed with HIV in the unlinked
anonymous scroprevalcnce surveys.' Similar trends among
HIVtesting in England
GUM clinic attcndcrs have been found in Amsterdam (first
testers)" and America (all testers)," where declines in HIV
prevalence among MSM and mu contrast with stable
prevalence among heterosexuals and those with no identified
risk.
Our study has limitations. In this study we focused on
positivity as a proxy for prevalence, and therefore cannot
infer incidence or changes in incidence. It has previously
been suggested that a decrease in prevalence can mask stable
or increasing incidence," evident from studies in the
Netherlands." the United States," and England."
There was marked heterogeneity among the seven parti-
cipating laboratories in terms of case mix and prevalence.
This will be masked by their aggregation into London and
outside London regions. The heterogeneity is most evident in
the analysis of trends in the numbers HIV testing at GPs.
There is limited information from this study about
variations in HIV prevalence according to behavioural risk.
In particular, identification of repeat testers as a proxy for
high risk behaviour would have provided further classifica-
tion of exposure categories but was not available in this study
of first HIV tests.
Matching HIV tests using identical clinic number or
identical name and date of birth to identify the first test of
individuals cannot completely identify all repeat tests on all
individuals. This may have allowed HIV tests that were not
the first test of the individual to have been included in the
analysis. Also, the hierarchical classification of HIV exposure
categories is intended to assign patients the "exposure of
greatest risk" if multiple risk behaviours have been reported.
This will tend to oversimplify patients' exposures but similar
assumptions have been made in other HIV surveillance
systems."
Finally, the classification of exposure categories was
incomplete, as patient HIV exposure information was not
fully available from GUM clinics or GPs. Failure to complete
forms could have led to misclassification bias, as exposures
may be less likely to be reported in the absence of high risk
behaviours. This may have led to overestimation of pre-
valence in each exposure category and underestimation of the
number of heterosexuals tested. There was a low prevalence
among those with no identified risk (0.9% males, 0.4%
females), which suggests the majority were heterosexuals
with no other specified risk.
The results of our paper will nevertheless be of interest to
those involved in sexual health policy. The English National
Strategy for Sexual Health and HIV has prioritised the uptake
of HIV testing as a core HIV prevention intervention with two
main aims.' The first is to reduce the number of HIV infected
individuals who remain undiagnosed after attending a GUM
clinic. The second is to encourage HIV testing of people at a
wider range of sites including primary care and general
medical settings.' Ongoing surveillance of HIV testing as
outlined in this paper will provide a key mechanism for
monitoring progress on these goals. Alongside increased
offers of HIV testing, this analysis supports the need for
targeting groups at high risk of HIV infection with HIV
testing interventions, including MSM, mu, and adults who
have had heterosexual contact in Africa. Such focused
promotion of HIV testing will be more cost effective than
testing of individuals at lower risk, as fewer HIV tests are
needed to diagnose one HIV infection. However, it is
estimated that nearly twice as many HIV infected hetero-
sexuals were living with undiagnosed HIV as homosexual or
bisexual men at the end of 2001' and it is known that a large
proportion of heterosexuals were not diagnosed until late in
the course of infection between 1990 and 2000 in England."
The strategy for sexual health addresses these issues through
targeted campaigns to encourage the uptake of HIV testing in
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high risk groups and policies to increase the offer of HIV tests
at healthcare sites, which should also capture heterosexual
individuals with high risk behaviours. However, it should be
acknowledged that GUM clinics will need to be supported as
promotion of HIV testing further adds to their workload.
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A VIEW FROM THE SOUTH .
Conference presentations (it's all a matter of timing)
Juniars 19 presented of wham
2 ran aver ~me (11%)
9 presented of wham
.4 ran aver ~me (44%)
18 presented of wham
9 ran aver ~me (50%)
Test lor trend p-0.D11
Consultants
Senior
academics
Juniors v consuhants differenco 33%
(95% Cl 1 to 64)
difference 39%
(95% ClIO to 62)
difference 6%
(95% Cl -30 to +39)
Juniors v
senior academics
Con.ultant. v
senior academics
www.stijaurnal.cam
Many chairs at academic meetings remind the speakers to stick to time, and it is nowcommonplace to hear a warning alarm as the prcscntatlon should be nearing its end.Despite this some people run over time. Theoretically, this observation should be evenly
distributed among junior and senior speakers, although anecdotally this does not appear to be
the case. The objective of this study was to determine the proportion of speakers who overran
rheir allotted time, by grade of speaker.
All individuals giving an oral presentation at the Medical Society for the Study of Venereal
Disease (MSSVD) annual spring meeting (2001) were included.
Each speaker was placed into one of three groups:
(I) Juniors (junior doctors, nurses, health advisers, junior scientists)
(2) Consultants
(3) Academic consultants and senior scientists (professors, senior lecturers)
A record was made of each speaker's allotted time (according to the conference programme)
and the actual lime spent speaking (using a stopwatch). Time given to questions was not
included.
Remarks to the speakers about time keeping were noted.
The results are given in the tables
At the start of each session only juniors were reminded of the importance of sticking to time.
COMMENT
Irrespective of seniority all speakers at academic conferences should limit their presentations to
their allotted times. However, both consultants and senior a adcmics were statistically
significantly more likely to run over time in their presentations when compared with juniors.
There was no evidence of any difference between consultants and senior academics.
Ideally, conferences should promote through presentation and discussion the development of
ideas, the ongoing progression of research, and the practical application of such research in the
real world. Time is often limitcd by the amount of material being presented. It is onc of the
chair's responsibilities to keep oral presentations to timc. If talks arc allowed to overrun, time
for other valued academic pursuits,' discussion, and poster observations arc consequently
shortened.
Wiese et al.' through a structured instruction programme, improved both the quality and
efficiency of oral presentations among a group of medical undergraduates. II is probable that
the results in this study are a onscqucncc of similar preparations. Many a speaker will
remember as a junior writing and rewriting their talks; and rehearsing their presentation in
front of colleagues in an attempt to get it perfect for the conference.
It was also observed at this meeting that chairs reserved their warnings of time keeping and
threats of interruption to junior speakers-that is, the group least likely to run over time.
As a result of [his study should chairs now concentrate such words on the groups of speakers
most likely to run over time?
G Rooney
Sexual Hea)th Deportment, Great Western Hospitol, Swindon SN3 688, UK
Correspondence to: G Rooney; guyrooneY@Yahoo.cam
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Behavioural surveillance: the value of national
coordination
C A McGarrigle, K A Fenton, 0 N Gill, G Hughes, D Morgan, BEvans
Behavioural surveillance programmes have enabled the
description of population patterns of risk behaviours for
STI and HIV transmission and aid in the understanding
of how epidemics of STI are generated. They have been
instrumental in helping to refine public health
interventions and inform the targeting of sexual health
promotion and disease control strategies. The
formalisation and coordination of behavioural
surveillance in England and Wales could optimise our
ability to measure the impact of interventions and health
promotion strategies on behaviour. This will be
particularly useful for monitoring the progress towards
specific disease control targets set in the Department of
Health's new Sexual Health and HIV Strategy.
..........................................................................
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Sexually transmitted infections (STI) and HIVresult in considerable morbidity and mor-tality with substantial social and economic
cost.' They place considerable burden on health-
care resources required for their treatment and
prevention as well as long term management
required for their sequelae including ectopic
pregnancy, cervical cancer, and infertility. STIsare
important in their own right but may also be
markers for risk of HIY. Teenagers and young
adults, women, and some ethnic minority groups
are disproportionately affected." Sexual behav-
iour remains the key determinant of SII trans-
mission. Thus, the key indicators for understand-
ing and monitoring transmission rates need to be
appropriate for the population and risk group
under consideration.
There is evidence of deterioration in sexual
health in the United Kingdom. Surveillance data
indicate large recent increases in the numbers
and rates of bacterial and viral SIIs in the United
Kingdom. In 2001 there were 673 000 new
episodes seen at genitourinary medicine (GUM)
clinics in England.' New diagnoses of STI
between 1996 and 2001 rose by 86% for gonor-
rhoea, 501% for infectious syphilis, and by 106%
for genital chlamydia. The highest numbers of
HIV diagnoses were seen in 2001 and there is evi-
dence to suggest that HIV transmission is not
slowing.' There have also been outbreaks of
syphilis in homosexual men, many of whom have
HIV." These rises have been attributed to increas-
ing high risk sexual behaviour, including unpro-
tected sex and high rates of partner change
particularly in young heterosexuals" II and men
who have sex with men (MSM).'·" Data from
Sex Transm Infect 2002;78:398-405
the National Survey of Sexual Attitudes and Life-
style (Natsal) confirm this." Similar increases
have been seen in western"" and eastern
Europe'"'' and the United States.":" The resur-
gence of acute SII, the emergence of STI
outbreaks among MSM, and concomitant in-
creases in the risk of HIV transmission are cause
for concern.
HIV and STI surveillance data in the United
Kingdom are useful for monitoring trends in
diagnoses. However, they are relatively poor indi-
cators of infection incidence and burden in the
population as they are influenced by a number of
factors including frequency of symptomatic dis-
ease, test sensitivity and uptake, health seeking
behaviours, and referral patterns. These factors
also limit their usefulness for measuring the suc-
cess of prevention programmes. Several factors
unrelated to prevention programmes can contrib-
ute to observed stabilisation or decrease in STI
and HIV prevalence in a given setting. These can
include mortality, saturation effects in subpopula-
tions at higher risk, differential migration pat-
terns, or sampling bias.
Although disease surveillance data suggest
deterioration in sexual health in the United
Kingdom since the mid -1990s, they do not
provide information on the sexual behaviours or
mixing patterns that may be underlying this
trend. Public health surveillance of sexual behav-
iour is needed to measure risk behaviours that
will both allow the monitoring of the effective-
ness of prevention programmes and may provide
early warning signs for the spread of HIV and
STIs. This has been achieved in many other
countries including some in Asia.":" Africa,"
Europe," and the United States." Trends over time
are needed because while one-ofTstudies can pro-
vide useful baseline information trends are
necessary for interpretation. The outcome should
be timely, relevant, and have high quality data,
which can allow those in health promotion and
disease prevention to respond effectively to
observed changes."
WHAT IS BEHAVIOURAL SURVEILLANCE?
Behavioural surveillance is the ongoing system-
atic collection, analysis, and interpretation of
behavioural data relevant to understanding
trends in the sexual transmission of infection."
This should be followed by timely dissemination
of these data to those responsible for prevention
and control. Knowledge of the size of the popula-
tion groups at risk, and the nature and determi-
nants of risk within those populations are neces-
sary. Behavioural surveillance generally aims to
monitor trends in two broad groups of indicators;
Behavioural surveillance
firstly, those that allow the identification of population
subgroups at increased risk-for example, age, sex, sexual on-
entation, and ethnicity. Secondly, those behaviours that are
amenable to change-for example, number and type of sexual
partnerships, condom use, unprotected anal intercourse. The
validity and reliability of sensitive data on behaviour are criti-
cal as they are self reported and can't be directly measured."
The triangulation of a small set of core measures selected from
surveillance data and other complementary sources can
strengthen the interpretation of these data as the relation
between sexual behaviour and STI transmission is complex.
Any attempt to establish behavioural surveillance in
England and Wales should therefore seek to answer the
following questions: which behaviours are important deterrnl-
nants of current STI and HIV transmission? How are these
behaviours distributed and how can they be measured over
time? What key behavioural data are not currently being col-
lected? How best can these gaps be filled?
HOW MAY IT BE ACHIEVED?
General population surveys
Behavioural surveillance is generally conducted at two levels,
among the general population and within targeted risk
groups. General population surveys are useful in assessing
overall trends and distribution of behaviours that may be
associated with STI transmission. These provide the most
robust estimates of prevalence of behaviours, as they largely
avoid the biases inherent in most targeted population surveys.
Although regular repeated surveys are needed to measure
changes in behaviours over time their expense may make this
difficult. Adding additional questions to existing population
social surveys is a method that has been successfully deployed
in other countries" as a cost effective way of getting
population based estimates. This has been suggested for
collecting sexual behaviour data in the United Kingdom." A
large number of surveys are currently carried out which could
be used in this way." " This kind of survey makes it possible to
access a general population sample, but does limit the number
of questions that can be asked.
General population surveys are usually less suitable for
obtaining detailed information on population subgroups at
highest risk. These groups tend to be small, more clustered,
and difficult to access and small subgroups of individuals with
relatively rare risk behaviours may not be captured in
sufficient numbers. Groups of particular interest for HIV and
STI transmission include homosexual and bisexual men,
injecting drug users, commercial sex workers, and ethnic
minorities, particularly those from or who have contact with
countries with a high HIV/STIprevalence. These problems can
be overcome through adapting study designs to include over-
sampling and focused enumeration."
Targeted population surveys
Targeted population surveys are also a useful adjunct to these
general population surveys as they give greater detail on
populations at highest risk. However, the difficulty in
accessing these populations makes probability sampling
costly. More cost effective sampling strategies are needed;
these can include advertising, snowballing, recruiting from
GUM clinics, and social and commercial venues. However,
these strategies may result in a sample selection bias and
decreased representativeness of results. Targeted behavioural
surveillance can include serial cross sectional surveys, using
the same sampling strategy and using core questions to ascer-
tain the prevalence of risk behaviours.
The disadvantage of targeted population surveys is that
they are likely to be unrepresentative, given the nature of the
convenience sampling. Those accessed through this mixture of
social venues can only be representative of those using these
sites. In addition, even among venue attenders the behaviour
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of study respondents may systematically differ from non-
respondents. In order to overcome this problem, surveys from
a range of settings are needed, in order to achieve a more rep-
resentative sample. New and innovative ways of accessing
these populations are needed-for example, accessing MSM
through internet chatrooms." " Cross comparability of sur-
veys done in different populations accessed through different
means will allow an overview picture of the distribution of
behavioural risk within the population under investigation.
Questions that will allow the linking of the populations will
enhance the interpretation of the individual surveys."
Behaviouralsurvemanee in England and Wales:
assessing the existing eapacity
Disease surveillance
Current surveillance systems collect limited data on the
behavioural determinants of STI transmission. Where they
exist they are often limited to facilitate ease of completion by
busy clinical staff. Most systems rely on methods more
focused on disease outcome, practicality, uniformity, and
rapidity rather than on obtaining full demographic and
behavioural details. Generally, the additional data collected are
minimal (typically age, sex, sexual orientation) (table I).
These allow the grouping of diseases by risk factors, although
clearly these are not behaviours amenable to change. Some
enhanced surveillance systems have been developed that
include more detailed behavioural data to allow the charac-
terisation of those with diagnosed Infectlons"" (table I) For
example, the enhanced KC60surveillance system will not only
allow more risk factor information to be collected on an indio
vidual basis, but will also allow rates of co-infection and
re-infection of STl to be examined and core groups to be more
accurately described.' 1M
There is comprehensive national surveillance of AIDS cases
and diagnosed HIVinfections .'~, This surveillance system has
recently been enhanced, and now clinicians are also asked to
report all newly diagnosed HIV infections. The new clinician
HIV and AIDS report form collects more behavioural data at
the time of first HIVdiagnosis (table I) and provides the most
comprehensive picture of all surveillance systems.
The unlinked anonymous HIV seroprevalence surveys
provide sentinel HIV prevalence data and have been ongoing
since 1990." Limited demographic and behavioural data are
collected with the unlinked residual specimens following
clinical tests. The surveys cover both those at higher risk of
infection, such as homosexual men and heterosexuals attend-
ing GUM clinics and injecting drug users attending services,
and a more general population sample through monitoring
HIVprevalence in over 60%of all pregnant women. The survey
of injecting drug users differs in that a voluntary saliva sam-
pie is provided with a self completed questionnaire detailing
demographic, sexual, and drug injecting behaviour. This
survey represents some of the most detailed sexual behaviour
data collected within the existing surveillance systems."
Data from the National Blood Service (NBS) provide preva-
lence information in a lower risk population group, as the cri-
teria for donation excludes those at increased risk of blood
borne infections, including men who have had sex with men,
those who have ever injected drugs, and those who have had
heterosexual contact with high risk partners" (table I). Labo-
ratory reports for confirmed acute hepatitis B are also
routinely collected nationally." ...
BEHAVIOURAL SURVEYS
Thble 2 illustrates existing ongoing behavioural surveys
carried out by different academic and research groups in Brit-
ain. 'lwo general population surveys of adults are currently
carried out. The first, Natsal, a probability sample study has
been carried out twice a decade apart," ., remains the largest
probability sample study of its kind in Britain. The 2000 survey
www.sextransinf.com
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also collected and tested urine samples for genital Chlamydia
trachoma/is using ligase chain reaction (LCR) techniques to
provide the first national prevalence estimates." The second,
the Omnibus survey is a multipurpose survey of the adult
population routinely carried out by the Office for National
Statistics. A module on contraceptive use and general sexual
health including condom use has been included annually
since 1997" (table 2).
A national survey of young people is currently being carried
out by the Teenage Pregnancy Unit, as part of an evaluation of
the teenage pregnancy strategy (table 2). An individual based
tracking survey will be repeated three times a year to collect
information from young people aged 13-21 and parents of
young people aged 10-17 over a 3 year period. It will collect
information on knowledge, attitudes, and behaviours around
sex and relationships."
A number of annual surveys of homosexual men attending
social venues.":" GUM clinics," and Gay Pride events" are
currently carried out (table 2). These use a stable set of behav-
ioural indicators that can be monitored repeatedly. The three
surveys developed and used a common set of core behaviour
questions that allow comparisons of the three populations of
MSM. A number of other surveys of injecting drug users""
and among ethnic minorities' • 51 " have also been carried out
but none have been sustained. There is clearly a need for more
ongoing investment and support to continue projects once
established.
HOW DO WE USE BEHAVIOURAL DATA?
Behavioural surveillance data can be used in a number of
ways. They can alJow the monitoring of the risk behaviours
underlying HIV and STI transmission over time. UNAlDS has
recommended that behavioural data collection should be a
central part of HIV and STI surveillance programmes." "
A range of indicators can be used to measure the effective-
ness of both HIV and STl prevention interventions in England
and Wales. These include the behavioural determinants of dis-
ease transmission (for example, condom use, reported sexual
partnerships) as well as disease incidence and prevalence in
England and Wales. These "prevention indicators" have been
developed to monitor four key areas relevant to HIV transmis-
sion and disease prevention and include HIV prevalence, HTV
incidence, risk behaviour, and healthcare utilisation." The
indicators for monitoring the success (or failure) of HIV pre-
vention in men who have sex with men are illustrated in table
3. Similar indicators have been used elsewhere," " .J although
the use of behaviour change as a proxy marker for STI
incidence has raised debate." "' The disproportionate effect of
some factors on the transmission dynamics of STI means that
reported risk behaviour doesn't entirely correlate with
transmission. The role of sexual networks in transmission is
important and behavioural surveillance cannot always meas-
ure these. Prevention indicators have been evaluated in a
number of settings, however, and found to be useful for meas-
uring the success of prevention programmes, although multi-
ple sources of data are necessary to provide context." This in
turn facilitates more effective HIV prevention and community
planning. Prevention indicators may be developed using a
variety of available data within ongoing surveillance systems.
This allows the interpretation of HIV and STI trends within
different population groups, and through the monitoring of
risk behaviours, can indicate when outbreaks of infection may
occur."
A potential research priority highlighted in the new
national strategy for sexual health and HIV was a need for
better understanding of the sexual networks, health seeking
behaviour, and risk behaviour of targeted groups." The moni-
toring of behavioural indicators within different population
groups would provide data on both health seeking behaviours
www.sextransinf.com
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Area Subcategory
Table 3 Prevention indicators for HIV and hepatitis transmission in homo/bisexual men
Prevalence markers
New diagnoses of HIV infections UK
Prevalent diagnosed HIV infections receiving care
First HIV tesls 01 six senlinellaboralories
England
England
Prevalence of previously undiagnosed HIV infeclion in GUM
clinic anenderst
london
Elsewhere in England and Wales <25
Incidence markers
Median age 01 diagnosis of HIV infeclion
Median CD4 counts 01 year of HIV infeclion diagnosist
<25
>25
Tolal
All
Tolal
Proportion positive
<25
labaralory reports of acule hepalilis B acquired through sex
between men
UK
England and Wales
All
<25
>25
AllEngland and Wales
Markers of rilk
Homosexually acquired gonorrhoea
Acule STI in HIV pasilive GUM clinic ottanders
All
Known positive
England and Wales
England and Woles
Percenloge reparting unprotected anal inlercourse in Ihe pasl
year
london
Markers of heolthcare utilisation
AHending GUM clinic in Ihe pasl year london
Having an HIV lesl in Ihe past year london
England and WalesHIV lests carried oul 01 GUM clinics§
tUndiognosed before the clinic cnendonce.
tMean CD4 counl.
§HIV lesting wilh counselling: new episodes seen algenilourinary medicine clinics.
and risk behaviours. Behavioural surveillance could also
measure progress towards increased HIV testing of GUM
clinic attendees through monitoring HIV testing patterns in
different population groups.
Finally, behavioural surveillance data will enable us to
identify priority areas for further in-depth epidemiological or
socioanthropological research. Much of this research should
be developed in collaboration with local academic and service
partners in the most vulnerable areas or population groups.
WHAT ARE OUR OPTIONS?
Behavioural surveillance programmes have now been imple-
mented in the United States," '" Switzerland," Australia, and
Hong Kong." The United States has formed a HIY/STD
Behavioural Surveillance Working Group to build and
maintain a behavioural surveillance system for HIV and STI.
They have achieved this through developing standardised
measures of risk behaviours for comparability of data across
systems and used these in monitoring a combination of gen-
eral population, at-risk populations, and infected populations.
Modules of questions have been provided at the national level
for states to use as appropriate." In addition, HIY prevention
indicators have been developed, which have set out specific
indicators suitable for monitoring at state and local level. Col-
lection of data for these is coordinated at local level.
Canada has similarly combined national behaviour tele-
phone surveys with more targeted behavioural surveys in
homosexual men and injecting drug users (IOU) although
they have not established nationally standardised modules of
questions. Australia has used a combination of targeted
behavioural surveys in MSM and mu, from which key indica-
tors are coordinated nationally with HIY surveillance and
incidence data. They are currently moving towards national
coordination of STl surveillance," and the development of a
Propartion wilh STI
Number wilh STI
Tolal
Any partners
Partners of unknown or
serodiscordanl HIV slalus
Proportion
Number
Proportion
Number
Number
coordinated national approach to collection of behavioural
risk factor data. The first national survey of sexual health and
sexual behaviour and attitudes administered through tele-
phone interview is currently being carried out. Hong Kong has
established a behavioural surveillance system, carrying out an
annual general population survey of sexual behaviour in men
aged 18-60 using a combination of personal Interview and a
prerecorded telephone interview using a mobile phone."
A combination of approaches could be used in England and
Wales. A behavioural surveillance unit (BSU) within the HlV
and STI Division has now been established at the Communi-
cable Disease Surveillance Centre (CDSC). In association with
key external partners the unit aims to collate data derived
from ongoing local and national sexual behavioural surveil-
lance and research programmes within CDSC and outside.
The BSU will streamline current behavioural data collection
through existing surveillance systems. Collaborative partner-
ships with academic and research institutions involved in
behavioural research will be established to define and collate
key behavioural indicators relevant to H1V and other STI
transmission. These indicators will include sexual behaviours
such as number of sexual partners, types of sexual intercourse
(vaginal, anal, and oral), and potentially preventative behav-
iours such as condom use and health service use for HIV and
other STI screening. This would give an overview of
behaviours at the population level in both the general popula-
tion and in those with disease. A surveillance system, which
will allow the prospective monitoring of the important risk
indicators, could then be established.
A set of core questions wilJ be established, which will draw
on existing validated questions used in a variety of studies.
This will enable improved comparability of data from diverse
sources, at both national and local level. It will provide a com-
prehensive picture of sexual health, which can be monitored
over time.
www.sextronsinf.com
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Key points
• Surveillance data show large recent rises in STls in the UK
but lack details on the sexual behaviours and mixing
patterns underlying these trends
• Behavioural surveillance has successfully monitored the
effectiveness of prevention programmes internationally
• Key indicators will be produced from the wealth of existing
disease and behavioural survey data available
• The impact of interventions and health promotion strategies
on behaviour in England and Wales can be measured
using these indicators
As a secondary, longer term objective, the BSU will work
towards developing new behavioural surveillance systems for
monitoring groups where there are currently inadequate data.
Specially designed studies will be developed to complete the
knowledge gaps-for example, in primary care and in ethnic
minorities, where data cannot be obtained through enhancing
existing systems. Again this is likely to be best achieved in
partnership with external collaborators.
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